Quarterlytics / Technology / Hardware, Equipment & Parts / Energous

Energous

watt · NASDAQ Technology
Claim this profile
Ticker watt
Exchange NASDAQ
Sector Technology
Industry Hardware, Equipment & Parts
Employees 51-200
← All annual reports
FY2016 Annual Report · Energous
Sign in to download
Loading PDF…
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-K

(Mark One)

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Fiscal Year Ended  December 31, 2016

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________________ to __________________

Commission file number: 001-36379

ENERGOUS CORPORATION
(Exact Name of Registrant as Specified in Its Charter)

Delaware
(State or Other Jurisdiction of Incorporation or Organization)

46-1318953
(I.R.S. Employer Identification No.)

3590 North First Street, Suite 210, San Jose, CA
(Address of Principal Executive Offices)

95134
(Zip Code)

(408) 963-0200
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Securities registered pursuant to Section 12 (g) of the Act:  Common Stock, par value $0.001 per share

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes ¨  No x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

Yes ¨ No x

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and
(2) has been subject to such filing requirements for the past 90 days. Yes x  No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every

Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for
such shorter period that the registrant was required to submit and post such files). Yes x  No ¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will

not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of
this Form 10-K or any amendment to this Form 10-K. ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller

reporting company. See definitions of "large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the
Exchange Act. (Check one):

Large accelerated filer ¨

Accelerated filer x

Non-accelerated filer ¨ (Do not check if a smaller reporting company)

Smaller reporting company ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act):  Yes  ¨  No x

The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price

at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the
registrant’s most recently completed second fiscal quarter was $216,604,925. Solely for the purposes of this calculation, shares held by
directors, executive officers and 10% owners of the registrant have been excluded. Such exclusion should not be deemed a determination or
an admission by the registrant that such individuals are, in fact, affiliates of the registrant.

As of March 6, 2017, there were 20,525,942 shares of the registrant’s common stock outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The registrant intends to file a definitive proxy statement pursuant to Regulation 14A within 120 days after the end of the fiscal year ended
December 31, 2016. Portions of such proxy statement are incorporated by reference into Part III of this Form 10 - K.

 
 
ENERGOUS CORPORATION
TABLE OF CONTENTS

PART I

Item 1.  Business
Item 1A.  Risk Factors
Item 1B.  Unresolved Staff Comments
Item 2.  Properties
Item 3.  Legal Proceedings
Item 4.  Mine Safety Disclosures

PART II

Item 5.  Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Item 6.  Selected Financial Data
Item 7.  Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 7A.  Quantitative and Qualitative Disclosures About Market Risk
Item 8.  Financial Statements and Supplementary Data
Item 9.  Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
Item 9A.  Controls and Procedures
Item 9B.  Other Information.

PART III

Item 10.  Directors, Executive Officers and Corporate Governance.
Item 11. Executive Compensation
Item 12.  Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters.
Item 13.  Certain Relationships and Related Transactions, and Director Independence
Item 14.  Principal Accountant Fees and Services

PART IV

Item 15.  Exhibits, Financial Statements and Schedules

1
2
10
22
22
22
22
23
23
24
24
30
31
32
32
32
33
33
33
33
33
33
34
34

 
 
 
 
 
As used in this Form 10-K, unless the context otherwise requires the terms “we,” “us,” “our,” and “Energous” refer to Energous
Corporation, a Delaware corporation.

PART I

1

 
 
 
 
 
 
FORWARD LOOKING STATEMENTS

This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933,
as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the “safe harbor”
created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and
expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “will,” “should,” “could,”
“seek,” “intend,” “plan,” “estimate,” “anticipate” or other comparable terms. All statements other than statements of historical facts
included in this Annual Report on Form 10-K regarding our strategies, prospects, financial condition, operations, costs, plans and objectives
are forward-looking statements. Examples of forward-looking statements include, among others, statements we make regarding proposed
services, market opportunities and acceptance, expectations for revenues, cash flows and financial performance, intentions for the future
and the anticipated results of our development efforts. These forward-looking statements are based only on our current beliefs, expectations
and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy
and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and
changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial
condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these
forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those
indicated in the forward-looking statements include, among others, the following: our ability to develop a commercially feasible
technology; receipt of necessary regulatory approval; our ability to find and maintain development partners, market acceptance of our
technology, the amount and nature of competition in our industry; our ability to protect our intellectual property; and the other risks and
uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations
sections of this Annual Report on Form 10-K and our subsequently filed Quarterly Reports on Form 10-Q. We undertake no obligation to
publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new
information, future developments or otherwise.

Item 1. Business

Overview

We have developed a technology called WattUp® that consists of proprietary semiconductor chipsets, software, hardware designs and
antennas that enables RF-based charging for electronic devices, providing wire-free charging solutions for contact-based charging as well
as at a distance charging, ultimately enabling charging with mobility under full software control. Pursuant to our Strategic Alliance
Agreement with Dialog Semiconductor plc (Dialog), Dialog will manufacture and distribute integrated circuit (“IC”) products
incorporating our RF-based wire-free charging technology. Dialog will be our exclusive supplier of these ICs for the general market. We
believe our proprietary technology can be utilized in a variety of devices, including wearables, hearing aids, earbuds, Bluetooth headsets,
Internet of Things (“IoT”) devices, smartphones, tablets, e-book readers, keyboards, mice, remote controls, rechargeable lights, cylindrical
batteries, medical devices and any other device with similar charging requirements that would otherwise need a battery or a connection to a
power outlet.

We believe our technology is novel in its approach, in that we are developing a solution that charges electronic devices by surrounding
them with a focused, three-dimensional (“3D”) radio frequency (“RF”) energy pocket (“RF energy pocket”). We are engineering solutions
that we expect to enable the wire-free transmission of energy for contact-based applications as well as far field applications of up to 15 feet
in radius or in a circular charging envelope of up to 30 feet. We are also developing our Far Field transmitter technology to seamlessly mesh
(much like a network of WiFi routers) to form a wire-free charging network that will allow users to charge their devices as they walk from
room-to-room or throughout a large space. To date, we have developed multiple transmitter prototypes in various form factors and power
capabilities. We have also developed multiple receiver prototypes, including smartphone battery cases, toys, fitness trackers, Bluetooth
headsets and tracking devices, as well as stand-alone receivers.

When the company was first founded, we recognized the need to build and design an enterprise-class network management and control
system (“NMS”) that was integral to the architecture and development of our wire-free charging technology. Our NMS system can be
scaled up to control an enterprise consisting of thousands of devices or scaled down to work in a home or IoT environment.

The power, distance and mobility capabilities of the WattUp technology were validated by an internationally recognized independent
testing lab in October 2015, and the results are published on our website.

2

 
 
 
 
 
 
  
 
 
 
 
 
Our technology solution consists principally of transmitter and receiver ICs and novel antenna designs driven through innovative
algorithms and software applications. We submitted our first IC design for wafer fabrication in November 2013 and have since been
developing multiple generations of transmitter and receiver ICs, multiple antenna designs, as well as algorithms and software designs that
we believe, in the aggregate, will optimize our technology by reducing size and cost, while increasing performance to a level that will
enable our technology to be integrated into a broad spectrum of devices. We have developed a “building block” approach which allows us
to scale our product implementations by combining multiple transmitter building blocks and/or multiple receiver building blocks to provide
the power, distance, size and cost performance necessary to meet application requirements. While the technology is very scalable, in order
to provide the necessary strategic focus to grow the company effectively, we have defined our market as devices that require 10 watts or
less of power to charge. We will continue to invest in IC development as well as in the other components of the WattUp system to improve
product performance, efficiency, cost-performance and miniaturization as required to grow the business and expand the ecosystem, while
also distancing us from any potential competition.

We believe that if our development, regulatory and commercialization efforts are successful, our transmitter and receiver technology will
support a broad spectrum of charging solutions ranging from contact-based charging or charging at distances of a few millimeters (“near
field”) to charging at distances of up to 15 feet (“far field”).

In February 2015, we signed a Development and License Agreement with one of the top consumer electronic companies in the world based
on total worldwide revenues. The agreement is milestone-based and while there are no guarantees that the WattUp® technology will ever
be integrated into our strategic partner’s consumer devices, we continue to progress the relationship as evidenced by the achievement of
our revenues in 2016 from engineering services resulting from the achievement of certain milestones under the agreement. We anticipate
continued progress with the relationship which we expect will result in additional engineering services revenue and ultimately, if they
choose to incorporate our technology into one or more products, significant revenues based on the WattUp® technology being integrated
into products being shipped to consumers.

In February 2016, we began delivering evaluation kits to potential licensees to allow their respective engineering and product management
departments to test and evaluate our technology. We expect that the testing and evaluations currently taking place will lead to products
beginning to be shipped to consumers in the second half of 2017.

In November 2016, we entered into a Strategic Alliance Agreement with Dialog, pursuant to which Dialog will manufacture and distribute
IC products incorporating our wire-free charging technology. Dialog will be our exclusive supplier of these products for the general market.
Our WattUp technology will use Dialog's SmartBond® Bluetooth low energy solution as the out-of-band communications channel between
the wireless transmitter and receiver. In most cases Dialog's power management technology will then be used to distribute power from the
WattUp receiver IC to the rest of the device while Dialog's AC/DC Rapid Charge™ power conversion technology delivers power to the
wireless transmitter.

We have implemented an aggressive intellectual property strategy and are continuing to pursue patent protection for new innovations. As of
March 15, 2017, we had in excess of 250 pending patent and provisional patent applications. Additionally, the U.S. Patent and Trademark
Office (or the PTO) has issued 22 patents and notified us of the allowance of 10 additional patents. In addition to the inventions covered by
these patents and patent applications, we have identified a significant number of additional specific inventions we believe are novel and
patentable. We intend to file for patent protection for the most valuable of these, as well as for other new inventions that we expect to
develop. Our strategy is to continually monitor the costs and benefits of each patent application and pursue those that will best protect our
business and expand the core value of the Company.

We have recruited and hired a seasoned management team with both private and public company experience and relevant industry
experience to develop and execute our operating plan. In addition, we have identified and hired key engineering resources in the areas of IC
development, antenna development, hardware, software and firmware engineering as well as integration and testing which will allow us to
continue to expand our technology and intellectual property as well as meet the support requirements of our licensees.

Our common stock is quoted on the NASDAQ Stock Market under the symbol “WATT”. As of March 15, 2017, we had 73 full-time
employees, 57 of which were engineers. We were incorporated in Delaware in October 2012. Our corporate headquarters is located at 3590
North First Street, Suite 210, San Jose, CA 95134. Our website can be accessed at www.energous.com. The information contained on, or
that may be obtained from our website, is not, and shall not be deemed to be, part of this Annual Report on Form 10-K.

Our Technology

The wire-free charging solution we are developing employs transmitter technology that creates a targeted 3D RF energy pocket around a
receiving device (which may be mobile or fixed).

3

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 below shows a basic diagram of our solution. Today this solution is able to send RF energy from the transmitter (also referred to as
a Power Router) to single as well as multiple devices.

Figure 1: Our Wire-free Charging Solution Diagram

First, our proprietary power router, or transmitter, locates the receiver(s) in 3-dimensional space via technology we have developed using
standard Bluetooth® communications. Next, the transmitter, through software control, generates a controlled and focused RF-waveform to
create an RF energy pocket around the receiver(s). Receiver(s) equipped with our antennas and ICs, and controlled by our software, are
able to harvest power from this focused RF energy pocket. We believe that these receivers will be incorporated into various devices such as
smartphones, wearables, fitness trackers, keyboards and mice, cameras, tablets, toys, IoT devices, sensors, remote controls, medical devices
and other small electronics which contain embedded batteries.

Our transmitter uses proprietary software algorithms to dynamically direct, focus and control our RF waveform in three dimensions as it
transmits energy to a moving object (such as a user holding their mobile device as they walk around a room).

Our initial demonstration system was able to transmit energy to multiple devices within a range of 15 feet in radius or in a circular charging
envelope of 30 feet. We believe our current generation ICs and those in development will also allow us to significantly reduce the size and
cost of both our transmitters and our receivers as well as provide increased delivered power and efficiency and faster synchronization
speeds.

In January 2016, we announced a new Miniature WattUp Near Field Transmitter as well as a small form factor receiver, both of which were
developed as a direct result of our efforts to reduce cost and size. The Miniature WattUp Near Field Transmitter offers contact-based
charging. Contact-based charging, for which we have received FCC approval, allows for low power charging up to 5mm distances. Due to
its low cost and small size, the miniature transmitter is anticipated to be bundled in-box with WattUp receiver enabled devices, replacing
alternative charging solutions like power adapters and charging cables. The ability to bundle and provide a low cost, portable charging
solution for receiver devices, provides portability to the WattUp solution, and is anticipated to accelerate the ecosystem build out.

4

 
 
 
 
 
 
 
 
 
 
 
 
Our Competition

There are numerous existing and commercially available methods to provide charging for battery-powered devices, including wall plug-in
charging, inductive charging, magnetic resonance charging, charging stations and more. To our knowledge, almost all consumer electronic
devices equipped with a rechargeable battery come bundled with a method to charge the device (for example, a power cord). Studies
indicate that the consumer has grown tired and frustrated with tethered charging solutions and that the market is poised and will be
receptive to untethered wire-free power solutions like our WattUp technology. We believe that the positive market response and interest in
the WattUp technology we have seen suggests that consumer electronic companies that develop products incorporating our technology will
generate incremental sales and realize highly differentiated competitive advantages.

We believe our WattUp technology has a number of advantages compared to traditional charging technologies in terms of size, cost,
mobility and portability. Further, our technology allows us to target a device and track that device if it moves or is moving, and transmit
focused energy to the targeted device to charge the device without having to remove the battery or plug in the device.

There are a variety of other wireless charging technologies on the market or under development today. These competitive technologies fall
into the following categories:

Magnetic Induction. Magnetic induction uses a magnetic coil to create resonance, which can transmit energy over very short distances.
Power is delivered as a function of coil size (the larger the coil, the more power), and coils must be directly paired (one receiver coil to one
transmitter coil = directly coupled pair) within a typical distance of less than one inch. Products utilizing magnetic induction have been
available for 10+ years in products such as rechargeable electronic toothbrushes.

Magnetic Resonance. Magnetic resonance is similar to magnetic induction, as it uses magnetic coils to transmit energy. This technology
uses coils that range in size depending on the power levels being transmitted. It has the ability to transmit power at distances up to ~11
inches (30cm) which can be increased with the use of resonance repeaters.

Conductive. Conductive charging uses conductive power transfer to eliminate wires between the charger (often a charging mat) and the
charging device. It requires the use of a charging board as the power transmitter to deliver the power, and a charging device, with a built-in
receiver, to receive the power. This technology requires direct metal contact between the charging board and the receiver. Once the
charging board recognizes the receiver, the charging begins.

RF Harvesting. Harvesting RF energy is at the core of our WattUp technology. RF harvesting typically utilizes directional antennas to
target and deliver energy. To our knowledge, there are two other companies attempting to utilize a directional pocket of energy similar to
that being developed by us.

Laser. Laser charging technology uses very short wavelengths of light to create a collimated beam that maintains its size over distance,
using what is described as distributed resonance to deliver power to an optical receiver.

Ultrasound. Ultrasound charging technology converts electric energy into acoustic energy in the form of ultrasound waves. It then
reconverts those waves through an “energy-harvesting” receiver.

Our Business Strategy

Pursuant to our Strategic Alliance Agreement with Dialog, Dialog will manufacture and distribute IC products incorporating our wire-free
charging technology. Dialog will be our exclusive supplier of these products for the general market. We believe there are several verticals
with large volumes of potential annual sales  that would benefit from our technology, and as a result, may purchase our proprietary
components through the Strategic Alliance Agreement. Our intent is not to design and manufacture consumer electronic products, but rather
to support the development and proliferation of our WattUp® technology to form a ubiquitous wire-free charging ecosystem.

We believe that our greatest market opportunity lies in creating a ubiquitous ecosystem for wire-free charging at a distance, in much the
same way as the Wi-Fi ecosystem has developed. The goal is to ensure interoperability between transmitters and receivers that are based on
our technology, regardless of who made them, installed them into finished goods, or marketed them. The implementation of previous
ubiquitous solutions such as Wi-Fi and Bluetooth helps to illustrate our goal. For example, Wi-Fi routers, regardless of their designer or
manufacturer, work with Wi-Fi receivers installed in various consumer electronic devices, regardless of the manufacturer. As a result, we
are following the same rollout strategy as Wi-Fi in that we :

•
•
•
•
•
•

•

Carefully select initial target markets;
Build multiple silicon-based chips to advance the technology;
Partner with leading product companies;
Develop reference designs to reduce early adopter risks and foster adoption;
Provide game-changing benefits to the consumer in terms of utility and convenience;
Design initial iterations of the technology to be small but scalable implementations that are compatible on both a local and enterprise
scale;
Invest in ease of use;

5

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
•
•

•

Develop a strategy to build out the ecosystem starting with the consumer and expanding to enterprise, industrial and military;
Implement a plan to initially sell ICs migrating to a combination of selling ICs and integrating our device libraries into third-party
silicon such as Bluetooth Low Energy and Power Management Chips; and
Support a consortium like the AirFuel™ Alliance (AFA) that is expected to lead to a qualification
process to ensure compatibility of our WattUp technology across vendors and develop a common user
experience at the application level.

In order for our technology to become a ubiquitous solution for charging at a distance, we intend to pursue an ecosystem strategy for our
technology, engaging not only potential licensees for our transmitter and receiver technologies, but also their upstream and downstream
value chain partners. We also intend to prioritize protecting our intellectual property portfolio, as we believe this strategy will make it less
likely that a competing platform will be able to gain a solid foothold in the RF-based wireless charging-at-a-distance market and compete
with our technology in a meaningful way.

We believe our strategic relationship with Dialog will enable us to reap the benefits of our technology much faster and with greater
penetration than by manufacturing and distributing products ourselves. We believe this strategic relationship allows us to concentrate our
efforts and resources on engineering, development and commercialization projects to accelerate the introduction and adoption of the
WattUp solution.

In order to engage with potential licensees of the WattUp technology we have developed evaluation kits consisting of a transmitter and a
receiver along with the enabling software to allow potential strategic partners to test the technology in their labs. The kits form a base
“building block” component that is scalable to meet the needs of specific applications. We are developing processes and the support
capabilities to assist potential customers as they evaluate the technology and develop specific designs to incorporate it.

In selecting our initial customers, our goal is to identify those customers who have an internal product cycle that will support rapid
deployment with the end goal to release WattUp devices to the consumer as quickly as possible thereby securing a first to market advantage
and accelerating the path to revenue and profitability.

Since we are developing a new paradigm as to how consumers will charge their electronic devices, the operational details of our strategy
continue to evolve as our technology matures and our engagements with strategic partners solidify. As a result, we expect to make
operational course corrections as we steer the company towards our goal of a ubiquitous wire-free charging solution.

Our Target Markets

We believe that our technology will be compelling to many vertical markets, each of which may have several potential customers. To focus
our activities and see WattUp-enabled products in the hands of consumers as quickly as possible, we will likely select certain initial target
markets and customers because of their time-to-market capabilities and their market potential. As we continue to develop our technology,
we intend to add additional markets and partners to expand our market presence.

We identify our initial target markets within these two hardware categories:

Transmitter Target Markets

We believe our transmitter technology will be developed and released to the consumer in three basic categories:

•
•

•

Stand-alone transmitters that are either sold independently or bundled as part of a pairing with a WattUp-enabled receiver device;
Transmitters that are integrated into third party devices like televisions, computer monitor bezels, sound bars, refrigerator doors,
etc.; and
Transmitters that are integrated with Wi-Fi routers to form a single device that provides both connectivity and wire-free power.

Stand-Alone Transmitters:

Our current plans call for stand-alone transmitters to be released in three separate and distinct categories:

Near Field WattUp Transmitters:

Because of the distinct advantages compared to other existing forms of contact-based wireless charging including ease of manufacturing
and relative ease of regulatory approval, we expect that products using our Near Field transmitter technology will be the first WattUp
enabled products on the market. Our Near Field transmitters are ideally suited for wearables, IoT devices and other small electronics which
require a small form factor receiver and a low-cost charging solution. These small, inexpensive transmitters will likely be USB-powered,
and will have a range of up to five millimeters. These solutions will initially be one-to-one (one transmitter to one receiver) with follow-on
versions being one transmitter to multiple receivers.

6

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mid Field WattUp Transmitters:

We expect that our Mid Field WattUp transmitters will be geared to the desktop and automotive markets and will likely have a range of a
few centimeters to one meter from the transmitter. We also intend for the Mid Field transmitters to have tracking ability to support mobile
applications and multiple receiving devices. Likely implementations of midsized WattUp transmitters will include small desktop and
nightstand transmitters designed to send low power at distances for accessories and wearables. The same technology may also likely be
integrated into third party devices like computer monitor bezels, nightstand consumer electronics, accessories such as low voltage portable
battery chargers and integrated automotive applications.

Far Field WattUp Transmitters:

Far Field WattUp transmitters are full featured transmitters with the power to charge multiple devices at distances of up to 15 feet or
anywhere within a 30-foot diameter circle. We also expect that Far Field WattUp transmitters will have the ability to “pair” with other Far
Field WattUp transmitters allowing the user to create a large charging envelope encompassing many different rooms or large spaces while
seamlessly providing charging to mobile devices that are moving through the coverage space. Far Field WattUp transmitters may also play
a significant role in the powering of IoT devices that are fixed such as security cameras and sensors. These may also be charged from a
WattUp-enabled wifi router, which adds RF-based charging-at-a-distance functionality.

7

 
 
 
 
 
 
 
 
Transmitters Integrated into Third Party Devices:

The “building block” core architecture developed for the WattUp technology is ideally suited to a broad spectrum of third party devices
like televisions and refrigerator doors. The flexibility of the architecture in terms of size, power, distance, and cost affords Energous
licensees the opportunity to match our technology with specific requirements and limitations typically found with complex integrations. For
example, the WattUp technology could be integrated into the door of a small refrigerator typically found in college dorm rooms providing
charging capabilities to mobile devices anywhere in the room. Further, the “pairing” capabilities of the transmitter technology could enable
licensees to develop venue-specific consumer electronics products like integrated televisions that are paired with integrated picture frames
to provide mobile charging across a large room such as an airport lounge.

Wi-Fi Routers

We see the combination of the wire-free power router and the Wi-Fi router as a natural integration point and a synergistic application of
both technologies. The WattUp wire-free power router shares a number of technical characteristics with Wi-Fi routers in that both devices
operate in the airwaves in the unlicensed industrial, scientific and medical (“ISM”) bands, both devices owe their success to the utility and
convenience they bring to the consumer, both devices rely on antenna structures to send power and data, and both devices “pair” or provide
hand off capabilities which allow for large “enabled” sites similar to a mesh network. We also believe that our 3D pocket-forming
technology may enhance the data signal of a Wi-Fi router, which we believe will provide an even stronger value proposition to wireless
data router manufacturers. Finally, we plan to collaborate with our tier-one consumer electronics company partner to engage with third
party Wi-Fi transmitter companies. Our belief is that through this joint approach we will be able to enhance the marketing and
manufacturing of transmitters which in turn would help drive the demand for receiving devices and accelerate the build out of the WattUp
ecosystem.

The Wi-Fi router market has two segments: commercial and residential. The key differentiator between these segments is that commercial
routers tend to have much more robust security features, including virtual private networks and advanced content filtering. We believe that
our technology is applicable to both the commercial and residential Wi-Fi router markets based on the building block capabilities
mentioned earlier that will enable the WattUp technology to effectively serve and support both markets.

In addition, the Wi-Fi router market has other key players. These include consumer electronics supply chain firms, including original
equipment manufacturers (“OEMs”), original design manufacturers (“ODMs”), component manufacturers and branded consumer
electronics firms. We believe that each of these categories of players can help to integrate our technology into a commercially available
Wi-Fi router.

An ODM designs products either collaboratively with their customers or on their own and manufactures them for sale to companies under
the end customer’s brand. Additionally, an ODM may engage multiple companies with similar designs that are then marketed under several
different end customers’ brands. An OEM manufactures products for sale under another firm’s brand.

In January 2016, we entered into an agreement with Pegatron, an ODM company, to explore the production of Near Field WattUp
transmitters. This Near Field transmitter design is intended to replace the typical USB cord and power adapter included with many small
electronics products today. Incorporation of the WattUp® technology into a Near Field transmitter would allow the intended receiver
product to become waterproof as there is no longer a need for a power input port on the device, while still allowing for an in-box charging
solution.

8

 
 
 
 
 
 
 
 
 
 
 
 
As part of our go-to-market strategy under the Strategic Alliance Agreement with Dialog, we are currently working with customers offering
consumer and commercial applications of our technology. We also intend to engage with concentrated consumer destinations, for example,
coffee shop and restaurant chains, airport lounges and airports.

Receiver Target Markets

We believe there are a wide variety of potential uses for our receiver technology, including:

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

Smartphones
Hearing aids
IOT devices
Wearables
Tablets
Mice
Gaming consoles and controllers
Keyboards
e-book readers
Remote controls
Sensors (such as thermostats)
Toys
Rechargeable batteries
Rechargeable lights
Automotive accessories
Personal care products (such as toothbrushes or shavers)
Retail inventory management (such as RFID tags)
Hand-held industrial devices (such as scanners or keypads)
Medical devices

This list is meant for illustrative purposes only; we cannot guarantee that we will address any of these markets, and we may decide to
address a market that is not on the above list. We intend to continuously evaluate our target markets and choose new markets based on
factors including (but not limited to) time-to-market, market size and growth, and the strength of our value proposition for a specific
application.

Key Strategic Partnership

In January 2015, we signed a Development and License Agreement with a tier-one consumer electronics company to embed WattUp wire-
free charging receiver technology in various products including mobile consumer electronics and related accessories.

This Development and License Agreement and subsequent amendments contains both invention and development milestones requirements
that we will need to achieve through fiscal 2017 and potentially beyond. If we achieve such milestones, we are entitled to receive
milestone-based development payments under the agreement.

During the development phase until one year after the first customer shipment, we will afford this customer a time to market advantage in
the licensed product categories.

This agreement was last amended in February 2016 to allow us to develop technology for competing customers in certain vertical markets.
In addition, the amendment more clearly defines that the technology and associated intellectual property we are developing under the
Development and License Agreement remains the property of Energous.

WattUp uses small form factor antennas that are formed using the existing device's printed circuit board, removing the need for larger,
more expensive coils. This enables broader adoption of wireless charging in a larger range of battery-powered devices, such as
smartphones, tablets, Internet of Things (IoT) devices, small form factor wearables, gaming and Virtual Reality (VR)/Augmented Reality
(AR) devices.

If successful, we believe this agreement presents an opportunity to accelerate critical mass adoption for WattUp® wire-free power. We also
believe that with our partner, this critical mass could be driven first by the wide adoption of our receiver technology and second by the
broad distribution of embedded or stand-alone transmitters into other consumer electronics devices. Finally, having this wide adoption on
both the transmitter and the receiver side should create demand for broad adoption of our technology from circles outside of our key
strategic partner.

9

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In November 2016, we entered into a Strategic Alliance Agreement with Dialog for the manufacture and distribution of IC products
incorporating our wire-free charging technology. We agreed to engage Dialog as our exclusive supplier of these products for specified
fields of use. Our WattUp chipsets will be ordered through and manufactured by Dialog, will carry the Dialog brand and will be shipped
and supported by Dialog. Dialog agreed to not distribute, sell or work with any third party to develop any competing products without our
approval. Energous and Dialog agreed on a revenue sharing arrangement and will collaborate on the commercialization of licensed products
based on a mutually-agreed upon plan.

Our WattUp technology will use Dialog's SmartBond® Bluetooth low energy solution as the out-of-band communications channel between
the wireless transmitter and receiver. Dialog's power management technology will then be used to distribute power from the WattUp
receiver IC to the rest of the device while Dialog's AC/DC Rapid Charge™ power conversion technology delivers power to the wireless
transmitter.

Research and Development

Research and development costs account for a substantial portion of our operating expenses. Our research and development expenses were
$32.8 million, $18.8 million, and $12.5 million for the years ended December 31, 2016, 2015, and 2014, respectively. Research and
development expenses are expected to increase in the future as we concentrate our efforts and resources on the commercialization of our
technology.

Our Intellectual Property

As a company with a primary focus on licensing, we expect that our most valuable asset will be our intellectual property. This includes U.S.
and foreign patents, patent applications and know-how. We are pursuing an aggressive intellectual property strategy and are developing
new patents. As of March 15, 2017, we have in excess of 250 pending patent and provisional patent applications. Additionally, the PTO has
issued our first 22 patents and notified us of the allowance of ten additional patents. In addition to the inventions covered by these patents
and patent applications, we have identified a significant number of additional specific inventions we believe may be novel and patentable.
We intend to file for patent protection for the most valuable of these, as well as for other new inventions that we expect to develop.

Government Regulation

Our wire-free charging technology involves the transmission of power using RF energy waves, which is subject to regulation by the
Federal Communications Commission (“FCC”), and may be subject to regulation by other federal, state, local and international agencies.
We believe our technology is safe, and we are consulting with the FCC and other regulatory bodies to establish a process by which devices
incorporating WattUp® technology can secure required approvals.

Concerning FCC approvals, as part of the regulatory approval process, we believe devices incorporating the WattUp® technology will
need to obtain approvals under both FCC Part 15 and FCC Part 18. We are confident that our technology allows devices to be approved
under Part 15. In addition, because our technology involves the transmission of power greater than the power threshold limits of Part 15, we
also expect devices incorporating our technology will need to obtain FCC Part 18 approval. The design of the WattUp® technology is such
that we believe we will be able to demonstrate that our power transmissions do not violate current FCC regulations pertaining to human
exposure to RF emissions and that WattUp® technology complies with the Part 18 technical requirements. However, the transmission of
power in this manner by a consumer product at the ranges we are proposing has not yet been approved by the FCC. There can be no
assurance that the FCC will determine that devices incorporating WattUp® technology are eligible for Part 18 approval, that FCC approval
will be able to be obtained for specific devices, or that other governmental approvals will not be required

Employees

As of March 15, 2017, we had 73 full-time employees. None of these employees are covered by a collective bargaining agreement, and we
believe our relationship with our employees is good. We also employ consultants, including technical advisors, on an as-needed basis to
supplement existing staff. Consultants and technical advisors provide us with expertise in electrical engineering, software development and
other specialized areas of engineering and science.

Item 1A. Risk Factors

We are subject to many risks that may harm our business, prospects, results of operations and financial condition. This discussion
highlights some of the risks that might adversely affect our future operating results in material ways. We believe these are the risks and
uncertainties that are the most important ones we face. We cannot be certain that we will successfully address these risks, and if we are
unable to address them, our business may not grow, our stock price may suffer and you could lose the value of your investment in our
company. Other risks and uncertainties that we do not currently recognize as material risks, or that are similar to risks faced by other
companies in our industry, may also impair our business, prospects, results of operations and financial condition. The risks discussed
below include forward-looking statements, and our actual results may differ substantially from what is in these forward-looking
statements.

10

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Risks Related to Our Business

Other than engineering services revenues, we have no history of generating revenue, have a history of operating losses, and we may
never achieve or maintain profitability.

We have a limited operating history upon which investors may rely in evaluating our business and its prospects. We have generated only
very limited revenues to date and we have a history of losses from operations. As of December 31, 2016, we had an accumulated deficit of
approximately $125 million. Our ability to generate revenues on a more reliable and larger scale, and to achieve profitability, will depend
on our ability to execute our business plan, complete the development of our technology, and incorporate it into products that customers
wish to buy, and to do so rapidly with appropriate financing if necessary. If we are unable to generate revenues of significant scale to cover
our costs of doing business, our losses will continue and we may not achieve profitability, which could negatively impact the value of your
investment in our securities.

Terms of our Development and License Agreement with a tier-one consumer electronics company could inhibit potential licensees from
working with us in specific markets.

We have entered into a Development and License Agreement with a tier-one consumer electronics company to embed our WattUp wire-
free charging receiver and transmitter technology in various products, including mobile consumer electronics and related accessories. This
agreement provides our strategic partner a time-to-market advantage during the development and until one year after the first customer
shipment for specified consumer WattUp-enabled products. This may inhibit other potential licensees of our technology from engaging with
us and may cause them to seek solutions offered by other companies, which could have a negative impact on our revenue opportunities and
financial results.

11

 
 
 
 
 
 
 
 
 
We may be unable to demonstrate the feasibility of our technology.

We have developed working prototypes of products using our technology, but additional research and development is required to
commercialize our technology for mid field and far field applications so that it can be successfully integrated into commercial products.
Our research and development efforts remain subject to the risks associated with the development of new products that are based on
emerging technologies, such as unanticipated technical problems, the inability to identify products utilizing our technology that will be in
demand with customers, getting our technology designed in to those products, designing new products for manufacturability, and achieving
acceptable price points for final products. Any delays in developing our technology that arise from factors of this sort would aggravate our
exposure to the risk of having inadequate capital to fund the research and development needed to complete development of these products.
Technical problems causing delays would cause us to incur additional expenses that would increase our operating losses. If we experience
significant delays in developing our technology and products based on it for use in potential commercial applications, particularly after
incurring significant expenditures, our business may fail and you could lose the value of your investment in our company. To our
knowledge, the technological concepts we are applying have never previously been successfully applied. If we fail to develop practical and
economical commercial products based on our technology, our business may fail and you could lose the value of your investment in our
stock.

The FCC may deny approval for our technology, and future legislative or regulatory changes may impair our business.

Our wire-free charging technology involves transmission of power using radio frequency energy, which is subject to regulation by the
Federal Communications Commission, or FCC, and may be subject to regulation by other federal, state and local agencies. We intend to
design our technology to operate in a frequency band that is also used for Wi-Fi routers and other wireless consumer electronics. Different
customer applications may require us to develop our technology to work at different frequencies. For those products, the FCC grants
product approval if, among other things, the human exposure to radio frequency emissions is below specified thresholds. For some of our
products that transmit more power, additional FCC approvals would be required. We received an initial approval for near field charging
technology in 2016. There is no guarantee that additional FCC approvals that may be necessary to commercialize our technology will be
obtained. To our knowledge, the transmission of power using RF energy by a consumer product at the ranges and power levels we are
proposing has not previously been approved by the FCC. There can be no assurance that devices incorporating our technology will be able
to obtain FCC approval or that other governmental approvals will not be required. Our efforts to have devices using our technology to be
authorized by the FCC could be costly and time consuming, making it more difficult to achieve our business plan. If manufacturers of
these products are unable to receive required approvals in a timely and cost-efficient manner, our technology may be used less often and
our business and operating results could be materially harmed. The cost of compliance with new laws or regulations governing our
technology could adversely affect our revenues and financial results. Any such new laws or regulations could impose restrictions or
obligations on us that could require us to redesign our technology or future products, and may impose restrictions that are difficult or
impracticable to comply with, which could harm our business and operating results.

We are currently dependent upon our strategic relationship with Dialog Semiconductor, a provider of electronics products, and there
can be no assurance that we will achieve the expected benefits of this relationship.

We have entered into a strategic cooperation agreement with Dialog Semiconductor, a provider of electronics products, pursuant to which
we licensed our WattUp technology to Dialog and it became the exclusive provider of our technology. We intend to leverage Dialog’s sales
and distribution channels and its operational capabilities to accelerate market adoption of our technology, while we focus our resources on
research and development of our technology. There can be no assurance that Dialog will promote our technology successfully, or that it
will be successful in producing and distributing products containing our technology to our customers’ specifications. Dialog may have
other priorities or may encounter difficulties in its own business that interfere with the success of our relationship. If this strategic
relationship does not work as we intend, then we may be required to seek an arrangement with another strategic partner, or to develop
internal capabilities, which will require a commitment of management time and our financial resources to identify a replacement strategic
partner, or to develop our own production and distribution capabilities. As a result, we may be unable without undue expense to replace this
agreement with one or more new strategic relationships to promote and provide our technology to end users.

We may require additional financing in order to achieve our business plans, and there is no guarantee that additional financing will be
available on acceptable terms, or at all.

We believe our technology is novel and promising in offering, but the electronics industry in general – and the power, recharging and
alternative recharging segments of that industry in particular – are subject to intense competition and new technologies often emerge to
dominate other technologies. Accordingly, for our business plans to succeed we believe it will be important for us to move quickly to
develop our technology, obtain required regulatory approvals and engage with strategic partners. As a small company, we may be unable to
successfully implement our ambitions of targeting large markets in a competitive industry segment without significantly increasing our
resources. We may not have sufficient funds to fully implement our business plan. While we believe our current cash on hand, together
with anticipated payments received under product development projects entered into with customers, will be sufficient to fund our
operations through 2017. Depending on how soon we are able to begin to generate meaningful commercial revenue we may need to raise
capital through new financings. Such financings could include equity financing, which may be dilutive to stockholders, or debt financing,
which could restrict our ability to borrow from other sources. In addition, such securities may contain rights, preferences or privileges
senior to those of current stockholders. There can be no assurance that additional funds will be available on terms attractive to us, or at all,
which may require us to curtail development of our technology or reduce our operations. We could be forced to sell or dispose of our rights
or assets we may have. Accordingly, if we are not able to raise adequate funds on commercially reasonable terms could have a material
adverse effect on our business, results of operation and financial condition, including the possibility that a lack of funds could cause our
business to fail and liquidate with little or no return to investors.

12

 
 
  
 
 
 
 
 
 
 
 
 
We may have difficulty managing growth in our business.

Expanding our activities as we intend will increase the demands on our financial, technical, operational and management resources. If we
do not upgrade our technical, administrative, operating and financial control systems, or the unexpected expansion difficulties arise,
including issues relating to our research and development activities and retention of experienced scientists, managers and engineers, could
have a material adverse effect on our business, our results of operations and financial condition, and our ability to timely execute our
business plan. If we are unable to implement these actions in a timely manner, our results may be adversely affected.

If products incorporating our technology are launched commercially but do not achieve widespread market acceptance, we will not be
able to generate the revenue necessary to support our business.

Acceptance of a wire-free charging system as a preferred method to recharge low-power fixed and mobile electronic devices will be crucial
to our continued success. Consumers and commercial customers will not begin to use or increase the use of products incorporating our
technology unless they agree that the convenience of our wire-free charging solution would be worth the additional expense of purchasing
such products. These and other factors, including the following factors, may affect the rate and level of market acceptance of products in
our industry:

•
•
•
•

•

•

the price of products incorporating our technology relative to other products or competing methods of recharging;
the effectiveness of sales and marketing efforts of our commercialization partners;
the support and rate of acceptance of our technology and solutions with our joint development partners;
Perception, by individual and enterprise users, of our wire-free charging solution’s convenience, safety, efficiency and benefits
compared to competing methods of recharging;
press and blog coverage, social media coverage, and other publicity and public relations factors which are not within our control;
and
regulatory developments related to our solution or their inclusion in others’ products.

If we are unable to achieve or maintain market acceptance of our technology and related products, our business would be significantly
harmed.

If products incorporating our technology are commercially launched, we may experience seasonality or other unevenness in our
financial results in consumer markets or a long and variable sales cycle in enterprise markets.

While we do not now have license revenue, , our strategy depends on the development of successful commercial products and effectively
licensing our technology into the consumer, enterprise and commercial markets. We will need to understand procurement and buying
cycles to be successful in licensing our technology into those markets. We anticipate it is possible that demand for our technology could
vary similarly with the market for products with which our technology may be used, for example, the market for new purchases of laptops,
tablet, mobile phones, gaming systems, toys, wearables and the like. Such consumer markets are often seasonal, with peaks in and around
the December holiday season and the August-September back-to-school season. Enterprises and commercial markets may have annual or
other budgeting and buying cycles that could affect us, and, particularly if we are designated as a capital improvement project, we may have
a long or unpredictable sales cycle.

We may not be able to achieve all the features we seek to include in our technology.

We have developed working prototypes of commercial products that utilize our technology. Additional features and performance
specifications we seek to include in our technology have not yet been developed. For example, certain customer applications may require
specific combinations of cost, footprint, efficiencies and capabilities at various charging power levels and distances as part of an overall
system. We believe our research and development efforts will yield additional functionality and capabilities over time. However, there can
be no assurance that we will be successful in achieving all the features we are targeting and our inability to do so may limit the appeal of
our technology to consumers.

13

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Use of our technology or other future products based on our technology may require the user to purchase additional products to use
with existing devices. To the extent these additional purchases are inconvenient, the adoption of our technology under development or
other future products could be slowed, which would harm our business.

For rechargeable devices that utilize our receiver technology, the technology may be embedded in a sleeve, case or other enclosure. For
example, products such as remote controls or toys equipped with replaceable AA size or other batteries would need to be outfitted with
enhanced batteries and other hardware enabling the devices to be rechargeable by our system. In each case, an end user would be required
to retrofit the device with a receiver and may be required to upgrade the battery technology used with the device (unless, for example,
compatible battery technology and a receiver are built into the device). These additional steps and expenses may offset the convenience for
some users and discourage some users from purchasing our technology under development or other future products. Such factors may
inhibit adoption of our technology, which could harm our business. We have not developed an enhanced battery for use in devices with our
technology, and our ability to enable use of our technology with devices that require an enhanced battery will depend on our ability to
develop a commercial version of such a battery that could be manufactured at a reasonable cost. If we fail to develop or enable a
commercially practicable enhanced battery, our business could be harmed, and we may need to change our strategy and target markets.

Laboratory conditions differ from field conditions, which could affect the effectiveness of our technology under development or other
future products. Failures to move from laboratory to the field effectively would harm our business.

When used in the field, our technology may not perform as expected based on test results and performance of our technology under
controlled laboratory circumstances. For example, in the laboratory a configuration of obstructions of transmission will be arranged in
some fashion, but in the field receivers may be obstructed in many different and unpredictable ways over which we have no control. These
conditions may significantly diminish the power received at the receiver or the effective range of the transmitter, because the RF energy
from the transmitter may be absorbed by obscuring or blocking material or may need to be reflected off a surface to reach the receiver,
making the transmission distance longer than straight-line distances. The failure of products using our technology or other future products
to be able to meet the demands of users in the field could harm our business.

Safety concerns and legal action by private parties may affect our business.

We believe that our technology is safe. However, it is possible that we could discover safety issues with our technology or that some people
may be concerned with wire-free transmission of power in a manner that has occurred with some other wireless technologies as they were
put into residential and commercial use, such as the safety concerns that were raised by some regarding the use of cellular telephones and
other devices to transmit data wirelessly in close proximity to the human body. While we plan to at least partially address this potential
concern by developing our management software and sensor technology to be configurable by users to selectively recharge devices in ways
that would be intended to avoid recharging in close proximity to a human body, such as recharging only during predetermined time periods
or recharging only when the device is not moving, we do not plan to conduct any tests to determine whether RF waves produce harmful
effects on humans or other animals. We may be unable to effectively prevent recharging in close proximity to a user’s body, which could
affect the marketability of our technology or could result in requests for law or regulation governing our technology under development or a
class of products in which our technology under development would be included. In addition, while we believe our technology is safe, users
of our technology under development or other future products who suffer medical ailments may blame the use of products incorporating
our technology, as occurred with a small number of users of cellular telephones. A discovery of safety issues relating to our technology
could have a material adverse effect on our business and any legal action against us claiming our technology caused harm could be
expensive, divert management and adversely affect us or cause our business to fail, whether or not such legal actions were ultimately
successful.

14

 
 
 
 
 
 
 
 
 
 
Our industry is subject to intense competition and rapid technological change, which may result in products or new solutions that are
superior to our technology under development or other future products we may bring to market from time to time. If we are unable to
anticipate or keep pace with changes in the marketplace and the direction of technological innovation and customer demands, our
technology and products may become less useful or obsolete and our operating results will suffer.

The consumer and commercial electronics industry in general and the power, recharging and alternative recharging segments of that
industry in particular are subject to intense and increasing competition and rapidly evolving technologies. Because products incorporating
our technology are expected to have long development cycles, we must anticipate changes in the marketplace and the direction of
technological innovation and customer demands. To compete successfully, we will need to demonstrate the advantages of our products and
technologies over well-established alternative solutions, products and technologies, as well as newer methods of power delivery and
convince consumers and enterprises of the advantages of our products and technologies. Traditional wall plug-in recharging remains an
inexpensive alternative to our technology under development. Also, directly competing technologies such as inductive charging, magnetic
resonance charging, conductive charging, ultrasound and other yet unidentified solutions may have greater consumer acceptance than the
technologies we have developed. Furthermore, certain competitors may have greater resources than us and may be better established in the
market than we are. We cannot be certain which other companies may have already decided to or may in the future choose to enter our
markets. For example, consumer electronics products companies may invest substantial resources in wireless power or other recharging
technologies and may decide to enter our target markets. Successful developments of competitors that result in new approaches for
recharging could reduce the attractiveness of our products and technologies or render them obsolete.

Our future success will depend in large part on our ability to establish and maintain a competitive position in current and future
technologies. Rapid technological development may render our technology under development or future products based on our technology
obsolete. Many of our competitors have greater corporate, financial, operational, sales and marketing resources than we have, as well as
more experience in research and development. We cannot assure you that our competitors will not succeed in developing or marketing
technologies or products that are more effective or commercially attractive than our products or that would render our technologies and
products obsolete. We may not have or be able to raise or develop the financial resources, technical expertise, marketing, distribution or
support capabilities to compete successfully in the future. Our success will depend in large part on our ability to maintain a competitive
position with our technologies.

Our competitive position also depends on our ability to:

•

•
•

•
•
•
•
•
•

generate widespread awareness, acceptance and adoption by the consumer and enterprise markets of our technology under
development and future products;
design a product that may be sold at an acceptable price point;
develop new or enhanced technologies or features that improve the convenience, efficiency, safety or perceived safety, and
productivity of our technology under development and future products;
properly identify customer needs and deliver new products or product enhancements to address those needs;
limit the time required from proof of feasibility to routine production;
limit the timing and cost of regulatory approvals;
attract and retain qualified personnel;
protect our inventions with patents or otherwise develop proprietary products and processes; and
secure sufficient capital resources to expand both our continued research and development, and sales and marketing efforts.

If our technology is not competitive based on these or other factors, our business could be harmed.

It is difficult and costly to protect our intellectual property and our proprietary technologies, and we may not be able to ensure their
protection.

Our success depends significantly on our ability to obtain, maintain and protect our proprietary rights to the technologies used in products
incorporating our technologies. Patents and other proprietary rights provide uncertain protections, and we may be unable to protect our
intellectual property. For example, we may be unsuccessful in defending our patents and other proprietary rights against third party
challenges. If we do not have the resources to defend our intellectual property, the value of our intellectual property and our licensed
technology will decline, threatening our potential revenue and results of operations.

15

 
 
 
 
 
 
 
 
 
 
 
 
We have in excess of 250 pending U.S. patents and provisional patent applications on file. The PTO issued our first twenty-two patents
and notified us of the allowance of ten additional patents to protect our technology.

In addition to patents, we expect to rely on a combination of trade secrets, copyright and trademark laws, nondisclosure agreements and
other contractual provisions and technical security measures to protect our intellectual property rights. These measures may not be adequate
to safeguard our technology. If they do not protect our rights adequately, third parties could use our technology, and our ability to compete
in the market would be reduced. Although we are attempting to obtain patent coverage for our technology where available and where we
believe appropriate, there are aspects of the technology for which patent coverage may never be sought or received. We may not possess
the resources to or may not choose to pursue patent protection outside the United States or any or every country other than the United
States where we may eventually decide to sell our future products. Our ability to prevent others from making or selling duplicate or similar
technologies will be impaired in those countries in which we have no patent protection. Although we have in excess of 250 pending and
provisional patent applications on file in the United States protecting aspects of our technology under development, our patents may not
issue as a result of those applications drawing priority or otherwise based on those patent applications, may issue only with limited coverage
or may issue and be subsequently successfully challenged by others and held invalid or unenforceable.

Similarly, even if patents do issue based on our applications or future applications, any issued patents may not provide us with any
competitive advantages. Competitors may be able to design around our patents or develop products that provide outcomes comparable or
superior to ours. Our patents may be held invalid or unenforceable as a result of legal challenges by third parties, and others may challenge
the inventorship or ownership of our patents and pending patent applications. In addition, if we choose to and are able to secure protection
in countries outside the United States, the laws of some foreign countries may not protect our intellectual property rights to the same extent
as do the laws of the United States. In the event a competitor infringes upon our patent or other intellectual property rights, enforcing those
rights may be difficult and time consuming. Even if successful, litigation to enforce our intellectual property rights or to defend our patents
against challenge could be expensive and time consuming and could divert our management’s attention. We may not have sufficient
resources to enforce our intellectual property rights or to defend our patents against a challenge.

Our strategy is to deploy our technology into the market, license patent and other proprietary rights to aspects of our technology to third
parties and customers. Disputes with our licensors may arise regarding the scope and content of these licenses. Further, our ability to
expand into additional fields with our technologies may be restricted by existing licenses or licenses we may grant to third parties in the
future.

The policies we use to protect our trade secrets may not be effective in preventing misappropriation of our trade secrets by others. In
addition, confidentiality agreements executed by our employees, consultants and advisors may not be enforceable or may not provide
meaningful protection for our trade secrets or other proprietary information in the event of unauthorized use or disclosure. Litigating a
trade secret claim is expensive and time consuming, and the outcome is unpredictable. In addition, courts outside the United States are
sometimes less willing to protect trade secrets. Moreover, our competitors may independently develop equivalent knowledge methods and
know-how. If we are unable to protect our intellectual property rights, we may be unable to prevent competitors from using our own
inventions and intellectual property to compete against us, and our business may be harmed.

We may be subject to patent infringement or other intellectual property lawsuits that could be costly to defend.

Because our industry is characterized by competing intellectual property, we may become involved in litigation based on claims that we
have violated the intellectual property rights of others. Determining whether a product infringes a patent involves complex legal and factual
issues, and the outcome of patent litigation actions is often uncertain. No assurance can be given that third party patents containing claims
covering our products, parts of our products, technology or methods do not exist, have not been filed, or could not be filed or issued.
Because of the number of patents issued and patent applications filed in our technical areas or fields (including some pertaining specifically
to wireless charging technologies), our competitors or other third parties may assert that our products and technology and the methods we
employ in the use of our products and technology are covered by United States or foreign patents held by them. In addition, because patent
applications can take many years to issue and because publication schedules for pending applications vary by jurisdiction, there may be
applications now pending which may result in issued patents that our technology under development or other future products would
infringe. Also, because the claims of published patent applications can change between publication and patent grant, there may be
published patent applications that may ultimately issue with claims that we infringe. There could also be existing patents that one or more
of our technologies, products or parts may infringe and of which we are unaware. As the number of competitors in the market for wire-free
power and alternative recharging solutions increases, and as the number of patents issued in this area grows, the possibility of patent
infringement claims against us increases. Some of our competitors may be able to sustain the costs of complex patent litigation more
effectively than we can because they have substantially greater resources. In addition, any uncertainties resulting from the initiation and
continuation of any litigation could have a material adverse effect on our ability to raise the funds necessary to continue our operations.

16

 
 
 
 
 
 
 
 
 
 
 
In the event that we become subject to a patent infringement or other intellectual property lawsuit and if the relevant patents or other
intellectual property were upheld as valid and enforceable and we were found to infringe or violate the terms of a license to which we are a
party, we could be prevented from selling any infringing products of ours unless we could obtain a license or were able to redesign the
product to avoid infringement. If we were unable to obtain a license or successfully redesign, we might be prevented from selling our
technology under development or other future products. If there is a determination that we have infringed the intellectual property rights of
a competitor or other person, we may be required to pay damages, pay a settlement, or pay ongoing royalties, or be enjoined. In these
circumstances, we may be unable to sell our products or license our technology at competitive prices or at all, and our business and
operating results could be harmed.

We could become subject to product liability claims, product recalls, and warranty claims that could be expensive, divert management’s
attention and harm our business.

Our business exposes us to potential liability risks that are inherent in the marketing and sale of products used by consumers. We may be
held liable if our technology under development now or in the future causes injury or death or are found otherwise unsuitable during usage.
Our technology under development incorporates sophisticated components and computer software. Complex software can contain errors,
particularly when first introduced. In addition, new products or enhancements may contain undetected errors or performance problems that,
despite testing, are discovered only after installation. While we believe our technology is safe, users could allege or possibly prove defects
(some of which could be alleged or proved to cause harm to users or others) because we design our technology to perform complex
functions involving RF energy, possibly in close proximity to users. A product liability claim, regardless of its merit or eventual outcome,
could result in significant legal defense costs. The coverage limits of our insurance policies we may choose to purchase to cover related
risks may not be adequate to cover future claims. If sales of products incorporating our technology increase or we suffer future product
liability claims, we may be unable to maintain product liability insurance in the future at satisfactory rates or with adequate amounts. A
product liability claim, any product recalls or excessive warranty claims, whether arising from defects in design or manufacture or
otherwise, could negatively affect our sales or require a change in the design or manufacturing process, any of which could harm our
reputation and business, harm our relationship with licensors of our products, result in a decline in revenue and harm our business.

In addition, if a product that we or a strategic partner design is defective, whether due to design or manufacturing defects, improper use of
the product or other reasons, we or our strategic partners may be required to notify regulatory authorities and/or to recall the product. A
required notification to a regulatory authority or recall could result in an investigation by regulatory authorities of products incorporating
our technology, which could in turn result in required recalls, restrictions on the sale of such products or other penalties. The adverse
publicity resulting from any of these actions could adversely affect the perception of our customers and potential customers. These
investigations or recalls, especially if accompanied by unfavorable publicity, could result in our incurring substantial costs, losing revenues
and damaging our reputation, each of which would harm our business.

We are subject to risks associated with our utilization of consultants.

To improve productivity and accelerate our development efforts while we build out our own engineering team, we use experienced
consultants to assist in selected business functions, including the development of our ICs. We take steps to monitor and regulate the
performance of these independent third parties. However, arrangements with third party service providers may make our operations
vulnerable if these consultants fail to satisfy their obligations to us as a result of their performance, changes in their own operations,
financial condition, or other matters outside of our control. Effective management of our consultants is important to our business and
strategy. The failure of our consultants to perform as anticipated could result in substantial costs, divert management’s attention from other
strategic activities, or create other operational or financial problems for us. Terminating or transitioning arrangements with key consultants
could result in additional costs and a risk of operational delays, potential errors and possible control issues as a result of the termination or
during the transition.

17

 
 
 
 
 
 
 
 
 
 
We expect to depend on consumer electronics supply chain firms to manufacture and market products using our technology. If these
firms fail to successfully manufacture, market and distribute our technology under development, our business and results of operations
will be materially harmed.

We intend to license our system architecture, proprietary waveform, antenna designs to consumer electronics supply chain firms, rather
than manufacture our technology ourselves. We will not be able to control the efforts and resources these consumer electronics supply
chain firms devote to marketing our technology under development or other future products. Those firms may not be able to successfully
market and sell the products they develop based on our technology, may not devote sufficient time and resources to support the marketing
and selling efforts, and may not market those products at prices that will permit the products to develop, achieve or sustain market
acceptance. Finding new licensors could be an expensive and time-consuming process and we may not be able to find suitable consumer
electronics supply chain firms and other distribution strategic partners on acceptable terms or at all. If we cannot find suitable third party
partners or our third-party partners experience difficulties, do not actively market our technology under development or future products or
do not otherwise perform under our license agreements, our potential for revenue may be dramatically reduced, and our business could be
harmed.

We intend to pursue licensing of our technology as a primary means of commercialization but we may not be able to secure
advantageous license agreements. If we are not able to secure advantageous license agreements, our business and results of operations
will be adversely affected.

We are pursuing the licensing of our technology as a primary means of commercialization. We believe there are many companies that
would be interested in implementing our technology into their devices. Many of these companies are well-known, world-wide companies.
We have entered into one product development and license agreement with a tier-one consumer electronics company that has the potential
to yield license revenue. In addition, we have also entered into a number of evaluation and joint development agreements with potential
strategic partners. However, these agreements do not commit either party to a long-term relationship and any of these parties may
disengage with us at any time. Creating a license or other business relationship with these classes of companies will take a substantial
effort, as we expect to have to convince them of the efficacy of our technology, meet their design and manufacturing requirements, satisfy
their marketing and product needs, and comply with their selection, review and contracting requirements. There can be no assurance that
we will be able to gain entry to these companies, or that they will ultimately decide to integrate our technology with their products. We may
not be able to secure license agreements with customers on terms that are advantageous to us. Furthermore, the timing and volume of
revenue earned from license agreements will be outside of our control. If the license agreements we enter into do not prove to be
advantageous to us, our business and results of operations will be adversely affected.

18

 
 
 
 
 
 
 
 
We may not be able to develop a technology that meets the specifications required by our Development and License Agreement with our
tier-one consumer products company customer. Even if we succeed in developing a technology that meets all the specifications, this
customer could decline to use our technology in its products. Any of these events would have a material adverse effect on our business.

The terms of our Development and License Agreement with a tier-one consumer products company require us to meet stringent
performance specifications and aggressive technical milestones. While we are devoting substantial corporate time and resources to the
development of our technology for this company’s products, there can be no assurance that we can meet the performance specifications and
technical milestones in the timeframe required by the Development and License Agreement or at all. Further, the decision to embed our
technology within its products is completely in our development partner’s discretion and it could decline to use our technology in its
products even if we meet all the performance specifications and technical milestones set forth in the agreement. Additionally, the
Development and License Agreement prohibits us from the development of our technology for certain product categories until one year
following our development partner’s introduction of products with our technology embedded in those categories to consumers. If we are
unable to meet the stringent performance specifications and aggressive technical milestones required by the Development and License
Agreement or our development partner declines to embed our technology in its products, our business could be significantly harmed in the
absence of additional license agreements that equal or exceed the potential of this agreement. The harm to our business resulting from
either of these scenarios will exacerbated by the fact that we have agreed to limited exclusivity in certain product categories with our
development partner.

We are highly dependent on key members of our executive management team. Our inability to retain these individuals could impede our
business plan and growth strategies, which could have a negative impact on our business and the value of your investment.

Our ability to implement our business plan depends, to a critical extent, on the continued efforts and services of a very small number of key
executives. If we lose the services of any of these persons, we would be required to expend significant time and money in the pursuit of
replacements, which may result in a delay in the implementation of our business plan and plan of operations. We can give no assurance that
we could find satisfactory replacements for these individuals on terms that would not be unduly expensive or burdensome to us. We do not
currently carry a key-man life insurance policy that would assist us in recouping our costs in the event of the death or disability of any of
these executives.

Our success and growth depend on our ability to attract, integrate and retain high-level engineering talent.

Because of the highly specialized and complex nature of our business, our success depends on our ability to attract, hire, train, integrate and
retain high-level engineering talent. Competition for such personnel is intense because we compete for talent against many large profitable
companies and our inability to adequately staff our operations with highly qualified and well-trained engineers could render us less efficient
and impede our ability to develop and deliver a commercial product. Such a competitive market could put upward pressure on labor costs
for engineering talent. We may incur significant costs to attract and retain highly qualified talent, and we may lose new employees to our
competitors or other technology companies before we realize the benefit of our investment in recruiting and training them. Volatility or
lack of performance in our stock price may also affect our ability to attract and retain qualified personnel.

Risks Related to Ownership of Our Common Stock

You may lose all of your investment.

Investing in our common stock involves a high degree of risk. As an investor, you may never recoup all, or even part of, your investment
and you may never realize any return on your investment. You must be prepared to lose all of your investment.

Our stock price could be volatile and investors may have difficulty selling their shares.

Our common stock is currently listed on The NASDAQ Stock Market under the symbol “WATT.” For the period from March 28, 2014
when trading began on The NASDAQ Stock Market through March 6, 2017, the daily trading volume for shares of our common stock
ranged from 6,200 to 6,288,000 shares traded per day, and the average daily trading volume during such period was approximately 394,000
shares.

19

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The market price of the common stock has fluctuated significantly since it was first listed on The NASDAQ Stock Market on March 28,
2014. Since this date, through March 6, 2017, the intra-day trading price has fluctuated from a low of $3.65 to a high of $20.55. The price
of our common stock may continue to fluctuate significantly in response to factors, many of which are beyond our control, including the
following:

•
•
•
•
•
•
•
•

actual or anticipated variations in operating results;
the limited number of holders of the common stock;
changes in the economic performance and/or market valuations of other technology companies;
our announcements of significant strategic partnerships or other events;
announcements by other companies in the wire-free charging space;
articles published or rumors circulated by third parties regarding our business, technology or development partners;
additions or departures of key personnel; and
sales or other transactions involving our capital stock, including sales that may occur following the termination of applicable lock-
up periods.

We are an “emerging growth company,” and are able to take advantage of reduced disclosure requirements applicable to “emerging
growth companies,” which could make our common stock less attractive to investors.

We are an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012, or JOBS Act, and, for as long as
we continue to be an “emerging growth company,” we intend to take advantage of certain exemptions from various reporting requirements
applicable to other public companies but not to “emerging growth companies,” including, but not limited to, not being required to comply
with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive
compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote
on executive compensation and stockholder approval of any golden parachute payments not previously approved. We could be an
“emerging growth company” for up to five years, or until the earliest of (i) the last day of the first fiscal year in which our annual gross
revenues exceed $1 billion, (ii) the date that we become a “large accelerated filer” as defined in Rule 12b-2 under the Exchange Act, which
would occur if the market value of our common stock that is held by non-affiliates exceeds $700.0 million as of the last business day of our
most recently completed second fiscal quarter, or (iii) the date on which we have issued more than $1 billion in non-convertible debt during
the preceding three year period. We cannot predict if investors will find our common stock less attractive if we choose to rely on these
exemptions. If some investors find our common stock less attractive as a result of any choices to reduce future disclosure, there may be a
less active trading market for our common stock and our stock price may be more volatile.

We have not paid dividends in the past and have no immediate plans to pay dividends.

We plan to reinvest all of our earnings, to the extent we have earnings, in order to market our products and technology and to cover
operating costs and to otherwise become and remain competitive. We do not plan to pay any cash dividends with respect to our securities in
the foreseeable future. We cannot assure you that we would, at any time, generate sufficient surplus cash that would be available for
distribution to the holders of our common stock as a dividend.

Concentration of ownership among our existing executive officers, directors and significant stockholders may prevent new investors
from influencing significant corporate decisions.

All decisions with respect to the management of our company are made by our board of directors and our officers, who beneficially own
approximately 8% of our common stock collectively. In addition, other greater than 5% stockholders such as DvineWave which
beneficially owned approximately 7.7% of our common stock as of December 31, 2016 and Ascend Capital LLC and its affiliates, which
beneficially owned approximately 17.8% of our common stock. As a result, these stockholders will be able to exercise a significant level of
control over all matters requiring stockholder approval, including the election of directors, amendment of our certificate of incorporation
and approval of significant corporate transactions. This control could have the effect of delaying or preventing a change of control of our
company or changes in management and will make the approval of certain transactions difficult or impossible without the support of these
stockholders.

20

 
 
 
 
 
 
 
 
 
 
 
 
We expect to continue to incur significant costs as a result of being a public reporting company and our management will be required to
devote substantial time to meet our compliance obligations.

As a public reporting company, we incur significant legal, accounting and other expenses. We are subject to reporting requirements of the
Securities Exchange Act of 1934 and rules subsequently implemented by the Securities and Exchange Commission (“SEC”) that require us
to establish and maintain effective disclosure controls and financial controls, as well as some specific corporate governance practices. Our
management and other personnel are expected to devote a substantial amount of time to compliance initiatives associated with our public
reporting company status.

We may be subject to securities litigation, which is expensive and could divert management attention.

Our stock price has fluctuated in the past and may be volatile in the future. In the past, companies that have experienced volatility in the
market price of their securities have been subject to securities class action litigation, and we may be the target of litigation of this sort in the
future. Securities litigation is costly and can divert management attention from other business concerns, which could seriously harm our
business and the value of your investment in our company.

An active trading market for our common stock may not be maintained.

Our stock is currently traded on The NASDAQ Stock Market, but we can provide no assurance that we will be able to maintain an active
trading market on The NASDAQ Stock Market or any other exchange in the future. If an active market for our common stock is not
maintained, it may be difficult for our stockholders to sell shares without depressing the market price for the shares or at all. An inactive
market may also impair our ability to raise capital to continue to fund operations by selling shares and may impair our ability to acquire
other companies or technologies by using our shares as consideration.

If securities or industry analysts do not publish research or reports about our business, or publish negative reports about our business,
our stock price and trading volume could decline.

The trading market for our common stock will depend in part on the research and reports that securities or industry analysts publish about
us or our business. We do not have any control over these analysts. There can be no assurance that analysts will continue to cover us or
provide favorable coverage. If one or more of the analysts who cover us downgrade our stock or change their opinion of our stock, our
stock price would likely decline. If one or more of these analysts cease coverage of our company or fail to regularly publish reports on us,
we could lose visibility in the financial markets, which could cause our stock price or trading volume to decline.

Our charter documents and Delaware law may inhibit a takeover that stockholders consider favorable.

Provisions of our certificate of incorporation and bylaws, and applicable Delaware law, may delay or discourage transactions involving an
actual or potential change in control or change in our management, including transactions in which stockholders might otherwise receive a
premium for their shares, or transactions that our stockholders might otherwise deem to be in their best interests. The provisions in our
certificate of incorporation and bylaws:

•

•
•
•
•

authorize our board of directors to issue preferred stock without stockholder approval and to designate the rights, preferences and
privileges of each class; if issued, such preferred stock would increase the number of outstanding shares of our capital stock and
could include terms that may deter an acquisition of us;
limit who may call stockholder meetings;
do not permit stockholders to act by written consent;
do not provide for cumulative voting rights; and
provide that all vacancies may be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum.

In addition, Section 203 of the Delaware General Corporation Law may limit our ability to engage in any business combination with a
person who beneficially owns 15% or more of our outstanding voting stock unless certain conditions are satisfied. This restriction lasts for
a period of three years following the share acquisition. These provisions may have the effect of entrenching our management team and may
deprive you of the opportunity to sell your shares to potential acquirers at a premium over prevailing prices. This potential inability to
obtain a control premium could reduce the price of our common stock.

21

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 1B. Unresolved Staff Comment

Not applicable.

Item 2. Properties

On September 10, 2014, we entered into a Lease Agreement with Balzer Family Investments, L.P. (the “Landlord”) related to space located
at Northpointe Business Center, 3590 North First Street, San Jose, California. The initial term of the lease is 60 months, with initial
monthly base rent of $36,720 and the lease is subject to certain annual escalations as defined in the agreement. On October 1, 2014, we
relocated our headquarters to this new location.  We issued to the Landlord 41,563 shares of the Company’s common stock valued at
$500,000, of which $400,000 will be applied to reduce our monthly base rent obligation by $6,732 per month and of which $100,000 was
for certain tenant improvements. We recorded $400,000 as prepaid rent on our balance sheet, which is being amortized over the term of the
lease and recorded $100,000 as leasehold improvements.

On February 26, 2015, we entered into a sub-lease agreement for additional space in the San Jose area. The agreement has a term which
expires on June 30, 2019 and an initial monthly rent of $6,109 per month. On August 25, 2015, we entered into an additional amended sub-
lease agreement for additional space in San Jose, CA. The agreement has a term which expires on June 30, 2019 and an initial monthly rent
of $4,314 per month. These leases are subject to certain annual escalations as defined in the agreements.

On July 9, 2015, we entered into a sub-lease agreement for additional space in Costa Mesa, CA. The agreement has a term which expires
on September 30, 2017 and a monthly rent of $6,376.

Item 3. Legal Proceedings

We are not currently a party to any pending legal proceedings that we believe will have a material adverse effect on our business or
financial conditions. We may, however, be subject to various claims and legal actions arising in the ordinary course of business from time
to time.

Item 4. Mine Safety Disclosures

Not applicable.

22

 
 
 
 
 
 
 
 
 
 
 
 
 
 
PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Our shares of common stock are listed on the NASDAQ Stock Market under the symbol “WATT.” The table below provides, for the fiscal
quarters indicated, the reported high and low closing sales prices for our common stock on the NASDAQ Stock Market since January 1,
2015.

Fiscal Year Ended December 31, 2015

First Quarter
Second Quarter
Third Quarter
Fourth Quarter

Fiscal Year Ended December 31, 2016

First Quarter
Second Quarter
Third Quarter
Fourth Quarter

Price Range

High

Low

  $
  $
  $
  $

  $
  $
  $
  $

12.16    $
9.58    $
8.40    $
8.84    $

11.02    $
13.65    $
19.61    $
19.26    $

8.63 
6.98 
5.90 
6.57 

3.86 
9.58 
11.74 
12.92 

As of December 31, 2016, there were 14 holders of record of our common stock. We believe we have significantly more beneficial holders
of our common stock.

We have never paid cash dividends on our securities and we do not anticipate paying any cash dividends on our shares of common stock in
the foreseeable future. We intend to retain any future earnings for reinvestment in our business. Any future determination to pay cash
dividends will be at the discretion of our board of directors, and will be dependent upon our financial condition, results of operations,
capital requirements and such other factors as our board of directors deems relevant.

23

 
 
 
 
 
 
 
 
 
 
   
 
 
 
   
 
 
   
      
  
 
 
 
 
 
Item 6. Selected Financial Data

The data set forth below should be read in conjunction with Item 7 – “Management's Discussion and Analysis of Financial Condition and
Results of Operations” and the Company’s Financial Statements and notes thereto.

2016

2015

2014

Selected data from the Statements of Operations:
Revenue
Loss from operations
Change in fair value of derivative liabilities
Net loss
Basic and diluted net loss per common share

Selected data from Balance Sheets:
Total Assets

2,500,000    $

1,451,941    $

  $
- 
  $ (45,830,720)   $ (27,577,339)   $ (20,374,709)
  $
-    $ (26,265,177)
  $ (45,817,394)   $ (27,561,702)   $ (45,603,110)
(5.75)
  $

(2.60)   $

(2.07)   $

-    $

  $

35,258,940    $

32,675,528    $

33,828,923 

The Company has had no long-term liabilities, preferred stock or dividends declared.

Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations

Overview

We have developed a technology called WattUp® that consists of proprietary semiconductor chipsets, software, hardware designs and
antennas that enables RF-based charging for electronic devices, providing wire-free charging solutions for contact-based charging as well
as at a distance charging, ultimately enabling charging with mobility under full software control. Pursuant to our Strategic Alliance
Agreement with Dialog Semiconductor plc, Dialog will manufacture and distribute integrated circuit (“IC”) products incorporating our RF-
based wire-free charging technology. Dialog will be our exclusive supplier of these ICs for the general market. We believe our proprietary
technology can be utilized in a variety of devices, including wearables, hearing aids, earbuds, Bluetooth headsets, Internet of Things (“IoT”)
devices, smartphones, tablets, e-book readers, keyboards, mice, remote controls, rechargeable lights, cylindrical batteries, medical devices
and any other device with similar charging requirements that would otherwise need a battery or a connection to a power outlet.

We believe our technology is novel in its approach, in that we are developing a solution that charges electronic devices by surrounding
them with a focused, three-dimensional (“3D”) radio frequency (“RF”) energy pocket (“RF energy pocket”). We are engineering solutions
that we expect to enable the wire-free transmission of energy for contact-based applications as well as far field applications of up to 15 feet
in radius or in a circular charging envelope of up to 30 feet. We are also developing our Far Field transmitter technology to seamlessly mesh
(much like a network of WiFi routers) to form a wire-free charging network that will allow users to charge their devices as they walk from
room-to-room or throughout a large space. To date, we have developed multiple transmitter prototypes in various form factors and power
capabilities. We have also developed multiple receiver prototypes, including smartphone battery cases, toys, fitness trackers, Bluetooth
headsets and tracking devices, as well as stand-alone receivers.

When the company was first founded, we recognized the need to build and design an enterprise-class network management and control
system (“NMS”) that was integral to the architecture and development of our wire-free charging technology. Our NMS system can be
scaled up to control an enterprise consisting of thousands of devices or scaled down to work in a home or IoT environment.

The power, distance and mobility capabilities of the WattUp technology were validated by an internationally recognized independent
testing lab in October 2015, and the results are published on our website.

24

 
 
 
 
 
 
   
   
 
 
 
 
   
 
   
 
 
   
      
      
  
 
   
      
      
  
   
      
      
  
 
 
 
 
 
 
 
 
 
 
Our technology solution consists principally of transmitter and receiver ICs and novel antenna designs driven through innovative
algorithms and software applications. We submitted our first IC design for wafer fabrication in November 2013 and have since been
developing multiple generations of transmitter and receiver ICs, multiple antenna designs, as well as algorithms and software designs that
we believe, in the aggregate, will optimize our technology by reducing size and cost, while increasing performance to a level that will
enable our technology to be integrated into a broad spectrum of devices. We have developed a “building block” approach which allows us
to scale our product implementations by combining multiple transmitter building blocks and/or multiple receiver building blocks to provide
the power, distance, size and cost performance necessary to meet application requirements. While the technology is very scalable, in order
to provide the necessary strategic focus to grow the company effectively, we have defined our market as devices that require 10 watts or
less of power to charge. We will continue to invest in IC development as well as in the other components of the WattUp system to improve
product performance, efficiency, cost-performance and miniaturization as required to grow the business and expand the ecosystem, while
also distancing us from any potential competition.

We believe that if our development, regulatory and commercialization efforts are successful, our transmitter and receiver technology will
support a broad spectrum of charging solutions ranging from contact-based charging or charging at distances of a few millimeters (“near
field”) to charging at distances of up to 15 feet (“far field”).

In February 2015, we signed a Development and License Agreement with one of the top consumer electronic companies in the world based
on total worldwide revenues. The agreement is milestone-based and while there are no guarantees that the WattUp® technology will ever
be integrated into our strategic partner’s consumer devices, we continue to progress the relationship as evidenced by the achievement of
our revenues in 2016 from engineering services resulting from the achievement of certain milestones under the agreement. We anticipate
continued progress with the relationship which we expect will result in additional engineering services revenue and ultimately, if they
choose to incorporate our technology into one or more products, significant revenues based on the WattUp® technology being integrated
into products being shipped to consumers.

In February 2016, we began delivering evaluation kits to potential licensees to allow their respective engineering and product management
departments to test and evaluate our technology. We expect that the testing and evaluations currently taking place will lead to products
beginning to be shipped to consumers in the second half of 2017.

In November 2016, we entered into a Strategic Alliance Agreement with Dialog, pursuant to which Dialog will manufacture and distribute
IC products incorporating our wire-free charging technology. Dialog will be our exclusive supplier of these products for the general market.
Our WattUp technology will use Dialog's SmartBond® Bluetooth low energy solution as the out-of-band communications channel between
the wireless transmitter and receiver. In most cases Dialog's power management technology will then be used to distribute power from the
WattUp receiver IC to the rest of the device while Dialog's AC/DC Rapid Charge™ power conversion technology delivers power to the
wireless transmitter.

We have implemented an aggressive intellectual property strategy and are continuing to pursue patent protection for new innovations. As of
March 15, 2017, we had in excess of 250 pending patent and provisional patent applications. Additionally, the U.S. Patent and Trademark
Office (or the PTO) has issued 22 patents and notified us of the allowance of 10 additional patents. In addition to the inventions covered by
these patents and patent applications, we have identified a significant number of additional specific inventions we believe are novel and
patentable. We intend to file for patent protection for the most valuable of these, as well as for other new inventions that we expect to
develop. Our strategy is to continually monitor the costs and benefits of each patent application and pursue those that will best protect our
business and expand the core value of the Company.

Critical Accounting Estimates and Policies

The following discussion and analysis of financial condition and results of operations is based upon our financial statements, which have
been prepared in conformity with accounting principles generally accepted in the United States of America. Certain accounting policies and
estimates are particularly important to the understanding of our financial position and results of operations and require the application of
significant judgment by our management or can be materially affected by changes from period to period in economic factors or conditions
that are outside of our control. As a result, they are subject to an inherent degree of uncertainty. In applying these policies, our management
uses their judgment to determine the appropriate assumptions to be used in the determination of certain estimates. Those estimates are
based on our historical operations, our future business plans and projected financial results, the terms of existing contracts, our observance
of trends in the industry, information provided by our customers and information available from other outside sources, as appropriate.
Please see Note 3 to our financial statements for a more complete description of our significant accounting policies.

Basis of Presentation. The accompanying audited financial statements and footnotes for the years ended December 31, 2016 and 2015 have
been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and applicable
rules and regulations of the SEC regarding financial information.

25

 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue Recognition. We recognize revenue when the following criteria have been met: persuasive evidence of an arrangement exists,
services have been rendered, collection of the revenue is reasonably assured, and the fees are fixed or determinable.

We record revenue associated with product development projects that we enter into with certain customers. In general, these projects are
associated with complex technology development, and as such we do not have certainty about our ability to achieve the program
milestones. Achievement of the milestone is dependent on our performance and the milestone typically needs to be accepted by the
customer. The payment associated with achieving the milestone is generally commensurate with our effort or the value of the deliverable
and is nonrefundable. We record the expenses related to these projects, generally included in research and development expense, in the
periods incurred.

We also receive nonrefundable payments, typically at the beginning of a customer relationship, for which there are no milestones. We
recognize this revenue ratably over the initial engineering product development period. We record the expenses related to these projects,
generally included in research and development expense, in the periods incurred.

During the years ended December 31, 2016 and 2015, we recorded revenue of $1,451,941 and $2,500,000, respectively. We recorded no
revenue prior to 2015.

Research and Development. Research and development expenses are charged to operations as incurred. For internally developed patents, all
patent application costs are expensed as incurred as research and development expense. Patent application costs, generally legal costs, are
expensed as research and development costs until such time as the future economic benefits of such patents become more certain. The
Company incurred research and development costs of $32,832,677, $18,825,041 and $12,511,647 for the years ended December 31, 2016,
2015 and 2014, respectively.

Income Taxes. The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of items that have been
included or excluded in the financial statements or tax returns. Deferred tax assets and liabilities are determined on the basis of the
difference between the tax basis of assets and liabilities and their respective financial reporting amounts (“temporary differences”) at
enacted tax rates in effect for the years in which the temporary differences are expected to reverse.

For the years ended December 31, 2016, 2015 and 2014, the Company had $32,832,677, $15,464,406 and $11,519,310, respectively, of
research and development expenses capitalized for federal income tax purposes, with amortization commencing upon the Company
receiving an economic benefit from the related research. As of December 31, 2016, the Company had approximately $44,563,000 gross
federal net operating loss carryovers (“NOLs”) and a federal tax credit carryover of approximately $1,931,000. As of December 31, 2016
and 2015, deferred tax assets consisted principally of net operating loss and tax credit carryovers, the research and development costs and
stock-based compensation, and such deferred tax assets were fully reserved. Accordingly, the Company’s effective tax rate for the years
ended December 31, 2016, 2015 and 2014 was 0%.

Internal Revenue Code Section 382 imposes limitations on the use of net operating loss carryovers when the stock ownership of one or
more 5% shareholders (shareholders owning 5% or more of the Company’s outstanding capital stock) has increased on a cumulative basis
by more than 50 percentage points. Management cannot control the ownership changes occurring as a result of public trading of the
Company’s Common Stock. Accordingly, there is a risk of an ownership change beyond the control of the Company that could trigger a
limitation of the use of the loss carryover. The Company completed a Section 382 analysis as of December 31, 2016, and determined that
none of its NOLs or R&D credits would be limited.

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the
deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the future generation of taxable
income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of
deferred tax liabilities, projected future taxable income, and taxing strategies in making this assessment. Based on this assessment,
management has established a full valuation allowance against all of the net deferred tax assets for each period, since it is more likely than
not that all of the deferred tax assets will not be realized.

Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The
amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely to be realized upon settlement. A
liability for “unrecognized tax benefits” is recorded for any tax benefits claimed in the Company’s tax returns that do not meet these
recognition and measurement standards. As of December 31, 2016, and 2015, no liability for unrecognized tax benefits was required to be
reported. The guidance also discusses the classification of related interest and penalties on income taxes. The Company’s policy is to record
interest and penalties on uncertain tax positions as a component of income tax expense. No interest or penalties were recorded for the years
ended December 31, 2016, 2015 and 2014.

Common Stock Purchase Warrants and Other Derivative Financial Instruments. The Company classifies as equity any contracts that (i)
require physical settlement or net-share settlement or (ii) provides a choice of net-cash settlement or settlement in the Company’s own
shares (physical settlement or net-share settlement) providing that such contracts are indexed to the Company’s own stock as defined in
ASC 815-40 “Contracts in Entity’s Own Equity” (“ASC 815-40”). The Company classifies as assets or liabilities any contracts that (i)
require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the
Company’s control) or (ii) gives the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share
settlement). The Company assesses classification of common stock purchase warrants and other free standing derivatives at each reporting
date to determine whether a change in classification between assets and liabilities or equity is required.

26

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results of Operations

For the Years Ended December 31, 2016 and 2015

Revenues.  During the years ended December 31, 2016 and 2015, we recorded revenue of $1,451,941 and $2,500,000, respectively, upon
the achievement of milestones under a development and licensing agreement. The decrease in revenue of $1,048,059 is due to the timing of
the achievement of these milestones.

Operating Expenses.  During 2016, operating expenses are made up of research and development, sales and marketing, and general and
administrative expenses. Operating expenses for the years ended December 31, 2016 and 2015 were $47,282,661 and $30,077,339,
respectively.

Research and Development Costs. Research and development costs include costs for developing our technology, such as IC design costs,
salaries, software and facility costs. Research and development costs for the years ended December 31, 2016 and 2015 were $32,832,677
and $18,825,041, respectively. The increase in research and development costs of $14,007,636 is primarily due to a $4,640,880 increase in
compensation (including an increase in stock-based compensation of $1,409,597) from a larger headcount within the department, a
$4,483,417 increase in chip design, development and manufacturing costs for our receiver and transmitter chips, a $1,564,187 increase in
patent legal costs related to the management of our patent portfolio, an $883,272 increase in software expense due to incurring a full year of
the hosted design solution package and an increase in various engineering software licenses needed to support a larger staff and an $819,503
increase in consulting fees to assist in our quality assurance, design and regulatory efforts.

Sales and Marketing Costs. Sales and marketing costs for the years ended December 31, 2016 and 2015 were $3,201,549 and $3,221,303,
respectively. The decrease in sales and marketing costs of $19,754 is primarily due to minor decreases in consulting and travel, partially
offset by minor increases in compensation, recruiting and tradeshow expenses.

General and Administrative Expenses. General and administrative expenses include costs for general and corporate functions, including
facility fees, travel, telecommunications, insurance, professional fees, consulting fees and other overhead. General and administrative costs
for the years ended December 31, 2016 and 2015 were $11,248,435 and $8,030,995, respectively. The increase in general and
administrative expense of $3,217,440 is primarily due to a $2,966,474 increase in compensation, including stock-based compensation
increase of $2,547,733, from increased headcount within the department and newly executed executive stock award agreements, a $305,390
increase in telecommunications and miscellaneous office expenses to support a larger company headcount, a $232,667 increase in legal,
accounting and insurance fees, partially offset by a $163,341 decrease in consulting and outside service fees.

Loss from Operations.   Loss from operations for the years ended December 31, 2016 and 2015 was $45,830,720 and $27,577,339,
respectively.

Interest Income. Interest income for the year ended December 31, 2016 was $13,326 as compared to $15,637 for the year ended December
31, 2015.

Net Loss. As a result of the above, net loss for the year ended December 31, 2016 was $45,817,394 as compared to $27,561,702 for the
year ended December 31, 2015.

27

 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the Years Ended December 31, 2015 and 2014

Revenues.   During the year ended December 31, 2015, we recorded revenue of $2,500,000 upon the achievement of milestones under a
development and licensing agreement. We recorded no revenue in 2014.

Operating Expenses.   During 2015, operating expenses are made up of research and development, sales and marketing, and general and
administrative expenses. Operating expenses for the years ended December 31, 2015 and 2014 were $30,077,339 and $20,374,709,
respectively.

Research and Development Costs. Research and development costs include costs for developing our technology such as IC design costs,
salaries, software and facility costs. Research and development costs for the years ended December 31, 2015 and 2014 were $18,825,041
and $12,511,647, respectively. The increase in research and development costs of $6,313,394 is primarily due to a $6,324,357 increase in
compensation (including an increase in stock-based compensation of $1,892,005) from a larger headcount within the department, a
$698,690 increase in spending on components, third party design and engineering supplies principally in support of IC development, a
$543,928 increase in depreciation allocation, a $477,271 increase in office rent allocation and a $306,694 increase in software expenses
primarily from increased expenditures on engineering software, partially offset by a $1,460,768 decrease in consulting expenses as a result
of employees now handling duties formerly performed by consultants and a $719,224 decrease in patent filing expenses.

Sales and Marketing Costs. Sales and marketing costs for the years ended December 31, 2015 and 2014 were $3,221,303 and $2,803,359,
respectively. The increase in sales and marketing costs of $417,944 is primarily due to increased compensation of $339,355, including
increased stock-based compensation of $146,091, from an increased headcount within the department and an increase of $167,074 in trade
show expenses primarily as a result of participating in the 2015 Consumer Electronics Show, a $106,520 increase in public relations fees, a
$73,061 increase in depreciation allocation, a $41,516 increase in office rent allocation, partially offset by a $359,979 decrease in consulting
expenses primarily as a result of employees handling duties formerly performed by consultants.

General and Administrative Expenses. General and administrative expenses include costs for general and corporate functions, including
facility fees, travel, telecommunications, insurance, professional fees, consulting fees and other overhead. General and administrative costs
for the years ended December 31, 2015 and 2014 were $8,030,995 and $5,059,703, respectively. The increase in general and administrative
expense of $2,971,292 is primarily due to a $2,294,644 increase in compensation, including stock-based compensation increase of
$1,365,340, from increased headcount within the department and newly executed executive agreements in place during 2015, a $445,967
increase in legal, accounting and insurance costs primarily as a result of operating as a public company during the year ended December 31,
2015 and a $131,560 increase in consulting and outside information technology (IT) services, primarily as a result of increased outside IT
services to support a larger staff and fees paid to members of the board of directors.

Loss from Operations.   Loss from operations for the years ended December 31, 2015 and 2014 was $27,577,339 and $20,374,709,
respectively.

Change in Fair Value of Derivative Liabilities. Change in fair value of derivative liabilities for the year ended December 31, 2015 was $0
as compared to $26,265,177 for the year ended December 31, 2014, as the derivative liabilities were extinguished during the year ended
December 31, 2014.

Interest Income (Expense), Net. Interest income for the year ended December 31, 2015 was $15,637 as compared to interest expense, net of
$1,024,774 for the year ended December 31, 2014 which included amortization of debt discount of $0 and $964,851, respectively. The
change in interest income (expense), net, resulted primarily from the reduction in interest on the convertible notes, including the
amortization of debt discount. The related convertible notes were extinguished in April 2014 and accordingly there was no similar
amortization during the year ended December 31, 2015.

Gain on Debt Extinguishment. Gain on debt extinguishment for the year ended December 31, 2015 was $0 as compared to $2,084,368 for
the year ended December 31, 2014. The gain on debt extinguishment resulted from the April 2014 conversion of the convertible notes and
the related extinguishment of the notes, accrued interest payable and the derivative liability.

Net Loss. As a result of the above, net loss for the year ended December 31, 2015 was $27,561,702 as compared to $45,603,110 for the
year ended December 31, 2014.

28

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liquidity and Capital Resources

During years ended December 31, 2016 and 2015, we recorded revenue of $1,451,941 and $2,500,000, respectively. We incurred a net loss
of $45,817,394 and $27,561,702 for the years ended December 31, 2016 and 2015, respectively. Net cash used in operating activities was
$33,062,247 and $20,005,734 for the years ended December 31, 2016 and 2015, respectively. Since inception, we have met our liquidity
requirements principally through the private placement of convertible notes, the sale of our common stock in a registered initial public
offering, the sale of our common stock to a strategic investor, the issuance of our common stock to the Company’s landlord to reduce its
monthly base rent obligation and pay for certain tenant improvements, the sale of common stock in two secondary offerings, sale of stock
to investors in private placements and payments received under product development projects entered into with customers.

As of December 31, 2016, we had cash and cash equivalents of $31,258,637.

We believe our current cash on hand, together with anticipated payments under product development projects entered into with customers,
will be sufficient to fund our operations into the second quarter of 2018. However, depending on how soon we are able to achieve
meaningful commercial revenues, we may require additional financing to fully implement our business plan, the ultimate goal of which is
to license our technology to device manufacturers, wireless service providers and other commercial partners to make wire-free charging an
affordable, ubiquitous and convenient service for end users. Potential financing sources could include follow-on equity offerings, debt
financing, co-development agreements or other alternatives. Depending upon market conditions, we may choose to pursue additional
financing to, among other reasons, accelerate our product development efforts, regulatory activities and business development and support
functions with a view to capitalizing on the market opportunity we see for our wire-free charging technology. On April 24, 2015, we filed a
“shelf” registration statement on Form S-3, which became effective on April 30, 2015. The “shelf” registration statement allows the
Company from time to time to sell any combination of debt or equity securities described in the registration statement up to aggregate
proceeds of $75,000,000. In November 2015, the Company consummated an offering under the shelf registration of 3,000,005 shares of
common stock through which the Company raised net proceeds of $19,048,456.

During the year ended December 31, 2016, cash flows used in operating activities were $33,062,247, consisting of a net loss of
$45,817,394, less non-cash expenses aggregating $10,546,795 (representing principally stock-based compensation of $9,508,175 and
depreciation expense of $957,836), a $2,382,790 increase in accounts payable, a $492,616 increase in accrued expenses, partially offset by a
$652,336 increase in prepaid expenses and current assets. During the year ended December 31, 2015, cash flows used in operating activities
were $20,005,734, consisting of a net loss of $27,561,702, less non-cash expenses aggregating $6,849,927 (representing principally stock-
based compensation of $5,951,414 and depreciation expense of $817,729), a $157,769 increase in prepaid expenses and other current
assets, partially offset by an increase of $608,962 in accounts payable and an increase of $283,530 in accrued expenses.

During the years ended December 31, 2016 and 2015, cash flows used in investing activities were $1,137,446 and $1,032,795, respectively.
The cash used for year ended December 31, 2016 consisted of the purchase of laboratory equipment and software to help test our chips and
to accommodate the software needs of a larger engineering staff. The cash used for the year ended December 31, 2015 consisted of the
purchase of laboratory and computer equipment and software to accommodate newly hired employees and to support engineering services
and testing performed by our customers.

During the year ended December 31, 2016, cash flows provided by financing activities were $35,585,766, which primarily consisted of net
proceeds of $34,788,311 from the issuance of shares to private investors, proceeds from contributions to the employee stock purchase
program (“ESPP”) of $727,784, proceeds from the exercise of stock options of $382,351, offset by a total of $312,680 in shares
repurchased for tax withholdings on vesting of RSUs and PSUs. During the year ended December 31, 2015, cash flows provided by
financing activities were $19,416,501, which consisted of proceeds from the offering under the shelf registration of $19,048,456, proceeds
from contributions to the ESPP of $289,787, proceeds from the exercise of stock options of $65,647 and proceeds from the disgorgement of
profit from the sale of stock of $12,611.

Research and development of new technologies is, by its nature, unpredictable. Although we will undertake development efforts with
commercially reasonable diligence, there can be no assurance that our available resources including the net proceeds from our public
offerings will be sufficient to enable us to develop our technology to the extent needed to create future revenues to sustain our operations.

We cannot assure that our technology will be adopted, that we will ever earn revenues sufficient to support our operations, or that we will
ever be profitable. Furthermore, since we have no committed source of financing, there can be no assurance that we will be able to raise
capital as and when we need it to continue our operations.

Contractual Obligations

In the ordinary course of business, we routinely enter into purchase commitments for various aspects of our operations, such as purchases
of engineering supplies, lab equipment, chip design engineering, engineering consulting services and software licenses. We do not believe
these commitments will have a material effect on our financial condition, results of operations or cash flows.

29

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The following table summarizes our contractual obligations at December 31, 2016 and the effect such obligations are expected to have on
our liquidity and cash flows in future periods:

Operating leases
Engineering software commitment
Total

Off-Balance Sheet Transactions

Total

Less than 1 
Year

    1 to 3 Years    

More than 3 
Years

  $

  $

1,475,905    $
990,525     
2,466,430    $

572,722    $
792,420     
1,365,142    $

903,183    $
198,105     
1,101,288    $

- 
- 
- 

We do not have any off-balance sheet transactions.

Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

In the ordinary course of business, we may be exposed to certain market risks, such as interest rates. The annual impact of our results of
operations of a 100 basis point interest rate change on December 31, 2016 would be minimal. After an assessment of these risks to our
operations, we believe that the primary market risk exposures (within the meaning of Regulation S-K Item 305) are not material and are not
expected to have any material adverse impact on our financial position, results of operations or cash flows for the next fiscal year.

30

 
 
 
 
 
   
 
 
 
 
   
 
   
 
   
 
 
   
 
 
 
 
 
 
 
Item 8. Financial Statements and Supplementary Data.

Energous Corporation

INDEX TO FINANCIAL STATEMENTS

Report of Independent Registered Public Accounting Firm

Balance Sheets as of December 31, 2016 and 2015

Statements of Operations for the years ended December 31, 2016, 2015 and 2014

Statement of Changes in Stockholders' Equity (Deficit) for the years ended December 31, 2016, 2015 and 2014

Statements of Cash Flows for the years ended December 31, 2016, 2015 and 2014

Notes to Financial Statements

31

Page(s)

F-1

F-2

F-3

F-4

F-5

F-6

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders
of Energous Corporation

We have audited the accompanying balance sheets of Energous Corporation (the “Company”) as of December 31, 2016 and 2015 and the
related statements of operations, changes in stockholders’ equity (deficit), and cash flows for the years ended December 31, 2016, 2015 and
2014.  These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these
financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States).  Those
standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of
material misstatement.  The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial
reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are
appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control
over financial reporting. Accordingly, we express no such opinion.  An audit also includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.  We believe that our audit provides a reasonable basis for
our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Energous
Corporation as of December 31, 2016, and 2015, and the results of its operations and its cash flows for the years ended December 31, 2016,
2015 and 2014 in conformity with accounting principles generally accepted in the United States of America.

/s/ Marcum LLP
Marcum LLP
Melville, NY
March 16, 2017

F-1

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Energous Corporation
BALANCE SHEETS

ASSETS

Current assets:

Cash and cash equivalents
Accounts receivable
Prepaid expenses and other current assets
Prepaid rent, current
Total current assets

Property and equipment, net
Prepaid rent, non-current
Other assets

Total assets

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable
Accrued expenses
Deferred revenue

Total current liabilities

Commitments and contingencies

Stockholders’ equity:

Preferred Stock, $0.00001 par value, 10,000,000 shares authorized at December 31, 2016 and

December 31, 2015; no shares issued or outstanding

Common Stock, $0.00001 par value, 50,000,000 shares authorized at December 31, 2016 and
December 31, 2015; 20,367,929 and 16,298,208 shares issued and outstanding at December
31, 2016 and December 31, 2015, respectively.

Additional paid-in capital
Accumulated deficit

Total stockholders’ equity
Total liabilities and stockholders’ equity

F-2

As of
  December 31, 2016    December 31, 2015 

  $

  $

  $

31,258,637    $
149,500     
1,374,585     
80,784     
32,863,506     

2,209,475     
137,452     
48,507     
35,258,940    $

29,872,564 
- 
722,249 
80,784 
30,675,597 

1,730,365 
218,236 
51,330 
32,675,528 

4,707,763    $
1,867,995     
131,959     
6,707,717     

2,324,973 
1,075,879 
- 
3,400,852 

-     

- 

202     
153,075,595     

161 
107,981,695 

(124,524,574)    
28,551,223     
35,258,940    $

(78,707,180)
29,274,676 
32,675,528 

  $

 
 
 
 
 
 
 
   
      
  
   
      
  
   
   
   
   
 
   
      
  
   
   
   
 
   
      
  
   
      
  
   
      
  
   
   
   
 
   
      
  
   
      
  
 
   
      
  
   
      
  
   
   
   
   
   
 
 
 
Energous Corporation
STATEMENTS OF OPERATIONS

For the Year Ended December 31,
2015

2016

2014

Revenue

Operating expenses:

Research and development
Sales and marketing
General and administrative
Total operating expenses

Loss from operations

Other income (expense):

Change in fair value of derivative liabilities
Interest income (expense), net
Loss on retirement of fixed assets
Gain on debt extinguishment

Total

Net loss

  $

1,451,941    $

2,500,000    $

- 

32,832,677     
3,201,549     
11,248,435     
47,282,661     

18,825,041     
3,221,303     
8,030,995     
30,077,339     

12,511,647 
2,803,359 
5,059,703 
20,374,709 

(45,830,720)    

(27,577,339)    

(20,374,709)

-     
13,326     
-     
-     
13,326     

-     
15,637     
-     
-     
15,637     

(26,265,177)
(1,024,774)
(22,818)
2,084,368 
(25,228,401)

  $ (45,817,394)   $ (27,561,702)   $ (45,603,110)

Basic and diluted loss per common share

  $

(2.60)   $

(2.07)   $

(5.75)

Weighted average shares outstanding, basic and diluted

17,649,013     

13,303,715     

7,933,791 

F-3

 
 
 
 
 
 
 
 
   
   
 
 
   
     
     
 
 
   
      
      
  
   
      
      
  
   
   
   
   
 
   
      
      
  
   
 
   
      
      
  
   
      
      
  
   
   
   
   
   
 
   
      
      
  
 
   
      
      
  
 
   
      
      
  
   
 
 
 
Energous Corporation
STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)

Balance at January 1, 2014
Stock-based compensation - stock options
Stock-based compensation - IR consultant

warrant

Stock-based compensation - consultant restricted

stock units ("RSUs")

Stock-based compensation - shares issued to

consultant for services rendered

Issuance of shares to strategic investor, net of

Common Stock

Shares
2,708,217    $
-     

Amount

-     

-     

5,353     

27    $
-     

-     

-     

-     

263,972     

900,063     

50,000     

commission expense

210,527     

2     

899,998     

Additional 
Paid-in
Capital

    Accumulated    
Deficit
(5,542,368)   $
-     

197,249    $
1,333,943     

Total 
Stockholders'  
Equity
(5,345,092)
1,333,943 

Initial public offering on April 2, 2014, net of
underwriter's discount and offering costs of
$2,816,149

Conversion of convertible notes on April 2, 2014    
Sale of IPO underwriter warrant on April 2, 2014    
Extinguishment of derivative for consulting

warrant and financing warrant on June 25, 2014   

Shares issued to landlord for prepaid rent
Secondary offering on December 15, 2014, net
of underwriter's discount and offering costs of
$2,006,239

Net loss

Balance, December 31, 2014
Issuance of shares for services
Stock-based compensation - stock options
Stock-based compensation - IR warrants
Stock-based compensation - restricted stock units

("RSUs")

Stock-based compensation - employee stock

purchase plan ("ESPP")

Stock-based compensation - performance share

units ("PSUs")

Issuance of shares for RSUs
Issuance of shares for PSUs
Exercise of stock options
Disgorgement on account of short swing profit
Cashless exercise of warrants
Shares purchased from contributions to the ESPP    
Secondary offering on November 20, 2015, net
of underwriter's discount and offering costs of
$1,651,578

Net loss
Balance, December 31, 2015
Stock-based compensation - stock options
Stock-based compensation - restricted stock units

("RSUs")

Stock based compensation - deferred stock units

("DSUs")

Stock-based compensation - employee stock

purchase plan ("ESPP")

Stock-based compensation - performance share

units ("PSUs")

Issuance of shares for RSUs
Shares repurchased for tax withholdings on

vesting of RSUs

Issuance of shares for PSUs
Shares repurchased for tax withholdings on

vesting of PSUs

Exercise of stock options
Cashless exercise of warrants
Shares purchased from contributions to the ESPP    
Issuance of shares and warrants in private

4,600,000     
1,930,128     
-     

-     
41,563     

3,285,714     
-     
12,781,502    $

15,000     
-     
-     

-     

-     

-     
304,340     
1,072     
21,786     
-     
128,480     
46,023     

3,000,005     
-     
16,298,208    $
-     

-     

-     

-     

-     
519,200     

(20,669)    
209,673     

(3,607)    
130,354     
475,683     
85,356     

-     

-     

-     

-     

-     
-     
-     

-     
-     

263,972 

900,063 

50,000 

900,000 

24,783,851 
26,790,177 
1,000 

5,752,000 
500,000 

46     
19     
-     

24,783,805     
26,790,158     
1,000     

-     
-     

5,752,000     
500,000     

33     
-     
127    $

20,993,726     
-     

-     
(45,603,110)    
82,465,914    $ (51,145,478)   $

20,993,759 
(45,603,110)
31,320,563 

-     
-     
-     

147,900     
1,037,399     
85,831     

-     
-     
-     

147,900 
1,037,399 
85,831 

-     

4,225,728     

-     

4,225,728 

-     

-     
3     
-     
-     
-     
1     
-     

113,217     

489,239     
(3)    
-     
65,647     
12,611     
(1)    
289,787     

-     

-     
-     
-     
-     
-     
-     
-     

113,217 

489,239 
- 
- 
65,647 
12,611 
- 
289,787 

30     
-     

19,048,426     
-     

-     
(27,561,702)    
161    $ 107,981,695    $ (78,707,180)   $
-     

1,045,081     

-     

19,048,456 
(27,561,702)
29,274,676 
1,045,081 

-     

5,735,032     

-     

5,735,032 

-     

-     

-     
5     

-     
2     

-     
1     
5     
1     

123,644     

318,735     

2,285,683     
(5)    

(266,217)    
(2)    

(46,463)    
382,350     
(5)    
727,783     

-     

-     

-     
-     

-     
-     

-     
-     
-     
-     

123,644 

318,735 

2,285,683 
- 

(266,217)
- 

(46,463)
382,351 
- 
727,784 

 
 
 
 
 
   
 
 
   
   
   
   
 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
placements, net of issuance costs of $211,676    

Net loss
Balance, December 31, 2016

2,673,731     
-     
20,367,929    $

-     
27     
(45,817,394)    
-     
202    $ 153,075,595    $ (124,524,574)   $

34,788,284     
-     

34,788,311 
(45,817,394)
28,551,223 

F-4

   
   
 
 
 
Energous Corporation
STATEMENTS OF CASH FLOWS

For the Year Ended December 31,
2015

2016

2014

Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to:

Net cash used in operating activities:
Depreciation and amortization
Stock based compensation
Amortization of debt discount
Gain on conversion of notes payable and accrued interest
Change in fair market value of derivative liabilities
Loss on retirement of fixed assets
Amortization of prepaid rent from stock issuance to landlord

Changes in operating assets and liabilities:

Accounts receivable
Prepaid expenses and other current assets
Other assets
Accounts payable
Accrued expenses
Deferred revenue

Net cash used in operating activities

Cash flows used in investing activities:
Purchases of property and equipment
Net cash used in investing activities

Cash flows from financing activities:

Proceeds from IPO, net of underwriter's discount and offering expenses

Proceeds from the sale of stock to a strategic investor, net
Sale of Warrant to IPO underwriter
Proceeds from secondary offering, net of underwriter's discount and offering

expenses

Proceeds from shares issued under shelf registration, net of underwriter's discount

and offering expenses

Net proceeds from issuance of shares to private investors
Proceeds from the exercise of stock options
Proceeds from contributions to employee stock purchase plan
Shares repurchased for tax withholdings on vesting of RSUs
Shares repurchased for tax withholdings on vesting of PSUs
Proceeds from the disgorgement of short-swing profit

Net cash provided by financing activities

Net increase (decrease) in cash and cash equivalents

Cash and cash equivalents - beginning
Cash and cash equivalents - ending

Supplemental disclosure of non-cash financing activities:
Decrease in deferred offering costs charge to the IPO
Common stock issued upon conversion of notes payable and accrued interest

payable

Increase in additional paid in capital upon extinguishment of derivative liability for

warrants

Common stock issued to landlord for tenant improvement of $100,000 and prepaid

rent of $400,000

Common stock issued for services
Common stock issued for RSUs
Common stock issued for PSUs
Cashless exercise of warrants
Increase in accrued expenses for the purchase of property and equipment

F-5

  $ (45,817,394)   $ (27,561,702)   $ (45,603,110)

957,836     
9,508,175     
-     
-     
-     
-     
80,784     

817,729     
5,951,414     
-     
-     
-     
-     
80,784     

371,189 
2,547,978 
964,851 
(2,084,368)
26,265,177 
22,818 
20,196 

(149,500)    
(652,336)    
2,823     
2,382,790     
492,616     
131,959     
(33,062,247)    

-     
(157,769)    
(28,682)    
608,962     
283,530     
-     
(20,005,734)    

- 
(289,383)
(15,689)
1,354,973 
838,945 
- 
(15,606,423)

(1,137,446)    
(1,137,446)    

(1,032,795)    
(1,032,795)    

(1,619,694)
(1,619,694)

-     
-     
-     

-     

-     
-     
-     

24,872,170 
900,000 
1,000 

-     

20,993,759 

-     
34,788,311     
382,351     
727,784     
(266,217)    
(46,463)    
-     
35,585,766     

19,048,456     
-     
65,647     
289,787     
-     
-     
12,611     
19,416,501     

- 
- 
- 
- 
- 
- 
- 
46,766,929 

1,386,073     
29,872,564     
31,258,637    $

(1,622,028)    
31,494,592     
29,872,564    $

29,540,812 
1,953,780 
31,494,592 

-    $

-    $

-    $

-    $

88,319 

-    $

26,790,177 

-    $

5,752,000 

-    $
-    $
6    $
2    $
5    $
299,500    $

-    $
147,900    $
3    $
-    $
1    $
1    $

500,000 
- 
- 
- 
- 
- 

  $

  $

  $

  $

  $
  $
  $
  $
  $
  $

 
 
 
 
 
 
 
 
   
   
 
   
      
      
  
   
      
      
  
   
      
      
  
   
   
   
   
   
   
   
   
      
      
  
   
   
   
   
   
   
   
 
   
      
      
  
   
      
      
  
   
   
 
   
      
      
  
   
      
      
  
   
   
   
   
   
   
   
   
   
   
   
   
 
   
      
      
  
   
   
 
   
      
      
  
   
      
      
  
 
 
 
Note 1 - Business Organization, Nature of Operations

ENERGOUS CORPORATION
Notes to Financial Statements

Energous Corporation (the “Company”) was incorporated in Delaware on October 30, 2012. The Company has developed a technology
called WattUp® that consists of proprietary semiconductor chipsets, software, hardware designs and antennas that can enable RF-based
wire-free charging for electronic devices, providing power at a distance and ultimately enabling charging with mobility under full software
control. Pursuant to a Strategic Alliance Agreement with Dialog Semiconductor plc (“Dialog”), Dialog will manufacture and distribute
integrated circuit (“IC”) products incorporating the Company’s RF-based wire-free charging technology. Dialog will be the exclusive
supplier of these ICs for the general market. The Company believes its proprietary technology can potentially be utilized in a variety of
devices, including wearables, Internet of Things (IoT) devices, smartphones, tablets, e-book readers, keyboards, mice, remote controls,
rechargeable lights, cylindrical batteries and any other device with similar charging requirements that would otherwise need a battery or a
connection to a power outlet.

The Company is developing solutions that charge electronic devices by surrounding them with a contained three-dimensional (“3D”) radio
frequency (“RF”) energy pocket (“RF energy pocket”). The Company is engineering solutions that are expected to enable the wire-free
transmission of energy from multiple WattUp transmitters to multiple WattUp receiving devices within a range of up to 15 feet in radius or
in a circular charging envelope of up to 30 feet. The Company is also developing a transmitter technology to seamlessly mesh, (much like a
network of WiFi routers) to form a wire-free charging network that will allow users to charge their devices as they walk from room-to-room
or throughout a large space. To date, the Company has developed multiple transmitter prototypes in various form factors and power
capabilities. The Company has also developed multiple receiver prototypes supporting smartphone battery cases, toys, fitness trackers,
Bluetooth headsets and tracking devices, as well as stand-alone receivers.

Note 2 – Liquidity and Management Plans

During the year ended December 31, 2016, the Company has recorded revenue of $1,451,941. The Company incurred a net loss of
$45,817,394, 27,561,702 and $45,603,110 for the years ended December 31, 2016, 2015 and 2014, respectively. Net cash used in operating
activities was $33,062,247, 20,005,734 and $15,606,423 for the years ended December 31, 2016, 2015 and 2014, respectively. The
Company is currently meeting its liquidity requirements principally through sales of shares to three different private investors during
August 2016, November 2016 and December 2016, raising net proceeds of $34,788,311, and payments received under product
development projects entered into with a tier one customer.

As of December 31, 2016, the Company had cash on hand of $31,258,637. The Company expects that cash on hand as of December 31,
2016, together with anticipated revenues, will be sufficient to fund the Company’s operations into the second quarter of 2018.

Research and development of new technologies is, by its nature, unpredictable. Although the Company will undertake development efforts
with commercially reasonable diligence, there can be no assurance that its available resources including the net proceeds from the
Company’s IPO, secondary offering, shelf registration, and strategic investor financing will be sufficient to enable it to develop and obtain
regulatory approval of its technology to the extent needed to create future revenues sufficient to sustain its operations. The Company may
choose to pursue additional financing, depending upon the market conditions, which could include follow-on equity offerings, debt
financing, co-development agreements or other alternatives. Should the Company choose to pursue additional financing, there is no
assurance that the Company would be able to do so on terms that it would find acceptable.

F-6

 
 
 
 
 
 
 
 
 
 
 
 
ENERGOUS CORPORATION
Notes to Financial Statements

Note 3 – Summary of Significant Accounting Policies

Basis of Presentation

The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles
generally accepted in the United States of America (“U.S. GAAP”), and pursuant to the accounting and disclosure rules and regulations of
the U.S. Securities and Exchange Commission (the “SEC”).

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of
contingent liabilities at the date of the financial statements as well as the reported expenses during the reporting periods.

The Company’s significant estimates and assumptions include the valuation of stock-based compensation instruments, recognition of
revenue, the useful lives of long-lived assets, and income tax expense. Some of these judgments can be subjective and complex, and,
consequently, actual results may differ from these estimates. Although the Company believes that its estimates and assumptions are
reasonable, they are based upon information available at the time the estimates and assumptions were made. Actual results could differ
from those estimates.

Cash and Cash Equivalents

The Company considers all short-term, highly liquid investments with an original maturity at the date of purchase of three months or less to
be cash equivalents. The Company maintains cash balances that may be uninsured or in deposit accounts that exceed Federal Deposit
Insurance Corporation limits. The Company maintains its cash deposits with major financial institutions.

Revenue Recognition

The Company recognizes revenue when all of the following criteria have been met: persuasive evidence of an arrangement exists, services
have been rendered, collection of the revenue is reasonably assured, and the fees are fixed or determinable.

The Company records revenue associated with product development projects that it enters into with certain customers.  In general, these
projects are associated with complex technology development, and as such the Company does not have certainty about its ability to achieve
the program milestones. Achievement of the milestone is dependent on our performance and the milestone typically needs to be accepted
by the customer. The payment associated with achieving the milestone is generally commensurate with the Company’s effort or the value
of the deliverable and is nonrefundable. The Company records the expenses related to these projects, generally included in research and
development expense, in the periods incurred.

The Company also receives nonrefundable payments, typically at the beginning of a customer relationship, for which there are no
milestones. The Company recognizes this revenue ratably over the initial engineering product development period. The Company records
the expenses related to these projects, generally included in research and development expense, in the periods incurred.

Research and Development

Research and development expenses are charged to operations as incurred. For internally developed patents, all patent application costs are
expensed as incurred as research and development expense. Patent application costs, generally legal costs, are expensed as research and
development costs until such time as the future economic benefits of such patents become more certain. The Company incurred research
and development costs of $32,832,677, $18,825,041 and $12,511,647 for the years ended December 31, 2016, 2015 and 2014, respectively.

F-7

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ENERGOUS CORPORATION
Notes to Financial Statements

Note 3 – Summary of Significant Accounting Policies, continued

Stock-Based Compensation

The Company accounts for equity instruments issued to employees in accordance with accounting guidance that requires awards to be
recorded at their fair value on the date of grant and are amortized over the vesting period of the award. The Company recognizes
compensation costs on a straight line basis over the requisite service period of the award, which is typically the vesting term of the equity
instrument issued.

On April 10, 2015, the Company’s board of directors approved the Energous Corporation Employee Stock Purchase Plan (the “ESPP”),
under which 600,000 shares of common stock were reserved for purchase by the Company’s employees, subject to approval by the
stockholders. On May 21, 2015, the Company’s stockholders approved the ESPP. Under the plan, employees may purchase a limited
number of shares of the Company’s common stock at a 15% discount from the lower of the closing market prices measured on the first and
last days of each half-year period. The Company recognizes compensation expense for the fair value of the purchase options, as measured
on the grant date.

Income Taxes

Tax benefits are recognized only for tax positions that are more likely than not to be sustained upon examination by tax authorities. The
amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely to be realized upon settlement. A
liability for “unrecognized tax benefits” is recorded for any tax benefits claimed in the Company’s tax returns that do not meet these
recognition and measurement standards. As of December 31, 2016, no liability for unrecognized tax benefits was required to be reported.
The guidance also discusses the classification of related interest and penalties on income taxes. The Company’s policy is to record interest
and penalties on uncertain tax positions as a component of income tax expense. No interest or penalties were recorded during the years
ended December 31, 2016, 2015 and 2014. The Company files income tax returns with the United States and California governments.

Net Loss Per Common Share

Basic net loss per share is computed by dividing net loss available to common stockholders by the weighted average number of shares of
common stock outstanding during the period. Diluted earnings per share is computed using the weighted average number of common
shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental
common shares issuable upon the exercise of stock options and warrants (using the treasury stock method), the vesting of restricted stock
units (“RSUs”) and performance stock units (“PSUs”) and the enrollment of employees in the ESPP. The computation of diluted loss per
share excludes potentially dilutive securities of 6,975,651, 4,994,425 and 3,261,360 for the years ended December 31, 2016, 2015 and
2014, respectively, because their inclusion would be antidilutive.

Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net loss per share because the
effect of their inclusion would have been anti-dilutive.

Consulting Warrant to purchase common stock
Financing Warrant to purchase common stock
IPO Warrants to purchase common stock
IR Consulting Warrant
IR Incentive Warrant
Warrants issued to private investors
Options to purchase common stock
RSUs
PSUs
DSUs

Total potentially dilutive securities

F-8

For the Years Ended December 31,
2014
2015
2016
278,228 
146,252     
152,778 
152,778     
460,000 
460,000     
36,000 
36,000     
- 
15,000     
- 
-     
1,487,785      1,607,075 
727,279 
1,560,996     
- 
1,135,614     
- 
-     

-     
13,889     
11,600     
23,250     
15,000     
2,381,675     
1,309,444     
2,052,223     
1,153,617     
14,953     

6,975,651     

4,994,425      3,261,360 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
 
   
   
   
   
   
   
   
   
   
   
   
 
 
 
ENERGOUS CORPORATION
Notes to Financial Statements

Note 3 – Summary of Significant Accounting Policies, continued

Fair Value Measurements

The carrying amounts of cash and cash equivalents, accounts payable and accrued expenses, approximate fair value due to the short-term
nature of these instruments. Fair value is defined as an exit price, representing the amount that would be received upon the sale of an asset
or payment to transfer a liability in an orderly transaction between market participants. Fair value is a market-based measurement that is
determined based on assumptions that market participants would use in pricing an asset or liability. A three-tier fair value hierarchy is used
to prioritize the inputs in measuring fair value as follows:

Level 1
Level 2

Level 3

Quoted prices in active markets for identical assets or liabilities.
Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities
in markets that are not active, or other inputs that are observable, either directly or indirectly.
Significant unobservable inputs that cannot be corroborated by market data.

The assets or liability’s fair value measurement within the fair value hierarchy is based upon the lowest level of any input that is significant
to the fair value measurement.

As of December 31, 2014, the Company no longer had financial instruments which were derivative liabilities.

The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities that are measured at
fair value on a recurring basis:

Beginning balance
Change in fair value of conversion feature and warrants
Extinguishment of derivative liability upon conversion of Convertible Notes
Extinguishment of derivative liability upon modification of Financing Warrant
Extinguishment of derivative liability upon modification of Consulting Warrant
Ending balance

For the Year 
Ended 
December 31, 
2014
6,277,000 
26,265,177 
(26,790,177)
(1,733,000)
(4,019,000)
- 

  $

  $

The conversion feature of the Convertible Notes immediately prior to conversion was measured at fair value using a Monte Carlo
simulation (which also represented the intrinsic value of the conversion feature) and was classified within Level 3 of the valuation
hierarchy. The warrant liabilities for the Financing Warrant and the Consulting Warrant, immediately prior to modification were measured
at fair value using a Monte Carlo simulation and were classified within Level 3 of the valuation hierarchy. The significant assumptions and
valuation methods that the Company used to determine fair value and the change in fair value of the Company’s derivative financial
instruments are discussed in Note 6 – Private Placement.

Level 3 liabilities are valued using unobservable inputs to the valuation methodology that are significant to the measurement of the fair
value of the derivative liabilities. For fair value measurements categorized within Level 3 of the fair value hierarchy, the Company’s Chief
Financial Officer determined its valuation policies and procedures. The development and determination of the unobservable inputs for
Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s Chief Financial Officer with support
from the Company’s financial staff and consultants and which are approved by the Chief Financial Officer.

Level 3 financial liabilities consist of the derivative liabilities for which there is no current market for these securities such that the
determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of
the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate.

F-9

 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
   
   
 
 
 
 
 
 
ENERGOUS CORPORATION
Notes to Financial Statements

Note 3 – Summary of Significant Accounting Policies, continued

Fair Value Measurements, continued

The Company used a Monte Carlo model to value Level 3 financial liabilities at inception and on subsequent valuation dates, except that
the conversion feature of the convertible notes immediately prior to conversion was valued at intrinsic value. This simulation incorporates
transaction details such as the Company’s stock price, contractual terms, maturity, risk free rates, as well as, volatility. The Company also
used a binomial simulation and Black-Scholes economic model as supplemental valuation tools in order to validate the reasonableness of
the results of the Monte Carlo simulation when measuring the Financing Warrant and the Consulting Warrant.

A significant increase in the volatility or a significant increase in the Company’s stock price, in isolation, would result in a significantly
higher fair value measurement. Changes in the values of the derivative liabilities were recorded in Change in Fair Value of Derivative
Liabilities within Other Expense (Income) on the Company’s Statements of Operations.

Management determined that the results of its valuations are reasonable.

Recent Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue
from Contracts with Customers” (Topic 606), which supersedes the revenue recognition requirements in ASC Topic 605, "Revenue
Recognition," and most industry-specific guidance. This ASU is based on the principle that revenue is recognized to depict the transfer of
goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those
goods or services. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows
arising from customer contracts, including significant judgments and changes in judgments, and assets recognized from costs incurred to
obtain or fulfill a contract. The amendments in the ASU must be applied using one of two retrospective methods and are effective for
annual and interim periods beginning after December 15, 2016. On July 9, 2015, the FASB modified ASU 2014-09 to be effective for
annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. As modified, the FASB
permits the adoption of the new revenue standard early, but not before the annual periods beginning after December 15, 2016. A public
organization would apply the new revenue standard to all interim reporting periods within the year of adoption. The Company will
evaluate the effects, if any, that adoption of this guidance will have on its financial statements.

In August 2014, FASB issued ASU No. 2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of
Uncertainties about an Entity’s Ability to Continue as a Going Concern. This standard is intended to define management’s responsibility to
evaluate whether there is substantial doubt about an organization’s ability to continue as a going concern and to provide related footnote
disclosures. Under U.S. GAAP, financial statements are prepared under the presumption that the reporting organization will continue to
operate as a going concern, except in limited circumstances. Financial reporting under this presumption is commonly referred to as the
going concern basis of accounting.

The going concern basis of accounting is critical to financial reporting because it establishes the fundamental basis for measuring and
classifying assets and liabilities. Currently, U.S. GAAP lacks guidance about management’s responsibility to evaluate whether there is
substantial doubt about the organization’s ability to continue as a going concern or to provide related footnote disclosures. This ASU
provides guidance to an organization’s management, with principles and definitions that are intended to reduce diversity in the timing and
content of disclosures that are commonly provided by organizations today in the financial statement footnotes. The amendments are
effective for annual periods ending after December 15, 2016, and interim periods within annual periods beginning after December 15, 2016.
The Company adopted ASU 2014-15 and management has made the appropriate evaluations and disclosures in Note 2 – Liquidity and
Management Plans.

In April 2015, the FASB issued ASU No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs.” This standard amends existing
guidance to require the presentation of debt issuance costs in the balance sheet as a deduction from the carrying amount of the related debt
liability instead of a deferred charge. It is effective for annual reporting periods beginning after December 15, 2015. The Company has
adopted ASU 2015-03 and the adoption of this standard did not have a material impact on the Company’s financial position and results of
operations.

F-10

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ENERGOUS CORPORATION
Notes to Financial Statements

Note 3 – Summary of Significant Accounting Policies, continued

Recent Accounting Pronouncements, continued

In August 2015, the FASB issued ASU No. 2015-15, “Presentation and Subsequent Measurement of Debt Issuance Costs Associated with
Line-of-Credit Arrangements” – Amendments to SEC Paragraphs Pursuant to Staff Announcement at June 18, 2015, which clarified the
SEC staff’s position on presenting and measuring debt issuance costs incurred in connection with line-of-credit arrangements. ASU 2015-
15 should be adopted concurrent with the adoption of ASU 2015-03. The Company has adopted ASU 2015-15 and the adoption of this
standard did not have a material impact on the Company’s financial position and results of operations.

In November 2015, the FASB issued ASU No. 2015-17, “Balance Sheet Classification of Deferred Taxes” (“ASU 2015-17”). The standard
requires that deferred tax assets and liabilities be classified as noncurrent in a classified statement of financial position. ASU 2015-17 is
effective for fiscal years and interim periods within those years, beginning after December 15, 2016. Early adoption is permitted. ASU
2015-17 may be applied either prospectively, for all deferred tax assets and liabilities, or retrospectively. The Company has early adopted
ASU 2015-17 effective December 31, 2015, retrospectively. Adoption had no impact on the results of operations.

In January 2016, the FASB issued ASU No. 2016-01, “Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement
of Financial Assets and Financial Liabilities” (“ASU 2016-01”). The standard addresses certain aspects of recognition, measurement,
presentation, and disclosure of financial instruments. ASU 2016-01 is effective for fiscal years, and interim periods within those years,
beginning after December 15, 2017. The Company is currently evaluating the impact the adoption of this new standard will have on its
financial statements.

In January 2016, the FASB issued ASU No. 2016-02, “Leases (Topic 842).” (“ASU 2016-02”) This standard requires that a lessee
recognize the assets and liabilities that arise from operating leases. A lessee should recognize in the statement of financial position a
liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease
term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset
not to recognize lease assets and lease liabilities. In transition, lessees and lessors are required to recognize and measure leases at the
beginning of the earliest period presented using a modified retrospective approach. ASU 2016-02 is effective for fiscal years, and interim
periods within those years, beginning after December 15, 2018. The Company is currently evaluating the impact the adoption of this new
standard will have on its financial statements.

In March 2016, the FASB issued ASU No. 2016-08, “Revenue from Contracts with Customers (Topic 606) – Principal versus Agent
Considerations (Reporting Revenue Gross versus Net)” (“ASU 2016-08”). ASU No. 2016-08 maintains the core principles of Topic 606 on
revenue recognition, but clarifies whether an entity is a principal or an agent in a contract and the appropriate revenue recognition
principles under each of these circumstances. The amendments in ASU 2016-08 affect the guidance of ASU 2014-09 which is not yet
effective. The Company will evaluate the effects, if any, that adoption of this guidance will have on its financial statements.

In March 2016, the FASB issued ASU No. 2016-09, “Compensation — Stock Compensation (Topic 718) — Improvements to Employee
Share-Based Payment Accounting.” ASU No. 2016-09 includes provisions to simplify certain aspects related to the accounting for share-
based awards and the related financial statement presentation. This ASU includes a requirement that the tax effect related to the settlement
of share-based awards be recorded in income tax benefit or expense in the statements of earnings. This change is required to be adopted
prospectively in the period of adoption. In addition, the ASU modifies the classification of certain share-based payment activities within the
statements of cash flows and these changes are required to be applied retrospectively to all periods presented, or in certain cases
prospectively, beginning in the period of adoption. ASU No. 2016-09 is effective for annual reporting periods beginning after December
15, 2016, including interim periods within that reporting period. Early adoption is permitted. The Company is currently evaluating the
impact the adoption of this new standard will have on its financial statements.

In April 2016, the FASB issued ASU No. 2016-10, “Revenue from Contracts with Customers (Topic 606) - Identifying Performance
Obligations and Licensing.” ASU No. 2016-10 maintains the core principles of Topic 606 on revenue recognition, but clarifies
identification of performance obligations and licensing implementation guidance. The amendments in ASU 2016-10 affect the guidance of
ASU 2014-09 which is not yet effective. The Company will evaluate the effects, if any, that adoption of this guidance will have on its
financial statements.

In May 2016, the FASB issued ASU No. 2016-12, “Revenue from Contracts with Customers (Topic 606) - Narrow- Scope Improvements
and Practical Expedients.” ASU No. 2016-12 maintains the core principles of Topic 606 on revenue recognition, but addresses
collectability, sales tax presentation, noncash consideration, contract modifications at transition and completed contracts at transition. The
amendments in ASU 2016-12 affect the guidance of ASU 2014-09 which is not yet effective. The Company will evaluate the effects, if
any, that adoption of this guidance will have on its financial statements.

F-11

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ENERGOUS CORPORATION
Notes to Financial Statements

Note 3 – Summary of Significant Accounting Policies, continued

Recent Accounting Pronouncements, continued

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments – Credit Losses (Topic 326) – Measurement of Credit Losses on
Financial Instruments.” ASU No. 2016-13 provides financial statement reader more decision-useful information about the expected credit
losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. The Company will
evaluate the effects, if any, that adoption of this guidance will have on its financial statements.

In August 2016, the FASB issued ASU No. 2016-15, “Statement of Cash Flows (Topic 230) – Classification of Certain Cash Receipts and
Cash Payments.” ASU No. 2016-15 addresses eight specific cash flow issues with the objective of reducing the existing diversity in
practice. It is effective for annual reporting periods beginning after December 15, 2017. The Company is currently evaluating the impact
this standard will have on its financial statements.

In November 2016, the FASB issued ASU No. 2016-18, “Statement of Cash Flows (230) – Restricted Cash.” ASU No. 2016-18 requires an
entity to include amounts described as restricted cash and restricted cash equivalents with cash and cash equivalents when reconciling the
beginning-of-period and end-of-period total amounts shown on the statement of cash flows. It is effective for annual reporting periods
beginning after December 15, 2018. The adoption of this standard is not expected to have a material impact on the Company’s financial
position and results of operations.

In December 2016, the FASB issued ASU No. 2016-20, “Technical Corrections and Improvements to Topic 606, Revenue from Contracts
with Customers.” ASU No. 2016-20 amends certain aspects of ASU No. 2014-09 and clarifies, rather than changes, the core revenue
recognition principles in ASU No. 2014-09. It is effective for annual reporting periods beginning after December 15, 2018. The adoption of
this standard is not expected to have a material impact on the Company’s financial position and results of operations.

Management’s Evaluation of Subsequent Events

The Company evaluates events that have occurred after the balance sheet date of December 31, 2016, through the date which the financial
statements are issued. Based upon the review, the Company did not identify any subsequent events that would have required adjustment or
disclosure in the financial statements.

F-12

 
 
 
 
 
 
 
 
 
 
 
 
 
ENERGOUS CORPORATION
Notes to Financial Statements

Note 4 – Property and Equipment

Property and equipment are as follows:

Computer software
Computer hardware
Furniture and fixtures
Leasehold improvements

Less – accumulated depreciation
Total property and equipment, net

As of December 31,

2016
1,085,258    $
2,109,983     
533,175     
613,111     
4,341,527     
(2,132,052)    
2,209,475    $

2015

650,386 
1,203,021 
457,887 
593,287 
2,904,581 
(1,174,216)
1,730,365 

  $

  $

The Company currently uses the following expected life terms for depreciating property and equipment: computer software – 1 year,
computer hardware – 3 years, furniture and fixtures – 7 years, leasehold improvements – remaining life of the lease.

Total depreciation and amortization expense of the Company’s property and equipment was $957,836, $817,729 and $371,189 for the years
ended December 31, 2016, 2015 and 2014, respectively.

Note 5 – Accrued Expenses

Accrued expenses consist of the following:

Accrued compensation
Accrued legal expenses
Accrued equipment cost
Other accrued expenses
Total

  As of December 31,
2015

2016

  $ 997,908    $ 739,782 
- 
- 
336,097 
  $ 1,867,995    $ 1,075,879 

283,160     
299,500     
287,427     

F-13

 
 
 
 
 
 
 
 
 
   
 
   
   
   
 
   
   
 
 
 
 
 
 
 
 
   
 
   
   
   
 
 
 
ENERGOUS CORPORATION
Notes to Financial Statements

Note 6 – Commitments and Contingencies

Investor Relations Agreements

Effective January 13, 2014, the Company entered into an agreement with a vendor (“IR Firm”) to provide investor relations services to the
Company. Pursuant to the agreement, in addition to monthly cash compensation of $8,000 per month, on March 27, 2014 the Company
issued to the IR firm a consulting warrant (“IR Consulting Warrant”) for the purchase of 36,000 shares of common stock. The IR
Consulting Warrant has a strike price of $7.80, representing 130% of the IPO price. The IR Consulting Warrant had an initial catch up
vesting equivalent to 3,000 shares per month of service, partial months to be prorated on a thirty (30) day basis, from the effective date of
this agreement until March 27, 2014. Thereafter, the IR Consulting Warrant vested at a rate of 3,000 shares per month of service. On
February 26, 2015, the Company issued to the IR Firm incentive warrants (“IR Incentive Warrants”) to purchase 15,000 shares of common
stock with a strike price of $7.80 based upon certain qualified investors and/or institutional or brokerage firms having purchased at least
$250,000 in value of the Company’s common shares at the IPO price or greater in the open market on or after the 46th day following March
27, 2014. All IR Incentive Warrants granted during a six-month period will collectively vest at each six-month anniversary. Both the IR
Consulting Warrant and IR Incentive Warrants will have an expiration date four (4) years from the grant date. The shares underlying both
the IR Consulting Warrant and the IR Incentive Warrants may be exercised on a cashless basis if at the time of exercise, such warrant
shares have not been registered.

As of December 31, 2015, and 2014, 36,000 and 34,800 shares under the IR Consulting Warrant were vested. The Company incurred stock-
based compensation expense of $0, $7,522 and $263,972 for the years ended December 31, 2016, 2015 and 2014, respectively in
connection with the IR Consulting Warrant, which was included in general and administrative expense.

As of December 31, 2014, a total of 15,000 IR Incentive Warrants were deemed to have vested. Accordingly, as of December 31, 2014, the
Company recorded the accrued value of the IR Incentive Warrant of approximately $92,000 in general and administrative expenses, since
the Company does not record stock-based compensation until the associated warrant is approved by the Board of Directors and issued. On
February 26, 2015, the Board of Directors approved the issuance of a warrant to purchase 15,000 shares of the Company’s common stock
and the Company recorded stock-based compensation of $78,309.

On February 4, 2015, the Company entered into a six-month consulting agreement with a consultant to provide the Company with investor
relations services. Compensation under the agreement included the Company’s issuance on February 26, 2015, of 15,000 shares of common
stock valued at $147,900 and monthly cash payments of $5,000. The total value of the common stock compensation was recorded as a
prepaid expense and was amortized over the six-month contract period. The Company incurred amortization expense of $147,900 during
the year ended December 31, 2015, which was included in general and administrative expense. There was no amortization expense during
the year ended December 31, 2016.

Operating Leases

On September 10, 2014, the Company entered into a Lease Agreement with Balzer Family Investments, L.P. (the “Landlord”) related to
space located at Northpointe Business Center, 3590 North First Street, San Jose, California. The initial term of the lease is 60 months, with
initial monthly base rent of $36,720 and the lease is subject to certain annual escalations as defined in the agreement. On October 1, 2014,
the Company relocated its headquarters to this new location.  The Company issued to the Landlord 41,563 shares of the Company’s
common stock valued at $500,000, of which $400,000 will be applied to reduce the Company’s monthly base rent obligation by $6,732 per
month and of which $100,000 was for certain tenant improvements. The Company recorded $400,000 as prepaid rent on its balance sheet,
which is being amortized over the term of the lease and recorded $100,000 as leasehold improvements.

F-14

 
 
 
 
 
 
 
 
 
 
 
 
 
ENERGOUS CORPORATION
Notes to Financial Statements

Note 6 – Commitments and Contingencies, continued

Operating Leases, continued

On February 26, 2015, the Company entered into a sub-lease agreement for additional space in the San Jose area. The agreement has a term
which expires on June 30, 2019 and an initial monthly rent of $6,109 per month. On August 25, 2015 the Company entered into an
additional amended sub-lease agreement for additional space in San Jose, CA. The agreement has a term which expires on June 30, 2019
and an initial monthly rent of $4,314 per month. These leases are subject to certain annual escalations as defined in the agreements.

On July 9, 2015, the Company entered into a sub-lease agreement for additional space in Costa Mesa, CA. The agreement has a term which
expires on September 30, 2017 and a monthly rent of $6,376 per month.

The future minimum lease payments for leased locations are as follows:

For the Years Ended December 31,
2017
2018
2019
Total

Development and Licensing Agreement

  Amount

572,722 
530,531 
372,652 
 $ 1,475,905 

Effective January 28, 2015, the Company signed a development and licensing agreement with a consumer electronics company to embed
WattUp wire-free charging receiver technology in various products including, but not limited to certain mobile consumer electronics and
related accessories. During the development phase and through customer shipment of its first product, Energous will afford this customer an
exclusive “time to market advantage” in the licensed product categories.

This development and licensing agreement contains both invention and development milestones that the Company will need to achieve
during the next two years. Pursuant to the Agreement, on March 23, 2015, the Company received an initial non-refundable payment of
$500,000 which was recognized as revenue during the year ended December 31, 2015. The agreement provides for additional amounts to
be received by the Company based upon its achievement of certain milestones. During the year ended December 31, 2015, the Company
recognized revenue of $2,000,000 upon the achievement of additional milestones under the agreement.

Effective April 3, 2015, the Company entered into an amendment of the development and license agreement with this consumer electronics
company to include joint development of wire-free transmitter technology and technology license back to the Company. On June 5, 2015,
the Company entered into a second amendment of the development and license agreement with this consumer electronics company to
conform the agreement for technical changes in the product delivery milestones. Effective October 1, 2015, the Company entered into a
third amendment of the development and license agreement with this consumer electronics company to make certain changes to, among
other things, intellectual property ownership, payment terms and the products covered by the agreement. On March 31, 2016, the Company
received payment of $500,000 pursuant to the February 15, 2016 commencement of the second phase described in the third amendment, of
which the Company recorded $391,041 in revenue during the year ended December 31, 2016. During the year ended December 31, 2016,
the Company recognized revenue of $1,000,000 upon the achievement of additional milestones under the second phase of the agreement.

Effective May 27, 2016, the Company entered into an agreement with a commercial and industrial supply company, under which the
Company will develop wire-free charging solutions. Under the first phase of the associated Statement of Work, the Company made certain
deliverables for fees totaling $60,000. The first invoice for $30,000 was sent to the customer in June 2016 and revenue was initially
deferred until completion of the first phase. The second invoice for $30,000 was issued upon successful completion of the first phase during
September 2016 and revenue for the total fees of $60,000 was then recognized. In December 2016, the Company issued an invoice for
$22,500 to this customer for the first installment of the second phase of this agreement. Revenue for this invoice has been deferred until
completion of the second phase which is anticipated to occur during the first quarter of 2017.

Hosted Design Solution Agreement

On June 25, 2015, the Company entered into a three-year agreement to license electronic design automation software in a hosted
environment. Pursuant to the agreement, under which services began July 13, 2015, the Company is required to remit quarterly payments in
the amount of $100,568 with the last payment due March 30, 2018. On December 18, 2015, the agreement was amended to redefine the
hardware and software configuration and the quarterly payments increased to $198,105.

F-15

 
 
 
 
 
 
 
 
 
  
  
  
 
 
 
 
 
 
 
 
 
 
ENERGOUS CORPORATION
Notes to Financial Statements

Note 6 – Commitments and Contingencies, continued

Amended Employee Agreement – Stephen Rizzone

On April 3, 2015, the Company entered into an Amended and Restated Executive Employment Agreement with Stephen R. Rizzone, the
Company’s President and Chief Executive Officer (the “Employment Agreement”).

The Employment Agreement has an effective date of January 1, 2015 and an initial term of four years (the “Initial Employment Period”).
The Employment Agreement provides for an annual base salary of $365,000, and Mr. Rizzone is eligible to receive quarterly cash bonuses
with a total target amount equal to 100% of his base salary based upon achievement of performance-based objectives established by the
Company’s board of directors.

Pursuant to Mr. Rizzone’s prior employment agreement, on December 12, 2013 Mr. Rizzone was granted a ten year option to purchase
275,689 shares of common stock at an exercise price of $1.68 vesting over four years in 48 monthly installments beginning October 1, 2013
(the “First Option”). Mr. Rizzone was also granted a second option award to purchase 496,546 shares of common stock at an exercise price
of $6.00 (the “Second Option”). The Second Option vests over the same vesting schedule as the First Option.

Effective with the approval on May 21, 2015 by the Company’s stockholders of its new performance-based equity plan, the Employment
Agreement provided and Mr. Rizzone received, a grant of 639,075 Performance Share Units (the “PSUs”). The PSUs, which represent the
right to receive shares of common stock, shall be earned based on the Company’s achievement of market capitalization growth between the
effective date of the Employment Agreement and the end of the Initial Employment Period. If the Company’s market capitalization is $100
million or less, no PSUs will be earned. If the Company reaches a market capitalization of $1.1 billion or more, 100% of the PSUs will be
earned. For market capitalization between $100 million and $1.1 billion, the percentage of PSUs earned will be determined on a quarterly
basis based on straight line interpolation. PSUs earned as of the end of a calendar quarter will be paid 50% immediately and 50% will be
deferred until the end of the Initial Employment Period subject to Mr. Rizzone’s continued employment with the Company (See Note 9).

Mr. Rizzone is also eligible to receive all customary and usual benefits generally available to senior executives of the Company.

The Employment Agreement provides that if Mr. Rizzone’s employment is terminated due to his death or disability, if Mr. Rizzone’s
employment is terminated by the Company without cause or if he resigns for good reason, twenty-five percent (25%) of the shares subject
to the First Option and the Second Option shall immediately vest and become exercisable, he will have a period of one year post-
termination to exercise the First Option and the Second Option, and if a Liquidation Event (as defined in the Employment Agreement) shall
occur prior to the termination of the First Option and the Second Option, one hundred percent (100%) of the shares subject to the First
Option and Second Option shall immediately vest and become exercisable effective immediately prior to the consummation of the
Liquidation Event. In addition, any outstanding deferred PSUs shall be immediately vested and paid, but any remaining unearned portion of
the PSUs shall immediately be canceled and forfeited.

Offer Letter – Brian Sereda

Effective July 13, 2015, the Company appointed Brian Sereda to serve as Vice President and Chief Financial Officer, replacing Interim
Chief Financial Officer Howard Yeaton.

In connection with Mr. Sereda’s appointment as Vice President and Chief Financial Officer, the Company and Mr. Sereda executed an
offer letter effective July 13, 2015 (the “Sereda Offer Letter”). Under the Sereda Offer Letter, Mr. Sereda will receive an annual base
salary of $250,000 per year, and is eligible to earn an annual performance bonus of up to 75% of his then current base salary in accordance
with performance objectives established by the Company’s independent compensation committee or the Board of Directors. In addition,
under the Sereda Offer Letter and as an inducement to join the Company, Mr. Sereda received an inducement restricted stock unit award
covering a total of 120,000 shares of common stock. This restricted stock unit award vests over a period of four years in four equal annual
installments on July 13 of each of 2016, 2017, 2018 and 2019, subject to Mr. Sereda’s continued employment with the Company through
each vesting date.

In the event Mr. Sereda is terminated without cause, he is entitled to (1) six months of his then-current base salary and (2) payment of
COBRA premiums for up to six months. In the event of a liquidation event and termination of employment, except for cause, 100% of the
inducement award shall immediately vest.

F-16

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ENERGOUS CORPORATION
Notes to Financial Statements

Note 6 – Commitments and Contingencies, continued

Patent Validity Challenge

In June 2016, Ossia Inc. filed two post grant review petitions with the U.S. Patent and Trademark Office (“PTO”) requesting proceedings to
challenge the validity of one of our issued patents. One of the post grant reviews was denied completely, and the other was terminated
when the Company voluntarily cancelled two claims of the patent. There was no other material impact on the Company’s intellectual
property or patent portfolio as a result of these petitions.

Strategic Alliance Agreement

On November 7, 2016, the Company and Dialog Semiconductor plc entered into a Strategic Alliance Agreement (“Alliance Agreement”)
for the manufacture, distribution and commercialization of products incorporating the Company’s wire-free charging technology
(“Licensed Products”). Pursuant to the terms of the Alliance Agreement, the Company agreed to engage Dialog as the exclusive supplier of
the Licensed Products for specified fields of use, subject to certain exceptions (the “Company Exclusivity Requirement”). Dialog agreed to
not distribute, sell or work with any third party to develop any competing products without the Company’s approval (the “Dialog
Exclusivity Requirement”). In addition, both parties agreed on a revenue sharing arrangement and will collaborate on the commercialization
of Licensed Products based on a mutually-agreed upon plan. Each party will retain all of its intellectual property.

The Alliance Agreement has an initial term of seven years and will automatically renew annually thereafter unless terminated by either
party upon 180 days’ prior written notice. The Company may terminate the Alliance Agreement at any time after the third anniversary of
the Agreement upon 180 days’ prior written notice to Dialog, or if Dialog breaches certain exclusivity obligations. Dialog may terminate
the Agreement if sales of Licensed Products do not meet specified targets. The Company Exclusivity Requirement will terminate upon the
earlier of January 1, 2021 or the occurrence of certain events relating to the Company’s pre-existing exclusivity obligations. The Dialog
Exclusivity Requirement will terminate if no Licensed Products have received the necessary Federal Communications Commission
approvals within specified timeframes.

Note 7 – Stockholders’ Equity

Authorized Capital

The holders of the Company’s common stock are entitled to one vote per share. Holders of common stock are entitled to receive ratably
such dividends, if any, as may be declared by the board of directors out of legally available funds. Upon the liquidation, dissolution or
winding up of the Company, holders of common stock are entitled to share ratably in all assets of the Company that are legally available for
distribution.

Disgorgement of Short Swing Profits

On April 11, 2015, $12,611 of proceeds was received from an officer of the Company who had purchased shares in the December 2014
secondary offering, representing the disgorgement of a short swing profit on the officer’s April 2015 sale of the Company’s stock.

Filing of registration statement

On April 24, 2015, the Company filed a “shelf” registration statement on Form S-3, which became effective on April 30, 2015. The “shelf”
registration statement allows the Company from time to time to sell any combination of debt or equity securities described in the
registration statement up to aggregate proceeds of $75,000,000.

F-17

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ENERGOUS CORPORATION
Notes to Financial Statements

Note 7 – Stockholders’ Equity, continued

Consummation of Offering under Shelf Registration

Pursuant to the shelf registration, on November 17, 2015, the Company consummated an offering of 3,000,005 shares of common stock at
$6.90 per share and received from the underwriters’ net proceeds of $19,333,032 (net of underwriters’ discount of $1,242,002 and
underwriters’ offering expenses of $125,000). The Company incurred additional offering expenses of $284,576, yielding net proceeds from
the offering under shelf registration of $19,048,456.

Private Placements

On August 9, 2016, the Company entered into a securities purchase agreement with Ascend Legend Master Fund, Ltd. pursuant to which
the Company agreed to sell to Ascend Legend Master Fund, Ltd. 1,618,123 shares of common stock at a price of $12.36 per share and a
warrant to purchase up to 1,618,123 shares of common stock at an exercise price of $23.00 per share. The aggregate proceeds from the sale
of shares of common stock was $20,000,000.

On November 7, 2016, the Company and Dialog Semiconductor entered into a securities purchase agreement pursuant to which the
Company agreed to sell to Dialog Semiconductor 763,552 shares of common stock at a price of $13.0967 per share and a warrant to
purchase up to 763,552 shares of common stock that may be exercised only on a cashless basis at a price of $17.0257 per share, and may be
exercised at any time between the date that is six months and a day after the closing date of the transaction and the three-year anniversary
of the Closing Date. The aggregate proceeds from the sale of shares of common stock was 10,000,011.

On December 30, 2016, the Company and JT Group entered into a securities purchase agreement pursuant to which the Company agreed to
sell to JT Group 292,056 shares of common stock at a price of $17.12 per share. The aggregate proceeds from the sale of shares of common
stock was $4,999,975.

F-18

 
 
 
 
 
 
 
 
 
 
 
 
ENERGOUS CORPORATION
Notes to Financial Statements

Note 8 – Stock Based Compensation

Equity Incentive Plans

2013 Equity Incentive Plan

In December 2013 the Company’s board and stockholders approved the “2013 Equity Incentive Plan”, providing for the issuance of equity
based instruments covering up to an initial total of 1,042,167 shares of common stock.

Effective on March 10, 2014, the Company’s board of directors and stockholders approved the First Amendment to the 2013 Equity
Incentive Plan which provided for an increase in the aggregate number of shares of common stock that may be issued pursuant to the Plan
to equal 18% of the total number of shares of common stock outstanding immediately following the completion of the IPO (assuming for
this purpose the issuance of all shares issuable under the Company’s equity plans, the conversion into common stock of all outstanding
securities that are convertible by their terms into common stock and the exercise of all options and warrants exercisable for shares of
common stock and including shares and warrants issued to the underwriters for such IPO upon exercise of its over-allotment options).

Effective March 27, 2014, the aggregate total shares which may be issued under the 2013 Equity Incentive Plan were increased to
2,335,967.

Effective on May 19, 2016, the Company’s stockholders approved the amendment and restatement of the 2013 Equity Incentive Plan to
increase the number of shares reserved for issuance thereunder by 2,150,000 shares, bringing the total number of approved shares to
4,485,967 under the 2013 Equity Incentive Plan.

As of December 31, 2016, 1,562,832 shares of common stock remain eligible to be issued through equity-based instruments under the 2013
Equity Incentive Plan.

2014 Non-Employee Equity Compensation Plan

On March 6, 2014, the Company’s board of directors and stockholders approved the 2014 Non-Employee Equity Compensation Plan for
the issuance of equity-based instruments covering up to 250,000 shares of common stock to directors and other non-employees.

Effective on May 19, 2016, the Company’s stockholders approved the amendment and restatement of the 2014 Equity Incentive Plan to
increase the number of shares reserved for issuance thereunder by 350,000 shares, bringing the total number of approved shares to 600,000
under the 2014 Non-Employee Equity Compensation Plan.

As of December 31, 2016, 349,899 shares of common stock remain eligible to be issued through equity-based instruments under the 2014
Non-Employee Equity Compensation Plan.

2015 Performance Share Unit Plan

On April 10, 2015, the Company’s board of directors approved the Energous Corporation 2015 Performance Share Unit Plan (the
“Performance Share Plan”), under which 1,310,104 shares of common stock became available for issuance as PSUs to a select group of
employees and directors, subject to approval by the stockholders. On May 21, 2015 the Company’s stockholders approved the Performance
Share Plan.

As of December 31, 2016, 31,951 shares of common stock remain eligible to be issued through equity based instruments under the
Performance Share Unit Plan.

Employee Stock Purchase Plan

On April 10, 2015, the Company’s board of directors approved the ESPP, under which 600,000 shares of common stock have been
reserved for purchase by the Company’s employees, subject to approval by the stockholders. On May 21, 2015, the Company’s
stockholders approved the ESPP. Employees may designate an amount not less than 1% but not more than 10% of their annual
compensation, but for not more than 7,500 shares during an offering period. An offering period shall be six months in duration
commencing on or about January 1 and July 1 of each year. The exercise price of the option will be the lesser of 85% of the fair market of
the common stock on the first business day of the offering period and 85% of the fair market value of the common stock on the applicable
exercise date.

As of December 31, 2016, 468,621 shares of common stock remain eligible to be issued through equity based instruments under the ESPP.
For the year ended December 31, 2016, eligible employees contributed $727,784 through payroll deductions to the ESPP and 85,356 shares
were deemed delivered for the year ended December 31, 2016.

F-19

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ENERGOUS CORPORATION
Notes to Financial Statements

Note 8 – Stock Based Compensation, continued

Stock Option Award Activity

The following is a summary of the Company’s stock option activity during the year ended December 31, 2016:

Outstanding at January 1, 2016

Granted
Exercised
Forfeited

Outstanding at December 31, 2016

Weighted 
Average 
Exercise 
Price

Weighted 
Average 
Remaining 
Life In 
Years

Intrinsic 
Value

4.34     
-     
2.93     
2.49     
4.55     

8.0    $ 5,310,340 
- 
- 
- 
7.1    $ 16,107,929 

-     
-     
-     

Number of 
Options
    1,487,785    $
-     
(130,354)   
(47,987)   
    1,309,444    $

Exercisable at December 31, 2016

    1,057,187    $

4.55     

7.1    $ 12,998,601 

As of December 31, 2016, the unamortized value of options was $638,910. As of December 31, 2016, the unamortized portion will be
expensed over a weighted average period of 0.8 years.

The aggregate intrinsic value of options exercised was $984,144, $92,728 and $0 for the years ended December 31, 2016, 2015 and 2014,
respectively.

No options were granted during the years ended December 31, 2016 and 2015. The weighted average grant date fair value per share of
options granted during the year ended December 31, 2014 was $2.60.

F-20

 
 
 
 
 
 
 
 
   
   
   
 
   
   
   
 
   
      
      
      
  
 
 
 
 
 
 
ENERGOUS CORPORATION
Notes to Financial Statements

Note 8 – Stock Based Compensation, continued

Restricted Stock Units (“RSUs”)

On January 4, 2016, the compensation committee of the board of directors granted to various directors, RSUs under which the holders have
the right to receive an aggregate of 26,916 shares of the Company’s common stock. These awards were granted under the 2014 Non-
Employee Equity Compensation Plan. The awards granted vest fully on the first anniversary of the grant date.

On January 4, 2016, the compensation committee of the board of directors granted to John Gaulding, director and chairman of the board,
RSUs under the 2014 Non-Employee Equity Compensation Plan for which Mr. Gaulding has the right to receive 25,000 shares of the
Company’s common stock. These shares were issued to Mr. Gaulding in connection with his role as an independent director and chairman
of the Board of Directors. The award granted vests fully on the first anniversary of the grant date.

On February 25, 2016, the compensation committee of the board of directors granted certain employees inducement RSU awards under
which the holders have the right to receive an aggregate 38,000 shares of the Company’s common stock. The awards granted vest over four
years beginning on the first anniversary of the date of hire.

On March 4, 2016, the compensation committee of the board of directors granted an employee inducement RSU awards under which the
holder has the right to receive an aggregate of 12,500 shares of the Company’s common stock. The award granted vests over four years
beginning on the first anniversary of the date of hire and is contingent upon meeting certain job performance milestones.

On May 19, 2016, the compensation committee of the board of directors granted certain employees inducement RSU awards under which
the holders have the right to receive an aggregate of 126,000 shares of the Company’s common stock. The awards granted vest over four
years beginning on the first anniversary of the dates of hire.

On May 19, 2016, the compensation committee of the board of directors granted a consultant an RSU award under the 2013 Equity
Incentive Plan for which the holder has the right to receive an aggregate of 3,250 shares of the Company’s common stock. The award
granted vests immediately.

On June 10, 2016, the board of directors granted non-employee directors RSU awards under the 2014 Non-Employee Equity Compensation
Plan under which the holders have the right to receive an aggregate of 70,040 shares of the Company’s common stock. These awards vest
annual over three years beginning on June 13, 2017.

On October 24, 2016, the board of directors granted Stephen Rizzone, the Company’s President, Chief Executive Officer and Director an
RSU award under the 2013 Equity Incentive Plan under which Mr. Rizzone has the right to receive 150,000 shares of the Company’s
common stock. The shares of this award vest over four years beginning on August 18, 2017.

On October 24, 2016, the compensation committee of the board of directors approved an RSU award for Brian Sereda, Chief Financial
Officer, covering a total of 45,000 shares of common stock. This restricted stock unit award vests over a period of four years in four equal
installments on August 18 of each of 2017, 2018, 2019 and 2020.

On October 24, 2016, the compensation committee of the board of directors granted certain employees inducement RSU awards under
which the holders have the right to receive an aggregate of 95,000 shares of the Company’s common stock. The awards granted vest over
four years beginning on the first anniversary of the dates of hire.

On October 24, 2016, the compensation committee of the board of directors granted various employees RSU awards under which the
holders have the right to receive an aggregate of 331,950 shares of the Company’s common stock. These awards vest over a period of four
years in four equal installments on August 18 of each of 2017, 2018, 2019 and 2020.

On October 24, 2016, the compensation committee of the board of directors granted Cesar Johnston, Senior Vice President of Engineering,
an RSU award under which Mr. Johnston has the right to receive 85,000 shares of the Company’s common stock. A total of 25% of the
shares vest immediately upon grant, while the remaining shares vest annually over three years beginning August 18, 2017.

F-21

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ENERGOUS CORPORATION
Notes to Financial Statements

Note 8 – Stock Based Compensation, continued

Restricted Stock Units (“RSUs”), continued

On October 24, 2016, the compensation committee of the board of directors granted Michael Leabman, Founder, Chief Technology Officer
and Director, an RSU award under which Mr. Leabman has the right to receive 100,000 shares of the Company’s common stock. This
restricted stock unit award vests over a period of four years in four equal installments on August 18 of each of 2017, 2018, 2019 and 2020.

The Company accounts for RSUs granted to consultants using the accounting guidance included in ASC 505-50 “Equity-Based Payments
to Non-Employees” (“ASC 505-50”). In accordance with ASC 505-50, the Company estimates the fair value of the unvested portion of the
RSU award each reporting period using the closing price of the Company’s common stock.

At December 31, 2016, the unamortized value of the RSUs was $20,635,176. The unamortized amount will be expensed over a weighted
average period of 3.1 years. A summary of the activity related to RSUs for the year ended December 31, 2016 is presented below:

Outstanding at January 1, 2016
RSUs granted
RSUs forfeited
RSUs vested
Outstanding at December 31, 2016

Performance Share Units (“PSUs”)

Weighted 
Average Grant 
Date Fair Value  
8.83 
14.18 
9.62 
9.16 
11.58 

Total
1,560,996    $
1,110,156    $
(107,529)  $
(511,400)  $
2,052,223    $

Performance share units (“PSUs”) are grants that vest upon the achievement of certain performance goals. The goals are commonly related
to the Company’s market capitalization or market share price of the common stock.

The PSUs originally issued during 2015 to certain board members and senior management shall be earned based on the Company’s
achievement of market capitalization growth between the effective date of the Employment Agreement and the end of the Initial
Employment Period. If the Company’s market capitalization is $100 million or less, no PSUs will be earned. If the Company reaches a
market capitalization of $1.1 billion or more, 100% of the PSUs will be earned. For market capitalization between $100 million and $1.1
billion, the percentage of PSUs earned will be determined on a quarterly basis based on straight line interpolation.

On March 4, 2016, the compensation committee of the board of directors granted an executive inducement PSUs under which the executive
is eligible to receive 63,908 shares of the Company’s common stock based on similar market capitalization criteria indicated above.

The Company determined that the PSUs were equity awards with both market and service conditions. The Company utilized a Monte Carlo
simulation to determine the fair value of the market condition, as described below. Grantees of PSUs are required to be employed through
December 31, 2018 in order to earn the entire award, if and when vested.

Market capitalization
Dividend yield
Expected volatility
Risk-free interest rate

Performance Share 
Units (PSUs) Granted 
During the Year Ended 
December 31, 2016  
102,600,000 

 $

Performance Share 
Units (PSUs) Granted 
During the Year Ended 
December 31, 2015  
106,270,000 

 $
0%  
75%  
1.04%  

0%
60%
0.95%

The fair value of the grants of PSUs to purchase a total of 1,342,061 shares of common stock (including 1,278,153 PSUs granted under the
2015 Performance Share Unit Plan and 63,908 granted as an inducement) was determined to be approximately $3,218,000, and is amortized
over the service period of May 21, 2015 through December 31, 2018, on a straight-line basis.

F-22

 
 
 
 
 
 
 
 
 
 
   
   
   
   
   
   
 
 
 
 
 
 
 
 
 
  
  
  
 
 
 
 
ENERGOUS CORPORATION
Notes to Financial Statements

Note 8 – Stock Based Compensation, continued

Performance Share Units (“PSUs”), continued

On October 24, 2016, the compensation committee of the board of directors granted Mr. Rizzone a PSU award under the 2013 Equity
Incentive Plan under which Mr. Rizzone has the right to receive 150,000 shares of the Company’s common stock. The shares of this award
vest upon the Company’s stock price meeting specific targets.

For the PSU award grant issued to Stephen Rizzone, Chief Executive Officer, a Monte Carlo simulation was used to determine the fair
value at each of the five target prices of the Company’s common stock, using a market capitalization of $298,857,000, dividend yield of
0%, expected volatility of 75% and a risk-free interest rate of 0.66%.

The fair value of the PSUs granted to Mr. Rizzone under the 2013 Equity Incentive Plan was determined to be $2,332,000, and is amortized
over the estimated service period from October 24, 2016 through October 30, 2017.

Amortization for all PSU awards was $2,285,683 and $489,239 for the years ended December 31, 2016 and 2015, respectively.

At December 31, 2016, the unamortized value of all PSUs was approximately $2,774,507. The unamortized amount will be expensed over
a weighted average period of 1.16 years. A summary of the activity related to PSUs for the year ended December 31, 2016 is presented
below:

Outstanding at January 1, 2016
PSUs granted
PSUs forfeited
PSUs vested
Outstanding at December 31, 2016

F-23

Weighted 
Average Grant 
Date Fair Value  
2.62 
11.84 
- 
6.60 
3.66 

Total
1,135,614    $
213,908    $
-    $
(195,905)  $
1,153,617    $

 
 
 
 
 
 
 
 
 
 
 
 
   
   
   
   
   
   
 
 
 
ENERGOUS CORPORATION
Notes to Financial Statements

Note 8 – Stock Based Compensation, continued

Deferred Stock Units (“DSUs”)

On January 4, 2016, the compensation committee of the board of directors granted to John Gaulding, director and chairman of the board,
DSUs under the 2014 Non-Employee Equity Compensation Plan for which Mr. Gaulding has the right to receive 14,953 shares of the
Company’s common stock. These shares were issued to Mr. Gaulding in lieu of $125,000 of his anticipated compensation for his services
on the board, including $75,000 worth of DSUs and $50,000 of his regular board stipends. The award granted vests fully on the first
anniversary of the grant date. Amortization was $123,644 for the year ended December 31, 2016.

At December 31, 2016, the unamortized value of the DSUs was $1,362. A summary of the activity related to DSUs for the year ended
December 31, 2016 is presented below:

Outstanding at January 1, 2016
DSUs granted
DSUs forfeited
DSUs vested
Outstanding at December 31, 2016

Employee Stock Purchase Plan (“ESPP”)

Total

Weighted 
Average Grant 
Date Fair Value 
- 
8.36 
- 
- 
8.36 

-  $
14,953  $
-  $
-  $
14,953  $

During the year ended December 31, 2016, there were two offering periods for the ESPP. The first offering period started on January 1,
2016 and concluded on June 30, 2016. The second offering period started on July 1, 2016 and concluded on December 31, 2016. During the
year ended December 31, 2015, there was one initial offering period for the ESPP, which started on July 1, 2015 and concluded on
December 31, 2015.

The weighted-average grant-date fair value of the purchase option for each designated share purchased under this plan was approximately
$5.20 and $2.46 during the years ended December 31, 2016 and 2015, respectively, which represents the fair value of the option, consisting
of three main components: (i) the value of the discount on the enrollment date, (ii) the proportionate value of the call option for 85% of the
stock and (iii) the proportionate value of the put option for 15% of the stock. The Company recognized compensation expense for the plan
of $318,735 and $113,217 for the years ended December 31, 2016 and 2015, respectively.

The Company estimated the fair value of the purchase options granted during the years ended December 31, 2016 and 2015 using the
Black-Scholes option pricing model. The fair values of the purchase options granted were estimated using the following assumptions:

Stock price range
Dividend yield
Expected volatility range
Risk-free interest rate range
Expected life

Stock price
Dividend yield
Expected volatility
Risk-free interest rate
Expected life

For the Year Ended 
December 31, 2016  
8.36 - 12.16 
 $

0%
56 - 100%
0.37 – 0.49%
6 months 

For the Year Ended 
December 31, 2015  
7.41 
 $

0%
65%
0.13%

6 months 

F-24

 
 
 
 
 
 
 
 
 
  
  
  
  
  
  
 
 
 
 
 
 
 
  
  
  
  
 
 
 
  
  
  
  
 
 
 
ENERGOUS CORPORATION
Notes to Financial Statements

Note 8 – Stock Based Compensation, continued

Stock-Based Compensation Expense

The following tables summarize total stock-based compensation costs recognized for years ended December 31, 2016, 2015 and 2014:

Stock options
RSUs
PSUs
DSUs
ESPP
IR warrants
Shares issued to consultant for services rendered
Total

  $

  $

For the Years Ended December 31,
2015
1,037,399    $
4,225,728     
489,239     
-     
113,217     
85,831     
-     
5,951,414    $

2016
1,045,081    $
5,735,032     
2,285,683     
123,644     
318,735     
-     
-     
9,508,175    $

2014
1,333,943 
900,063 
- 
- 
- 
263,972 
50,000 
2,547,978 

The total amount of stock-based compensation was reflected within the statements of operations as:

Research and development
Sales and marketing
General and administrative
Total

  $

  $

F-25

For the Years Ended December 31,
2015
2,816,707    $
729,329     
2,405,378     
5,951,414    $

2016
4,226,304    $
328,760     
4,953,111     
9,508,175    $

924,702 
583,238 
1,040,038 
2,547,978 

2014

 
 
 
 
 
 
 
 
 
 
 
   
   
 
   
   
   
   
   
   
 
 
 
 
 
 
 
   
   
 
   
   
 
 
 
ENERGOUS CORPORATION
Notes to Financial Statements

Note 9 – Income Taxes

As of December 31, 2016, and 2015, the Company’s deferred tax assets (liabilities) consisted of the effects of temporary differences
attributable to the following:

Deferred tax assets (liabilities):

Tax credit
Net operating loss carryovers
Property and equipment
Research and development costs
Start-up and organizational costs
Stock-based compensation
Other accruals
Total gross deferred tax assets
Less: valuation allowance

Deferred tax assets, net

The change in the Company’s valuation allowance is as follows:

January 1,
Increase in valuation allowance
December 31,

December 31,

2016

2015

  $ 2,802,573    $ 2,958,771 
7,511,765 
    16,174,712     
(98,235)
(58,747)   
    18,628,913      10,380,961 
1,333 
1,175,821 
155,472 
    39,719,606      22,085,888 
    (39,719,606)    (22,085,888)
- 
-    $
  $

1,222     
1,829,843     
341,090     

2016

2015

  $ 22,085,888    $ 9,630,687 
    17,633,718      12,455,201 
  $ 39,719,606    $ 22,085,888 

The Company has federal and state net operating loss carryovers of approximately $44,563,000 and $44,661,000, respectively, available to
offset future taxable income. The federal and state NOL carryforwards will expire at various dates beginning in 2033. The Company has
federal and state research and development tax credit carryovers of approximately $1,931,000 and $1,321,000, respectively. The federal
R&D credit carryovers will expire beginning in 2032 and state R&D credit carryovers do not expire. The ultimate realization of the net
operating loss is dependent upon future taxable income, if any, of the Company and may be limited in any one period by alternative
minimum tax rules. Although management believes that the Company may have sufficient future taxable income to absorb the net
operating loss carryovers and research and development tax credit carryovers before the expiration of the carryover period, there may be
circumstances beyond the Company’s control that limit such utilization. Accordingly, management has determined that a full valuation
allowance of the deferred tax asset is appropriate at December 31, 2016 and 2015.

Internal Revenue Code Section 382 imposes limitations on the use of net operating loss carryovers when the stock ownership of one or
more 5% shareholders (shareholders owning 5% or more of the Company’s outstanding capital stock) has increased on a cumulative basis
by more than 50 percentage points. Management cannot control the ownership changes occurring as a result of public trading of the
Company’s Common Stock. Accordingly, there is a risk of an ownership change beyond the control of the Company that could trigger a
limitation of the use of the loss carryover. The Company completed a Section 382 analysis as of December 31, 2016, and determined that
none of its NOLs or R&D credits would be limited.

F-26

 
 
 
 
 
 
 
 
 
 
   
 
 
 
   
 
 
   
   
   
   
 
 
 
 
   
 
 
 
 
 
ENERGOUS CORPORATION
Notes to Financial Statements

Note 9 – Income Taxes, continued 

Tax benefit at federal statutory rate
State income taxes
Permanent differences:

Stock-based compensation
Meals and entertainment

True-up of federal deferred taxes
True-up of state deferred taxes
Other
Research and development tax credit, federal
Research and development tax credit, state
Increase in valuation allowance, federal
Increase in valuation allowance, state
Effective income tax rate

Note 10 – Related Party

  For the Year Ended December 31,

2016

2015

(34.0)%    

(5.7)

0.8 
0.1 
1.7 
1.2 
- 
(1.5)
(1.1)
32.9 
5.6 
0.0%

(34.0)%
(5.5)

1.3 
0.1 

(0.2)
0.7 
(4.4)
(3.1)
36.3 
8.8 
0.0%

On July 14, 2014, the Company’s Board of Directors appointed Howard Yeaton as the Company’s Interim Chief Financial Officer. On July
13, 2015, the Company appointed Brian Sereda as the Company’s Chief Financial Officer, replacing Interim Chief Financial Officer
Howard Yeaton. Howard Yeaton is the Managing Principal of Financial Consulting Strategies LLC (“FCS”). During the year ended
December 31, 2016, the Company had incurred fees of $0 in connection with Mr. Yeaton’s services as Interim Chief Financial Officer and
$13,306 for other financial advisory and accounting services provided by FCS. During the year ended December 31, 2015, the Company
incurred fees of $61,848 in connection with Mr. Yeaton’s services as Interim Chief Financial Officer and $88,813 for other financial
advisory and accounting services provided by FCS. During the year ended December 31, 2014, the Company incurred fees of $68,413 in
connection with Mr. Yeaton’s services as Interim Chief Financial Officer and $126,153 for other financial advisory and accounting
services provided by FCS.

Note 11 – Unaudited Quarterly Financial Information

Summarized quarterly information for the years ended December 31, 2016 and 2015 is listed below:

  March 31

June 30

    September 30     December 31  

For the quarter ended

2016
Revenue
Operating expenses
Net loss
Loss per share, basic and diluted

2015
Revenue
Operating expenses
Net loss
Loss per share, basic and diluted

136,364    $
10,936,772    $

129,786 
  $
  $
14,744,905 
  $ (10,796,542)   $ (10,284,555)   $ (10,125,063)   $ (14,611,234)
(0.75)
  $

1,003,973    $
11,131,994    $

181,818    $
10,468,990    $

(0.62)   $

(0.66)   $

(0.57)   $

  $
  $
  $
  $

200,000    $
7,131,600    $
(6,925,279)   $
(0.54)   $

225,000    $
6,374,970    $
(6,146,582)   $
(0.48)   $

2,075,000    $
7,683,317    $
(5,605,661)   $
(0.43)   $

- 
8,887,452 
(8,884,180)
(0.61)

F-27

 
 
 
 
 
 
 
 
 
 
   
   
   
   
  
   
  
   
   
   
   
   
   
  
   
   
   
   
   
   
   
   
   
   
   
   
   
   
 
 
 
 
 
 
 
 
 
   
   
      
      
      
  
 
   
      
      
      
  
   
      
      
      
  
 
 
 
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

None.

Item 9A. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

We have established disclosure controls and procedures to ensure that material information relating to us is made known to the officers
who certify our financial reports and the board of directors.

Based on their evaluation as of December 31, 2016, our principal executive and principal financial and accounting officers have concluded
that these disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective as of
December 31, 2016 to provide reasonable assurance that information required to be disclosed by us in reports that we file under the
Exchange Act is recorded, processed, summarized, and reported, within the time periods specified in Securities and Exchange Commission
rules and forms and that material information relating to the Company is accumulated and communicated to management, including our
principal executive officer and our principal financial officer, as appropriate to allow timely decisions regarding required disclosures.

Management’s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as such term is defined
in Exchange Act Rule 13a-15(f). Internal control over financial reporting is a process used to provide reasonable assurance regarding the
reliability of our financial reporting and the preparation of our financial statements for external purposes in accordance with generally
accepted accounting principles in the United States. Internal control over financial reporting includes policies and procedures that pertain to
the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets; provide
reasonable assurance that transactions are recorded as necessary to permit preparation of our financial statements in accordance with
generally accepted accounting principles in the United States, and that our receipts and expenditures are being made only in accordance
with the authorization of our board of directors and management; and provide reasonable assurance regarding prevention or timely
detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.

An internal control system over financial reporting has inherent limitations and may not prevent or detect misstatements. Therefore, even
those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and
presentation. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. However,
these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process
safeguards to reduce, though not eliminate, this risk.

The Company’s management, under the supervision of and with the participation of the principal executive and principal financial and
accounting officers, have assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2016
based on criteria for effective control over financial reporting described in Internal Control — Integrated Framework (2013) created by the
Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on this assessment, the Company’s management
concluded that the Company’s internal control over financial reporting was effective as of December 31, 2016.

This Annual Report on Form 10-K does not include an attestation report of our independent registered public accounting firm regarding
internal control over financial reporting as such report is not required for filers exempt for certain initial periods under the JOBS Act.

Changes in Internal Control Over Financial Reporting

For the quarter ended December 31, 2016, there were no changes in our internal control over financial reporting that have materially
affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on the Effectiveness of Controls

A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of
the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute
assurance that all control issues and instances of fraud, if any, within a company have been detected. Our disclosure controls and
procedures are designed to provide reasonable assurance of achieving its objectives. Our principal executive and principal financial and
accounting officer concluded that our disclosure controls and procedures are effective at that reasonable assurance level.

Item 9B. Other Information.

Not applicable.

32

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 10. Directors, Executive Officers and Corporate Governance.

PART III

The information required under this item is incorporated by reference to the following sections of our proxy statement for our 2016 Annual
Meeting of Stockholders: “Information Concerning Directors and Nominees for Director,” “Information Concerning Executive Officers,”
“Section 16(a) Beneficial Ownership Reporting Compliance,” “Corporate Governance Principles and Board Matters,” and “The Board of
Directors and Its Committees.”

Item 11. Executive Compensation

The information required under this item is incorporated by reference to the following sections of our proxy statement for our 2016 Annual
Meeting of Stockholders: “Compensation and Other Information Concerning Directors and Officers,” and “The Board of Directors and Its
Committees.”

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters.

The information required under this item is incorporated by reference to the following sections of our proxy statement for our 2016 Annual
Meeting of Stockholders: “Equity Compensation Plan Information” and “Securities Ownership of Certain Beneficial Owners and
Management.”

Item 13. Certain Relationships and Related Transactions, and Director Independence

The information required under this item is incorporated by reference to the following sections of our proxy statement for our 2016 Annual
Meeting of Stockholders: “Certain Relationships and Related Transactions” and “Corporate Governance Principles and Board Matters.”

Item 14. Principal Accountant Fees and Services

The information required under this item is incorporated by reference to the following sections of our proxy statement for our 2016 Annual
Meeting of Stockholders: “Independent Registered Public Accounting Firm” and “Pre-Approval Policies and Procedures.”

33

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 15. Exhibits, Financial Statements and Schedules

(a)

List of documents filed as part of this report:

PART IV

1.

2.

3.

Financial Statements (see “Financial Statements and Supplementary Data” at Item 8 and incorporated herein by reference).

Financial Statement Schedules (Schedules to the Financial Statements have been omitted because the information required to be set
forth therein is not applicable or is shown in the accompanying Financial Statements or notes thereto)

Exhibit Index (The exhibits required to be filed as a part of this Report are listed in the Exhibit Index following the signature page
to this report and is incorporated herein by reference).

34

 
 
 
 
 
 
 
 
 
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this

report to be signed on its behalf by the undersigned, thereunto duly authorized.

SIGNATURES

Dated:   March 16, 2017

Dated:   March 16, 2017

Energous Corporation

By:

By:

/s/ Stephen R. Rizzone
Stephen R. Rizzone
President, Chief Executive Officer (Principal Executive
Officer) and Director

/s/ Brian Sereda
Brian Sereda
Vice President and Chief Financial Officer (Principal
Financial Officer and Principal Accounting Officer)

POWER OF ATTORNEY AND SIGNATURES

We, the undersigned officers and directors of Energous Corporation, hereby severally constitute and appoint Stephen R. Rizzone
our true and lawful attorney, with full power to him to sign for us and in our names in the capacities indicated below, any amendments to
this Annual Report on Form 10-K, and generally to do all things in our names and on our behalf in such capacities to enable Exact Sciences
Corporation to comply with the provisions of the Securities Exchange Act of 1934, as amended, and all the requirements of the Securities
Exchange Commission.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons

on behalf of the registrant and in the capacities and on the dates indicated.

Signatures

Title

Date

/s/ Stephen R. Rizzone
Stephen R. Rizzone

/s/ Michael Leabman
Michael Leabman

/s/ John R. Gaulding
John R. Gaulding

/s/ Martin Cooper
Martin Cooper

/s/ Robert J. Griffin
Robert J. Griffin

/s/ Rex S. Jackson
Rex S. Jackson

  President, Chief Executive Officer and Director

March 16, 2017

  Chief Technology Officer and Director

March 16, 2017

  Director and Chairman

  Director

  Director

  Director

35

March 16, 2017

March 16, 2017

March 16, 2017

March 16, 2017

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exhibit
No.

3.1

Description of Document
Second Amended and Restated Certificate of Incorporation of Energous Corporation (incorporated by reference to Exhibit 3.1
to Amendment No. 1 to the Registrant’s Registration Statement on Form S-1/A (File No. 333-193522) filed on March 13,
2014)

3.2

Amendment No. 1 to the Second Amended and Restated Certificate of Incorporation of Energous Corporation (incorporated by
reference to Exhibit 3.2 to the Registrant’s Quarterly Report on Form 10-Q filed on May 14, 2014)

3.3

Amended and Restated Bylaws of Energous Corporation (incorporated by reference to Exhibit 3.1 to Amendment No. 1 to the
Registrant’s Registration Statement on Form S-1/A (File No. 333-193522) filed on March 13, 2014)

4.1

4.2

4.3

Specimen Certificate representing shares of common stock of Energous Corporation (incorporated by reference to Exhibit 4.1
to Amendment No. 2 to the Registrant’s Registration Statement on Form S-1/A (File No. 333-193522) filed on March 21,
2014)

Amended and Restated Warrant issued to MDB Capital Group, LLC (ARW-1) dated December 13, 2013 (incorporated by
reference to Exhibit 10.12 to the Registrant’s Registration Statement on Form S-1 (File No. 333-193522) filed on January 24,
2014)

Amended and Restated Warrant issued to MDB Capital Group, LLC (ARW-2) dated December 13, 2013 (incorporated by
reference to Exhibit 10.13 to the Registrant’s Registration Statement on Form S-1 (File No. 333-193522) filed on January 24,
2014)

4.4

Form of Underwriter’s Warrant (incorporated by reference to Exhibit 4.2 to Amendment No. 2 to the Registrant’s Registration
Statement on Form S-1/A (File No. 333-193522) filed on March 21, 2014)

4.5

Form of Amendment to Warrant to Purchase Common Stock Dated June 25, 2014 (incorporated by reference to Exhibit 10.1 to
the Registrant’s Quarterly Report on Form 10-Q filed on August 13, 2014

10.1

Executive Employment Agreement between the Company and Michael Leabman dated October 1, 2013 (incorporated by
reference to Exhibit 10.9 to the Registrant’s Registration Statement on Form S-1 (File No. 333-193522) filed on January 24,
2014)*

10.2

Form of Indemnification Agreement (incorporated by reference to Exhibit 10.10 to the Registrant’s Registration Statement on
Form S-1 (File No. 333-193522) filed on January 24, 2014)*

10.3

Energous Corporation 2013 Equity Incentive Plan (incorporated by reference to Exhibit 10.16 to the Registrant’s Registration
Statement on Form S-1 (File No. 333-193522) filed on January 24, 2014)*

10.4

Form of stock option award under 2013 Omnibus Equity Incentive Plan (incorporated by reference to Exhibit 10.17 to the
Registrant’s Registration Statement on Form S-1 (File No. 333-193522) filed on January 24, 2014)*

10.5

Form of Non-Statutory Option Award (incorporated by reference to Exhibit 10.19 to Amendment No. 1 to the Registrant’s
Registration Statement on Form S-1/A (File No. 333-193522) filed on March 13, 2014)*

10.6

First Amendment to Energous Corporation 2013 Equity Incentive Plan (incorporated by reference to Exhibit 10.20 to
Amendment No. 1 to the Registrant’s Registration Statement on Form S-1/A (File No. 333-193522) filed on March 13, 2014)*

10.7

2014 Non-Employee Equity Compensation Plan (incorporated by reference to Exhibit 10.21 to Amendment No. 1 to the
Registrant’s Registration Statement on Form S-1/A (File No. 333-193522) filed on March 13, 2014)*

10.8

Form of stock option award under 2014 Non-Employee Equity Compensation Plan (incorporated by reference to Exhibit 10.22
to Amendment No. 2 to the Registrant’s Registration Statement on Form S-1/A (File No. 333-193522) filed on March 21,
2014)*

36

 
 
 
 
    
 
    
 
    
 
    
 
    
 
    
 
    
 
    
 
    
 
    
 
    
 
    
 
    
 
    
 
    
 
 
 
 
10.9

Offer Letter effective as of July 14, 2014 between Energous Corporation and Cesar Johnston (incorporated by reference to
Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q filed on November 10, 2014)*

10.10

Consulting Agreement effective as of July 14, 2014 between Energous Corporation and Howard Yeaton (incorporated by
reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q filed on November 10, 2014)*

10.11

Form of Restricted Stock Unit Award Agreement effective as of August 14, 2014 between Energous Corporation and Cesar
Johnston (incorporated by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q filed on November 10,
2014)*

10.12

Lease Agreement dated as of September 10, 2014 between the Company and Balzer Family Investments, L.P. (incorporated by
reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on September 16, 2014)

10.13

Form of Restricted Stock Unit Award Agreement under 2013 Omnibus Equity Incentive Plan (incorporated by reference to
Exhibit 10.21 to the Registrant's Annual Report on Form 10-K filed on March 30, 2015)*

10.14

Form of Inducement Restricted Stock Unit Award Agreement (incorporated by reference to Exhibit 10.22 to the Registrant's
Annual Report on Form 10-K filed on March 30, 2015)*

10.15

Amended and Restated Executive Employment Agreement dated as of April 3, 2015 between the Company and Stephen R.
Rizzone (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on April 9, 2015)*

10.16

Energous Corporation Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.1 to the Registrant’s Current
Report on Form 8-K filed on May 22, 2015)*

10.17

Energous Corporation 2015 Performance Unit Share Plan (incorporated by reference to Exhibit 10.2 to the Registrant’s Current
Report on Form 8-K filed on May 22, 2015)*

10.18

Amendment No. 1 to Energous Corporation 2015 Performance Unit Share Plan (incorporated by reference to Exhibit 10.3 to
the Registrant’s Current Report on Form 8-K filed on May 22, 2015)*

10.19

Energous Corporation Director Compensation Policy (incorporated by reference to Exhibit 10.4 to the Registrant’s Quarterly
Report on Form 10-Q filed on August 13, 2015)*

10.20

Brian Sereda Offer Letter (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on
July 14, 2015)*

10.21

Non-Employee Director Compensation Policy, dated December 17, 2015 (incorporated by reference to Exhibit 10.21 to
Registrant’s Annual Report on Form 10-K filed on March 15, 2016)

10.22

Securities Purchase Agreement between the Company and Ascend Legend Master Fund, Ltd., dated August 9, 2016 +

10.23

Amendment No. 1 to Securities Purchase Agreement between the Company and Ascend Legend Master Fund, Ltd., dated
August 12, 2016 +**

10.24   Strategic Alliance Agreement between the Company and Dialog Semiconductor (UK) Ltd., dated November 6, 2016 + **

10.25   Securities Purchase Agreement between the Company and Dialog Semiconductor (UK) Ltd., dated November 6, 2016 +

21.1  Subsidiaries of the Registrant +

23.1  Consent of Marcum LLP +

24.1  Power of Attorney (included on signature page) +

31.1  Certification Pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 +

31.2  Certification Pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 +

32.1  Certification Pursuant to 18 U.S.C Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 +

101.INS  XBRL Instance Document +

101.SCH  XBRL Taxonomy Schema +

101.CAL  XBRL Taxonomy Extension Calculation Linkbase +

 
 
 
    
 
    
 
    
 
    
 
    
 
    
 
    
 
    
 
    
 
    
 
    
 
    
 
     
 
 
 
     
     
     
    
    
    
    
    
    
    
    
    
101.DEF  XBRL Taxonomy Extension Definition Linkbase +

101.LAB  XBRL Taxonomy Extension Label Linkbase +

101.PRE  XBRL Taxonomy Extension Presentation Linkbase +

*

+

**

Indicates a management contract or any compensatory plan, contract or arrangement.

Filed herewith.

Registrant has omitted portions of the referenced exhibit and submitted such exhibit separately with a request for confidential
treatment under Rule 24b-2 promulgated under the Exchange Act.

37

    
    
 
 
 
 
 
 
SECURITIES PURCHASE AGREEMENT

Exhibit 10.22

THIS SECURITIES PURCHASE AGREEMENT  (the “Agreement”), is dated as of August 9, 2016, by and among Energous
Corporation, a Delaware corporation (the “Company”)  and Ascend  Legend  Master  Fund,  Ltd.,  an  exempted  company  formed  under  the
laws of the Cayman Islands (the “Investor”).

BACKGROUND

A.                  The  Company  and  the  Investor  are  executing  and  delivering  this Agreement  in  reliance  upon  the  exemption  from
registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “ Securities Act”), and/or Rule 506 of Regulation D
(“Regulation D”) as promulgated by the United States Securities and Exchange Commission (the “SEC”) under the Securities Act.

B.          The Investor wishes to purchase, and the Company wishes to sell and issue to the Investor, upon the terms and subject to
the conditions stated in this Agreement, (i) an aggregate of up to 1,618,123 shares of the Common Stock at a purchase price of $12.36 per
share  (as  adjusted  by  any  stock  split,  dividend  or  other  distribution,  recapitalization  or  similar  event,  the  “Shares”)  and  (ii)  warrants  to
purchase an aggregate of up to 1,618,123 shares (subject to adjustment as described in the Warrants) of Common Stock (the “Warrants”)
in the form attached hereto as Exhibit B, which Warrants shall be exercisable at any time on or after date which is six months and one day
after the date hereof and have an exercise price equal to $23.00 per share (subject to adjustment as described Warrants) (“Exercise Price”)
and a term of exercise of five (5) years from and after the Closing (as defined below).

NOW,  THEREFORE,  IN  CONSIDERATION  of  the  mutual  covenants  contained  in  this  Agreement,  and  for  other  good  and

valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and the Investor agree as follows:

ARTICLE I
DEFINITIONS

1 . 1          Definitions.  In  addition  to  the  terms  defined  elsewhere  in  this Agreement,  the  following  terms  have  the  meanings

indicated:

or is under common control with a Person, as such terms are used in and construed under Rule 144 under the Securities Act.

“Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by

“Agreement” has the meaning set forth in the Preamble.

“Applicable Law” collectively means any and all laws, rules, regulations, and governmental, judicial or administrative
decrees,  orders  and  decisions  that  are  applicable  to  the  Company  or  any  of  its  Subsidiaries,  this  Agreement,  the  other  Transaction
Documents, including the U.S. Gramm-Leach-Bliley Act of 1999, as amended, and the regulations promulgated under such Act, the U.S.
Fair Credit Reporting Act of 1970, as amended, or any regulations or guidelines promulgated under such Act, the U.S. Bank Secrecy Act,
orders and guidelines of the Office of Foreign Assets Control and the USA Patriot Act, and any other applicable data protection, privacy,
consumer protection or confidentiality laws or regulations (including the rules and regulations of any self-regulatory organization to which
the Company or its securities are subject, including The Nasdaq Stock Market or comparable securities trading market).

 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Board” has the meaning set forth in Section 2.2.

New York are authorized or required by Applicable Law to remain closed.

“Business Day”  means  any  day  other  than  Saturday,  Sunday  or  other  day  on  which  commercial  banks  in  The  City  of

“Change of Control of the Company” means a change in ownership or control of the Company effected through any of
the following transactions: (a) a merger, consolidation or other reorganization approved by the Company’s stockholders, unless securities
representing  more  than  fifty  percent  (50%)  of  the  total  combined  voting  power  of  the  voting  securities  of  the  successor  corporation  are
immediately thereafter beneficially owned, directly or indirectly and in substantially the same proportion, by the Persons who beneficially
owned  the  Company’s  outstanding  voting  securities  immediately  prior  to  such  transaction;  (b)  a  stockholder-approved  sale,  transfer  or
other disposition of all or substantially all of the Company’s assets; or (c) the closing of any transaction or series of transactions to which
any Person or any group of Persons comprising a “group” within the meaning of Rule 13d-5(b)(1) of the Exchange Act becomes directly or
indirectly  the  beneficial  owner  (within  the  meaning  of  Rule  13d-3  or  the  Exchange Act)  of  securities  possessing  (or  convertible  into  or
exercisable  for  securities  possessing)  more  than  fifty  percent  (50%)  of  the  total  combined  voting  power  of  the  Company’s  securities  (as
measured in terms of the power to vote with respect to the election of Board members) outstanding immediately after the consummation of
such  transaction  or  series  of  transactions,  whether  such  transaction  involves  a  directly  issuance  from  the  Company  or  the  acquisition  of
outstanding securities held by one or more of the Company’s existing stockholders.

“Closing” means the closing of the purchase and sale of the Securities pursuant to  Section 2.1.

Company and the Investor.

“Closing Date” means the date and time of the Closing and shall be on such date and time as is mutually agreed to by the

“Common Stock” means the common stock of the Company, par value $0.00001 per share.

“Company” has the meaning set forth in the Preamble.

“Company Plans” has the meaning set forth in Section 3.1(k).

“Disclosure Letter” has the meaning set forth in the lead-in paragraph to Article III.

“Disclosure Materials” has the meaning set forth in Section 3.1(h).

-2-

 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Effectiveness Period” has the meaning set forth in Section 6.1(b).

“Exchange Act” means the Securities Exchange Act of 1934, as amended.

“Exercise Price” has the meaning set forth in the Background.

“GAAP” has the meaning set forth in Section 3.1(h).

“Indemnified Party” has the meaning set forth in Section 6.4(c).

“Indemnifying Party” has the meaning set forth in Section 6.4(c).

“Insolvent” has the meaning set forth in Section 3.1(i).

“Investor” has the meaning set forth in the Preamble.

“Investor  Controlled  Entity” shall  mean  an  entity  of  which  the  Investor  collectively  owns  or  controls,  directly  or
indirectly, not less than a majority of the outstanding voting power entitled to vote in the election of directors of such entity (or, in the event
the entity is not a corporation, the governing members, board or other similar body of such entity).

first refusal, mortgage, deed of trust, title retention, conditional sale or other security arrangement, or adverse claim of title.

“Lien” means, with respect to any asset, any pledge, lien, collateral assignment, security interest, encumbrance, right of

limitation, reasonable attorneys’ fees.

“Losses”  means  any  and  all  losses,  claims,  damages,  liabilities,  settlement  costs  and  expenses,  including,  without

“Material Adverse Effect ” means (i) a material adverse effect on the legality, validity, or enforceability of any of the
Transaction Documents, (ii) a material adverse effect on the results of operations, assets, business or financial condition of the Company
and the Subsidiaries, taken as a whole on a consolidated basis, or (iii) a material adverse effect on the Company’s ability to perform on a
timely basis its obligations under any of the Transaction Documents.

“Material Permits” has the meaning set forth in Section 3.1(m).

“Non-Voting Convertible Securities ” means any securities of the Company that are convertible into, exchangeable for
or otherwise exercisable to acquire Voting Stock of the Company, including convertible securities, warrants, rights or options to purchase
Voting Stock of the Company.

“Person” means any individual, corporation, limited liability company, partnership, joint venture, trust, incorporated or
unincorporated  association,  joint  stock  company,  unincorporated  organization,  a  government  or  any  department,  subdivision  or  agency
thereof, or other entity of any kind.

-3-

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Preferred Stock” means the preferred stock of the Company, par value $0.00001 per share.

proceeding, such as a deposition), whether commenced or threatened in writing.

“Proceeding”  means  an  action,  claim,  suit,  investigation  or  proceeding  (including,  without  limitation,  or  a  partial

“Prospectus” means the prospectus included in a Registration Statement (including, without limitation, a prospectus that
includes  any  information  previously  omitted  from  a  prospectus  filed  as  part  of  an  effective  registration  statement  in  reliance  upon  Rule
430A promulgated under the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the
offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the
Prospectus including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in
such Prospectus.

“Purchase Price” has the meaning set forth in Section 2.1.

“Registrable  Securities”  means  the  Shares  and  the  Warrant  Shares  issued  or  issuable  pursuant  to  the  Transaction
Documents, together with any securities issued or issuable upon any stock split, dividend or other distribution, recapitalization or similar
event with respect to the foregoing.

“Registration  Statement”  means  each  registration  statement  filed  under Article  VI,  including  (in  each  case)  the
Prospectus, amendments and supplements to such registration statement or Prospectus, including pre- and post-effective amendments, all
exhibits thereto, and all material incorporated by reference or deemed to be incorporated by reference in such registration statement.

“Regulation D” has the meaning set forth in the Background.

“Rule  144,”  “Rule  144(c),”  “Rule  415,”  and  “Rule  424”  means  Rule  144,  Rule  144(c),  Rule  415  and  Rule  424,
respectively, promulgated by the SEC pursuant to the Securities Act, as such Rules may be amended from time to time, or any similar rule
or regulation hereafter adopted by the SEC having substantially the same effect as such Rule.

“SEC” has the meaning set forth in the Background.

“SEC Reports” has the meaning set forth in Section 3.1(h).

“Securities” means, collectively, the Shares purchased hereunder, the Warrants and the Warrant Shares.

“Securities Act” has the meaning set forth in the Background.

“Shares” has the meaning set forth in the Background.

“Subsidiary” means any direct or indirect subsidiary of the Company.

-4-

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Total  Current  Voting  Power ”  shall  mean,  with  respect  to  any  entity,  at  the  time  of  determination  of  Total  Current
Voting Power, the total number of votes which may be cast in the election of members of the board of directors of the corporation if all
securities  entitled  to  vote  in  the  election  of  such  directors  are  present  and  voted  (or,  in  the  event  the  entity  is  not  a  corporation,  the
governing members, board or other similar body of such entity).

or comparable securities trading market, or (b) if trading ceases to occur on any such market, any Business Day.

“Trading Day” means (a) any day on which the Securities are listed or quoted and traded on The Nasdaq Stock Market

“Transaction Documents” means this Agreement, the schedules and exhibits attached hereto, and the Warrants.

“Transfer Agent” means Wells Fargo or any successor transfer agent for the Company.

“Voting Period” has the meaning set forth in Section 4.7.

vote in the election of members of the Board.

“Voting Stock” means shares of Common Stock and any other securities of the Company having the ordinary power to

“Warrants” has the meaning set forth in the Background.

stock split, dividend or other distribution, recapitalization or similar event).

“Warrant Shares” means the shares of Common Stock to be issued upon exercise of the Warrants (as adjusted by any

“13D Group” means any group of Persons that would be required under Section 13(d) of the Exchange Act, and the rules
and  regulations  promulgated  thereunder,  to  file  a  statement  on  Schedule  13D  or  Schedule  13G  with  the  SEC  as  a  “person”  within  the
meaning of Section 13(d)(3) of the Exchange Act if such group beneficially owned Voting Stock representing more than 5% of any class of
Voting Stock then outstanding.

ARTICLE II
PURCHASE AND SALE

2.1         Purchase and Sale of the Shares and Warrants. Subject to the terms and conditions of this Agreement, the Investor hereby
agrees  to  purchase,  and  the  Company  hereby  agrees  to  sell  and  issue  to  the  Investor,  the  Shares  and  Warrants  as  set  forth  opposite  the
Investor’s name on Exhibit A for the aggregate purchase price (the “ Purchase Price”) set forth opposite the Investor’s name on Exhibit A.

2.2         Closing.

(a)          At the Closing, the Company shall deliver to the Investor (i) the Shares and Warrants, registered in the name of
the Investor as indicated on Exhibit A and (ii) a certificate, in the form set forth on Exhibit C, executed by the secretary of the Company
and  dated  as  of  the  Closing  Date,  as  to  the  Certificate  of  Incorporation,  by-laws,  foreign  qualification,  incumbency  of  the  Company’s
officers and good standing of the Company and the resolutions adopted by the Company’s Board of Directors (the “Board”) authorizing
the transactions contemplated by the Transaction Documents.

-5-

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
immediately available funds to an account specified by the Company in writing.

(b)          At the Closing, the Investor shall deliver to the Company the Purchase Price to the Company by wire transfer of

ARTICLE III
REPRESENTATIONS AND WARRANTIES

3.1         Representations and Warranties of the Company . Except as disclosed in the SEC Reports filed since March 27, 2014 (but
excluding all disclosures contained in the exhibits to such SEC Reports and the schedules to such exhibits, excluding the “Risk Factors”
section contained in such SEC Reports, and excluding forward-looking statements identifying risks and uncertainties that are not historical
facts contained in such SEC Reports) or the Disclosure Letter delivered by the Company to the Investor concurrently with the execution
hereof (the “Disclosure Letter”), the Company hereby represents and warrants to the Investor as follows:

( a )          Subsidiaries.  The  Company  has  no  Subsidiaries  other  than  those  listed  on  Section 3.1(a)  of  the  Disclosure
Letter. Except as disclosed in  Section 3.1(a) of the Disclosure Letter, the Company owns, directly or indirectly, all of the capital stock or
comparable  equity  interests  of  each  Subsidiary  free  and  clear  of  any  Lien  and  all  the  issued  and  outstanding  shares  of  capital  stock  or
comparable equity interest of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights.

( b )          Organization and Qualification. Each of the Company and its Subsidiaries is an entity duly organized, validly
existing and in good standing under the Applicable Laws of the jurisdiction of its incorporation or organization (as applicable), with the
requisite legal authority to own or lease and use its properties and assets and to carry on its business as currently conducted. Neither the
Company nor any Subsidiary is in violation of any of the provisions of its respective certificate or articles of incorporation or by-laws or
other  organizational  or  charter  documents.  Each  of  the  Company  and  its  Subsidiaries  is  duly  qualified  to  do  business  and  is  in  good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it
makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, has not had and
would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

( c )          Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to
consummate the transactions contemplated by each of the Transaction Documents and otherwise to carry out its obligations hereunder and
thereunder.  The  execution  and  delivery  of  each  of  the  Transaction  Documents  by  the  Company  and  the  consummation  by  it  of  the
transactions contemplated hereby and thereby have been duly authorized by all necessary corporate action on the part of the Company and
no  further  consent  or  action  is  required  by  the  Company,  its  officers,  the  Board  or  its  stockholders.  The  issuance  of  the  Shares,  the
Warrants and the Warrant Shares do not require the approval of the stockholders of the Company. Each of the Transaction Documents has
been  (or  upon  delivery  will  be)  duly  executed  by  the  Company  and  is,  or  when  delivered  in  accordance  with  the  terms  hereof,  will
constitute, the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as may
be limited by (i) applicable bankruptcy, insolvency, reorganization or other Applicable Laws of general application relating to or affecting
the enforcement of creditors rights generally; and (ii) the effect of rules of law governing the availability of specific performance and other
equitable remedies.

-6-

 
 
 
 
 
 
 
 
 
 
( d )          No Conflicts. The execution, delivery and performance by the Company of the Transaction Documents and the
consummation  by  the  Company  of  the  transactions  contemplated  hereby  and  thereby  do  not  and  will  not  (i)  conflict  with  or  violate  any
provision  of  the  Company’s  or  any  Subsidiary’s  certificate  or  articles  of  incorporation,  by-laws  or  other  organizational  or  charter
documents; (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, or
give  to  others  any  rights  of  termination,  amendment,  acceleration  or  cancellation  (with  or  without  notice,  lapse  of  time  or  both)  of,  any
agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) to which the Company or any
Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected; or (iii) result in a violation
of any Applicable Law, except, in the case of clause (ii) or (iii), to the extent that such conflict or violation has not had and would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

( e )          Filings, Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or
order of, give notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or
other  Person  in  connection  with  the  execution,  delivery  and  performance  by  the  Company  of  the  Transaction  Documents  or  the
consummation  of  the  transactions  contemplated  hereby  and  thereby,  other  than  (i)  the  filings  required  to  comply  with  the  Company’s
registration  obligations  hereunder,  (ii)  the  application(s)  to  The  Nasdaq  Stock  Market  for  the  listing  of  the  shares  of  Common  Stock
purchased pursuant to this Agreement and the Warrant Shares for trading thereon in the time and manner required thereby, and (iii) filings
required under applicable U.S. federal and state securities laws.

f

(

)          The Securities.  The  Securities  are  duly  authorized  and,  when  issued  and  paid  for  in  accordance  with  the
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens and will not be subject to
preemptive rights, rights of first refusal, or similar rights of stockholders. The Company has reserved from its duly authorized capital stock
the maximum number of shares of Common Stock issuable pursuant to this Agreement and upon exercise of the Warrants.

-7-

 
 
 
 
 
 
 
( g )          Capitalization. As of August 9, 2016, the aggregate number of shares and type of all authorized, issued and
outstanding classes of capital stock, options and other securities of the Company (whether or not presently convertible into or exercisable or
exchangeable for shares of capital stock of the Company) consists of (i) 50,000,000 authorized shares of Common Stock, with 17,043,703
shares of Common Stock outstanding; (ii) 10,000,000 shares of Preferred Stock, none of which are outstanding; (iii) 24,785,395 shares of
Common Stock, on a diluted basis, reserved for issuance upon the exercise of outstanding warrants; and (iv) 4,037,888 shares of Common
Stock, reserved for issuance upon the exercise of outstanding employee stock options and/or restricted stock units. Since August 9, 2016,
the  Company  has  not  issued  or  granted,  as  applicable,  any  capital  stock,  options  or  other  securities  of  the  Company  (whether  or  not
presently  convertible  into  or  exercisable  or  exchangeable  for  shares  of  capital  stock  of  the  Company). All  outstanding  shares  of  capital
stock are duly authorized, validly issued, fully paid and nonassessable and have been issued in compliance with all applicable securities
laws and regulations. Except as disclosed in this Section 3.1(g) or in Section 3.1(g) of the Disclosure Letter, the Company does not have
outstanding any other options, warrants, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities,
rights  or  obligations  convertible  into  or  exercisable  or  exchangeable  for,  or  entered  into  any  agreement  giving  any  Person  any  right  to
subscribe for or acquire, any shares of Preferred Stock or Common Stock, or securities or rights convertible or exchangeable into shares of
Preferred  Stock  or  Common  Stock.  There  are  no  anti-dilution  or  price  adjustment  provisions  contained  in  any  security  issued  by  the
Company  (or  in  any  agreement  providing  rights  to  security  holders)  and  the  issuance  and  sale  of  the  Securities  will  not  obligate  the
Company to issue shares of Common Stock or other securities to any Person (other than the Investor) and will not result in a right of any
holder of securities to adjust the exercise, conversion, exchange or reset price under such securities. To the knowledge of the Company,
based solely on an examination of Schedules 13D and Schedules 13G on file with the SEC, except pursuant to this Agreement, no Person or
group of related Persons beneficially owns (as determined pursuant to Rule 13d-3 under the Exchange Act) or has the right to acquire, by
agreement  with  or  by  obligation  binding  upon  the  Company,  beneficial  ownership  of  in  excess  of  five  percent  (5%)  of  the  outstanding
Common Stock.

( h )          SEC  Reports;  Financial  Statements .  The  Company  has  filed  all  reports  required  to  be  filed  by  it  under  the
Securities Act  and  the  Exchange Act  since  March  27,  2014,  including  pursuant  to  Sections  13(a)  or  15(d)  of  the  Exchange Act,  or  has
received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. Such
reports required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) of
the Exchange Act, together with any materials filed or furnished by the Company under the Securities Act and the Exchange Act, whether
or not any such reports were required being collectively referred to herein as the “SEC Reports” and, together with this Agreement and the
Disclosure Letter, the “Disclosure Materials”. As of their respective dates, the SEC Reports filed by the Company complied in all material
respects  with  the  requirements  of  the  Securities  Act  and  the  Exchange  Act,  as  applicable,  and  the  rules  and  regulations  of  the  SEC
promulgated thereunder, and none of the SEC Reports, when filed by the Company, contained any untrue statement of a material fact or
omitted  to  state  a  material  fact  required  to  be  stated  therein  or  necessary  in  order  to  make  the  statements  therein,  in  the  light  of  the
circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Reports comply
in all material respects with applicable accounting requirements and the rules and regulations of the SEC with respect thereto as in effect at
the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles
applied on a consistent basis during the periods involved (“GAAP”), except as may be otherwise specified in such financial statements or
the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all
material respects the consolidated financial position of the Company and its consolidated Subsidiaries taken as a whole as of and for the
dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal,
immaterial,  year-end  audit  adjustments. All  material  agreements  to  which  the  Company  or  any  Subsidiary  is  a  party  or  to  which  the
property or assets of the Company or any Subsidiary are subject that are required to be filed with the SEC or identified on the SEC Reports
are included as part of or identified in the SEC Reports. The Company is eligible to use Form S-3 to register the resale of the Registrable
Securities. The Company has not received any comments from  the  SEC  or  the  staff  of  the  SEC  Division  of  Corporation  Finance  on  the
Company’s  SEC  Reports  (or  any  Company  filings  with  the  SEC  during  the  years  ended  December  31,  2014  and  2015)  that  remain
unresolved.

-8-

 
 
 
 
 
 
( i )          No Change. Except as otherwise disclosed in the SEC Reports, since March 27, 2014, (A) there has been no
event,  occurrence  or  development  that,  individually  or  in  the  aggregate,  has  had  or  would  reasonably  be  expected  to  have  a  Material
Adverse Effect, (B) the Company has not incurred any liabilities (contingent or otherwise) other than those arising from operations in the
ordinary course of business consistent with past practice, and (C) the Company has not declared or made any dividend or distribution of
cash or other property to its stockholders, or purchased, redeemed, or made any agreements to purchase or redeem any shares of its capital
stock other than pursuant to the Company’s stock repurchase plan described in the SEC Reports. The Company has not taken any steps to
seek protection pursuant to any bankruptcy law nor does the Company believe that its creditors intend to initiate involuntary bankruptcy
Proceedings or have any actual knowledge of any fact which would reasonably lead a creditor to do so. The Company is not Insolvent (as
hereinafter defined) as of the date hereof, and will not be Insolvent after giving effect to the transactions contemplated hereby to occur at
the applicable Closing. For purposes of this Section 3.1(i), “Insolvent” means (i) the present fair saleable value of the Company’s assets is
less  than  the  amount  required  to  pay  the  Company’s  total  indebtedness,  (ii)  the  Company  is  unable  to  pay  its  debts  and  liabilities,
subordinated, contingent or otherwise, as such debts and liabilities become absolute and matured or (iii) the Company has unreasonably
small capital with which to conduct the business in which it is engaged as such business is now conducted and is proposed to be conducted.

j

(

)          Litigation.  Except  as  disclosed  in Section 3.1(j)  of  the  Disclosure  Letter  or  the  SEC  Reports,  there  is  no
Proceeding pending or, to the knowledge of the Company, threatened against the Company or any Subsidiary or any of its properties that
has or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. Neither the Company, nor, to the
knowledge of the Company, any director or officer thereof, is or has been the subject of any Proceeding involving a claim of violation of or
liability  under  federal  or  state  securities  laws  or  a  claim  of  breach  of  fiduciary  duty.  There  has  not  been,  and  to  the  knowledge  of  the
Company,  there  is  not  pending  or  contemplated,  any  investigation  involving  the  Company  or,  to  the  knowledge  of  the  Company,  any
current or former director or officer of the Company. Except as disclosed in the Disclosure Letter, neither the Company nor any Subsidiary
is  a  party  or  subject  to  the  provisions  of  any  order,  writ,  injunction,  judgment  or  decree  of  any  court  or  government  agency  or
instrumentality that has had or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. There is
no Proceeding by the Company or any Subsidiary currently pending or which the Company or any Subsidiary intends to initiate that would
reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. Since March 27, 2014, (i) the Common Stock
has been designated for quotation on The Nasdaq Stock Market, (ii) trading in the Common Stock has not been suspended by the SEC or
The  Nasdaq  Stock  Market  and  (iii)  the  Company  has  received  no  communication,  written  or  oral,  from  the  SEC  or  The  Nasdaq  Stock
Market regarding the suspension or delisting of the Common Stock.

-9-

 
 
 
 
 
 
(k)          Key Employees. There are no currently effective employment contracts, offer letters containing economic terms,
consulting agreements, deferred compensation arrangements, bonus plans, incentive plans, profit sharing plans, retirement agreements or
other employee compensation plans or agreements (“Company Plans”) containing terms and conditions that would result in the material
payment to any employee or former employee of the Company or any of its Subsidiaries of any material money or other property or the
acceleration, vesting or provision of any other material rights or benefits to any employee or former employee of the Company or any of its
Subsidiaries by virtue of the issuance of the Securities pursuant to this Agreement (either alone or upon the occurrence of any other event).

l

(

)          Registration  Rights  and  Voting  Rights.  Except  as  required  pursuant  to Article  VI  of  this Agreement,  the
Company  is  presently  not  under  any  obligation,  and  has  not  granted  any  rights,  to  register  any  of  the  Company’s  presently  outstanding
securities or any of its securities that may hereafter be issued that have not expired or been satisfied. To the knowledge of the Company, no
stockholder of the Company has entered into any agreement with respect to the voting of equity securities of the Company.

( m )         Compliance with Laws; Permits. Neither the Company nor any of its Subsidiaries is, or since March 27, 2014
has been, in violation of any Applicable Law in respect of the conduct of its business or the ownership of its properties, which violation has
had  or  would  reasonably  be  expected  to  have,  individually  or  in  the  aggregate,  a  Material  Adverse  Effect.  The  Company  and  its
Subsidiaries  possess  all  certificates,  authorizations  and  permits  issued  by  the  appropriate  federal,  state,  local  or  foreign  regulatory
authorities necessary to conduct their respective businesses as described in the SEC Reports (“Material Permits”), except where the failure
to possess such permits has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect, and neither the Company nor any Subsidiary has received any notice of Proceedings relating to the revocation or modification of
any  Material  Permit,  the  revocation  or  modification  of  which  has  had  or  would  reasonably  be  expected  to  have,  individually  or  in  the
aggregate, a Material Adverse Effect.

( n )          Offering Valid. Assuming  the  accuracy  of  the  representations  and  warranties  of  the  Investor  contained  in
Section 3.2  hereof,  the  offer,  sale  and  issuance  of  the  Common  Stock,  the  Warrants,  and  the  Warrant  Shares  will  be  exempt  from  the
registration  requirements  of  the  Securities  Act,  and  will  have  been  registered  or  qualified  (or  are  exempt  from  registration  and
qualification) under the registration, permit or qualification requirements of all applicable state securities laws.

( o )          Private Placement. Neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf,
has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or
sale  of  the  Securities.  Neither  the  Company  nor  any  of  its Affiliates  nor,  any  Person  acting  on  the  Company’s  behalf  has,  directly  or
indirectly, at any time within the past six months, made any offer or sale of any security or solicitation of any offer to buy any security
under circumstances that would (i) eliminate the availability of the exemption from registration under Regulation D in connection with the
offer  and  sale  by  the  Company  of  the  Securities  as  contemplated  hereby  or  (ii)  cause  the  offering  of  the  Securities  pursuant  to  the
Transaction Documents to be integrated with prior offerings by the Company for purposes of any Applicable Law or stockholder approval
provisions, including, without limitation, under the rules and regulations of The Nasdaq Stock Market in a manner which would require any
stockholder approval.

-10-

 
 
 
 
 
 
 
 
 
( p )          Transfer Taxes. On the Closing Date, all stock transfer or other taxes (other than income taxes) required to be
paid in connection with the sale and transfer of the shares of Common Stock to be sold to the Investor hereunder will be, or will have been,
fully paid or provided for by the Company, and all Applicable Laws imposing such taxes will be or will have been complied with fully.

(q)          Placement Agent’s Fees. The Company has not employed any broker, investment banker, finder or other Person
in a similar capacity and has not incurred any liability for any financial advisory fees, brokerage fees, commissions or finder’s fees, and no
broker,  investment  banker,  finder  or  other  Person  in  a  similar  capacity  has  acted,  directly  or  indirectly,  for  the  Company  or  any  of  its
Subsidiaries, in connection with this Agreement or the transactions contemplated hereby. The Company shall pay, and hold the Investor
harmless against, any liability, loss or expense (including, without limitation, reasonable attorney’s fees and out-of-pocket expenses) arising
in  connection  with  any  such  claim  for  fees  arising  out  of  the  issuance  of  the  Securities  pursuant  to  this Agreement  and  the  Transaction
Documents.

( r )          Application of Takeover Protections . Except as described in Section 3.1(r) of the Disclosure Letter, there is no
control  share  acquisition,  business  combination,  poison  pill  (including  any  distribution  under  a  rights  agreement)  or  other  similar  anti-
takeover  provision  under  the  Company’s  charter  documents  or  the Applicable  Laws  of  its  state  of  incorporation  or  otherwise,  that  is  or
could become applicable to the Investor as a result of the Investor and the Company fulfilling their obligations or exercising their rights
under  the  Transaction  Documents,  including,  without  limitation,  as  a  result  of  the  Company’s  issuance  of  the  Securities  (including  the
issuance of the Warrant Shares) and the Investor’s ownership of the Securities.

3.2          Representations, Warranties and Covenants of the Investor. The Investor hereby represents and warrants to the Company

as follows:

(a)          Organization; Authority. The Investor is an entity duly organized, validly existing and in good standing under the
Applicable Laws of the jurisdiction of its organization with the requisite corporate, partnership or other power and authority to enter into
and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations thereunder. The
purchase by the Investor of the Securities hereunder has been duly authorized by all necessary corporate, partnership or other action on the
part of the Investor. This Agreement has been duly executed and delivered by the Investor and constitutes the valid and binding obligation
of  the  Investor,  enforceable  against  it  in  accordance  with  its  terms,  except  as  may  be  limited  by  (i)  applicable  bankruptcy,  insolvency,
reorganization or other Applicable Laws of general application relating to or affecting the enforcement of creditors rights generally, and (ii)
the effect of rules of law governing the availability of specific performance and other equitable remedies. The Investor is not required to
obtain any consent, waiver, authorization or order of, give notice to, or make any filing or registration with, any court or other federal, state,
local or other governmental authority or other Person in connection with the execution, delivery and performance by the Investor of the
Transaction  Documents  or  the  consummation  of  the  transactions  contemplated  hereby  and  thereby,  other  than  filings  required  under
applicable U.S. federal and state securities laws.

-11-

 
 
 
 
 
 
 
 
 
( b )          No Public Sale or Distribution . The Investor is (i) acquiring the Common Stock and the Warrants and (ii) upon
exercise of the Warrants will acquire the Warrant Shares issuable upon exercise thereof, not with a view towards, or for resale in connection
with, the public sale or distribution thereof, except pursuant to sales registered under the Securities Act or under an exemption from such
registration and in compliance with applicable federal and state securities laws, and the Investor does not have a present arrangement to
effect any distribution of the Securities to or through any person or entity; provided, however, that by making the representations herein, the
Investor  does  not  agree  to  hold  any  of  the  Securities  for  any  minimum  or  other  specific  term  and  reserves  the  right  to  dispose  of  the
Securities at any time in accordance with or pursuant to a registration statement or an exemption under the Securities Act.

( c )          Investor Status. At  the  time  the  Investor  was  offered  the  Securities,  it  was,  and  at  the  date  hereof  it  is,  an
“accredited  investor”  as  defined  in  Rule  501(a)  under  the  Securities Act  or  a  “qualified  institutional  buyer”  as  defined  in  Rule  144A(a)
under the Securities Act.

( d )          Experience of the Investor. The Investor, either alone or together with its representatives, has such knowledge,
sophistication  and  experience  in  business  and  financial  matters  so  as  to  be  capable  of  evaluating  the  merits  and  risks  of  the  prospective
investment in the Securities, and has so evaluated the merits and risks of such investment. The Investor understands that it must bear the
economic risk of this investment in the Securities, and is able to bear such risk and is able to afford a complete loss of such investment.

( e )          Access  to  Information.  The  Investor  acknowledges  that  it  has  had  access  to  the  Disclosure  Materials  and
information  about  the  Company  and  the  Subsidiaries  and  their  respective  financial  condition,  results  of  operations,  business,  properties,
management and prospects sufficient to enable it to evaluate its investment. No information, inquiry, or investigation conducted by or on
behalf of the Investor or its representatives or counsel shall modify, amend or affect the Investor’s right to rely on the truth, accuracy and
completeness of the Disclosure Materials and the Company’s representations and warranties contained in the Transaction Documents.

( f )          Restricted Securities. The Investor understands that  the  Securities  are  characterized  as  “restricted  securities”
under  the  U.S.  federal  securities  laws  inasmuch  as  they  are  being  acquired  from  the  Company  in  a  transaction  not  involving  a  public
offering and that under such laws and applicable regulations such securities may be resold without registration under the Securities Act only
in  certain  limited  circumstances.  The  Investor  has  been  advised  or  is  aware  that  it  may  be  deemed  to  be  an  “affiliate”  of  the  Company
within the meaning of the Securities Act following the execution of this Agreement.

-12-

 
 
 
 
 
 
 
 
 
( g )          Placement Agent’s Fees . The Investor has not employed any broker, investment banker, finder or other Person
in a similar capacity or incurred any liability for any financial advisory fees, brokerage fees, commissions or finder’s fees, and no broker,
investment banker, finder or other Person in a similar capacity has acted, directly or indirectly, for the Company or any of its Subsidiaries,
in  connection  with  this Agreement  or  the  transactions  contemplated  hereby.  The  Investor  shall  pay,  and  hold  the  Company  harmless
against,  any  liability,  loss  or  expense  (including,  without  limitation,  reasonable  attorney’s  fees  and  out-of-pocket  expenses)  arising  in
connection with any such claim for any such fees described in the preceding sentence arising out of the purchase of the Securities pursuant
to this Agreement.

( h )          Litigation. There is no Proceeding pending or, to the Investor’s knowledge, threatened against the Investor or
any subsidiary or any of its properties which in any manner challenge or seek to prevent, enjoin, alter or materially delay the transactions
contemplated by this Agreement.

(i)          No Ownership of Company Securities. Except as set in disclosure provided to the Company, as of the date of this
Agreement,  neither  the  Investor,  nor  any  Investor  Controlled  Entity, Affiliate  of  the  Investor  (other  than  any  officer  or  director  of  the
Investor) or any 13D Group of which the Investor or any of its Affiliates is a member, beneficially owns any shares of Common Stock, or
any other equity securities of the Company, or any options, warrants or other rights to acquire equity securities of the Company or any other
securities convertible into equity securities of the Company. Except as set in disclosure provided to the Company, since March 27, 2014,
neither the Investor, nor any Investor Controlled Entity, Affiliate of the Investor (other than any officer or director of the Investor) or any
13D Group of which the Investor or any of its Affiliates is a member, has purchased, sold, transferred, made any short sale of, granted any
option  for  the  purchase  of,  or  entered  into  any  hedging  or  similar  transaction  with  the  same  economic  effect  as  a  sale  of,  any  equity
securities or any options, warrants or other rights to acquire equity securities of the Company.

ARTICLE IV
OTHER AGREEMENTS OF THE PARTIES

4.1         Transfer Restrictions.

(a)          The Investor covenants that the Securities will only be disposed of pursuant to an effective registration statement
under,  and  in  compliance  with  the  requirements  of,  the  Securities Act,  to  the  Company  or  pursuant  to  an  available  exemption  from  the
registration requirements of the Securities Act, and in compliance with any applicable state securities laws. In connection with any transfer
of  Securities  other  than  pursuant  to  an  effective  registration  statement  or  to  the  Company,  the  Company  may  require  the  transferor  to
provide  to  the  Company  an  opinion  of  counsel  selected  by  the  transferor,  the  form  and  substance  of  which  opinion  shall  be  reasonably
satisfactory  to  the  Company,  to  the  effect  that  such  transfer  does  not  require  registration  under  the  Securities Act.  Notwithstanding  the
foregoing, the Company hereby consents to and agrees to register on the books of the Company and with its Transfer Agent, without any
such legal opinion, except to the extent that the Transfer Agent requests such legal opinion, any transfer of Securities by the Investor to an
Affiliate  of  the  Investor  (including  an  individual  retirement  account  related  thereto), provided  that  (i)  the  transferee  certifies  to  the
Company that it is an “accredited investor,” as defined in Rule 501(a) under the Securities Act and (ii) the transferee agrees in writing to be
subject to the terms and conditions of this Agreement.

-13-

 
 
 
 
 
 
 
 
 
 
any certificate evidencing any of the Securities:

(b)          The Investor agrees to the imprinting, so long as is required by this Section 4.1(b), of the following legends on

THESE  SECURITIES  HAVE  NOT  BEEN  REGISTERED  WITH  THE  SECURITIES AND  EXCHANGE  COMMISSION  OR
THE  SECURITIES  COMMISSION  OF  ANY  STATE  IN  RELIANCE  UPON  AN  EXEMPTION  FROM  REGISTRATION
UNDER  THE  SECURITIES ACT  OF  1933, AS AMENDED  (THE  “ SECURITIES ACT”),  OR ANY APPLICABLE  STATE
SECURITIES LAWS AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION  STATEMENT  UNDER  THE  SECURITIES  ACT  OR  PURSUANT  TO  AN  AVAILABLE  EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT
AND IN COMPLIANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS.

THESE  SECURITIES  ARE  SUBJECT  TO  TRANSFER  RESTRICTIONS  AS  SET  FORTH  IN  A  CERTAIN  SECURITIES
PURCHASE AGREEMENT  BETWEEN  THE  ISSUER AND  THE  ORIGINAL  HOLDER  OF  THESE  SHARES, A  COPY  OF
WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE ISSUER.

Certificates  evidencing  Securities  shall  not  be  required  to  contain  the  legends  set  forth  above  (i)  following  any  sale  of  such
Securities pursuant to a Registration Statement covering the resale of the Securities is effective under the Securities Act; (ii) following any
sale of such Securities pursuant to Rule 144 if the holder provides the Company with a legal opinion reasonably acceptable to the Company
to the effect that the Securities have been sold under Rule 144; (iii) if the Securities are eligible for sale under Rule 144(b)(1); or (iv) if the
holder provides the Company with a legal opinion reasonably acceptable to the Company to the effect that the legend is not required under
applicable requirements of the Securities Act (including controlling judicial interpretations and pronouncements issued by the staff of the
SEC). The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on
transfer  set  forth  in  this Section  4.1(b)  unless  required  by  Applicable  Law.  Notwithstanding  anything  to  the  contrary  in  any  of  the
Transaction  Documents,  the  Securities  may  be  pledged  in  connection  with  a  bona  fide  margin  account  or  other  loan  or  financing
arrangement  secured  by  the  Securities  and  such  pledge  of  Securities  shall  not  be  deemed  to  be  a  transfer,  sale  or  assignment  of  the
Securities hereunder, and in connection with a pledge of Securities, the question shall not be required to provide the Company with any
notice  thereof  or  otherwise  make  any  delivery  to  the  Company  pursuant  to  any  provision  of  this Agreement  or  any  other  Transaction
Document.

-14-

 
 
 
 
 
 
 
 
(c)          Notwithstanding the foregoing provisions of this Section 4.1, during the Voting Period, Investor agrees that it
shall not sell, transfer or dispose of, directly or indirectly, any Securities, other than pursuant to an effective registration statement, pursuant
to  Rule  144,  or  to  the  Company,  unless  the  transferee  agrees  in  writing  to  be  bound  by  and  subject  to  the  terms  and  conditions  of  this
Agreement.

4.2         Furnishing of Information. During the time a Registration Statement is required to be effective, the Company covenants to
timely  file  (or  obtain  extensions  in  respect  thereof  and  file  within  the  applicable  grace  period)  all  reports  required  to  be  filed  by  the
Company after the date hereof pursuant to the Exchange Act. Upon the request of the Investor, the Company shall deliver to the Investor a
written certification of a duly authorized officer as to whether it has complied with the preceding sentence. As long as the Investor owns
Securities, if the Company is not required to file reports pursuant to the Exchange Act, it will prepare and furnish to the Investor and make
publicly available in accordance with Rule 144(c) such information as is required for the Investor to sell the Securities under Rule 144. The
Company  further  covenants  that  it  will  take  such  further  action  as  the  Investor  may  reasonably  request,  all  to  the  extent  necessary  from
time  to  time  to  enable  such  Person  to  sell  such  Securities  without  registration  under  the  Securities  Act  within  the  limitation  of  the
exemptions provided by Rule 144.

4 . 3         Integration. The Company shall not, and shall use its commercially reasonably efforts to ensure that no Affiliate thereof
shall, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities
Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act
of  the  sale  of  the  Securities  to  the  Investor  or  that  would  be  integrated  with  the  offer  or  sale  of  the  Securities  such  that  approval  of  the
stockholders  of  the  Company  would  be  required  pursuant  to  the  rules  and  regulations  of  The  Nasdaq  Stock  Market  or  a  comparable
securities trading market.

4 . 4         Reservation of Securities. The Company shall maintain a reserve from its duly authorized shares of Common Stock for
issuance pursuant to the Transaction Documents in such amount as may be required to fulfill its obligations to issue Warrant Shares under
the Transaction Documents. In the event that at any time the then authorized shares of Common Stock are insufficient for the Company to
satisfy  its  obligations  to  issue  such  Warrant  Shares  under  the  Transaction  Documents,  the  Company  shall  promptly  take  such  actions  as
may be required to increase the number of authorized shares.

4 . 5         Listing of Common Stock. The Company hereby agrees to use best efforts to maintain the listing of the Common Stock
on The Nasdaq Stock Market or a comparable securities trading market, and promptly following the Closing (but not later than the 30 day
anniversary  of  the  Closing)  to  list  the  Shares  and  Warrant  Shares  on  The  Nasdaq  Stock  Market.  The  Company  further  agrees,  if  the
Company applies to have the Common Stock traded on any other securities trading market, it will include in such application the Shares
and the Warrant Shares, and will take such other action as is necessary or desirable in the reasonable opinion of the Investor to cause the
Shares and Warrant Shares to be listed on such other securities trading market as promptly as possible. The Company will take all action
reasonably necessary to continue the listing and trading of its Common Stock on The Nasdaq Stock Market or comparable securities trading
market and will comply in all material respects with the Company’s reporting, filing and other obligations under the by-laws or rules of
such market.

-15-

 
 
 
 
 
 
 
 
 
4 . 6         Anti-Takeover Provisions. If any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or other similar anti-takeover provision under the Company’s charter documents or the Applicable Laws of its
state of incorporation or otherwise, that is or would reasonably be expected to become applicable to the Investor as a result of the Investor
and the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including, without limitation, as a
result of the Company’s issuance of the Securities and/or Investor’s exercise of Warrants and the Investor’s ownership of the Securities,
shall become applicable to the transactions contemplated by the Transaction Documents, the Company and the Board shall use best efforts
to grant such approvals and take such actions as are necessary so that the transactions contemplated by the Transaction Documents may be
consummated as promptly as practicable on the terms contemplated hereby and otherwise act to minimize the effects of any such statute or
regulation on the transactions contemplated hereby.

4 . 7         Voting. During the period commencing upon the date hereof and ending five (5) years from and after the Closing (the
“Voting Period”), each of the Investor, any Investor Controlled Entity, any Affiliate of the Investor (other than any officer or director of the
Investor) and any 13D Group of which the Investor or any of its Affiliates is a member shall vote all Common Stock of the Company they
hold in each vote of the Company’s stockholders in the manner recommended by the Board;  provided that this Section 4.7 shall not apply
to proposals seeking approvals of the Company’s stockholders with respect to amendments to the Company’s Certificate of Incorporation
or  by-laws  that  directly  conflict  with  the  rights  of  the  Investor  under  this Agreement,  or  that  directly  affect  the  Investor  by  naming  the
Investor specifically in such amendment, (ii) if the Company has materially breached any of its representations or warranties hereunder, or
(iii)  if  the  Company  has  breached  any  of  its  covenants  hereunder  without  curing  such  breach  within  ten  days  after  notice  thereof.  With
respect  to  votes  of  the  Company’s  stockholders  relating  to  the  election  of  members  of  the  Board,  each  of  the  Investor,  any  Investor
Controlled  Entity  and  any  13D  Group  of  which  the  Investor  or  any  of  its Affiliates  is  a  member  shall  vote  all  Common  Stock  of  the
Company  they  hold  in  favor  of  individuals  recommended  by  the  Board  for  election  to  the  Board,  provided  that  the  provisions  of  this
sentence shall not apply in the event of any fraud or malfeasance by, or any material change in, the senior executive management of the
Company. During the Voting Period, the Investor agrees to take such actions as may be reasonably necessary to ensure that any Common
Stock held by the Investor, any Investor Controlled Entity, any Affiliate of the Investor (other than any officer or director of the Investor)
and any 13D Group of which the Investor or any of its Affiliates is a member are present for any vote of the Company’s stockholders for
purposes of establishing a quorum with respect to such vote.

4.8         Standstill; Required Sales.

(a)          The Investor agrees that during the Voting Period, neither the Investor, nor any Investor Controlled Entity, Affiliate of the
Investor (other than any officer or director of the Investor) or any 13D Group of which the Investor or any of its Affiliates is a member shall
directly or indirectly:

Company;

(i)                    otherwise  act,  alone  or  in  concert  with  others,  to  seek  to  control  the  management,  Board  or  policies  of  the

-16-

 
 
 
 
 
 
 
 
 
(ii)         enter into any joint venture, securities lending or option agreement, put or call, guarantee of loans, guarantee of
profits  or  division  of  losses  or  profits,  contract,  arrangement  or  understanding  with  any  Person  with  respect  to  any  securities  of  the
Company or any Subsidiary of the Company;

(iii)        acquire additional shares of Voting Stock without the consent of the Board, except for the Warrant Shares;

any person with respect to the voting of any Voting Stock (other than as otherwise provided or contemplated by this Agreement);

(iv)        solicit or participate in the solicitation of proxies with respect to any Voting Stock, or seek to advise or influence

Voting Stock to any arrangement or agreement with any third party with respect to the voting of such Voting Stock;

(v)         deposit any Voting Stock in a voting trust or, except as otherwise provided or contemplated herein, subject any

acquiring, holding, voting or disposing of Voting Stock or Non-Voting Convertible Securities;

(vi)        join a 13D Group (other than a group comprising solely of the Investor and its Affiliates) for the purpose of

business combination or merger involving the Company or any of its subsidiaries or divisions;

(viii)      take any action which might require the Company to make a public announcement regarding the possibility of a

(ix)         disclose any intention, plan or arrangement inconsistent with the foregoing;

(x)          advise, assist or encourage any other Persons in connection with any of the foregoing; or

indirectly, amend or waive any provision of this Section 4.8(a) in a manner that may require public disclosure of such a request.

(xi)                  request  that  the  Company  (or  its  respective  directors,  officers,  affiliates,  employees  or  agents),  directly  or

Notwithstanding  anything  to  the  contrary  in  this Agreement,  (i)  the  prohibitions  in  this Article IV  shall  not  affect  the
Investor’s  ability  to  hold  the  Shares,  the  Warrants  and  the  Warrant  Shares  and  (ii)  in  the  event  that  it  shall  be  publicly  announced  or
disclosed that the Company has entered into an agreement to effect a Change of Control of the Company, that the Company has received
an unsolicited offer (determined to be bona fide by the Board in good faith) for a majority of the outstanding shares of capital stock of the
Company or for the sale of the Company or substantially all of its assets at any time, the Investor shall be released from compliance with
the terms of this Section 4.8(a) for the pendency of such transaction, offer or process.

(b)         Intentionally omitted

-17-

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 . 9         Lock-Up. From and after the Closing, the Investor hereby agrees not to (i) sell, transfer or otherwise dispose of, directly
or  indirectly,  any  Shares  or  Warrant  Shares  or  (ii)  enter  into  any  swap  or  other  arrangement  that  transfers  to  another  Person  any  of  the
economic consequences of ownership of Shares or Warrant Shares, until the six month anniversary of the closing, except to the Company,
in response to a Change of Control (or agreement related to a Change of Control), or a tender or exchange offer for the Common Stock
(other than a tender or exchange offer by the Investor, any Investor Controlled Entity, any Affiliate of the Investor or any 13D Group of
which the Investor or any of its Affiliates is a member) or as part of a transaction in which all outstanding shares of Common Stock of the
Company are converted into or exchanged for other consideration and is approved by the stockholders of the Company. This Section 4.9
shall not, with respect to Securities, apply to (a) bona fide gifts, whether to charitable organizations or otherwise, provided the recipient
thereof agrees in writing to be bound by the terms of this Section 4.9, (b) dispositions to any individual retirement account, foundation,
trust, partnership, or limited liability company, as the case may be, for the direct or indirect benefit of the Investor and/or the immediate
family  of  the  Investor  or  any  Investor  Related  Entity,  provided  that  such  transferee  agrees  in  writing  to  be  bound  by  the  terms  of  this
Section 4.9, (c) transfers as required by law, (d) dispositions by a corporation, partnership or limited liability company to a shareholder,
partner or member thereof, provided such shareholder, partner or member agrees in writing to be bound by the terms of this Section 4.9, or
(e) any obligations regarding the Securities under any existing pledge, margin account or similar agreement, including, but not limited to,
sales and transfers of such Undersigned Shares.

4.10       Press Releases. No later than the Trading Day immediately following the execution of this Agreement, the Company will
issue  a  press  release  disclosing  the  transactions  contemplated  by  the Agreement,  and  the  Company  shall  file  a  Form  8-K  relating  to  the
Transaction Documents. The Company and the Investor shall consult with each other in issuing any subsequent press releases with respect
to the transactions contemplated hereby, and the Company and the Investor shall not issue any such subsequent press release or otherwise
make any such public statement without the prior consent of the other party, which consent shall not be unreasonably withheld, conditioned
or delayed, except if such disclosure is required by Applicable Law, in which case the disclosing party shall if possible promptly provide
the other party with prior notice of such public statement or communication.

4.11       Antitrust Filings. If the exercise of the Warrants requires any antitrust filings under Applicable Law, then the Investor and

the Company agree to make any such required filings and to cooperate with each other in making any such filings.

ARTICLE V
CONDITIONS PRECEDENT

5.1         Conditions Precedent to the Obligations of the Investor. The obligation of the Investor to acquire Securities at the Closing

is subject to the satisfaction or waiver by the Investor, at the Closing, of each of the following conditions:

( a )          Representations and Warranties . The representations and warranties of the Company contained herein shall be
true  and  correct  in  all  material  respects  (other  than  those  representations  and  warranties  that  are  qualified  by  materiality  or  Material
Adverse Effect qualifiers, which shall be true and correct in all respects) as of the date when made and as of the Closing as though made on
and as of such date.

-18-

 
 
 
 
 
 
 
 
 
 
( b )          Performance.  The  Company  shall  have  performed,  satisfied  and  complied  in  all  material  respects  with  all
covenants, agreements and conditions required by the Transaction Documents to be performed, satisfied or complied with by it at or prior
to the Closing.

( c )          No  Stockholder Approval  Required .  No  approval  on  the  part  of  the  stockholders  of  the  Company  shall  be
required in connection with the execution and delivery by the Company of this Agreement and the other Transaction Documents and the
consummation of the transactions to be performed by the Company contemplated by the Transaction Documents.

(d)          Regulatory Approvals. All material approvals, authorizations and consents of any governmental entity or Person
required  to  consummate  the  transactions  contemplated  by  this  Agreement  and  the  other  Transaction  Documents  (including  any  such
approvals, authorizations and consents under applicable foreign antitrust laws) shall have been obtained and remain in full force and effect,
and all statutory waiting periods relating to such approvals, authorizations and consents shall have expired or been terminated.

( e )          Qualification  Under  State  Securities  Laws. All  registrations,  qualifications,  permits  and  approvals,  if  any,
required to be obtained prior to the Closing under applicable state securities laws shall have been obtained for the lawful execution, delivery
and performance of this Agreement and the other Transaction Documents, including, without limitation, the offer and sale of the Securities.

( f )          No Litigation. No litigation, order, writ, injunction, judgment, decree or other claim shall be pending or, to the
knowledge of the Investor, threatened that questions the validity of this Agreement or the other Transaction Documents or the right of the
Company or the Investor to enter into such agreements or to consummate the transactions contemplated hereby and thereby.

( g )          No Violation. No statute, rule, regulation, order, or interpretation shall have been enacted, entered or deemed
applicable by any domestic or foreign government or governmental or administrative agency or court which would make the transactions
contemplated by the Agreement or the other Transaction Documents illegal.

5 . 2         Conditions Precedent to the Obligations of the Company. The obligation of the Company to sell the Securities at the

Closing is subject to the satisfaction or waiver by the Company, at the Closing, of each of the following conditions:

true and correct in all material respects as of the date when made and as of the Closing Date as though made on and as of such date.

( a )          Representations and Warranties . The representations and warranties of the Investor contained herein shall be

( b )          Performance.  The  Investor  shall  have  performed,  satisfied  and  complied  in  all  material  respects  with  all
covenants,  agreements  and  conditions  required  by  this Agreement  and  the  other  Transaction  Documents  to  be  performed,  satisfied  or
complied with by the Investor at or prior to the Closing.

-19-

 
 
 
 
 
 
 
 
 
 
 
 
 
(c)          Regulatory Approvals. All material approvals, authorizations and consents of any governmental entity or Person
required  to  consummate  the  transactions  contemplated  by  this  Agreement  and  the  other  Transaction  Documents  (including  any  such
approvals, authorizations and consents under applicable foreign antitrust laws) shall have been obtained and remain in full force and effect,
and all statutory waiting periods relating to such approvals, authorizations and consents shall have expired or been terminated.

( d )          Qualification  Under  State  Securities  Laws. All  registrations,  qualifications,  permits  and  approvals,  if  any,
required to be obtained prior to the Closing under applicable state securities laws shall have been obtained for the lawful execution, delivery
and performance of this Agreement and the other Transaction Documents, including, without limitation, the offer and sale of the Securities.

( e )          No Litigation. No litigation, order, writ, injunction, judgment, decree or other claim shall be pending or, to the
knowledge of the Company, threatened that questions the validity of this Agreement or the other Transaction Documents or the right of the
Company or the Investor to enter into such agreements or to consummate the transactions contemplated hereby and thereby.

( f )          No Violation. No statute, rule, regulation, order, or interpretation shall have been enacted, entered or deemed
applicable by any domestic or foreign government or governmental or administrative agency or court which would make the transactions
contemplated by this Agreement or the other Transaction Documents illegal.

6.1          Registration Statement.

ARTICLE VI
REGISTRATION RIGHTS

(a)          Until such time as the date that all Registrable Securities covered by such Registration Statement have been sold
or  can  be  sold  publicly  under  Rule  144  without  volume  limitation,  upon  written  request  by  the  Investor,  the  Company  shall,  as  soon  as
reasonably  practicable  following  Investor’s  request,  prepare  and  file  with  the  SEC  a  Registration  Statement  covering  the  resale  of  such
portion of the Registrable Securities requested by the Investor for an offering to be made on a continuous basis pursuant to Rule 415. Each
Registration Statement shall be on Form S-3 or any successor form thereto (except if the Company is not then eligible to register for resale
the Registrable Securities on Form S-3 or any successor form thereto, in which case such registration shall be on another appropriate form
in accordance with the Securities Act and the Exchange Act). The Company shall not be obligated to file and have declared effective more
than  three  (3)  Registration  Statements  per  year  pursuant  to  this Article  VI  and  each  registration  hereunder  shall  include  Registrable
Securities  consisting  of  not  less  than  200,000  shares  of  Common  Stock  (as  adjusted  by  any  stock  split,  dividend  or  other  distribution,
recapitalization or similar event).

(b)          The Company shall use its best efforts to cause each Registration Statement to be declared effective by the SEC
as  promptly  as  practical  after  the  filing  thereof  (but  in  no  event  sooner  than  six  months  after  the  Closing  Date  of  this Agreement),  and,
subject to Section 6.1(e), shall use its best efforts to keep each Registration Statement continuously effective under the Securities Act for all
Registrable Securities for a period up to the earlier of seventy five (75) days or until the date that all Registrable Securities covered by such
Registration Statement have been sold or can be sold publicly under Rule 144 on a single day (the “Effectiveness Period”).

-20-

 
 
 
 
 
 
 
 
 
 
 
 
receiving notification from the SEC that a Registration Statement has been declared effective.

(c)          The Company shall notify the Investor in writing promptly (and in any event within two (2) Trading Days) after

under the Securities Act to effect the registration contemplated hereunder.

(d)          The Company may require the Investor to provide such information regarding the Investor as may be required

(e)          If at any time after a Registration Statement has become effective, the Company is engaged in any plan, proposal
or  agreement  with  respect  to  any  financing,  acquisition,  recapitalization,  reorganization  or  other  material  transaction  or  development  the
public disclosure of which would be detrimental to the Company, then the Company may direct that such request be delayed or that use of
the  Prospectus  contained  in  such  Registration  Statement  be  suspended,  as  applicable,  for  a  period  of  up  to  45  days.  The  Company  will
notify  the  Investor  of  the  delay  or  suspension.  In  the  case  of  notice  suspending  an  effective  Registration  Statement,  the  Investor  will
immediately discontinue any sales of Registrable Securities pursuant to such Registration Statement until the Investor has received copies
of a supplemented or amended Prospectus or until the Investor is advised in writing by the Company that the then-current Prospectus may
be used and has received copies of any additional or supplemental filings that are incorporated or deemed incorporated by reference in such
Prospectus. The Company may exercise the rights provided by this Section 6.1(e) for an aggregate of 90 days within any 365-day period.

(f)                  The  Company  will  use  its  best  efforts  to  cooperate  with  the  Investor  in  the  disposition  of  the  Registrable  Securities

covered by a Registration Statement.

6.2         Registration Procedures. In connection with the Company’s registration obligations hereunder, the Company shall:

(a)          (i) Prepare and file with the SEC such amendments, including post-effective amendments, to each Registration
Statement and the Prospectus used in connection therewith as may be necessary to keep each Registration Statement continuously effective,
as  to  the  applicable  Registrable  Securities  for  the  Effectiveness  Period  and  prepare  and  file  with  the  SEC  such  additional  Registration
Statements in order to register for resale under the Securities Act all of the Registrable Securities during the Effectiveness Period; (ii) cause
the related Prospectus to be amended or supplemented by any required Prospectus supplement, and as so supplemented or amended to be
filed pursuant to Rule 424; (iii) respond as promptly as reasonably practical, to any comments received from the SEC with respect to each
Registration Statement or any amendment thereto; and (iv) comply in all material respects with the provisions of the Securities Act and the
Exchange Act applicable to the Company with respect to the disposition of all Registrable Securities covered by a Registration Statement
during  the  applicable  period  in  accordance  with  the  intended  methods  of  disposition  by  the  Investor  thereof  set  forth  in  a  Registration
Statement as so amended or in such Prospectus as so supplemented.

-21-

 
 
 
 
 
 
 
 
 
 
(b)          Notify the Investor as promptly as reasonably practical, and confirm such notice in writing no later than two (2)
Trading  Days  thereafter,  of  any  of  the  following  events:  (i)  any  Registration  Statement  or  any  post-effective  amendment  is  declared
effective;  (ii)  the  Company  becomes  aware  that  the  SEC  has  issued  any  stop  order  suspending  the  effectiveness  of  any  Registration
Statement  or  initiates  any  Proceedings  for  that  purpose;  (iii)  the  Company  receives  notice  of  any  suspension  of  the  qualification  or
exemption from qualification of any Registrable Securities for sale in any jurisdiction, or the initiation or threat of any Proceeding for such
purpose; or (iv) the financial statements included in any Registration Statement become ineligible for inclusion therein or any Registration
Statement or Prospectus or other document contains any untrue statement of a material fact or omits to state any material fact required to be
stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.

(c)          Use its best efforts to avoid the issuance of or, if issued, obtain the withdrawal of (i) any order suspending the
effectiveness  of  any  Registration  Statement,  or  (ii)  any  suspension  of  the  qualification  (or  exemption  from  qualification)  of  any  of  the
Registrable Securities for sale in any jurisdiction, as soon as possible.

(d)          If requested by the Investor, promptly provide the Investor, without charge, at least one conformed copy of each
Registration Statement and each amendment thereto, including financial statements and schedules, and all exhibits to the extent requested
by the Investor (including those previously furnished or incorporated by reference) promptly after the filing of such documents with the
SEC.

(e)          Promptly deliver to the Investor, without charge, as many copies of the Prospectus or Prospectuses (including
each  form  of  prospectus)  and  each  amendment  or  supplement  thereto  as  the  Investor  may  reasonably  request.  The  Company  hereby
consents to the use of such Prospectus and each amendment or supplement thereto by the Investor in connection with the offering and sale
of the Registrable Securities covered by such Prospectus and any amendment or supplement thereto to the extent permitted by federal and
state securities laws and regulations.

(f)          Prior to any public offering of Registrable Securities, use its best efforts to register or qualify or cooperate with
the Investor in connection with the registration or qualification (or exemption from such registration or qualification) of such Registrable
Securities for offer and sale under the securities or Blue Sky laws of such jurisdictions within the United States as the Investor requests in
writing,  to  keep  each  such  registration  or  qualification  (or  exemption  therefrom)  effective  for  so  long  as  required,  but  not  to  exceed  the
duration of the Effectiveness Period, and to do any and all other acts or things reasonably necessary or advisable to enable the disposition in
such  jurisdictions  of  the  Registrable  Securities  covered  by  a  Registration  Statement; provided, however,  that  the  Company  shall  not  be
obligated to file any general consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction
in which it is not so qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise so
subject.

-22-

 
 
 
 
 
 
 
 
 
(g)          Upon sale of such Registrable Securities pursuant to an effective Registration Statement, cooperate with the
Investor to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be delivered to a transferee,
which  certificates  shall  be  free,  to  the  extent  permitted  by  this Agreement  and  under Applicable  Law,  of  all  restrictive  legends,  and  to
enable such Registrable Securities to be in such denominations and registered in such names as any the Investor may reasonably request.

(h)          Promptly upon the occurrence of any event described in Section 6.2(b)(iv), prepare a supplement or amendment,
including a post-effective amendment, to a Registration Statement or a supplement to the related Prospectus or any document incorporated
or  deemed  to  be  incorporated  therein  by  reference,  and  file  any  other  required  document  so  that,  as  thereafter  delivered,  neither  such
Registration Statement nor such Prospectus will contain an untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.

of the Securities.

(i)          Comply with all rules and regulations of the SEC applicable to the Company in connection with the registration

(j)          The Company shall comply with all applicable rules and regulations of the SEC under the Securities Act and the
Exchange Act,  including,  without  limitation,  Rule  172  under  the  Securities Act,  file  any  final  Prospectus,  including  any  supplement  or
amendment thereof, with the SEC pursuant to Rule 424  under  the  Securities Act,  promptly  inform  the  holders  in  writing  if,  at  any  time
during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof, the holders are
required to make available a Prospectus in connection with any disposition of Registrable Securities and take such other actions as may be
reasonably necessary to facilitate the registration of the Registrable Securities hereunder.

6.3           Registration Expenses. The Company shall pay all fees and expenses incident to the performance of or compliance with
Article VI of this Agreement, but excluding underwriting discounts and commissions of the Investor, including without limitation (a) all
registration and filing fees and expenses, including without limitation those related to filings with the SEC, The Nasdaq Stock Market or
comparable securities trading market and in connection with applicable state securities or Blue Sky laws, (b) printing expenses (including
without limitation expenses of printing certificates for Registrable Securities), (c) messenger, telephone and delivery expenses incurred by
the Company, (d) fees and disbursements of counsel for the Company, (e) fees and expenses of all other Persons retained by the Company
in connection with the consummation of the transactions contemplated by this Agreement, (f) reasonable fees and expenses of one special
counsel  for  the  Investor  (not  to  exceed  $25,000  per  registration  or  $100,000  in  the  aggregate  for  all  registrations  pursuant  to  this
Agreement); and (g) all listing fees to be paid by the Company to The Nasdaq Stock Market or comparable securities trading market.

-23-

 
 
 
 
 
 
 
 
 
6.4          Indemnification.

( a )          Indemnification  by  the  Company .  The  Company  shall,  notwithstanding  any  termination  of  this Agreement,
indemnify and hold harmless the Investor, the officers, directors, partners, members, agents and employees of each of them, each Person
who  controls  the  Investor  (within  the  meaning  of  Section  15  of  the  Securities Act  or  Section  20  of  the  Exchange Act)  and  the  officers,
directors,  partners,  members,  agents  and  employees  of  each  such  controlling  Person,  to  the  fullest  extent  permitted  by Applicable  Law,
from  and  against  all  Losses  arising  out  of  or  relating  to  any  untrue  or  alleged  untrue  statement  of  a  material  fact  contained  in  any
Registration Statement, any Prospectus or any form of Company prospectus or in any amendment or supplement thereto or in any Company
preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or
necessary  to  make  the  statements  therein  (in  the  case  of  any  Prospectus  or  form  of  prospectus  or  supplement  thereto,  in  the  light  of  the
circumstances under which they were made) not misleading, provided, however, that the Company shall not be liable in any such case to
the extent that such Losses arise out of, or are based upon, an untrue statement or omission or alleged untrue statement or omission made in
such  Registration  Statement  in  reliance  upon  and  in  conformity  with  information  that  relates  solely  to  the  Investor  or  the  Investor’s
proposed  method  of  distribution  of  Registrable  Securities  and  was  provided  by  the  Investor  in  writing  for  use  in  such  Registration
Statement, such Prospectus or such form of Prospectus or in any amendment or supplement thereto.

( b )          Indemnification  by  the  Investor.  The  Investor  shall,  notwithstanding  any  termination  of  this Agreement,
indemnify and hold harmless the Company, its officers, directors, partners, members, agents and employees of each of them, each Person
who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the officers,
directors,  partners,  members,  agents  and  employees  of  each  such  controlling  Person,  to  the  fullest  extent  permitted  by Applicable  Law,
from and against all Losses arising out of any untrue statement of a material fact contained in any Registration Statement, any Prospectus or
any form of Company prospectus or in any amendment or supplement thereto or in any Company preliminary prospectus, or arising out of
or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein
(in the case of any Prospectus or form of prospectus or supplement thereto, in the light of the circumstances under which they were made)
not misleading, in each case, on the effective date thereof, but only to the extent that such untrue statement or omission is based solely upon
information regarding the Investor furnished to the Company by the Investor in writing expressly for use therein, or to the extent that such
information solely relates to the Investor or the Investor’s proposed method of distribution of Registrable Securities and was provided by
the Investor for use in such Registration Statement, such Prospectus or such form of Prospectus or in any amendment or supplement thereto.
In no event shall the liability of the Investor under this Article VI be greater in amount than the dollar amount of the net proceeds received
by the Investor upon the sale of the Registrable Securities giving rise to such indemnification obligation.

-24-

 
 
 
 
 
 
 
( c )          Conduct of Indemnification Proceedings .  If  any  Proceeding  shall  be  brought  or  asserted  against  any  Person
entitled to indemnity hereunder (an “Indemnified Party”), such Indemnified Party shall promptly notify the Person from whom indemnity
is sought (the “Indemnifying Party”) in writing, and the Indemnifying Party shall assume the defense thereof, including the employment
of counsel reasonably satisfactory to the Indemnified Party and the payment of all reasonable fees and expenses incurred in connection with
defense  thereof; provided  that  the  failure  of  any  Indemnified  Party  to  give  such  notice  shall  not  relieve  the  Indemnifying  Party  of  its
obligations or liabilities pursuant to this Agreement, except (and only) to the extent that such failure shall have materially and adversely
prejudiced the Indemnifying Party. An Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to
participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties
unless:  (i)  the  Indemnifying  Party  has  agreed  in  writing  to  pay  such  fees  and  expenses;  (ii)  the  Indemnifying  Party  shall  have  failed
promptly to assume the defense of such Proceeding; or (iii) the named parties to any such Proceeding (including any impleaded parties)
include  both  such  Indemnified  Party  and  the  Indemnifying  Party,  and  such  Indemnified  Party  shall  have  been  advised  by  counsel  that  a
conflict  of  interest  is  likely  to  exist  if  the  same  counsel  were  to  represent  such  Indemnified  Party  and  the  Indemnifying  Party  or  that
additional  or  different  defenses  may  be  available  to  the  Indemnified  Party  (in  which  case,  if  such  Indemnified  Party  notifies  the
Indemnifying Party in writing that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party
shall not have the right to assume the defense thereof and the reasonable fees and expenses of separate counsel shall be at the expense of
the Indemnifying Party), it being understood, however, that the Indemnifying Party shall not, in connection with any one such Proceeding
(including separate Proceedings that have been or will be consolidated before a single judge) be liable for the fees and expenses of more
than one separate firm of attorneys at any time for all Indemnified Parties. The Indemnifying Party shall not be liable for any settlement of
any such Proceeding effected without its written consent, unless such consent is unreasonably withheld or delayed. No Indemnifying Party
shall, without the prior written consent of the Indemnified Party, effect any settlement of any pending Proceeding in respect of which any
Indemnified Party is a party, unless such settlement includes an unconditional release of such Indemnified Party from all liability on claims
that are the subject matter of such Proceeding. All reasonable fees and expenses of the Indemnified Party (including reasonable fees and
expenses to the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with
this Section 6.4(c))  shall  be  paid  to  the  Indemnified  Party,  as  incurred,  within  twenty  (20)  Trading  Days  of  written  notice  thereof  to  the
Indemnifying Party (regardless of whether it is ultimately determined that an Indemnified Party is not entitled to indemnification hereunder;
provided that the Indemnifying Party shall reimburse all such fees and expenses to the extent it is finally judicially determined that such
Indemnified Party is not entitled to indemnification hereunder).

( d )          Contribution. If a claim for indemnification under Section 6.4(a) or (b) is unavailable to an Indemnified Party
(by reason of public policy or otherwise), then each Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to
the amount paid or payable by such Indemnified Party as a result of such Losses, in such proportion as is appropriate to reflect the relative
fault of the Indemnifying Party and Indemnified Party in connection with the actions, statements or omissions that resulted in such Losses
as  well  as  any  other  relevant  equitable  considerations.  The  relative  fault  of  such  Indemnifying  Party  and  Indemnified  Party  shall  be
determined  by  reference  to,  among  other  things,  whether  any  action  in  question,  including  any  untrue  or  alleged  untrue  statement  of  a
material  fact  or  omission  or  alleged  omission  of  a  material  fact,  has  been  taken  or  made  by,  or  relates  to  information  supplied  by,  such
Indemnifying Party or Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or
prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include,
subject to the limitations set forth in Section 6.4(c), any reasonable attorneys’ or other reasonable fees or expenses incurred by such party in
connection  with  any  Proceeding  to  the  extent  such  party  would  have  been  indemnified  for  such  fees  or  expenses  if  the  indemnification
provided for in this Section 6.4(d) was available to such party in accordance with its terms. The parties hereto agree that it would not be just
and equitable if contribution pursuant to this Section 6.4(d) were determined by pro rata allocation or by any other method of allocation that
does not take into account the equitable considerations referred to in the immediately preceding paragraph. Notwithstanding the provisions
of this Section 6.4(d), the Investor shall not be required to contribute, in the aggregate, any amount in excess of the amount by which the
net proceeds actually received by the Investor from the sale of the Registrable Securities subject to the Proceeding exceeds the amount of
any  damages  that  the  Investor  has  otherwise  been  required  to  pay  by  reason  of  such  untrue  or  alleged  untrue  statement  or  omission  or
alleged  omission.  No  Person  guilty  of  fraudulent  misrepresentation  (within  the  meaning  of  Section  11(f)  of  the  Securities Act)  shall  be
entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation.

-25-

 
 
 
 
 
 
6 . 5         Dispositions. The Investor agrees that it will comply with the prospectus delivery requirements of the Securities Act as
applicable  to  it  in  connection  with  sales  of  Registrable  Securities  pursuant  to  a  Registration  Statement  and  shall  sell  its  Registrable
Securities in accordance with the Plan of Distribution set forth in the Prospectus. The Investor further agrees that, upon receipt of a notice
from the Company of the occurrence of any event of the kind described in Sections 6.2(b)(ii), (iii) or (iv), the Investor will use best efforts
to discontinue disposition of Registrable Securities under a Registration Statement until the Investor is advised in writing by the Company
that  the  use  of  the  Prospectus,  or  amended  Prospectus,  as  applicable,  may  be  used.  The  Investor  acknowledges  and  agrees  that  the
provisions of Section 4.9 of this Agreement shall apply with respect to any proposed disposition pursuant to a Registration Statement filed
pursuant to this Article VI. The Company may provide appropriate stop orders to enforce the provisions of this paragraph.

6 . 6         “Market  Stand-Off” Agreement.  For  so  long  as  the  Investor  and/or  any  Investor  Controlled  Entity, Affiliate  of  the
Investor or any 13D Group of which the Investor or any of its Affiliates is a member collectively owns at least 5% of the voting power of
the Company, the Investor agrees that neither the Investor, nor any Investor Controlled Entity, Affiliate of the Investor or any 13D Group
of which the Investor or any of its Affiliates is a member shall, to the extent requested by the Company or an underwriter of securities of the
Company, sell, transfer, make any short sale of, grant any option for the purchase of, or enter into any hedging or similar transaction with
the same economic effect as a sale, any Common Stock (or other securities) of the Company held by such Person for a period specified by
the representative of the underwriters of Common Stock (or other securities) of the Company not to exceed ninety (90) days following the
effective date of any registration statement of the Company filed under the Securities Act other than a Registration Statement filed pursuant
to Section 6.1; provided  that  all  officers  and  directors  of  the  Company  enter  into  similar  agreements.  The  obligations  described  in  this
Section 6.6 shall not apply to a registration relating solely to employee benefit plans on Form S-8 or similar forms that may be promulgated
in the future, or a registration relating solely to a Commission Rule 145 transaction on Form S-4 or similar forms that may be promulgated
in the future. The Investor further agrees to execute (and cause any Investor Controlled Entity, Affiliate of the Investor or any 13D Group
of which the Investor or any of its Affiliates is a member to execute) such agreements as may be reasonably requested by the underwriters
in connection with such registration that are consistent with this Section 6.6 or that are necessary to give further effect thereto. The Investor
agrees  that  the  Company  may  instruct  its  transfer  agent  to  place  stop-transfer  notations  in  its  records  to  enforce  the  provisions  of  this
Section 6.6.

-26-

 
 
 
 
 
 
6 . 7          Assignment  of  Registration  Rights.  The  registration  rights  under  this Article VI  of  this Agreement  with  respect  to
applicable shares transferred by Investor pursuant to this agreement shall be automatically transferred to any transferee of all or any portion
of Investor’s Registrable Securities,, to the extent of such shares transferred, if (a) Investor agrees in writing with the transferee or assignee
to assign such rights and a copy of such agreement is furnished to the Company within a reasonable time after such assignment; (b) the
Company is furnished with written notice of (i) the name and address of such transferee, and (ii) the securities with respect to which such
registration  rights  are  being  transferred;  (c)  following  such  transfer  or  assignment,  the  further  disposition  of  such  securities  by  the
transferee is restricted under this Agreement, the Securities Act and applicable state securities laws; (d) at or before the time the Company
receives the written notice contemplated by clause (b) of this sentence the transferee agrees in writing to be bound by all of the provisions
of this Agreement; and (e) such transfer shall have been made in accordance with the applicable requirements of this Agreement.

ARTICLE VII
MISCELLANEOUS

7 . 1          Termination. This Agreement may be terminated by the Company or the Investor, by written notice to the other, if the
Closing has not been consummated by the third Business Day following the date of this Agreement;  provided that no such termination will
affect the right of any party to sue for any breach by the other party (or parties).

7 . 2          Fees and Expenses. The Company shall pay all Transfer Agent fees, stamp taxes and other taxes and duties levied in

connection with the sale and issuance of the Securities.

7 . 3          Entire Agreement. The Transaction Documents and the non-disclosure agreement dated August 4, 2016 between the
Company and the Investor, together with the exhibits and schedules thereto, contain the entire understanding of the parties with respect to
the subject matter hereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the
parties acknowledge have been merged into such documents, exhibits and schedules.

7 . 4          Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is
delivered via facsimile at the facsimile number specified in this Section 7.4 prior to 6:30 p.m. (New York City time) on a Trading Day, (b)
the  next  Trading  Day  after  the  date  of  transmission,  if  such  notice  or  communication  is  delivered  via  facsimile  at  the  facsimile  number
specified in this Section 7.4 on a day that is not a Trading Day or later than 6:30 p.m. (New York City time) on any Trading Day, (c) the
Trading Day following the date of deposit with a nationally recognized overnight courier service, or (d) upon actual receipt by the party to
whom such notice is required to be given. The addresses, facsimile numbers for such notices and communications are as follows:

-27-

 
 
 
 
 
 
 
 
 
 
Notices for the Company :

Energous Corporation, Inc.
3590 North First Street, Suite 210
San Jose, CA 95134
Attention: Brian Sereda
Telephone No.: [telephone]

With a copy to:

Fenwick & West LLP
801 California Street
Mountain View, CA 94041
Attention: Mark Leahy and Horace Nash
Telephone No.: [telephone]
Facsimile No.:  [fax]

Notices for the Investor:

Ascend Legend Fund, Ltd.
c/o Stone Coast Fund Services Ltd.
c/o Codan Trust Company (Cayman) Limited
Boundary Hall, 2nd Floor, Cricket Square
PO Box 2681
Grand Cayman KY1-1111
Telephone: [telephone]
Facsimile:  [fax]

With a copy to:

Ascend Capital Limited Partnership
c/o Ascend Capital, LLC
4 Orinda Way
Orinda, CA 94563
Attn: Benjamin Slavet, Chief Operating Officer and Chief Financial Officer
Telephone No.: [telephone]
Facsimile No.:  [fax]

7.5         Amendments; Waivers. No provision of this Agreement may be waived or amended except in a written instrument signed,
in  the  case  of  an  amendment,  by  the  Company  and  the  Investor.  No  waiver  of  any  default  with  respect  to  any  provision,  condition  or
requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of
any other provision, condition or requirement hereof, nor shall any delay or omission of either party to exercise any right hereunder in any
manner impair the exercise of any such right.

-28-

 
 
 
 
 
 
 
 
 
 
 
 
 
7 . 6         Construction. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be
deemed to limit or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen by
the parties to express their mutual intent, and no rules of strict construction will be applied against any party.

7.7         Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and  permitted  assigns.  The  Company  shall  not  assign  this Agreement  or  any  rights  or  obligations  hereunder  without  the  prior  written
consent of the Investor. Notwithstanding the foregoing, nothing in this Section 7.7 shall prevent any assignment of this Agreement by the
Company or the Investor that is deemed to occur in connection with a Change of Control of the Company. The Investor may assign some
or all of its rights hereunder in connection with transfer of any of its Securities without the consent of the Company, in which event such
assignee shall be deemed to be an Investor hereunder with respect to such assigned rights.

7 . 8         No  Third-Party  Beneficiaries.  This Agreement  is  intended  for  the  benefit  of  the  parties  hereto  and  their  respective
successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except that
each Indemnified Party is an intended third party beneficiary of Section 6.4 and (in each case) may enforce the provisions of such Section
6.4 directly against the parties with obligations thereunder.

7

.

9         Governing  Law;  Venue;  Service  of  Process;  Waiver  of  Jury  Trial .  ALL  QUESTIONS  CONCERNING  THE

CONSTRUCTION,  VALIDITY,  ENFORCEMENT AND  INTERPRETATION  OF  THIS AGREEMENT  SHALL  BE  GOVERNED  BY
AND  CONSTRUED  IN ACCORDANCE  WITH  THE  LAWS  OF  THE  STATE  OF  NEW  YORK,  WITHOUT  GIVING  EFFECT  TO
THAT BODY OF LAWS PERTAINING TO CONFLICT OF LAWS. EACH PARTY HEREBY IRREVOCABLY SUBMITS TO THE
NON-EXCLUSIVE  JURISDICTION  OF  THE  STATE  AND  FEDERAL  COURTS  SITTING  IN  THE  CITY  OF  NEW  YORK,
BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH
OR WITH ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED HEREIN (INCLUDING WITH RESPECT TO THE
ENFORCEMENT  OF ANY  OF  THE  TRANSACTION  DOCUMENTS), AND  HEREBY  IRREVOCABLY  WAIVES, AND AGREES
NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE
JURISDICTION  OF ANY  SUCH  COURT AND  THAT  SUCH  SUIT, ACTION  OR  PROCEEDING  IS  IMPROPER.  EACH  PARTY
HEREBY  IRREVOCABLY  WAIVES  PERSONAL  SERVICE  OF  PROCESS AND  CONSENTS  TO  PROCESS  BEING  SERVED  IN
ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF VIA REGISTERED OR CERTIFIED MAIL OR
OVERNIGHT DELIVERY (WITH EVIDENCE OF DELIVERY) TO SUCH PARTY AT THE ADDRESS IN EFFECT FOR NOTICES
TO  IT  UNDER  THIS  AGREEMENT  AND  AGREES  THAT  SUCH  SERVICE  SHALL  CONSTITUTE  GOOD  AND  SUFFICIENT
SERVICE  OF  PROCESS AND  NOTICE  THEREOF.  NOTHING  CONTAINED  HEREIN  SHALL  BE  DEEMED  TO  LIMIT  IN ANY
WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW. THE COMPANY AND INVESTOR HEREBY
WAIVE ALL RIGHTS TO A TRIAL BY JURY.

-29-

 
 
 
 
 
 
 
 
7 . 1 0       Survival. The representations and warranties contained herein shall survive the Closing. The agreements and covenants

contained herein shall survive the Closing in accordance with their respective terms.

7 . 1 1       Execution.  This Agreement  may  be  executed  in  two  or  more  counterparts,  all  of  which  when  taken  together  shall  be
considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the
other  party,  it  being  understood  that  both  parties  need  not  sign  the  same  counterpart.  In  the  event  that  any  signature  is  delivered  by
facsimile transmission or email attachment, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf  such  signature  is  executed)  with  the  same  force  and  effect  as  if  such  facsimile  or  email-attached  signature  page  were  an  original
thereof.

7 . 1 2       Severability. If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and
enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties
will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing, shall incorporate
such substitute provision in this Agreement.

7.13       Replacement of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall promptly issue or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and
substitution therefor, a new certificate or instrument, and the Investor will pay only those costs and expenses that are customarily charged
by or on behalf the Company or the Transfer Agent to any stockholder of the Company in connection therewith. The Company may require
the execution by the holder thereof of a customary lost certificate affidavit of that fact and a customary agreement to indemnify and hold
harmless the Company (and Transfer Agent, if applicable) for any losses in connection therewith.

7 . 1 4       Remedies. In addition to being entitled to exercise all rights provided herein or granted by Applicable Law, including
recovery of damages, the Investor and the Company will be entitled to seek specific performance under the Transaction Documents. The
parties  agree  that  monetary  damages  may  not  be  adequate  compensation  for  any  loss  incurred  by  reason  of  any  breach  of  obligations
described in the foregoing sentence and hereby agrees to waive in any action for specific performance of any such obligation (other than in
connection with any action for temporary restraining order) the defense that a remedy at law would be adequate.

-30-

 
 
 
 
 
 
 
 
 
7 . 1 5       Indemnification. In consideration of the Investor’s execution and delivery of the Transaction Documents and acquiring
the Securities thereunder and in addition to all of the Company’s other obligations under the Transaction Documents, the Company shall
defend,  protect,  indemnify  and  hold  harmless  the  Investor  and  each  other  holder  of  the  Securities  (other  than  holders  of  Securities
purchased on any securities trading market), and all of the Investor’s stockholders, partners, members, officers, directors, employees and
direct or indirect investors and any of the foregoing Persons’ agents or other representatives (including, without limitation, those retained in
connection with the transactions contemplated by this Agreement) (collectively, the “Indemnitees”), as incurred, from and against any and
all  actions,  causes  of  action,  suits,  claims,  losses,  costs,  penalties,  fees,  liabilities  and  damages,  and  expenses  in  connection  therewith
(irrespective  of  whether  any  such  Indemnitee  is  a  party  to  the  action  for  which  indemnification  hereunder  is  sought),  and  including
reasonable  attorneys’  fees  and  disbursements,  but  excluding  any  consequential,  indirect  or  incidental  damages  (the  “Indemnified
Liabilities”), incurred by any Indemnitee as a result of, or arising out of, or relating to (a) any material misrepresentation or material breach
of any representation or warranty made by the Company in the Transaction Documents, (b) any material breach of any covenant, agreement
or  obligation  of  the  Company  contained  in  the  Transaction  Documents  that  remains  uncured  ten  (10)  days  after  the  Company  receives
notice  thereof,  or  (c)  any  cause  of  action,  suit  or  claim  brought  or  made  against  such  Indemnitee  by  a  third  party  (including  for  these
purposes a derivative action brought on behalf of the Company) and arising out of or resulting from (i) the execution, delivery, performance
or enforcement of the Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby, or (ii) any
transaction financed or to be financed in whole or in part, directly or indirectly, with the proceeds of the issuance of the Securities. To the
extent  that  the  foregoing  undertaking  by  the  Company  may  be  unenforceable  for  any  reason,  the  Company  shall  make  the  maximum
contribution to the payment and satisfaction of each of the Indemnified Liabilities which is permissible under applicable law. In no event
shall  aggregate  payments  under  this  Section  7.15  exceed  the  Purchase  Price.  Except  as  otherwise  set  forth  herein,  the  mechanics  and
procedures with respect to the rights and obligations under this Section 7.15 shall be the same as those set forth in Section 6.4(c).

7.16       Adjustments in Share Numbers and Prices. In the event of any stock split, subdivision, dividend or distribution payable in
shares of Common Stock (or other securities or rights convertible into, or entitling the holder thereof to receive directly or indirectly shares
of  Common  Stock),  combination  or  other  similar  recapitalization  or  event  occurring  after  the  date  hereof  and  prior  to  the  Closing,  each
reference in any Transaction Document to a number of shares or a price per share shall be amended to appropriately account for such event.

[SIGNATURE PAGES TO FOLLOW]

-31-

 
 
 
 
 
 
 
IN  WITNESS  WHEREOF,  the  parties  hereto  have  caused  this  Securities  Purchase  Agreement  to  be  duly  executed  by  their

respective authorized signatories as of the date first indicated above.

COMPANY:

ENERGOUS CORPORATION, INC.

By: /s/ Stephen R. Rizzone

Name: Stephen R. Rizzone

Title: President and Chief Executive Officer

Signature Page to Securities Purchase Agreement

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INVESTOR:

ASCEND LEGEND MASTER FUND, LTD.

By: /s/ Malcolm P. Fairbairn

Name: Malcolm P. Fairbairn

Title: Director

Signature Page to Securities Purchase Agreement

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exhibits:

A

B

C

Securities Purchased

Form of Warrant

Form of Secretary’s Certificate - Company

 
 
 
 
 
 
 
EXHIBIT A
SECURITIES PURCHASED

Investor
Ascend Legend Master Fund, Ltd.

Common Stock

Warrants

Purchase Price

1,618,123     

1,618,123    $

20,000,000 

 
 
 
 
   
   
 
   
 
 
Exhibit B
FORM OF WARRANT

 
 
 
 
NEITHER  THESE  SECURITIES  NOR  THE  SECURITIES  FOR  WHICH  THESE  SECURITIES ARE  EXERCISABLE  HAVE
BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF
ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION  FROM,  OR  IN  A  TRANSACTION  NOT  SUBJECT  TO,  THE  REGISTRATION  REQUIREMENTS  OF  THE
SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THESE SECURITIES AND
THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A
BONA  FIDE  MARGIN ACCOUNT  OR  OTHER  LOAN  SECURED  BY  SUCH  SECURITIES  IN ACCORDANCE  WITH  THE
PURCHASE AGREEMENT (AS DEFINED BELOW).

ENERGOUS CORPORATION

WARRANT

Warrant No. [     ]

Dated:  [               ]

Energous Corporation, a Delaware corporation (the “Company”), hereby certifies that, for value received, [          ], an
exempted company formed under the laws of the Cayman Islands, or its successors or assigns (the “Holder”), is entitled to purchase from
the Company up to a total of [          ] shares of common stock, $.00001 par value per share (the “Common Stock”), of the Company (each
such share, a “Warrant Share”  and  all  such  shares,  the  “Warrant Shares”)  at  an  exercise  price  initially  equal  to  $23.00  per  share  (as
adjusted from time to time as provided in Section 8, the “Exercise Price”), at any time on or after date which is six months and one day
after  the  date  hereof  (the  “Initial  Exercise  Date”)  and  through  and  including  the  date  that  is  five  (5)  years  after  the  date  hereof  (the
“Expiration Date”), and subject to the following terms and conditions. This Warrant (this “Warrant”) is issued pursuant to that certain
Securities Purchase Agreement, dated as of the date hereof, by and among the Company and the Investor named therein (as amended from
time to time, the “Purchase Agreement”).

1 .             Definitions. In addition to the terms defined elsewhere in this Warrant, capitalized terms that are not otherwise defined

herein have the meanings given to such terms in the Purchase Agreement.

2 .             Registration of Warrant . The Company shall register this Warrant, upon records to be maintained by the Company for
that  purpose  (the  “Warrant Register”),  in  the  name  of  the  Holder  of  record  hereof.  The  Company  may  deem  and  treat  the  registered
Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all
other purposes, absent actual notice to the contrary. The Warrant Shares shall be afforded the registration rights set forth in Article VI of
the Purchase Agreement.

 
 
 
 
 
 
 
 
 
 
3.            Exercise and Duration of Warrant.

(a)          This Warrant shall be exercisable by the Holder at any time and from time to time on or after the Initial Exercise
Date  to  and  including  the  Expiration  Date. At  6:30  P.M.,  New  York  City  time  on  the  Expiration  Date,  the  portion  of  this  Warrant  not
exercised prior thereto shall be and become void and of no value.

(b)          The Holder may exercise this Warrant by delivering to the Company (i) an exercise notice, in the form attached
hereto (the “Exercise Notice”),  appropriately  completed  and  duly  signed,  and  (ii)  payment  of  the  Exercise  Price  in  a  form  specified  in
Section 3(c)  hereof  for  the  number  of  Warrant  Shares  as  to  which  this  Warrant  is  being  exercised,  or,  if  applicable,  an  election  to  net
exercise this Warrant as provided in Section 3(d) hereof for the number Warrant Shares to be acquired in connection with such exercise, and
the date such items are delivered to the Company (as determined in accordance with the notice provisions hereof) is an “Exercise Date.”
The  Holder  shall  be  required  to  deliver  the  original  Warrant  in  order  to  effect  an  exercise  hereunder  unless  the  Holder  shall  deliver  an
affidavit of loss or such other documentation reasonably requested by the Company in lieu of such original Warrant in connection with any
such exercise. Execution and delivery of the Exercise Notice in respect of less than all the Warrant Shares issuable upon exercise of this
Warrant shall have the same effect as cancellation of the original Warrant and issuance of a new warrant to purchase Common Stock, in
substantially the form of this Warrant (any such new warrant, a “New Warrant”), evidencing the right to purchase the remaining number
of Warrant Shares.

(c)          Payment for the Warrant Shares upon exercise may be made by (i) a check payable to the Company’s order,
(ii) wire transfer of funds to the Company, (iii) by net exercise as provided in Section 3(d) hereof, or (iv) any combination of the foregoing.

(d)          Net Exercise Election. Holder may elect to convert all or any portion of this Warrant, without the payment by
Holder  of  any  additional  consideration,  by  the  surrender  of  this  Warrant  to  the  Company,  with  the  Exercise  Notice,  duly  executed  by
Holder, into up to the number of shares of Warrant Shares that is obtained under the following formula:

X = Y (A-B)
    A

where

X = the number of shares of Warrant Shares to be issued to Holder pursuant to a net exercise of this Warrant effected pursuant

to this Section 3(d).

Y = the number of Warrant Shares as to which this Warrant is then being net exercised.

A = the fair market value of one share of Warrant Shares, determined at the time of such net exercise as set forth in the last

paragraph of this Section 3(d).

B = the Exercise Price.

The Company will promptly respond in writing to an inquiry by Holder as to the then current fair market value of one share of Warrant
Stock.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
For purposes of the above calculation, fair market value of one share of Warrant Shares shall be determined by the Company’s Board of
Directors in good faith; provided, however, that if on the relevant exercise date for which such value must be determined, a public market
for the Company’s Common Stock exists, then the fair market value per share of the Warrant Shares shall be (A) the average of the closing
bid  and  asked  prices  of  the  Common  Stock  quoted  in  the  Over-The-Counter  Market  Summary  or  (B)  the  last  reported  sale  price  of  the
Common Stock or the closing price quoted on the exchange on which the Common Stock is listed, whichever is applicable, as published in
the Western Edition of The Wall Street Journal for the five (5) trading days prior to the date as of which the value of the fair market value
is to be determined.

4.            Delivery of Warrant Shares.

(a)          Upon exercise of this Warrant, the Company shall promptly issue or cause to be issued and cause to be delivered
to or upon the written order of the Holder and in such name or names as the Holder may designate, a certificate for the Warrant Shares
issuable upon such exercise (i) free of restrictive legends if sold under a registration statement covering the resale of the Warrant Shares
and  naming  the  Holder  as  a  selling  stockholder,  or  (ii)  if  such  shares  are  not  freely  transferable  without  volume  restrictions  pursuant  to
Rule 144 under the Securities Act, such certificate will bear the legends set forth in Section 4.1(b) of the Purchase Agreement. The Holder,
or any Person so designated by the Holder to receive Warrant Shares, shall be deemed to have become the holder of record of such Warrant
Shares as of the Exercise Date. The Company shall, upon request of the Holder, use best efforts to deliver, or to cause its transfer agent to
deliver,  Warrant  Shares  hereunder  electronically  through  The  Depository  Trust  Company  or  another  established  clearing  corporation
performing similar functions.

(b)          This Warrant is exercisable, either in its entirety or, from time to time, for a portion of the number of Warrant
Shares.  Upon  surrender  of  this  Warrant  following  one  or  more  partial  exercises,  the  Company  shall  issue  or  cause  to  be  issued,  at  its
expense, a New Warrant evidencing the right to purchase the remaining number of Warrant Shares.

(c)          The Company’s obligations to issue and deliver Warrant Shares in accordance with the terms hereof are absolute
and  unconditional,  irrespective  of  any  action  or  inaction  by  the  Holder  to  enforce  the  same,  any  waiver  or  consent  with  respect  to  any
provision  hereof,  the  recovery  of  any  judgment  against  any  Person  or  any  action  to  enforce  the  same,  or  any  setoff,  counterclaim,
recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other Person of any obligation to the Company
or  any  violation  or  alleged  violation  of  law  by  the  Holder  or  any  other  Person,  and  irrespective  of  any  other  circumstance  which  might
otherwise limit such obligation of the Company to the Holder in connection with the issuance of Warrant Shares. Nothing herein shall limit
the  Holder’s  right  to  pursue  any  other  remedies  available  to  it  hereunder,  at  law  or  in  equity  including,  without  limitation,  a  decree  of
specific  performance  and/or  injunctive  relief  with  respect  to  the  Company’s  failure  to  timely  deliver  certificates  representing  shares  of
Common Stock upon exercise of this Warrant as required pursuant to the terms hereof.

 
 
 
 
 
 
 
 
5 .            Charges, Taxes and Expenses. Issuance and delivery of certificates for shares of Common Stock upon exercise of this
Warrant shall be made without charge to the Holder for any issue or transfer tax, withholding tax, transfer agent fee or other incidental tax
or  expense  in  respect  of  the  issuance  of  such  certificates,  all  of  which  taxes  and  expenses  shall  be  paid  by  the  Company; provided,
however, that the Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the issuance,
delivery  or  registration  of  any  certificates  for  Warrant  Shares  or  Warrant  in  a  name  other  than  that  of  the  Holder.  The  Holder  shall  be
responsible  for  all  other  tax  liability  that  may  arise  as  a  result  of  holding  or  transferring  this  Warrant  or  receiving  Warrant  Shares  upon
exercise hereof.

6 .            Replacement of Warrant. If this Warrant is mutilated, lost, stolen or destroyed, the Company, at no cost to Holder, shall
issue or cause to be issued in exchange and substitution for and upon cancellation hereof, or in lieu of and substitution for this Warrant, a
New Warrant, but only upon receipt of an affidavit of such loss, theft or destruction and customary indemnity, if requested.

7 .            Reservation of Warrant Shares. The Company covenants that it will at all times reserve and keep available out of the
aggregate of its authorized but unissued and otherwise unreserved Common Stock, solely for the purpose of enabling it to issue Warrant
Shares upon exercise of this Warrant as herein provided, the number of Warrant Shares which are then issuable and deliverable upon the
exercise of this entire Warrant, free from preemptive rights or any other contingent purchase rights of persons other than the Holder (after
giving  effect  to  the  adjustments  and  restrictions  of Section 8,  if  any).  The  Company  covenants  that  all  Warrant  Shares  so  issuable  and
deliverable shall, upon issuance and the payment of the applicable Exercise Price in accordance with the terms hereof, be duly and validly
authorized, issued and fully paid and nonassessable. The Company will use reasonable commercial efforts to take all such action to assure
that  such  shares  of  Common  Stock  may  be  issued  as  provided  herein  without  violation  of  any  applicable  law  or  regulation,  or  of  any
requirements  of  any  securities  exchange  or  automated  quotation  system  upon  which  the  Common  Stock  may  be  listed,  in  each  case,
applicable to the Company.

8

.            Certain Adjustments.  The  Exercise  Price  and  number  of  Warrant  Shares  issuable  upon  exercise  of  this  Warrant  are

subject to adjustment from time to time as set forth in this Section 8.

( a )          Stock  Dividends,  Splits  and  Combinations.  If  the  Company,  at  any  time  while  this  Warrant  is  outstanding,
(i) pays a stock dividend on its Common Stock or otherwise makes a distribution on its Common Stock that is payable in shares of Common
Stock,  (ii)    subdivides  outstanding  shares  of  Common  Stock  into  a  larger  number  of  shares,  or  (iii)  combines  outstanding  shares  of
Common Stock into a smaller number of shares, then in each such case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock outstanding immediately before such event and of which the denominator shall
be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to clause (i) of this
paragraph shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend
or distribution, and any adjustment pursuant to clause (ii) or (iii) of this paragraph shall become effective immediately after the effective
date of such dividend, distribution, subdivision or combination.

 
 
 
 
 
 
 
 
( b )          Fundamental Transactions. If any capital reorganization, reclassification of the capital stock of the Company,
consolidation  or  merger  of  the  Company  with  another  corporation,  or  sale,  transfer  or  other  disposition  of  all  or  substantially  all  of  the
Company’s  assets  to  another  corporation  shall  be  effected  (all  such  transactions  being  hereinafter  referred  to  as  a  “ Fundamental
Transaction”), then the Company shall ensure that lawful and adequate provision shall be made whereby the Holder shall thereafter have
the  right  to  purchase  and  receive  upon  the  basis  and  upon  the  terms  and  conditions  herein  specified  and  in  lieu  of  the  Warrant  Shares
immediately theretofore issuable upon exercise of this Warrant, such shares of stock, securities or assets as would have been issuable or
payable  with  respect  to  or  in  exchange  for  a  number  of  Warrant  Shares  equal  to  the  number  of  Warrant  Shares  immediately  theretofore
issuable upon exercise of this Warrant, had such reorganization, reclassification, consolidation, merger, sale, transfer or other disposition
not taken place, and in any such case appropriate provision shall be made with respect to the rights and interests of the Holder to the end
that the provisions hereof (including, without limitation, provision for adjustment of the Exercise Price) shall thereafter be applicable, as
nearly equivalent as may be practicable in relation to any share of stock, securities or assets thereafter deliverable upon the exercise thereof.
The Company shall not effect any such consolidation, merger, sale, transfer or other disposition unless prior to or simultaneously with the
consummation  thereof  the  successor  corporation  (if  other  than  the  Company)  resulting  from  such  consolidation  or  merger,  or  the
corporation purchasing or otherwise acquiring such assets or other appropriate corporation or entity shall assume the obligation to deliver to
the  Holder,  at  the  last  address  of  the  Holder  appearing  on  the  books  of  the  Company,  such  shares  of  stock,  securities  or  assets  as,  in
accordance  with  the  foregoing  provisions,  the  Holder  may  be  entitled  to  purchase,  and  the  other  obligations  under  this  Warrant.  The
provisions of this Section 8(b) shall similarly apply to successive reorganizations, reclassifications, consolidations, mergers, sales, transfers
or other dispositions, each of which transactions shall also constitute a Fundamental Transaction.

(c)          Number of Warrant Shares. Simultaneously with any adjustment to the Exercise Price pursuant to this Section 8,
the number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased (as the case may be),
proportionately, so that after such adjustment the aggregate Exercise Price payable hereunder for the decreased or increased (as the case
may be) number of Warrant Shares shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment.

( d )          Calculations. All calculations under this Section 8 shall be made to the nearest cent or the nearest 1/100th of a
share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for
the account of the Company, and the disposition of any such shares shall be considered an issue or sale of Common Stock.

( e )          Notice of Adjustments . Upon the occurrence of each adjustment pursuant to this Section 8, the Company at its
expense will promptly compute such adjustment in accordance with the terms of this Warrant and prepare a certificate setting forth such
adjustment, including a statement of the adjusted Exercise Price and adjusted number or type of Warrant Shares or other securities issuable
upon exercise of this Warrant (as applicable), describing the transactions giving rise to such adjustments and showing in detail the facts
upon which such adjustment is based. Upon any such occurrence and/or otherwise upon written request by or on behalf of the Holder, the
Company will promptly deliver a copy of each such certificate to the Holder and to the Transfer Agent.

 
 
 
 
 
 
 
(f)          Notice of Corporate Events. If the Company (i) declares a dividend or any other distribution of cash, securities or
other property in respect of its Common Stock, including without limitation any granting of rights or warrants to subscribe for or purchase
any  capital  stock  of  the  Company,  (ii)  enters  into  any  agreement  contemplating,  or  solicits  stockholder  approval  for,  any  Fundamental
Transaction  or  Change  of  Control  or  (iii)  authorizes  the  voluntary  dissolution,  liquidation  or  winding  up  of  the  affairs  of  the  Company,
then  the  Company  shall  deliver  to  the  Holder  a  notice  describing  the  material  terms  and  conditions  of  such  transaction,  at  least  fifteen
calendar days prior to the applicable record or effective date on which a Person would need to hold Common Stock in order to participate in
or vote with respect to such transaction, and the Company will take all steps reasonably necessary to facilitate the exercise of the Warrant
pursuant  to  Section  3(b)  (which  exercise  may  be  conditioned  upon  the  occurrence  of  such  event); provided, however,  that  the  failure  to
deliver such notice or any defect therein shall not affect the validity of the corporate action required to be described in such notice.

9 .          Fractional Shares. The Company shall not be required to issue or cause to be issued fractional Warrant Shares on the
exercise of this Warrant. If any fraction of a Warrant Share would, except for the provisions of this  Section 9, be issuable upon exercise of
this Warrant, then the number of Warrant Shares to be issued will be rounded down to the nearest whole share.

1 0 .         Notices. Any and all notices or other communications or deliveries hereunder (including without limitation any Exercise
Notice)  shall  be  in  writing  and  shall  be  deemed  given  and  effective  on  the  earliest  of  (i)  the  date  of  transmission,  if  such  notice  or
communication is delivered via facsimile at the facsimile number specified in the Purchase Agreement prior to 6:30 p.m. (New York City
time) on a Trading Day, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile
at the facsimile number specified in the Purchase Agreement on a day that is not a Trading Day or later than 6:30 p.m. (New York City
time)  on  any  Trading  Day,  (iii)  the  Trading  Day  following  the  date  of  delivery  to  the  courier  service,  if  sent  by  nationally  recognized
overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. The address for such notices
or communications shall be as set forth in the Purchase Agreement.

1 1 .         Warrant Agent .  The  Company  shall  serve  as  warrant  agent  under  this  Warrant.  Upon  thirty  (30)  days’  notice  to  the
Holder,  the  Company  may  appoint  a  new  warrant  agent. Any  corporation  into  which  the  Company  or  any  new  warrant  agent  may  be
merged  or  any  corporation  resulting  from  any  consolidation  to  which  the  Company  or  any  new  warrant  agent  shall  be  a  party  or  any
corporation to which the Company or any new warrant agent transfers substantially all of its corporate trust or stockholder services business
shall  be  a  successor  warrant  agent  under  this  Warrant  without  any  further  act. Any  such  successor  warrant  agent  shall  promptly  cause
notice of its succession as warrant agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder’s last address as
shown on the Warrant Register.

 
 
 
 
 
 
 
12.          Miscellaneous.

(a)                    The  Company  shall  not,  by  amendment  of  its  Certificate  of  Incorporation  or  Bylaws,  or  through  any
reorganization,  transfer  of  assets,  consolidation,  merger,  scheme  of  arrangement,  dissolution,  issue  or  sale  of  securities  or  any  other
voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good
faith carry out all the provisions of this Warrant. Without limiting the generality of the foregoing, the Company (i) will not increase the par
value of any Warrant Shares above the amount payable therefor on such exercise and (ii) will not, and will not permit its transfer agent to,
close its stockholder books or records in any manner which interferes with the timely exercise of this Warrant.

( b )          GOVERNING LAW; VENUE; SERVICE OF PROCESS; WAIVER OF JURY TRIAL . ALL  QUESTIONS

CONCERNING  THE  CONSTRUCTION,  VALIDITY,  ENFORCEMENT AND  INTERPRETATION  OF  THIS AGREEMENT  SHALL
BE  GOVERNED  BY AND  CONSTRUED  IN ACCORDANCE  WITH  THE  LAWS  OF  THE  STATE  OF  NEW  YORK,  WITHOUT
GIVING EFFECT TO THAT BODY OF LAWS PERTAINING TO CONFLICT OF LAWS. EACH PARTY HEREBY IRREVOCABLY
SUBMITS TO THE NON-EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE CITY OF NEW
YORK,  BOROUGH  OF  MANHATTAN,  FOR  THE  ADJUDICATION  OF  ANY  DISPUTE  HEREUNDER  OR  IN  CONNECTION
HEREWITH  OR  WITH  ANY  TRANSACTION  CONTEMPLATED  HEREBY  OR  DISCUSSED  HEREIN  (INCLUDING  WITH
RESPECT  TO  THE  ENFORCEMENT  OF  ANY  OF  THE  TRANSACTION  DOCUMENTS),  AND  HEREBY  IRREVOCABLY
WAIVES,  AND  AGREES  NOT  TO  ASSERT  IN  ANY  SUIT,  ACTION  OR  PROCEEDING,  ANY  CLAIM  THAT  IT  IS  NOT
PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT AND THAT SUCH SUIT, ACTION OR PROCEEDING
IS  IMPROPER.  EACH  PARTY  HEREBY  IRREVOCABLY  WAIVES  PERSONAL  SERVICE  OF  PROCESS AND  CONSENTS  TO
PROCESS  BEING  SERVED  IN  ANY  SUCH  SUIT,  ACTION  OR  PROCEEDING  BY  MAILING  A  COPY  THEREOF  VIA
REGISTERED  OR  CERTIFIED  MAIL  OR  OVERNIGHT  DELIVERY  (WITH  EVIDENCE  OF  DELIVERY)  TO  SUCH  PARTY AT
THE ADDRESS  IN  EFFECT  FOR  NOTICES  TO  IT  UNDER  THIS AGREEMENT AND AGREES  THAT  SUCH  SERVICE  SHALL
CONSTITUTE  GOOD AND  SUFFICIENT  SERVICE  OF  PROCESS AND  NOTICE  THEREOF.  NOTHING  CONTAINED  HEREIN
SHALL  BE  DEEMED  TO  LIMIT  IN ANY  WAY ANY  RIGHT  TO  SERVE  PROCESS  IN ANY  MANNER  PERMITTED  BY  LAW.
EACH OF THE COMPANY AND THE HOLDER HEREBY WAIVES ALL RIGHTS TO A TRIAL BY JURY.

limit or affect any of the provisions hereof.

(c)          The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to

(d)          In case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the
validity and enforceability of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby and
the parties will attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonable substitute
therefor, and upon so agreeing, shall incorporate such substitute provision in this Warrant.

 
 
 
 
 
 
 
 
(e)          No course of dealing or any delay or failure to exercise any right hereunder on the part of the Holder shall
operate  as  a  waiver  of  such  right  or  otherwise  prejudice  the  Holder’s  rights,  powers  or  remedies,  notwithstanding  all  rights  hereunder
terminate on the Expiration Date.

(f)          No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant or purchase
Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the
purchase  price  of  any  Common  Stock  or  as  a  stockholder  of  the  Company,  whether  such  liability  is  asserted  by  the  Company  or  by
creditors of the Company.

(g)          The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages,
will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive the defense in
any action for specific performance that a remedy at law would be adequate.

(h)          Any term of this Warrant may be amended and the observance of any term of this Warrant may be waived with
the written consent of the Company and the holders of a majority of the outstanding unexercised warrants issued pursuant to the Purchase
Agreement.

[SIGNATURE PAGE FOLLOWS]

 
 
 
 
 
 
 
 
IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by its authorized officer as of the date first

indicated above.

ENERGOUS CORPORATION

By:
Name:
Title:

 
 
 
 
 
 
 
 
 
 
 
 
 
 
(To be executed by the Holder to exercise the right to purchase shares of Common Stock under the foregoing Warrant)

FORM OF EXERCISE NOTICE

To: Energous Corporation

The  undersigned  is  the  Holder  of  Warrant  No.  _______  (the  “ Warrant”)  issued  by  Energous  Corporation,  a  Delaware  corporation  (the
“Company”). Capitalized terms used herein and not otherwise defined herein have the respective meanings set forth in the Warrant.

1.

2.

3.

4.

5.

The Warrant is currently exercisable to purchase a total of ______________ Warrant Shares.

The undersigned Holder hereby exercises its right to purchase _________________ Warrant Shares pursuant to the Warrant.

The Holder is hereby paying the sum of $____________ to the Company in cash in accordance with the terms of the Warrant.

Pursuant to this exercise, the Company shall deliver to the holder _______________ Warrant Shares in accordance with the terms
of the Warrant.

Following this exercise, the Warrant shall be exercisable to purchase a total of ______________ Warrant Shares.

Dated:  ____________________, ______

Name of Holder:

(Print)

By:
Name:
Title:

(Signature must conform in all respects to name of holder as
specified on the face of the Warrant)

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EXHIBIT C
FORM OF SECRETARY’S CERTIFICATE – COMPANY

 
 
 
 
Energous Corporation
Secretary’s Certificate

I, Brian Sereda, certify that I am the Secretary of Energous Corporation, a Delaware corporation (the “Company”), and that, as
such,  I  am  authorized  to  execute  this  certificate  on  behalf  of  the  Company  and  in  connection  with  that  certain  Securities  Purchase
Agreement, dated as of August [__], 2016 (the “ Purchase Agreement”), by and among the Company and the Investor named therein (the
“Investor”), and do hereby further certify that:

1.     Attached hereto as Exhibit A is a true and complete copy of the Second Amended and Restated Certificate of Incorporation of the
Company filed with the Secretary of State of the State of Delaware (the “Certificate of Incorporation”), as amended by that Certificate of
Amendment dated March 26, 2016; no other amendments to the Certificate of Incorporation have been adopted, the Company has not filed
any amendments to the Certificate of Incorporation with the Secretary of State of the State of Delaware, and no action has been taken by
the  Company,  its  shareholders,  directors  or  officers  in  contemplation  of  the  filing  of  any  such  amendment  or  other  document;  the
Certificate of Incorporation remains in full force and effect on the date hereof;

2.     Attached hereto as Exhibit B is a certificate of good standing certified by the Secretary of State of the State of Delaware;

3.     Attached hereto as Exhibit C is a certificate of foreign qualification certified by the Secretary of State of the State of California;

4.     Attached hereto as Exhibit D is a true and complete copy of the By-laws of the Company; such By-laws have not been amended

and are in full force and effect as of the date hereof;

5.     Attached hereto as Exhibit E are true and complete copies of the resolutions adopted by the Board of Directors of the Company,
either  at  a  meeting  or  meetings  properly  held  or  by  the  unanimous  written  consent  of  the  Board  of  Directors,  relating  to  the  issuance,
offering and sale of the shares of the Company’s common stock (the “Common Stock”) and the warrants to purchase shares of Common
Stock (the “Warrants”) pursuant to the Purchase Agreement; all of such resolutions were duly adopted, have not been amended, modified
or  rescinded  and  remain  in  full  force  and  effect;  and  such  resolutions  are  the  only  resolutions  adopted  by  the  Board  of  Directors  with
respect to the issuance, offering and sale of the Common Stock and Warrants pursuant to the Purchase Agreement;

6.     Attached hereto as Exhibit F is a true and complete copy of an incumbency certificate of the Company’s officers.

[Signature page follows]

 
 
 
 
 
 
 
 
 
 
 
 
In witness whereof, I have hereunto signed my name this [    ]th day of August, 2016.

By:

Brian Sereda, Secretary

 
 
 
 
 
 
 
 
 
Exhibit A
Certificate of Incorporation

 
 
 
 
Exhibit B
Delaware Good Standing

 
 
 
 
Exhibit C
Foreign Qualification

 
 
 
 
Exhibit D
By-laws

 
 
 
 
Exhibit E
Board of Director Resolutions

 
 
 
 
Exhibit F
Incumbency Certificate

The undersigned individuals of Energous Corporation, a Delaware corporation (the “Corporation”), are designated as appropriate parties
with  the  power  and  authority  to  enter  into  contracts,  agreements  and  to  provide  written  directions  pertaining  to  services  associated  with
stock transfer and registrar needs:

Name

Title

Signature

Stephen R. Rizzone

  President and Chief Executive Officer

Brian Sereda

  Chief Financial Officer and Secretary

IN WITNESS WHEREOF I have hereunto set my hand and the Corporate Seal of the Corporation this __ day of August, 2016.

Name: Brian Sereda
Title: Secretary

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AMENDMENT NO. 1 TO
SECURITIES PURCHASE AGREEMENT

Exhibit 10.23

THIS AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT (this “ Amendment”) is entered into effective as of
August 12, 2016, by and among Energous Corporation, a Delaware corporation (the “Company”), Ascend Legend Master Fund, Ltd., an
exempted  company  formed  under  the  laws  of  the  Cayman  Islands  (“Ascend”),  and  the  investors  who  are  signatories  hereto  (each,  a
“Purchaser” and collectively, the “Purchasers”). This Amendment amends the Securities Purchase Agreement dated as of August 9, 2016
by and between the Company and Ascend (the “ Purchase Agreement”). All capitalized terms used in this Amendment without definition
shall have the respective meanings assigned to them in the Purchase Agreement.

Recitals:

WHEREAS,  pursuant  to  the  Purchase Agreement, Ascend  agreed  to  purchase,  and  the  Company  agreed  to  sell  and  issue  to
Ascend, upon the terms and subject to the conditions stated in the Purchase Agreement, (i) an aggregate of up to 1,618,123 shares of the
Company’s  common  stock  (“Common Stock”)  and  (ii)  warrants  to  purchase  an  aggregate  of  up  to  1,618,123  shares  of  the  Company’s
Common Stock (“Warrants”) at an exercise price of $23.00 per share.

WHEREAS, the Company and Ascend wish to amend the Purchase Agreement such that the Company instead agrees to sell and
issue (i) warrants to purchase up to 809,062 shares of Common Stock to The Kingdom Trust Company, Custodian, FBO Emily T Fairbairn
Roth  IRA  (7465812820)  (“EF  IRA”)  and  (ii)  warrants  to  purchase  up  to  809,061  shares  of  Common  Stock  to  The  Kingdom  Trust
Company,  Custodian,  FBO  Malcolm  P  Fairbairn  Roth  IRA  (9510281370)  (“ MF IRA”),  in  lieu  of  the  sale  and  issuance  to Ascend  of
warrants  to  purchase  1,618,123  shares  of  the  Company’s  Common  Stock,  upon  the  terms  and  subject  to  the  conditions  stated  in  the
Purchase Agreement.

NOW, THEREFORE, in consideration of the premises and covenants set forth herein, and intending to be legally bound hereby,

the parties hereto agree as follows:

1.            The Preamble of the Purchase Agreement is hereby deleted and the following is hereby inserted in lieu thereof:

“THIS SECURITIES PURCHASE AGREEMENT  (the “Agreement”), is dated as of August 9, 2016, by and among
Energous Corporation, a Delaware corporation (the “Company”)  and Ascend  Legend  Master  Fund,  Ltd.,  an  exempted  company  formed
under  the  laws  of  the  Cayman  Islands  (“Ascend”),  The  Kingdom  Trust  Company,  Custodian,  FBO  Emily  T  Fairbairn  Roth  IRA
(7465812820) (“EF IRA”),  and  The  Kingdom  Trust  Company,  Custodian,  FBO  Malcolm  P  Fairbairn  Roth  IRA  (9510281370)  (  “ MF
IRA,” and collectively with Ascend and EF IRA, the “Investor”).

 
 
 
 
 
 
 
 
 
 
 
2 .            Section B of the Background of the Purchase Agreement is hereby deleted and the following recital is hereby inserted in

lieu thereof:

“Ascend  wishes  to  purchase,  and  the  Company  wishes  to  sell  and  issue  to Ascend,  upon  the  terms  and  subject  to  the
conditions  stated  in  this Agreement,  an  aggregate  of  up  to  1,618,123  shares  of  the  Common  Stock,  for  the  purchase  price  specified  in
Exhibit A (as adjusted by any stock split, dividend or other distribution, recapitalization or similar event, the “Shares”). EF IRA and MF
IRA each wish to purchase, and the Company wishes to sell and issue to EF IRA and MF IRA, upon the terms and subject to the conditions
stated in this Agreement, warrants to purchase an aggregate of up to 1,618,123 shares (subject to adjustment as described in the Warrants)
of Common Stock (the “Warrants”) in the form attached hereto as Exhibit B, for the purchase price specified in Exhibit A, which Warrants
shall be exercisable at any time on or after the date which is six months and one day after the date hereof and have an exercise price equal to
$23.00 per share (subject to adjustment as described in the Warrants) (“Exercise Price”) and a term of exercise of five (5) years from and
after the Closing (as defined below).”

3.            Section 2.2 of the Purchase Agreement is hereby deleted and the following is hereby inserted in lieu thereof:

“2.2           Closing.

(a)          At the Closing, the Company shall deliver to each Investor (i) the Shares and Warrants, registered in the name of
such Investor as indicated on Exhibit A and (ii) a certificate, in the form set forth on Exhibit C, executed by the secretary of the Company
and  dated  as  of  the  Closing  Date,  as  to  the  Certificate  of  Incorporation,  by-laws,  foreign  qualification,  incumbency  of  the  Company’s
officers and good standing of the Company and the resolutions adopted by the Company’s Board of Directors (the “Board”) authorizing
the transactions contemplated by the Transaction Documents.

available funds to an account specified by the Company in writing.”

(b)          At the Closing, the Investors shall deliver the Purchase Price to the Company by wire transfer of immediately

4

.            The  Purchasers  certify  that  at  the  time  the  Purchasers  were  offered  the  Warrants,  and  at  the  date  hereof,  each  is  an
“accredited  investor”  as  defined  in  Rule  501(a)  under  the  Securities  Act  of  1933,  as  amended  (the  “Securities Act”)  or  a  “qualified
institutional buyer” as defined in Rule 144A(a) under the Securities Act. The Purchasers further covenant that each will be subject to and
comply with the terms and conditions as set forth in the Purchase Agreement.

2

 
 
 
 
 
 
 
 
 
 
 
5.            Exhibit A of the Purchase Agreement is hereby deleted and the following is hereby inserted in lieu thereof :

Ascend Legend Master Fund, Ltd.
The Kingdom Trust Company,
Custodian, FBO Emily T 
Fairbairn Roth IRA (7465812820)
The Kingdom Trust Company,
Custodian, FBO Malcolm P
Fairbairn Roth IRA (9510281370)

Exhibit A
SECURITIES PURCHASED

Investor

  Common Stock    Warrants

1,618,123     

    Purchase Price 
     $ 19,797,734.63 

809,062    $

101,132.75 

809,061    $

101,132.63 

6 .            Except for the changes expressly set forth herein, the parties acknowledge and agree that all of the terms, provisions,
covenants and conditions of the Purchase Agreement shall hereafter continue in full force and effect in accordance with the terms thereof;
provided,  however,  that  if  any  term  or  provision  of  this Amendment  shall  conflict  with  or  otherwise  be  inconsistent  with  any  term  or
provision of the Purchase Agreement, the terms and provisions of this Amendment shall prevail.

7 .            This Amendment shall be governed by and construed under the laws of the State of New York, without giving effect to

principles of conflicts of laws.

8.            This Amendment may be executed (by facsimile) in two or more counterparts, each of which shall be deemed an original,
but  all  of  which  together  shall  constitute  one  and  the  same  instrument.  Executed  counterparts  of  this Amendment  may  be  delivered  by
electronic or facsimile transmission with the same effect as if delivered personally.

(Signature page follows.)

3

 
 
 
 
   
   
      
   
      
 
 
 
 
 
 
 
IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above written.

ENERGOUS CORPORATION

By:  /s/ Stephen R. Rizzone

STEPHEN R. RIZZONE
Chief Executive Officer

ASCEND LEGEND MASTER FUND, LTD.

By:  /s/ Malcolm P. Fairbairn
Name:  Malcolm P. Fairbairn
Title:  Director

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PURCHASERS:

THE KINGDOM TRUST COMPANY,
CUSTODIAN, FBO EMILY T FAIRBAIRN
ROTH IRA (7465812820)

/s/ Emily Fairbairn

By:
Name: Emily Fairbairn
Title:

Kingdom Trust Company, Custodian
FBO: Emily T. Fairbairn
/s/ Authorized Signatory

THE KINGDOM TRUST COMPANY,
CUSTODIAN, FBO MALCOLM P FAIRBAIRN
ROTH IRA (9510281370)

/s/ Malcolm Fairbairn

By:
Name: Malcolm Fairbairn
Title:

Kingdom Trust Company, Custodian
FBO: Malcolm Fairbairn
/s/ Authorized Signatory

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[***]

Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately
with  the  Securities  and  Exchange  Commission  pursuant  to  Rule  24b-2  of  the  Securities  Exchange  Act  of  1934,  as
amended.

 Exhibit 10.24 

EXECUTION VERSION

STRATEGIC ALLIANCE AGREEMENT

THIS STRATEGIC ALLIANCE AGREEMENT (“Agreement”) is made and entered into as of November 6, 2016 (the “Effective
Date”)  by  and  between  Dialog  Semiconductor  (UK)  Ltd.,  a  corporation  organized  under  the  laws  of  England  and  Wales,  having  its
principal office at 100 Longwater Avenue, Green Park, Reading, RG2 6GP, United Kingdom (“ DIALOG”) and Energous Corporation, a
Delaware corporation, having its principal office at 3590 North First Street, Suite 210, San Jose, CA 95134 (“ENERGOUS”).

WHEREAS DIALOG is a supplier of mixed-signal semiconductor products;

WHEREAS  ENERGOUS  is  a  supplier  of  uncoupled  wirefree  charging  systems,  including  antennas,  semiconductors,  firmware,

software, algorithms, and sensors;

WHEREAS  concurrently  with  their  execution  of  this  Agreement,  DIALOG  and  ENERGOUS  are  entering  into  a  separate
Securities  Purchase Agreement,  pursuant  to  which  DIALOG  will  make  an  investment  in  ENERGOUS,  and  ENERGOUS  will  issue  to
DIALOG shares of its common stock and a warrant to purchase its common stock on the terms set forth therein.

WHEREAS  DIALOG  and  ENERGOUS  desire  to  enter  into  a  strategic  relationship  to  distribute  to  the  marketplace  certain
ENERGOUS  products  and  technology  and  to  potentially  collaborate  on  further  initiatives  pursuant  to  the  terms  and  conditions  of  this
Agreement.

NOW,  THEREFORE,  in  consideration  for  the  premises  and  mutual  covenants  contained  herein,  DIALOG  and  ENERGOUS

hereby agree as follows:

1.                  DEFINITIONS.

All capitalized terms used in this Agreement will have the meaning set out below, or if not defined below, the meaning as defined
elsewhere in the Agreement.

1.1               “Affiliate” means any person or entity that controls, is controlled by or is under common control with the specified
person or entity, but only so long as such control exists. The term “control” means the possession, directly or indirectly, of the power to
direct or cause the direction of the management and policies of an entity, whether through ownership of voting securities, by contract or
otherwise.

1.2              

“Approved  Production  Specifications”  means  those  materials,  processes  and  workmanship  specifications  of

Manufacturing Subcontractors as approved by ENERGOUS for the manufacture and production of the Products.

1.3               “Change of Control” means any transaction or series of transactions that results in (i) the consolidation or merger of
the  specified  party  (“Target”)  into  or  with  any  other  corporation  or  corporations,  (ii)  the  sale,  conveyance  or  disposition  of  all  or
substantially all of the assets of the Target, (iii) the transfer of more than fifty percent (50%) of the voting power of the Target to any entity
or entities not controlled by the Target, or (iv) any similar form of acquisition or any liquidation, dissolution or winding up of the Target or
other transaction that results in the discontinuance of the Target’s business; provided, however, that Change of Control will not include any
transaction or series of transactions entered into primarily for equity financing purposes (including, without limitation, any private equity
investment or any public offering of securities).

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.4               “Deposit Materials” means all chip level design databases, circuit schematics, test and characterization programs and
associated documentation reasonably required to have Products manufactured, or to allow design bugs or Epidemic Defects to be fixed in
the Product.

1.5              

“Design-In Phase” means the phase in the sales cycle with a prospective customer for a Product that follows the
customer’s decision to move forward with the potential Product, during which chip samples are delivered to customer and the parties work
together to design the evaluation board for in-system evaluation.

1.6               “Documentation” means all information that is necessary or useful to support DIALOG’s authorized manufacture,
testing,  sale  and  support  of  the  Products,  including  but  not  limited  to  Product  Specifications,  data  sheets,  application  notes,  application
board gerber files/BOM, sales and marketing collateral, Product errata, test reports, characterization reports, software (e.g., firmware, GUI),
test  plans  and  yield  data  in  connection  with  the  manufacture  and  sale  of  Products,  Approved  Production  Specifications,  test  and
characterization programs and associated documentation reasonably required to have Products manufactured, assembled and tested, designs
of all Tooling and all other items reasonably required for the manufacture of the Products.

1.7               “Epidemic Defects” means material defects of any Product resulting from a common root cause solely attributable to
the Product Specifications or Approved Production Specifications and which results in returns (in accordance with the returns procedure
mutually agreed between the parties in the Commercialization Plan) of more than [***] percent ([***]%) of the quantity of such Product
manufactured  in  any  [***]  day  period. Any  number  of  material  defects  affecting  any  number  of  Products  which  result  from  a  single
common root cause or combination of causes and result in returns of more than [***] ([***]%) of such Products manufactured in any [***]
day period will be treated as the occurrence of a single Epidemic Defect for purposes of this Agreement.

1.8              

“Insolvency Event” means (a) without a successor, the specified party fails to function as  a  going  concern  or  to
operate in the ordinary course, or (b) other than in the case when the specified party is a debtor-in-possession and continuing to fulfill all its
obligations  under  this Agreement,  a  receiver  or  trustee  in  bankruptcy  is  appointed  for  such  party  or  its  property,  or  such  party  makes  a
general  assignment  for  the  benefit  of  its  creditors,  or  such  party  commences,  or  has  commenced  against  it,  proceedings  under  any
bankruptcy, insolvency or debtor’s relief law, in each case which proceedings are not dismissed within ninety (90) days.

1.9              

“Intellectual  Property  Rights”  means  any  and  all  Patent  Rights,  copyright  rights,  Marks  rights  (including  all
associated goodwill), mask work rights, trade secret rights and all other intellectual and industrial property rights of any sort throughout the
world (including any application therefor).

* Confidential Treatment Requested

Page 2

 
 
 
 
 
 
 
 
 
 
 
 
1.10           “Invention” means any idea, concept, discovery, invention, development, technology, work of authorship, trade secret,
software, firmware, library, component, tool, mask work, process, method, technique, know-how, show-how, data, plan, formula, device,
apparatus, specification, design, documentation or other material or information, tangible or intangible, whether or not it may be patented,
copyrighted or otherwise protected (including all versions, modifications, enhancements and derivative works thereof).

1.11          

“Manufacturing Subcontractors”  means  (a)  [***]  and/or  its Affiliate  that  is  the  wafer  foundry  for  the  Products
(“[***]”), (b) [***] and/or its Affiliate that is responsible for the assembly, packaging and testing of the Products, and (c) and other third
party contractors DIALOG or ENERGOUS use, or may from time to time use, for the manufacturing, assembly, testing, or packaging of
the Licensed Products or Licensed Product components.

1.12          “Marks” means trademarks, service marks, trade dress and trade names.

1.13          “Mask Set” means the mask set for fabrication of wafers at a foundry supplier.

“Mass  Production  Qualified  Product”  means  a  fully  qualified  Product  which  has  completed  500  hour  high
temperature over lifetime (HTOL) testing and has been shipped in excess of [***] units for purposes of incorporation in customer products.

1.14          

1.15           MCM means a multichip module, being a single package that includes multiple integrated circuit dies, including a

Product die.

1.16          

“Net Sales” means the invoiced amounts for the Sale of Products less: (a) amounts credited for return of any such
Products; (b) amounts separately stated with respect to shipment of such Products for insurance, handling, duty, freight, and taxes; and (c)
any discounts, credits or rebates in the relevant royalty or service fee period.

1.17          

“New Product”  means  a  product  developed  by  or  on  behalf  of  ENERGOUS  after  the  Effective  Date  that  is  not  a

Product Update; provided, however, that “New Products” exclude any product developed by a successor or acquirer of ENERGOUS.

1.18          

“Patent”  means  any  United  States  or  foreign  patent  or  patent  application,  including  any  provisional  application,
continuation,  continuation-in-part,  divisional,  registration,  confirmation,  revalidation,  reissue,  PCT  application,  patent  term  extension,
supplementary protection certificate, and utility model, as well as all foreign counterparts of any of the foregoing, and related extensions or
restorations of terms thereof.

1.19          “Patent Rights” means rights under any Patent.

1.20          “Person” a human being or group of human beings, a company, corporation, a partnership or other legal entity (artificial

or juristic person) recognized by law as having rights and duties.

Page 3

* Confidential Treatment Requested

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.21          “Products” means the ENERGOUS products set forth in Exhibit A, as such Exhibit may be amended from time to time
by mutual agreement between the parties, that have been released by ENERGOUS to production, including all Product Updates, which will
be deemed to have been added to Exhibit A automatically, without any further action required by the parties, immediately following the
release to production date.

1.22          “Product Die” means the silicon die incorporated within Products.

1.23           “Product IP” means (a) all Intellectual Property Rights in and to the Products, including all Product Updates, (b) any
other Inventions and work products created or developed in connection with research and development or manufacturing efforts relating to
the Products, including all Intellectual Property Rights therein and (c) all Intellectual Property Rights in and to the Mask Sets and Tooling,
in each of the foregoing cases, that are owned or controlled by ENERGOUS, its Affiliates or any successor or assign.

1.24          

“Product Specifications”  means  ENERGOUS’  written  technical  specifications  for  the  Products  as  referenced  in
datasheets and related documentation such as errata sheets. All Product Specifications are subject to change with at least one (1) months
prior  written  notice  to  DIALOG,  provided  that  with  respect  to  any  warranty  for  Products  covered  by  this  Agreement,  the  Product
Specification  in  effect  at  the  time  of  shipment  of  the  relevant  Product  will  apply  for  warranty  purposes  notwithstanding  any  subsequent
change to the Product Specifications as provided herein.

1.25          

“Product Updates”  means  any  updates,  improvements  and  other  modifications  to  the  Products  made  by  or  for
ENERGOUS,  including,  without  limitation:  (a)  any  updates  or  modifications  to  the  software  (DSP  code,  firmware,  GUI  (graphical  user
interface) code); (b) modifications of silicon, including, without limitation; such modifications made solely for cost reduction purposes, and
including only metal layer as well as all layer mask changes; (c) modifications which increase the distance over which wireless power is
transmitted  or  received,  subject  to  the  limitations  set  out  in  Exhibit A;  (d)  modifications  which  increase  the  amount  of  power  which  is
transmitted or received; (e) modifications to improve functionality or efficiency or add or improve features; and (f) modifications required
to attain regulatory approvals, including, but not limited to, FCC approval; provided, however, that “Product Updates” will only include any
of the foregoing developed by an acquirer or successor of ENERGOUS for a period of [***] after a Change of Control of ENERGOUS,
and provided further that any Products incorporating Product Updates will be subject to separate terms and conditions to be agreed in good
faith by the Parties, which terms and conditions will be no less favourable to DIALOG than those with respect to the Product to which the
Product Update corresponds.

1.26           “Sale,” “Sell” or “Sold” mean the sale, transfer, exchange or other disposition of Products, by DIALOG or any of its
Affiliates  to  any  customer  or  other  third  party,  directly  or  indirectly  through  one  or  more  tiers  of  distribution,  for  consideration  that  is
recognized as revenue by DIALOG or its Affiliates according to applicable generally accepted accounting principles.

1.27          “Semiconductor Supplier” means any Person, other than DIALOG or its Affiliates, which primarily, or in its ordinary

course of business, sells or distributes integrated circuits in packaged, die, multichip module or similar form.

Page 4

* Confidential Treatment Requested

 
 
 
 
 
 
 
 
 
 
 
1.28          “Term” means the Initial Term and any and all Renewal Term(s) as set forth in Section 15.1 hereof.

1.29          “Third Party IP” means Intellectual Property Rights licensed from a third party relating to the Products.

1.30           “Tooling” means the physical Mask Sets, packaging fixtures, test fixtures, test programs, processes, software source
code and any other physical tooling or program source code required for the manufacture, packaging, assembly and testing of the Products.

1.31           “Uncoupled Power Transfer Technology”  means  a family of wire-free technology defined by the AirFuel Alliance
that provides power to devices at a distance, and that currently includes (i) RF, (ii) ultrasonic transduction, and (iii) Laser power beaming.
Notwithstanding the foregoing, the meaning of Uncoupled Power Transfer Technology excludes technology which functions primarily for
data transmission or direct-current-to-direct-current (DC-to-DC) power conversion.

2.                  LICENSE.

2.1              

License Grant.  Subject  to  the  restrictions  set  out  in  Section  2.2,  ENERGOUS  hereby  grants  to  DIALOG  a  non-
exclusive (subject to Section 2.5), irrevocable, worldwide, sub-licensable (solely in accordance with Section 2.4), royalty-bearing license
during the Term under all Product IP to:

(a)                 repackage or have repackaged the Product Die into various package formats or layouts, and to integrate the
Product Die into MCMs, which may incorporate DIALOG or third party intellectual property (such repackaged Product Die, MCMs and
Products, are individually and/or collectively referred to as the “Licensed Products”);

(b)                have the Licensed Products manufactured, tested and packaged by Manufacturing Subcontractors;

system design, troubleshooting and failure analysis support for DIALOG’s customers and their customers;

(c)                Sell, offer for Sale, import, export and support the Licensed Products, including without limitation, providing

(d)               use and modify the Tooling and Documentation for the purposes of paragraphs (a) to (d) of this Section 2.1.

2.2              

Excluded Applications.  Until  the  earlier  of  (i)  termination  of  ENERGOUS’  exclusivity  obligations  to  the  Key
Customer set forth in Exhibit F (the “Key Customer”) existing as of the Effective Date with respect to the following applications, or (ii)
[***]  that  incorporates  ENERGOUS  wireless  charging  technology,  or  (iii)  [***]  and  subject  to  the  exceptions  set  out  in  Section  2.3,
DIALOG will not be permitted to Sell Licensed Products for use in the following applications (the “Excluded Applications”):

(a)               [***];

Page 5

* Confidential Treatment Requested

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b)               [***];

(c)               [***];

(d)               [***]; and

(e)               [***] designed for use with any of the applications in paragraphs (a) to (d) of this Section 2.2.

For the avoidance of doubt, DIALOG will be permitted to Sell Licensed Products for use in any or all of the Excluded Applications (A) at
any time on or after [***] or, if earlier, (B) [***] that incorporates ENERGOUS wireless charging technology, or (C) upon the termination
of ENERGOUS’ exclusivity obligations to the Key Customer existing as of the Effective Date with respect to the above applications.

2.3               Exceptions to Excluded Applications. The following applications are exceptions to and excluded from the Excluded

Applications (the “Permitted Applications”):

(a)               [***];

(b)               [***];

(c)               [***];

(d)               [***];

(e)               [***];

(f)                [***];

(g)               [***];

(h)               [***];

(i)                [***]; and

(j)                [***].

The fact that a [***] has [***] does not automatically preclude such device from falling under paragraphs (b), (c) and (d) of this Section 2.3

2.4              

Sublicenses.  DIALOG  may  sublicense  the  foregoing  license  rights  to  any  of  its Affiliates.  DIALOG  will  be
responsible  for  the  observance  and  performance  by  all  such  Affiliates  of  all  of  DIALOG’s  obligations  pursuant  to  this  Agreement.
DIALOG may sublicense the foregoing license rights to Manufacturing Subcontractors solely to the extent necessary and appropriate for
them to manufacture, assemble, test and provide support for the Products. DIALOG may not sublicense the foregoing license rights to any
other third party without ENERGOUS’ prior written consent.

Page 6

* Confidential Treatment Requested

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
2.5              Exclusivity.

Subject  to  paragraph  (b)  of  this  Section  2.5,  ENERGOUS  will  not,  and  will  not  enable  any
Semiconductor  Supplier,  to  manufacture,  have  manufactured,  offer  for  sale,  sell,  import  or  export  the  Products  or  Product  Die  in
commercial volumes, except a Semiconductor Supplier to the Key Customer for use in the Excluded Applications.

(a)                        

(b)                         ENERGOUS will use its diligent, good faith efforts to promote DIALOG as the preferred supplier of
Products and Product Die. However, ENERGOUS is allowed to engage with a Semiconductor Supplier to supply comparable products or
product die to a customer if either (i) the customer which has not been engaged with DIALOG with respect to such product or product die
notifies ENERGOUS or DIALOG in writing by an authorized officer of the customer that it does not want to use DIALOG or a DIALOG
Affiliate  as  a  supplier  of  such  product  or  product  die;  or  (ii)  if  DIALOG  has  been  engaged  with  the  customer,  the  customer  notifies
ENERGOUS or DIALOG in writing prior to commencement of the Design-In Phase that it does not want to use DIALOG or a DIALOG
Affiliate  as  a  supplier  of  such  product  or  product  die.  For  clarity,  ENERGOUS  shall  not  intentionally  supply  Products,  Product  Die  or
comparable products or product die to customers directly or through distribution channels.

2.6              Branding.

(a)                 Products Sold by DIALOG or its Affiliates may be branded as DIALOG products. All sales and marketing
collateral, software tools and material for promotional activities relating to the Products will utilize ENERGOUS branding in a prominent
basis as an equivalent partner with respect to such Products.

(b)                To the extent the parties engage in any co-branding activities, then, subject to the terms and conditions of this
Agreement and during the Term, each party (in such capacity, “Licensor”) hereby grants to the other party (in such capacity, “Licensee”) a
non-exclusive, non-transferable, worldwide right and license (without the right to sublicense), under Licensor’s Intellectual Property Rights
in Licensor’s Marks, to use those Marks of Licensor set forth in  Exhibit D solely in connection with the marketing, sale and distribution of
such co-branded Products in accordance with this Agreement.

(c)       Use of Licensor’s Marks will be subject to the following terms and conditions: (i) all goodwill generated by use of
Licensor’s Marks by Licensee will inure to the benefit of Licensor; (ii) Licensee will use Licensor’s Marks only in such forms and with
such graphics as authorized by Licensor; and (iii) Licensee will identify Licensor’s Marks as being owned by Licensor and will (A) cause
the symbol “®” to appear adjacent to and slightly above any registered Licensor Mark, or (B) alternatively, for any Licensor Marks that are
not registered, the symbol “TM” or “SM”, as applicable.

2.7               No Other Rights. Except for the rights and licenses expressly granted in this Agreement, no other right is granted, no

other use is permitted and all other rights are expressly reserved.

Page 7

 
 
 
 
 
 
 
 
 
 
 
 
3.                  SOURCING.

3.1              Product Manufacture. Concurrent with or before execution of this Agreement, and substantially in the form attached as
Exhibit C, ENERGOUS will provide written authorization to its Manufacturing Subcontractors to confirm DIALOG’s and, if applicable,
DIALOG’s  Affiliates’  rights  to  procure  the  Licensed  Products  and  related  services  directly  from  such  Manufacturing  Subcontractors
utilizing ENERGOUS’ Tooling and any associated manufacturing resources. DIALOG and its sublicensed Affiliates may directly contract
with the Manufacturing Subcontractors for the manufacture and supply of Licensed Products under terms and conditions that DIALOG or
such Affiliates may directly negotiate with such third parties.

3.2               Additional Manufacturing Subcontractors. DIALOG at its sole discretion may qualify and establish an alternative
source to some or all of ENERGOUS’ Manufacturing Subcontractors for the manufacturing of the Licensed Products and ENERGOUS will
provide its written authorization thereof if requested by DIALOG.

3.3              Tooling. Subject to ENERGOUS’ rights in the Product IP and any Third Party IP (including, without limitation, that of
any Manufacturing Subcontractors), each party will own all right, title and interest in the physical Tooling procured or generated by that
party  for  the  manufacturing,  testing  and  packaging  of  the  Licensed  Products.  For  the  avoidance  of  doubt,  as  between  the  parties,
ENERGOUS will also continue to own all right, title and interest in and to the firmware, DSP code and GUI software embedded in the
Products,  including  all  Intellectual  Property  Rights  embodied  therein.  Upon  the  termination  of  DIALOG’s  right  to  manufacture  the
Licensed Products following any expiration or termination of the Agreement or any Wind Down Period or Continuing Obligation period, as
applicable,  then  all  right,  title  and  interest  in  the  Tooling  will  automatically  transfer  to  ENERGOUS  subject  to  any  Third  Party  IP,  and
DIALOG will, at ENERGOUS’ option, either sell any Tooling in its possession to ENERGOUS at cost or destroy the Tooling and certify in
writing as to same.

4.                  PRODUCT COMMERCIALIZATION.

4.1              Commercialization Plan.

(a)                

Exhibit  E  hereto  sets  out  the  plan  for  the  commercialization  of  the  Licensed  Products  (the
“Commercialization  Plan”).  The  Commercialization  Plan  sets  forth  the  parties’  respective  rights  and  obligations  with  respect  to
commercial and technical activities to be performed to maximize potential Sales of Licensed Products. The Commercialization Plan will be
reviewed and (if necessary) updated by the parties on a quarterly basis during the Term.

(b)                 Each party will appoint (and notify the other party of the name of) a member of their management team who
will serve as that party’s primary contact for all matters related to this Agreement (each, a “ Liaison”), including resolution of issues that
may arise under this Agreement. Each party may replace its Liaison at any time by notice in writing to the other party.

The  Commercialization  Plan  includes  a  go-to-market  plan.  ENERGOUS  will  provide  commercially
reasonable sales training, material and support to DIALOG’s global application, sales and marketing teams and customers, including the
support set out in Section 4.3.

(c)                

Page 8

 
 
 
 
 
 
 
 
 
 
 
 
 
(d)               ENERGOUS will also support DIALOG with an operations and quality plan, which will set forth information
relating  to  quality  matters,  including,  but  not  limited  to,  testing,  yield  management,  RMA  process,  failure  analysis/corrective  action
procedure, ECN/PCN process and detailed agreement on mutual rights and responsibilities with respect to any quality issues or warranty
claims (hereinafter “Quality Plan”). Both parties will work in good faith to finalize and implement the Quality Plan within 90 days after
the  Effective  Date  of  this Agreement.  DIALOG  will  be  responsible  for  its  own  frontline  quality  function  and  corrective  actions,  with
technical input from ENERGOUS as required.

The  parties  may  promote  the  relationship  with  marketing  initiatives  and  also  agree  to  engage  in  joint
marketing communication activities related to the relationship described in this Agreement or to the promotion of the Licensed Products, as
set forth in the Commercialization Plan or otherwise mutually agreed between the parties from time to time.

(e)                

4.2               Commercialization Meetings. The parties will meet regularly, but at least once each month during the Term, either in
person or by telephone, video or internet conference call, to share technical and commercial information as reasonably required to facilitate
the parties’ exercise of their respective rights and performance of their respective obligations under this Agreement. The information shared
by  the  parties  will  include,  but  is  not  limited  to  (a)  market  and  competitive  dynamic  updates,  (b)  activities  and  progress  updates  at
DIALOG’s customers, (c) technical review and feedback from customers, (d) non-binding 12 month rolling Sales and Royalty and Service
Fee forecasts for the Licensed Products, (e) initiatives to boost sales potential for the Licensed Products. Customer information shared will
be within the limits allowed by any non-disclosure agreements DIALOG may have entered into with such customers.

4.3              

Technical Support.  ENERGOUS  will  support  DIALOG’s  or  its Affiliates’  engineers  and,  in  some  cases  and  at
DIALOG’s  request,  the  customer  directly  in  providing  standard  design-in  support  (including  antenna  design  support)  for  customers’
products.  If  the  customer  requires  unique  or  custom  engineering  services  (i.e.,  support  and  services  not  limited  to  those  with  general
application  to  Product  customers),  then  ENERGOUS  will  contract  directly  with  such  customer  for  the  provision  of  such  services.
ENERGOUS will provide DIALOG with any and all information that is necessary or useful to support its authorized manufacture, testing,
marketing, Sale, troubleshooting, compatibility analysis, performance tuning, failure analysis, and other support of the Licensed Products,
including  the  Documentation  and  any  updates  thereto  or  revisions  thereof  which  are  reasonably  necessary  or  appropriate  to  provide
technical support for the Products to DIALOG customers. ENERGOUS receives the Service Fee for providing the support described in this
Section  4.3  to  DIALOG  and  its  customers  during  the  Term.  In  the  event  the  Technical  Support  provided  by  ENERGOUS  falls  below  a
mutually-agreed upon service level that is common to the semiconductor industry or reasonably requested by DIALOG’s customers, and
after  failure  by  ENERGOUS  to  address  such  deficiency  within  a  twenty  (20)  day  notice  period,  DIALOG  may  suspend  the  payment  of
Service  Fees  until  such  service  level  is  provided.  Furthermore,  in  the  event  ENERGOUS  fails  to  meet  its  obligations  as  set  forth  in  the
Quality Plan, and after failure by ENERGOUS to address such deficiency within a thirty (30) day notice period, DIALOG may suspend the
payment of Service Fees until such obligations are met.

Page 9

 
 
 
 
 
 
 
 
5.                  PRODUCT DEVELOPMENT AND PRODUCT UPDATES.

ENERGOUS  will  have  control  and  authority  over  the  design  and  development  of  the  Products,  including  without  limitation,
developing and implementing all Product Updates. ENERGOUS reserves the right to implement Product Updates at any time in its sole
discretion.  The  parties  will  consult  each  other  on  the  perceived  product  needs  of  the  market  and  DIALOG’s  customers  and  how  best  to
respond to such needs. DIALOG may suggest Product Updates to ENERGOUS provided, but all the development of Product Updates will
be  at  ENERGOUS’  sole  discretion.  ENERGOUS  will  share  its  relevant  product  roadmaps  from  time  to  time  to  maximize  collaboration
opportunities.

6.                  INTELLECTUAL PROPERTY OWNERSHIP.

6.1              

Product  IP.  ENERGOUS  retains  right,  title  and  interest  in  and  to  the  Product  IP,  ENERGOUS’  Marks  and
ENERGOUS’ Confidential Information, including all Intellectual Property Rights embodied therein. No transfer or grant is made hereunder
by ENERGOUS of any of these rights or any of its other rights, whether by implication, estoppel or otherwise, other than the limited rights
and licenses expressly granted by ENERGOUS in this Agreement, and all such other rights are hereby reserved.

6.2               DIALOG Intellectual Property. DIALOG retains rights, title and interest in and to DIALOG’s Marks and DIALOG’s
Confidential Information, including all Intellectual Property Rights embodied therein. No transfer or grant is made hereunder by DIALOG
of any of these rights or any of its other rights, whether by implication, estoppel or otherwise, other than the limited rights and licenses
expressly granted by DIALOG in this Agreement and all such other rights are hereby reserved.

7.                  PRODUCT SALES.

7.1               Sales. Subject to the terms and conditions of this Agreement, and except as set forth in the Commercialization Plan or
otherwise agreed in writing between the parties, DIALOG will market and Sell the Licensed Products as authorized under this Agreement.
DIALOG will independently manage and process its own forecasting, operations and order management.

7.2              

Discontinuation  of  Sale  of  Products.  If  DIALOG  decides  to  discontinue  Sales  of  any  Product,  it  will  notify
ENERGOUS at least [***] prior to such discontinuance, and following such notification, the exclusivity rights, if any, associated with that
Product  will  cease;  provided,  however,  this  provision  will  not  apply  in  the  event  that  DIALOG  continues  Sales  of  Product  Updates,
repackaged Product Dies or MCMs.

7.3 Supply of Products to ENERGOUS. DIALOG will provide 1000 samples of each Product free of charge to ENERGOUS for the
purposes  of  evaluation  and  demonstration.  For  additional  volumes  required  by  ENERGOUS,  DIALOG  will  sell  to  ENERGOUS  on  a
reasonable cost plus basis for the purposes of evaluation and demonstration. These samples are provided as is, are not intended for resale
by ENERGOUS, and no indemnification or other warranties from DIALOG will apply.

Page 10

* Confidential Treatment Requested

 
 
 
 
 
 
 
 
 
 
 
 
 
8.                  OTHER PRODUCTS.

8.1              

New Products.  In  the  event  that  ENERGOUS  develops  New  Product,  ENERGOUS  will  provide  DIALOG  with
written  notice  describing  the  New  Product  before  marketing,  selling  or  distributing  the  New  Product  with  or  to  any  third  party.  Upon
receipt of such notice, DIALOG will have [***] to notify ENERGOUS in writing that it desires to add such New Product as Product under
this Agreement. If DIALOG provides such a notice, for a period of [***] following ENERGOUS’ receipt of such notice, ENERGOUS and
DIALOG  will  negotiate  in  good  faith  the  terms  pursuant  to  which  such  New  Product  will  be  added  as  a  Product  to  this Agreement.
ENERGOUS may not negotiate with any third party the rights to market, sell or distribute any New Product until the earliest to occur of the
following (a) DIALOG does not provide ENERGOUS with notice that it desires to add such New Product to this Agreement within the
above-described [***] period, (b) ENERGOUS and DIALOG do not reach mutually agreeable terms for adding such New Product to this
Agreement during the [***] negotiation period or (c) DIALOG provides ENERGOUS with written notice that it does not wish to negotiate
with respect to such New Product. For clarity, after any of the events described in the foregoing subsections (a), (b) or (c) occurs, the New
Product  will  not  be  covered  under  this Agreement,  and  ENERGOUS  will  be  free  to  manufacture,  market,  sell,  distribute  and  otherwise
exploit such New Product as it deems fit in its sole discretion, including in collaboration with or through one or more third parties.

8.2              No Competing Products.

(a)                 Until expiration or earlier termination of the Agreement, DIALOG agrees that it and its Affiliates will not,
without  ENERGOUS’  written  approval,  intentionally  sell,  distribute  or  work  with  any  third  party  to  develop  products  incorporating  any
Uncoupled  Power  Transfer  Technology  other  than  Licensed  Products;  provided,  however,  that  DIALOG  shall  not  be  under  any  such
restrictions in relation to services or products it provides to the Key Customer in the event the Key Customer terminates its agreement with
ENERGOUS. 

(b)                              In  the  event  that  ENERGOUS  does  not  receive  Federal  Communications  Commission  approval  of  any
Licensed Product for power transmission [***] by the [***], (i) ENERGOUS may provide written notice to DIALOG which references this
Section 8.2(b) and indicates ENERGOUS’ intention to enable one or more Semiconductor Suppliers to supply Products for [***]; and (ii)
DIALOG  may  provide  written  notice  to  ENERGOUS  which  references  this  Section  8.2(b)  and  indicates  DIALOG’s  intention  to  sell,
distribute or work with one or more third parties to develop products incorporating Uncoupled Power Transfer Technology for [***]. [***]
following the date such notice is given pursuant to  Section  20.1,  the  restrictions  in  Section  8.2(a)  shall  no  longer  apply  to  DIALOG  for
Uncoupled Power Transfer Technology in [***] and the restrictions relating to enabling a Semiconductor Supplier in Section 2.5(a) shall
no longer apply to ENERGOUS for Products or Product Die in [***].

(c)                

In  the  event  that  ENERGOUS  does  not  receive  Federal  Communications  Commission  approval  of  any
Licensed Product for power transmission in [***] by the [***], (i) ENERGOUS may provide written notice to DIALOG which references
this Section 8.2(c) and indicates ENERGOUS’ intention to enable one or more Semiconductor Suppliers to supply Products for [***]; and
(ii) DIALOG may provide written notice to ENERGOUS which references this Section 8.2(c) and indicates DIALOG’s intention to sell,
distribute or work with one or more third parties to develop products incorporating Uncoupled Power Transfer Technology for [***]. [***]
following the date such notice is given pursuant to  Section  20.1,  the  restrictions  in  Section  8.2(a)  shall  no  longer  apply  to  DIALOG  for
Uncoupled Power Transfer Technology in [***] and the restrictions relating to enabling a Semiconductor Supplier in Section 2.5(a) shall
no longer apply to ENERGOUS for Products or Product Die in [***].

Page 11

* Confidential Treatment Requested

 
 
 
 
 
 
 
 
 
 
9.                  ROYALTIES AND SERVICE FEES.

9.1              

Royalties.  DIALOG  will  pay  ENERGOUS  the  Royalties  set  forth  in Exhibit B.  For  clarity,  DIALOG  will  be

responsible for paying to ENERGOUS any Royalties payable hereunder as a result of its Affiliates’ Licensed Product Sales.

9.2              

Service  Fee.  Subject  to  Section  4.3,  DIALOG  will  pay  ENERGOUS  the  Service  Fees  set  forth  in Exhibit B.  For
clarity, subject to Section 4.3, DIALOG will be responsible for paying to ENERGOUS any Service Fees payable hereunder for services
provided by ENERGOUS hereunder to DIALOG’s Affiliates or any of DIALOG’s or its Affiliates’ customers.

9.3              Payment. Payments of Royalties and Service Fees will be due on a calendar quarterly basis, within [***] days after the
end of the calendar quarter in which the applicable Licensed Products were Sold or services were rendered. From the date a payment is due,
unless otherwise agreed, any late payment will accrue a late payment fee of [***] per month, or the highest interest rate permitted by law,
whichever is less.

9.4               Reports. Each payment made hereunder will be accompanied by a report detailing (a) the total number of units, on a
product-by-product basis, of the Licensed Products Sold during the previous calendar quarter, (b) DIALOG’s and its Affiliates’ Net Sales
attributable to such Licensed Product units during such calendar quarter, and (c) reasonable details regarding the calculation of the quarterly
Royalty  payment  and  Service  Fee.  Such  information  will  be  maintained  in  strict  confidence  by  ENERGOUS  under  Section  10  of  this
Agreement.

9.5              

Books.  With  respect  to  its  exercise  of  the  rights  and  licenses  granted  in,  and  payment  obligations  under,  this
Agreement, DIALOG and its Affiliates will keep accurate books and other records, including but not limited to supporting documentation
for the Royalties and Service Fees paid hereunder (the “Records”). These Records will be maintained for a period of at least three (3) years
from the date of the related payment (“Record Retention Period”), notwithstanding any termination of expiration of this Agreement.

9.6              

Audit Rights.  During  the  Record  Retention  Period,  ENERGOUS  may  appoint  a  mutually  agreed  independent,
internationally  recognized  third-party  certified  auditor  who  will  have  the  right  to  inspect  and  copy  the  Records  upon  reasonable  prior
notice,  and  DIALOG  will  (and  will  cause  its Affiliates  to)  allow  necessary  access  including,  as  applicable,  to  its  premises  where  such
Records are located. ENERGOUS may exercise such right to this independent-third party audit no more than one time per calendar year
and each such audit will be conducted during normal business hours. Such audit may also not interfere with DIALOG’s or its Affliates’
quarterly  closing  of  its  books.  In  the  event  that  such  audit  reveals  an  underpayment  of  Royalties  or  Service  Fees  owed  by  DIALOG,
DIALOG will promptly pay ENERGOUS the amount of the underpayment. If such underpayment is in excess of [***] of the Royalties or
Service Fee due for the period audited, DIALOG will also reimburse ENERGOUS for its reasonable, out-of-pocket cost of such audit. In
the  event  that  such  audit  reveals  an  overpayment  of  Royalties  or  Service  Fees  owed  by  DIALOG,  ENERGOUS  will  promptly  pay
DIALOG the amount of the overpayment.

Page 12

* Confidential Treatment Requested

 
 
 
 
 
 
 
 
 
 
 
9.7              Taxes. Each party will be responsible to collect, bear and pay any and all taxes levied or based upon the party’s sale of
the Products, Product Die or Licensed Products, including, all sales, use, value added, withholding or similar taxes. In the event that the
government of a country imposes any income taxes on payments made by a party to the other hereunder and requires a party to withhold
such  tax  from  such  payments,  such  party  may  deduct  such  tax  from  such  payments.  Each  party  will  be  responsible  for  its  own  banking
costs  relating  to  the  receipt  of  payments  of  Royalties  and  Service  Fees  and  any  other  monies  payable  to  it  in  connection  with  this
Agreement.

9.8               Payment Currency. All payments due under this Agreement will be payable in U.S. Dollars. With respect to Net Sales
invoiced  in  a  currency  other  than  U.S.  Dollars,  the  Net  Sales  will  be  expressed  in  the  domestic  currency  of  the  entity  making  the  Sale,
together with the U.S. Dollar equivalent, calculated using the conversion rate existing in the United States (as reported in the Wall Street
Journal) on the last working day of each month of the calendar quarter in which the Net Sales were made. Such payments will be without
deduction of exchange, collection or other charges.

10.              CONFIDENTIALITY.

10.1           Scope. The term “Confidential Information” means all financial, business and technical information disclosed by or
on  behalf  of  a  party  in  relation  to  this  Agreement  (whether  tangible  or  intangible,  and  including  all  copies,  analyses  and  derivatives
thereof),  that  is  marked  or  otherwise  identified  as  proprietary  or  confidential  at  the  time  of  disclosure,  or  which  by  its  nature  would  be
understood  by  a  reasonable  person  to  be  proprietary  or  confidential,  including  all  copies,  abstracts,  summaries,  analyses  and  derivatives
thereof.  Confidential  Information  does  not  include  information  the  receiving  party  can  demonstrate  (a)  was  rightfully  furnished  to  it
without restriction by a third party without breach of any obligation to the disclosing party, (b) is generally available to the public without
breach  of  this Agreement,  (c)  was  available  to  or  already  in  the  possession  or  control  of  the  receiving  party  on  a  non-confidential  basis
before  receipt  from  the  disclosing  party  or  (d)  is  independently  developed  by  it  or  its  employees  without  reliance  on  such  information.
Information associated with DIALOG’s quarterly Royalty or Service Fee disclosures is Confidential Information of DIALOG.

10.2          Non-Disclosure. The receiving party agrees (a) not to copy or use the disclosing party’s Confidential Information except
and only for the purposes contemplated by this Agreement, (b) to maintain it as confidential, and exercise reasonable precautions to prevent
unauthorized access, use and disclosure, (c) not to disclose it to any third party other than the receiving party’s employees and contractors
who have a need to know for the permitted purpose and who are bound by obligations that are at least as protective as the restrictions in
this Agreement  and  (d)  not  to  export  or  re-export  in  violation  of  U.S.  or  other  export  control  laws  or  regulations  any  such  Confidential
Information or product thereof. Each party will bear the responsibility for any breach of this Section 10 by its and its Affiliates’ employees
and contractors. Upon any termination of this Agreement or, in the event of any Wind Down Period or Continuing Obligation period, upon
the  expiration  of  such  period,  and  within  fifteen  (15)  days  after  request  by  the  disclosing  party,  each  receiving  party  will  return  the
Confidential  Information  of  the  other  or  destroy  such  Confidential  Information  and  all  copies  of  it  and  all  information,  records  and
materials developed therefrom, except that the recipient may retain one copy for archival purposes to ensure compliance with the provisions
of this Agreement, and nothing contained herein will require the erasure, deletion, alteration or destruction of any Confidential Information
required to be retained for legal or regulatory purposes or stored on back-up tapes or other back-up media or archiving systems made in the
ordinary course of business, subject in each case to the confidentiality obligations set forth herein. Each party may only disclose the general
nature,  but  not  the  specific  terms,  of  this Agreement  without  the  prior  consent  of  the  other  party;  provided,  however,  either  party  may
provide  a  copy  of  this  Agreement  or  otherwise  disclose  its  terms  on  a  confidential  basis  in  connection  with  any  legal  or  regulatory
requirement, financing transaction or due diligence inquiry. For clarity, in the event that use, disclosure or retention of any Confidential
Information is required in order for DIALOG to exercise the license granted in Section 2, this Section 10 will not be deemed to prevent such
use, disclosure or retention.

Page 13

 
 
 
 
 
 
 
 
 
10.3          

Required  Disclosure.  Nothing  herein  will  prevent  a  receiving  party  from  disclosing  all  or  part  of  the  other’s
Confidential  Information  as  necessary  pursuant  to  court  order,  the  lawful  requirement  of  a  governmental  agency  or  when  disclosure  is
required by operation of law (including disclosures pursuant to applicable securities laws or regulations thereunder); provided, that prior to
any  such  disclosure,  the  receiving  party  will  use  reasonable  efforts  to  (a)  promptly  notify  the  disclosing  party  in  writing  of  such
requirement  to  disclose,  and  (b)  cooperate  fully  with  the  disclosing  party  in  protecting  against  or  minimizing  any  such  disclosure  or
obtaining a protective order.

11.              REPRESENTATIONS AND WARRANTIES; DISCLAIMERS.

11.1          Mutual Representations and Warranties. ENERGOUS and DIALOG hereby each represent and warrant to the other that

as of the Effective Date:

it is a duly and validly organized and existing corporation in good standing under the laws of the state or
country of its incorporation, as applicable, and that it is legally qualified to do business in each jurisdiction in which this Agreement may be
performed and the performance of its activities hereunder requires such qualification;

(a)                

(b)                

the performance of this Agreement and the consummation of the transactions contemplated herein will not
result in any breach or violation of any terms or provisions of, or constitute a default under, its certificate of incorporation or by-laws or
other organizational documents, or any material agreement or instrument to which it is a party, by which it is bound, or to which any of its
property is subject;

(c)                all requisite corporate action has been taken for the due authorization, execution, delivery and performance of
this Agreement  by  it,  and  this Agreement  constitutes  a  legally  binding  obligation,  enforceable  against  such  party  in  accordance  with  its
terms,  except  insofar  as  enforceability  may  be  limited  by  bankruptcy,  insolvency,  reorganization  or  similar  laws  affecting  the  rights  of
creditors generally; and

Page 14

 
 
 
 
 
 
 
 
 
 
(d)               it is not a party to any litigation relating to, or that could reasonably be expected to affect, its ability to

perform its obligations under this Agreement.

11.2          Product Warranty.

(a)                

ENERGOUS  warrants  that  (i)  when  manufactured  in  accordance  with  the  Approved  Production
Specifications, and as implemented in a suitable circuit application in accordance with the Product Specifications, the Products and Product
Die will conform to the Product Specifications and will be free from defects that could have been avoided in their design; (ii) the Products,
any constituent parts or functionality thereof, the Documentation and the Deposit Materials do not infringe any third party’s Intellectual
Property Rights; (iii) it did not misappropriate any third party’s trade secrets in the development of the Products, any constituent parts or
functionality  thereof,  the  Documentation  or  the  Deposit  Materials;  and  (iv)  when  delivered  (including  any  software  updates  if  any),  no
Product will contain any viruses, “Trojan horses” or other harmful code. The above warranties are valid for a period of [***] from the date
of shipment of any Licensed Product to any customer.

(b)                 The warranty contained in Section 11.2(a) does not apply to the extent any Product is operated in a manner
other than that specified by the Product Specifications, is treated with abuse, negligence or other improper treatment (including, without
limitation, use outside the device maximum ratings, package MSL (moisture sensitivity level) guidelines or environmental limits as may be
set forth in the Product Specifications), or is defective as a result of any materials or workmanship of the Manufacturing Subcontractors or
failure  of  the  Manufacturing  Subcontractors  to  manufacture  the  Product  according  to Approved  Production  Specifications. As  such,  any
warranty  claims  due  to  defects  in  build,  materials  or  workmanship  will  be  directed  to  the  Manufacturing  Subcontractors  as  part  of  that
contract between DIALOG or, if applicable, its Affiliate and such parties.

(c)                 With the exception of the warranties in Section 11.2(a)(ii) (third party IP infringement) and Section 11.2(a)
(iii) (misappropriation of third party trade secrets) related to any Product Die, the warranties in this Section 11.2 do not apply to MCMs or
repackaged Product Die developed by or for DIALOG or its Affiliates.

(d)               In the event any warranty claim is due to or arises from an Epidemic Defect, ENERGOUS will be responsible
for all costs and expenses directly incurred by DIALOG or its Affiliates or their respective customers as a result of reasonable inspection,
servicing, repairs, replacements, recall notices, recalls and responses with respect thereto, provided that ENERGOUS’ aggregate liability to
DIALOG and its Affiliates and their respective customers under this paragraph (d) will not exceed [***] per occurrence of an Epidemic
Defect. Each party will immediately notify the other upon becoming aware of the circumstance that could reasonably be construed to be an
indication of an Epidemic Defect, and, in any event, will notify the other party immediately upon becoming aware of the existence of an
Epidemic  Defect.  ENERGOUS  and  DIALOG  will  expeditiously  work  together  in  good  faith  to  determine  a  technical  resolution  of  the
Epidemic  Failure.  ENERGOUS  agrees  to  make  all  commercially  reasonable  efforts  to  promptly  diagnose  the  Epidemic  Failure’s  root
cause,  provide  DIALOG  a  report  detailing  the  results  of  ENERGOUS’  investigation  and  plan  an  effective  workaround  and  a  permanent
solution. ENERGOUS will consult with DIALOG on any proposed workarounds and other solutions. 

Page 15

* Confidential Treatment Requested

 
 
 
 
 
 
 
 
 
 
11.3           Infringement of Intellectual Property Rights. If any of the Products, Product Die, Documentation or Deposit Materials
is, or in ENERGOUS’ or DIALOG’s opinion is likely to become, the subject of an Intellectual Property Rights infringement claim, and as a
result DIALOG or any of its Affiliates or their respective customers are enjoined, or in ENERGOUS’ or DIALOG’s opinion are likely to be
enjoined, from using the Products, Product Die, Documentation or Deposit Materials, ENERGOUS will use its best efforts to:

procure  for  DIALOG  and  its Affiliates  and  their  respective  customers  the  right  to  continue  to  use  the
Products, Product Die, Documentation or Deposit Materials, as applicable; or, but only in the event that, despite ENERGOUS’ best efforts
to do so, ENERGOUS is unable to so procure such right,

(a)                

replace or modify the Products, Product Die, Documentation or Deposit Materials, as applicable, to make
them  non-infringing,  provided  that  the  replaced  or  modified  Products,  Product  Die,  Documentation  and  Deposit  Materials  remain
substantially similar in performance to the infringing Products, Product Die, Documentation and Deposit Materials.

(b)                

If none of the foregoing alternatives is available within a commercially reasonable time period, DIALOG may terminate this Agreement
with immediate effect, provided that it will give ENERGOUS prompt prior written notice thereof. Nothing in this Section 11.3 is intended
to limit DIALOG’s rights to indemnification under Section 12 in connection with any such infringement claim.

11.4           Disclaimer. EXCEPT AS EXPRESSLY SET FORTH IN THIS SECTION 11, THE PRODUCTS, THE PRODUCT IP,
TOOLING,  DOCUMENTATION,  DEPOSIT  MATERIALS,  CONFIDENTIAL  INFORMATION  AND  ALL  LICENSES,  SERVICES
AND  OTHER  ITEMS  PROVIDED  BY A  PARTY  TO  THE  OTHER  PARTY  HEREUNDER ARE  PROVIDED  “AS  IS”,  WITHOUT
WARRANTY  OF  ANY  KIND.  EXCEPT  FOR  THOSE  WARRANTIES  EXPRESSLY  PROVIDED  HEREIN,  EACH  PARTY
SPECIFICALLY  DISCLAIMS  ALL  WARRANTIES,  WHETHER  ORAL  OR  WRITTEN,  EXPRESS,  IMPLIED,  STATUTORY  OR
OTHERWISE,  WITH  RESPECT  TO ANY  SUBJECT  MATTER  OF  THIS AGREEMENT,  INCLUDING,  WITHOUT  LIMITATION,
ALL  WARRANTIES  OF  MERCHANTABILITY  AND  FITNESS  FOR  A  PARTICULAR  PURPOSE  AND  ALL  WARRANTIES
ARISING FROM COURSE OF PERFORMANCE, COURSE OF DEALING OR USAGE IN TRADE.

12.              INDEMNIFICATION.

12.1          Indemnification by Energous. Subject to Section 12.2, ENERGOUS agrees to indemnify, hold harmless and, in the case
of any third party claims, defend DIALOG and its Affiliates and each of their respective directors, officers, employees, contractors, agents,
distributors  and  customers  (collectively,  “ DIALOG  Indemnitees”)  from  and  against  and  in  respect  of  any  and  all  alleged  or  actual
demands, claims, actions, causes of action, suits or proceedings, assessments, awarded damages (including punitive damages), liabilities,
interest  and  penalties,  costs  and  expenses  (including,  without  limitation,  court  costs  and  reasonable  legal  fees  and  disbursements  in
connection  therewith)  (each,  a  “Claim”)  to  the  extent  resulting  from,  arising  out  of,  relating  to,  or  imposed  upon  or  incurred  by  any
DIALOG  Indemnitees  by  reason  of  (a)  death  or  bodily  injury  caused  by  or  resulting  from  use  of  the  Products,  (b)  any  breach  of  any
representation  or  warranty  made  by  ENERGOUS  hereunder  or  to  any  third  party  in  relation  to  the  Products  or  Product  Die,  (c)  the
infringement  or  misappropriation  of  any  third  party  Intellectual  Property  Rights  in  relation  to  the  Products  or  Product  Die,  (d)  the
infringement or misappropriation of any third party Intellectual Property Rights as a result of DIALOG’s or its Affiliates’ exercise of rights
in  accordance  with  the  terms  of  this Agreement,  including,  but  not  limited  to,  the  Manufacturing  Subcontractors’  manufacture  of  the
Products on their behalf, provided that the Products are manufactured in strict compliance with the Product Specifications and Approved
Production Specifications and only to the extent such Claims arise due to compliance with the Product Specifications and/or the Approved
Production Specifications or use of the Tooling provided by ENERGOUS hereunder, (e) the infringement by DIALOG of any third party
Marks rights as a result of its authorized use of the ENERGOUS Marks, (f) any failure by ENERGOUS to comply with applicable laws,
regulations and standards, or (g) ENERGOUS’ negligence, intentional misconduct or fraud.

Page 16

 
 
 
 
 
 
 
 
 
 
 
12.2           Exclusion. Notwithstanding the provisions of Section 12.1, ENERGOUS will not be liable to the extent any Claim
results  from  (a)  modification  of  the  Products  by  DIALOG,  its  Affiliates  and/or  any  third  party  (including  the  Manufacturing
Subcontractors), or combination of the Products with other products, offered by DIALOG, its Affiliates and/or any third party, (b) acts or
omissions of any Manufacturing Subcontractor (except to the extent such Claims are due to the infringement or misappropriation of third
party Intellectual Property Rights arising from such Manufacturing Subcontractor’s manufacturing of the Products on behalf of DIALOG in
strict compliance with the Product Specifications, Approved Production Specifications and Tooling provided by ENERGOUS), (c) failure
of any DIALOG Indemnitee to comply with applicable laws, regulations and standards, or (d) negligence, intentional misconduct or fraud of
any DIALOG Indemnitee. For clarification, if any of the foregoing is not the cause, in whole or in part of the Claim, ENERGOUS is not
relieved of its obligations under Section 12.1.

12.3           Conditions. DIALOG must notify ENERGOUS within thirty (30) business days after receipt of actual notice of any
Claim by a third party for which it seeks indemnification; provided, however, any failure or delay in notice will not relieve ENERGOUS of
its  obligations  hereunder  except  to  the  extent  that  ENERGOUS  is  actually  prejudiced  by  such  failure  to  notify.  ENERGOUS  will  have
control and authority with respect to the defense, litigation, compromise or settlement of such third party Claim (except to the extent that
any  settlement  involves  any  commitments,  responsibilities  or  obligations  on  the  part  of  DIALOG,  in  which  case  such  settlement  will
require the prior written consent of DIALOG, which consent will not be unreasonably delayed, conditioned or withheld). DIALOG will
cooperate  and  provide  assistance  and  information  as  may  reasonably  be  required  by  ENERGOUS  (but  at  ENERGOUS’  expense)  in
connection  therewith.  DIALOG  reserves  the  right  to  participate  at  its  own  cost  in  any  third  party  proceedings  with  counsel  of  its  own
choosing. In the event that ENERGOUS does not respond to any third party Claim or does not sufficiently defend such third party Claim,
DIALOG, acting reasonably, may step in and take over the defense of such Claim. Costs incurred in the settlement of any Claim, including,
but not limited to, reasonable legal expenses, may be off set against future Royalties and Service Fees payable.

Page 17

 
 
 
 
 
 
12.4          

Insurance. Each party will maintain, during the Term and for three (3) years thereafter, such comprehensive general
liability  insurance  (including  without  limitation,  products  liability)  as  will  adequately  protect  it  against  its  potential  liabilities  under  this
Agreement,  in  amounts  customary  in  the  semiconductor  industry  for  similar  services  and  products.  Each  party  will,  at  the  other  party’s
request, provide to the other party a certificate of insurance evidencing the foregoing insurance coverage.

13.              LIMITATION OF LIABILITY.

13.1           EXCEPT  IN  THE  CASE  OF  (a) ANY  BREACH  OF  SECTION  10  (CONFIDENTIALITY),  (b)  THE  PARTIES’
OBLIGATIONS  UNDER  SECTION  12  (INDEMNIFICATION),  (c)  A  PARTY’S  GROSS  NEGLIGENCE  OR  WILLFUL
MISCONDUCT, OR (d) LIABILITY ARISING FROM EPIDEMIC DEFECTS (WHICH WILL BE SUBJECT TO THE LIMITATION
SET  FORTH  IN  SECTION  11.2(d)),  IN  NO  EVENT  WILL  EITHER  PARTY  BE  LIABLE  UNDER  THIS  AGREEMENT,
REGARDLESS OF THE FORM OF ANY CLAIM OR ACTION (WHETHER IN CONTRACT, NEGLIGENCE, STRICT LIABILITY
OR  OTHERWISE),  FOR  ANY 
INCIDENTAL,  RELIANCE,  SPECIAL,  EXEMPLARY  OR
CONSEQUENTIAL  DAMAGES,  INCLUDING,  BUT  NOT  LIMITED  TO,  LOSS  OF  BUSINESS,  REVENUES,  PROFITS  OR
GOODWILL, OR (ii) AGGREGATE DAMAGES IN EXCESS OF [***]. IN ADDITION, ENERGOUS’ LIABILITY WITH RESPECT
TO  ITS  OBLIGATIONS  UNDER  SECTION  12.1(b)  SHALL  IN  NO  EVENT  EXCEED  [***].  THESE  LIMITATIONS  ARE
INDEPENDENT  FROM  ALL  OTHER  PROVISIONS  OF  THIS  AGREEMENT  AND  WILL  APPLY  NOTWITHSTANDING  THE
FAILURE OF ANY REMEDY PROVIDED HEREIN.

INDIRECT,  PUNITIVE, 

(i) 

14.              COMPLIANCE WITH LAWS.

Each party will comply with all law and regulations applicable such party’s performance under this Agreement, including but not
limited to U.S. Export Administration laws and regulations and any other export, import and re-export control laws applicable to such party.
The parties will refrain from exporting or re-exporting the Products or Product IP or any technical data or other materials received from
each other, or the direct product of any of these, to any country, individual or organization proscribed by the United States government,
unless properly authorized by the appropriate agencies of the United States government. Each party will provide all information under its
control which is necessary or useful for the other party to ship or receive the Products, including, but not limited to, U.S. Export Control
Classification  Numbers  (ECCNs),  U.S.  Customs  Certificates  of  Delivery,  Certificates  of  Origin  and  U.S.  Federal  Communications
Commission identifier, if applicable. Each party agrees that it will not act in any fashion or take any action in violation of any applicable
anti-bribery or anti-corruption legislation in any jurisdiction in which it does business, which prohibits the offering, giving or promising to
offer or give, directly or indirectly, money or anything of value to any official of a government, political party or instrumentality to assist it
in obtaining or retaining business, including the U.S. Foreign Corrupt Practices Act or any comparable legislation in another country.

Page 18

* Confidential Treatment Requested 

 
 
 
 
 
 
 
 
 
15.              TERM AND TERMINATION.

15.1           Term. This Agreement is effective on the Effective Date. Unless earlier terminated as provided herein, this Agreement
continues in effect for an initial term of seven (7) years (“Initial Term”) and will automatically renew for one or more annual periods after
the Initial Term (each a “ Renewal Term”) unless either party gives notice of non-renewal at least one hundred eighty (180) days prior to
the beginning of any Renewal Term.

15.2          Termination.

(a)                 Mutual Termination Rights. Either party may, in addition to any other remedies available to it under this
Agreement  or  at  law  or  in  equity,  terminate  this Agreement  (or,  in  the  event  this Agreement  has  been  previously  terminated,  the  Wind
Down  Period,  if  any)  immediately  upon  the  issuance  of  written  notice  to  the  other  party  in  the  event  that  (i)  the  other  party  materially
breaches a material provision of this Agreement, and fails to cure such breach within thirty (30) days, or (ii) the other party undergoes an
Insolvency Event.

(b)                Termination By ENERGOUS.

of [***] following closing of such acquisition, to terminate this Agreement upon written notice to DIALOG.

(i)                  If ENERGOUS is acquired by a third party, ENERGOUS’ acquirer will have the right, for a period

(ii)               ENERGOUS will have the right to terminate this Agreement immediately upon the issuance of
written  notice  to  DIALOG  (A)  if  DIALOG  undergoes  a  Change  of  Control  involving  a  competitor  of  ENERGOUS  (as  reasonably
determined by ENERGOUS), or (B) if DIALOG or any of its Affiliates acquires, whether directly or indirectly through a sale of assets or a
Change of Control transaction or otherwise, any competitor of ENERGOUS. DIALOG will provide ENERGOUS with notice of any such
Change  of  Control  or  acquisition  within  [***]  after  the  closing  thereof  and  ENERGOUS’  right  to  terminate  the Agreement  will  expire
[***] after receipt of such notice.

Agreement with or without cause upon not less than one hundred and eighty (180) days prior written notice to DIALOG.

(iii)             

ENERGOUS  may,  at  any  time  after  the  third  anniversary  of  the  Effective  Date,  terminate  this

(iv)              ENERGOUS will have the right to terminate this Agreement, upon not less than [***] prior written
notice to DIALOG, in the event that, following termination by the [***] of its agreement with ENERGOUS, DIALOG participates in or
indicates  its  intention  to  participate  in  the  development,  design  or  manufacture  of  products  incorporating  Uncoupled  Power  Transfer
Technology not provided by ENERGOUS to [***].

(c)                Termination by DIALOG.

[***] following closing of such acquisition, to terminate this Agreement upon written notice to ENERGOUS. 

(i)                 

If DIALOG is acquired by a third party, DIALOG’s acquirer will have the right, for a period of

Page 19

* Confidential Treatment Requested

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(ii)                              DIALOG  may  terminate  this  Agreement,  immediately  upon  issuance  of  written  notice  to
ENERGOUS in the event that: (A) DIALOG or its Affiliates fail to achieve a design-win pipeline with an annual projected sales value to
DIALOG of at least [***] in the [***] after the availability of a Mass Production Qualified Product; or (B) the aggregate annual Net Sales
of Products are below [***] by the [***] of the availability of a Mass Production Qualified Product, or below [***] by the [***] of the
availability  of  a  Mass  Production  Qualified  Product,  or  below  [***]  by  each  [***]  of  the  availability  of  a  Mass  Production  Qualified
Product during the remainder of the Term.

(iii)              DIALOG will have the right to terminate this Agreement immediately upon the issuance of written
notice  to  ENERGOUS  (A)  if  ENERGOUS  undergoes  a  Change  of  Control  involving  a  competitor  of  DIALOG,  or  (B)  if  ENERGOUS
acquires, whether directly through a sale of assets or through a Change of Control transaction, any competitor of DIALOG (as reasonably
determined by DIALOG). ENERGOUS will provide DIALOG with notice of any such Change of Control or acquisition within [***] after
the closing thereof and DIALOG’s right to terminate the Agreement will expire [***] after receipt of such notice.

15.3          

Effect  of  Termination.  Upon  any  termination  or  expiration  of  this Agreement,  all  rights,  licenses  (including  any
sublicenses  granted  by  DIALOG)  and  obligations  hereunder  will  cease,  except  that  the  provisions  of  Sections  6  (Intellectual  Property
Ownership), 9 (Royalties and Service Fees), 10 (Confidentiality), 11 (Representations and Warranties; Disclaimers), 12 (Indemnification),
13  (Limitation  of  Liability),  15.3  (Effect  of  Termination),  15.4  (Wind  Down  Period),  16  (Escrow),  18  (Non-Solicitation),  19  (Choice  of
Law and Dispute Resolution) and any provisions to give effect thereto, will survive such termination or expiration and remain in full force
and effect in accordance with their terms.

15.4          Wind Down Period.

(a)                 Notwithstanding any statement in Section 15.3 to the contrary, upon any termination or expiration of this
Agreement  and  until  the  later  to  occur  of  (i)  [***]  from  the  Effective  Date  or  (ii)  [***]  following  the  effective  date  of  termination  or
expiration  of  this Agreement  (the  “Wind  Down  Period”),  the  parties’  respective  rights  and  obligations  under  Sections  2  (License),  3
(Sourcing), 7 (Product Sales), 9 (Royalties and Service Fees), 11 (Representations and Warranties; Disclaimers), 12 (Indemnification), 13
(Limitation of Liability), 14 (Compliance with Laws), 15.2 (Termination), 16 (Escrow) and all Exhibits hereto which are associated with
any of the foregoing listed sections will remain in full force and effect as to (A) any Products or repackaged Product Die with respect to
which DIALOG or any of its Affiliates has secured a design win at a customer prior to or within one (1) month after the start of the Wind
Down  Period,  or  (B)  the  sale  of  any  MCMs  which  have  been  released  for  production  at  a  foundry,  provided,  however,  that  DIALOG’s
license rights under Section 2.1 (including any sublicenses granted by DIALOG pursuant to Section 2.4) will be non-exclusive during the
Wind Down Period.

(b)                 If, at the time of notice of any termination of this Agreement, DIALOG or any of its Affiliates has a written
supply contract with a customer that extends beyond the end of the Wind Down Period (a “Continuing Obligation”), DIALOG and/or its
Affiliates may continue to Sell Licensed Products to such customer through the term of the Wind Down Period and for the remainder of the
term  of  such  Continuing  Obligation,  provided  that  in  no  event  may  DIALOG  or  its Affiliates  Sell  Licensed  Products  to  such  customer
pursuant to this Section 15.4(b) for a period longer than [***] after the effective date of termination of this Agreement. In such event, the
provisions of this Agreement that survive during the Wind Down Period will continue to survive for the remainder of the period of time that
DIALOG is authorized to Sell Licensed Products to any customer in accordance with the foregoing sentence. The rights granted under this
Section 15.4(b) will be conditioned upon DIALOG providing ENERGOUS a complete or redacted copy of the applicable supply contract
demonstrating the existence of the Continuing Obligation as of the date of notice of termination or, if DIALOG or its Affiliate is prohibited
from providing a copy of the contract by the confidentiality obligations set forth therein, a written certification from an officer of DIALOG
attesting to the existence of the Continuing Obligation.

Page 20

* Confidential Treatment Requested

 
 
 
 
 
 
 
 
 
 
16.              ESCROW.

16.1           Escrow. ENERGOUS will at its expense, at DIALOG’s written request during the Term and any Wind Down Period,
enter  into  a  three-party  escrow  deposit  arrangement,  in  accordance  with  this  Section  16,  with  a  recognized  escrow  agent  (the  “Escrow
Agent”)  of  mutual  agreement.  ENERGOUS  will  keep  the  Deposit  Materials  in  escrow  and  ensure  on  a  quarterly  basis  that  all  the
information relating to the Deposit Materials in escrow is current, including deposit of any Product Updates.

16.2           Release of Deposit Materials. In the event of any Insolvency Event and where the design files need to be accessed by
DIALOG  to  fix  an  Epidemic  Defect  or  other  Product  design  or  production  issue  impacting  yield  or  quality  (“Release Condition”),  the
Escrow  Agent  will,  in  accordance  with  the  terms  of  the  escrow  agreement  between  the  parties  and  the  Escrow  Agent  (the  “ Escrow
Agreement”), release the Deposit Materials to DIALOG.

16.3           License.  ENERGOUS  hereby  grants  DIALOG  a  non-exclusive,  non-transferable  (except  as  set  forth  in  Section  2)
license under the Product IP to use any of the Deposit Materials released from escrow for the purpose of fixing an Epidemic Defect or other
Product design or production issue impacting yield or quality during the Term and, if applicable, any Wind Down Period or Continuing
Obligation period, including, but not limited to, authorizing any third party subcontractor to manufacture and supply Products, provided,
however,  that  DIALOG  continues  to  make  all  Royalty  payment  owed  to  ENERGOUS  (or  the  then-current  owner  of  the  Product  IP)  as
provided  in  this  Agreement.  No  Service  Fees  will  be  payable  under  this  license.  DIALOG  agrees  not  to  exercise  such  license  until
occurrence of a Release Condition, subject to the other restrictions set forth in this Section 16. Such license may be exercised by DIALOG
only during the Term and any Wind Down Period or Continuing Obligation period and is subject to DIALOG’s continued compliance with
all of the other applicable terms and conditions of this Agreement during any such applicable period. All Deposit Materials will be deemed
ENERGOUS’ Confidential Information hereunder. DIALOG’s license to possess and use the Deposit Materials does not include any right
to  disclose,  market,  sublicense  or  distribute  the  Deposit  Materials  to  any  third  party  other  than  its  Affiliates  and  Manufacturing
Subcontractors.

16.4          Rights in Bankruptcy. The licenses granted pursuant to this Agreement are license to rights in “intellectual property” (as
that  term  is  defined  in  Section  101  of  the  United  States  Bankruptcy  Code)  and  governed  by  11  USC  Section  365(n). Accordingly,  if  a
trustee in bankruptcy rejects the Escrow Agreement and/or this Agreement as executory contracts, then Company may elect to retain its
rights under this Agreement in accordance with and subject to the provisions of 11 USC Section 365(n).

Page 21

 
 
 
 
 
 
 
 
 
17.              PUBLICITY.

17.1           Publicity. Within 30 days of the Effective Date each party will issue a mutually agreed joint press release regarding the

strategic cooperation for the supply of Products and the strategic cooperation between the parties.

18.              NON-SOLICITATION.

18.1           Non-Solicitation. During the Term and for a [***], neither party will without the written consent of the other party
(which may be granted or denied in its sole discretion) (a) directly or indirectly recruit or solicit for employment or for the provision of
services any employee of the other party, (b) otherwise solicit, induce or influence any employee to leave their employment with the other
party, or (c) attempt to do any of the foregoing; provided, however, that the foregoing will not apply to (y) any employee of the other party
that responds to a public advertisement of employment opportunities or (z) any employee that was terminated without cause by the other
party. ENERGOUS and DIALOG acknowledge and agree that the covenants in this Section 18 are reasonable and necessary to protect each
of their trade secrets, Confidential Information and stable workforces.

19.              CHOICE OF LAW AND DISPUTE RESOLUTION.

19.1           Applicable Law.  This Agreement  will  be  governed  by  and  construed  in  accordance  with  the  laws  of  the  State  of

California, exclusive of conflict of laws principles.

19.2           Dispute Resolution; Jurisdiction. Any  dispute  or  claim  arising  out  of  or  relating  to  this Agreement  (including  any
matters regarding its existence, scope, validity, breach or termination, or any non-contractual obligations arising out of or related to it) that
is  not  able  to  be  resolved  through  negotiations  will  be  submitted  to  arbitration  in  San  Francisco,  California,  administered  by  the
International Chamber of Commerce under its Rules of Arbitration. There will be one arbitrator. The language of the arbitration will be
English. The award will be in writing, state the reasons for the award and be final and binding. Judgment on the award may be enforced in
any  court  of  competent  jurisdiction.  Except  as  may  be  required  by  law,  the  parties  will  preserve  the  confidentiality  of  all  aspects  of  the
arbitration. The arbitration will be the sole and exclusive forum for final resolution of any such dispute or claim, provided, however, that,
because each party will have access to and become acquainted with Confidential Information of the other party, the unauthorized use or
disclosure  of  which  may  cause  irreparable  harm  and  significant  injury  which  may  be  difficult  to  ascertain  and  which  may  not  be
compensable by damages alone, the parties agree that the damaged party will have the right to seek an injunction, specific performance or
other  equitable  relief  without  prejudice  to  any  other  rights  and  remedies  that  it  may  have  for  such  unauthorized  use  or  disclosure.  Each
party irrevocably waives all rights to a jury trial in any judicial proceeding permitted hereunder. For the avoidance of doubt, the validity,
construction,  and  enforceability  of  this Agreement  and  the  resolution  of  disputes  arising  out  of  and  relating  to  this Agreement,  will  be
governed solely by this Section 19.

Page 22

* Confidential Treatment Requested

 
 
 
 
 
 
 
 
 
 
 
20.              MISCELLANEOUS PROVISIONS.

20.1           Notices. All notices required or permitted under this Agreement will be in writing, reference this Agreement and be
deemed given: (a) when delivered personally; or (b) when sent by electronic mail with electronic confirmation of receipt, provided that such
notice is immediately confirmed as provided in (c) or (d) below; or (c) seven (7) days after having been sent by registered or certified mail,;
or (d) two (2) days after deposit with a commercial courier service, with written verification of receipt. All communications will be sent to
the addresses set forth below. Either party may change its address by giving notice pursuant to, and specifically referring to, this Section 20.

If to ENERGOUS:

Energous Corporation
3590 North First Street
Suite 210
San Jose, California 95134
U.S.A.
Attn: Brian Sereda, CFO 

If to DIALOG:

Dialog Semiconductor (UK) Ltd
100 Longwater Avenue
Green Park
Reading, RG2 6GP
United Kingdom
Attn: Legal Department

20.2           Relationship of Parties. ENERGOUS and DIALOG are independent business entities. Neither party nor its employees,
consultants, contractors or agents are agents, employees, partners or joint venturers of the other party, nor do they have any authority to
bind the other party by contract or otherwise to any obligation. The parties will not represent to the contrary, either expressly, implicitly, by
appearance or otherwise.

20.3           Force Majeure. Except for obligations to pay amounts due under this Agreement, neither party will be liable for any
failure or delay in its performance under this Agreement due to causes which are beyond its reasonable control, including, but not limited to,
acts of God, acts of civil or military authority, fires, epidemics, floods, earthquakes, riots, wars, sabotage, labor shortages or disputes, and
governmental actions; provided, however, that the affected party: (a) gives the other party written notice of such cause promptly, and in any
event within fifteen (15) days of discovery thereof; and (b) uses its reasonable efforts to correct such failure or delay in its performance as
soon  as  possible.  The  affected  party’s  time  for  performance  or  cure  under  this  Section  20.3  will  be  extended  for  a  period  equal  to  the
duration of the cause.

20.4           Severability. If any provision of this Agreement is held to be invalid or unenforceable in any jurisdiction in which this
Agreement  is  being  performed,  then:  (a)  such  provision  will  be  deleted  from  this Agreement  in  that  jurisdiction  to  the  extent  of  such
invalidity  or  unenforceability  without  invalidating  the  remaining  provisions  of  this  Agreement,  and  any  such  unenforceability  in  that
jurisdiction will not make that provision unenforceable in any other jurisdiction; and (b) the parties will agree on an alternative provision
that best accomplishes the objectives of such provision, to the extent legally permissible in such jurisdiction.

Page 23

 
 
 
 
 
 
 
 
 
 
 
 
20.5           No Waiver. No waiver or consent in connection with or relating to this Agreement will bind either party unless in
writing and signed by the party against which enforcement is sought. Waiver by either party of any default will not be deemed a waiver by
such party of the same or any other default that may thereafter occur.

20.6          Counterparts. This Agreement may be executed in one or more counterparts, each of which will be an original, but taken
together constituting one and the same instrument. Execution of a facsimile copy (including PDF) will have the same force and effect as
execution of an original, and a facsimile/electronic signature will be deemed an original and valid signature.

20.7           Headings and References. The headings and captions used in this Agreement are used for convenience only and are not

to be considered in construing or interpreting this Agreement.

20.8           Construction. The parties and their respective counsel have negotiated this Agreement. This Agreement will be fairly

interpreted in accordance with its terms and without any strict construction in favor of or against either party.

20.9           Complete Agreement. This Agreement constitutes the entire agreement between the parties with respect to the subject
matter  hereof  and  supersedes  and  replaces  all  prior  or  contemporaneous  understandings  or  agreements,  written  or  oral,  regarding  such
subject  matter.  No  amendment  to  or  modification  of  this Agreement  will  be  binding  unless  in  writing  and  signed  by  a  duly  authorized
representative of both parties.

20.10       Assignment. This Agreement may not be assigned by either party without the express written consent of the other party,
which approval will not be unreasonably withheld or delayed, except that either party may (without consent but with notice to the other
party) assign this Agreement in its entirety to any successor in the event of a Change of Control of such party.

20.11 Notice of Merger or Acquisition. Until the date that this Agreement terminates or is terminated in accordance with Section

15 hereof, ENERGOUS agrees that, [***].

Page 24

* Confidential Treatment Requested 

 
 
 
 
 
 
 
 
 
 
 
IN  WITNESS  WHEREOF,  the  parties  have  caused  this  Agreement  to  be  executed  by  their  duly  authorized  representatives  as  of  the
Effective Date.

ENERGOUS CORPORATION

By:

 /s/ Stephen R. Rizzore

Name:  Stephen R. Rizzore

DIALOG SEMICONDUCTOR (UK) LTD

By:

 /s Mark Tyndall

Name:   Mark Tyndall

Title:

  President and Chief Executive Officer

Title: SVP Corporate Development and Strategy

Page 25

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exhibit A

Products

Any  ENERGOUS  integrated  circuit  (IC)  designed  to  receive  power  wirelessly  and  any  ENERGOUS  IC  used  in  a  wireless  transmitter,
including, but not limited to, the following Products (and any related Product Updates):

[***]

Page 26

* Confidential Treatment Requested

 
 
 
 
 
 
 
 
 
Exhibit B

Royalties and Service Fees

Royalties and Service Fees payable by DIALOG and/or its Affiliates to ENERGOUS hereunder will be calculated on a Product by Product
basis as defined herein.

Margin Split:

Combined Royalties and Service Fees shall equal [***].

Dialog will retain the remaining [***].

[***].

[***].

Notwithstanding any provision of the Agreement, no Royalties or Service Fees will be payable to ENERGOUS hereunder in connection
with any Sale to any customer of prototype or sample Licensed Products [***].

Page 27

* Confidential Treatment Requested

 
 
 
 
 
 
 
 
 
 
 
 
 
Exhibit C

Example of Letter of Authorization: Mask Set(s) Authorization for Third Party’s Product(s)

To whom it may concern

Pursuant to a STRATEGIC ALLIANCE Agreement between Dialog Semiconductor (UK) Ltd and Energous Corporation dated November
6,  2016  (to  which  [Manufacturing  Subcontractor]  is  not  a  party),  we,  Energous  Corporation  (Energous),  hereby  agree  and  authorize
[Manufacturing Subcontractor], under the terms of this Letter of Authorization, to use the Mask Set(s) specified below for manufacturing
products for the supply to the Third Party specified in paragraph 2 below only:

1. Mask Set(s) details:
Mask Set(s) Product Type:
Foundry Code:

2. Third Party details:
Third Party’s Name: Dialog Semiconductor [purchasing entity to be determined]
Third Party’s Address:
Contact name of Third Party:

3. Volume of products
The number of products to be manufactured with the Mask Set(s) will be unlimited, unless otherwise instructed by us below:

Authorized Amount: [UNLIMITED]

4. Duration of Authorization
The duration of this Letter of Authorization will be unlimited, unless otherwise instructed by us below:

Duration of Authorization: [UNLIMITED]

5. Confidential Information
Other than wafers for products specified under paragraph 1 above (which contain Energous designs), [Manufacturing Subcontractor] will
not disclose to the Third Party any information which is proprietary or confidential to Energous.

Page 28

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6. Reporting
Upon Energous’ request (but not more frequently than once per calendar year), [Manufacturing Subcontractor] will provide Energous with
the  accumulated  wafer  volumes  ordered  (and  shipped)  to  the  Third  Party  under  this  Letter  of Authorization.  By  signing  this  Letter  of
Authorization, the Third Party authorizes [Manufacturing Subcontractor] to report to Energous accordingly.

8. Governing Law
This Letter of Authorization will be governed by and construed in accordance with the laws of California, excluding its conflict of laws
provisions, and be subject to the non-exclusive jurisdiction of the California courts.

Very truly yours,

Energous Incorporated

Name:

Title:

Date:

Agreed by Dialog Semiconductor (UK) Ltd

Name:

Title:

Date:

This Letter of Authorization is subject to the approval of the Manufacturing Subcontractors.

Page 29

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Exhibit D

Licensed Marks

DIALOG Licensed Marks:

Dialog
Dialog Semiconductor

ENERGOUS Licensed Marks:

Energous 
WattUp 
Unleash your power 

Pending:

[***]

Page 30

* Confidential Treatment Requested  

 
 
 
 
 
 
 
 
 
 
 
 
Exhibit E

Commercialization plan

Objective

The Commercialization Plan sets forth the parties’ respective rights and obligations with respect to commercial and technical activities to be
performed to maximize potential Sales of Licensed Products.

[***]

Review

o

The Commercialization Plan will be reviewed and (if necessary) updated by the parties on a quarterly basis throughout the
Term of the agreement.

Page 31

* Confidential Treatment Requested

 
 
 
 
 
 
 
 
 
 
 
 
Customer: [***]

Exhibit F

Page 32

* Confidential Treatment Requested

 
 
 
 
 
 
 
[***]

Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately
with  the  Securities  and  Exchange  Commission  pursuant  to  Rule  24b-2  of  the  Securities  Exchange  Act  of  1934,  as
amended.

Exhibit 10.25

EXECUTION VERSION

SECURITIES PURCHASE AGREEMENT

THIS  SECURITIES  PURCHASE AGREEMENT   (the  “Agreement”),  is  dated  as  of  November  6,  2016,  by  and  between
Energous  Corporation,  a  Delaware  corporation  (the  “Company”)  and  Dialog  Semiconductor  plc.,  a  public  limited  company  organized
under the laws of England and Wales (the “Investor”).

BACKGROUND

A.        The Company and Dialog Semiconductor (UK) Ltd are concurrently herewith entering into that certain Strategic Alliance

Agreement, of even date herewith (the “Strategic Alliance Agreement”).

B.                  The  Company  and  the  Investor  are  executing  and  delivering  this Agreement  in  reliance  upon  the  exemption  from
registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “ Securities Act”), and/or Rule 506 of Regulation D
(“Regulation D”) as promulgated by the United States Securities and Exchange Commission (the “SEC”) under the Securities Act.

C.         The Investor wishes to purchase, and the Company wishes to sell and issue to the Investor, upon the terms and subject to
the conditions stated in this Agreement, (i) an aggregate of up to 763,552 shares of the Common Stock at a purchase price of $13.0967 per
share  (as  adjusted  by  any  stock  split,  dividend  or  other  distribution,  recapitalization  or  similar  event,  the  “Shares”)  and  (ii)  warrants  to
purchase an aggregate of up to 763,552 shares (subject to adjustment as described in the Warrants) of Common Stock (the “Warrants”) in
the form attached hereto as Exhibit B, which Warrants shall have an exercise price equal to $17.0257 per share (subject to adjustment as
described Warrants) and a term of exercise of three (3) years from and after the Closing.

NOW,  THEREFORE,  IN  CONSIDERATION  of  the  mutual  covenants  contained  in  this  Agreement,  and  for  other  good  and

valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and the Investor agree as follows:

ARTICLE I
DEFINITIONS

1 . 1        Definitions.  In  addition  to  the  terms  defined  elsewhere  in  this Agreement,  the  following  terms  have  the  meanings

indicated:

or is under common control with a Person, as such terms are used in and construed under Rule 144 under the Securities Act.

“Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by

“Agreement” has the meaning set forth in the Preamble.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Applicable Law” collectively means any and all laws, rules, regulations, and governmental, judicial or administrative
decrees,  orders  and  decisions  that  are  applicable  to  the  Company  or  any  of  its  Subsidiaries,  this  Agreement,  the  other  Transaction
Documents, including the U.S. Gramm-Leach-Bliley Act of 1999, as amended, and the regulations promulgated under such Act, the U.S.
Fair Credit Reporting Act of 1970, as amended, or any regulations or guidelines promulgated under such Act, the U.S. Bank Secrecy Act,
orders and guidelines of the Office of Foreign Assets Control and the USA Patriot Act, and any other applicable data protection, privacy,
consumer protection or confidentiality laws or regulations (including the rules and regulations of any self-regulatory organization to which
the Company or its securities are subject, including The Nasdaq Stock Market or comparable securities trading market).

“Board” has the meaning set forth in Section 2.2.

New York are authorized or required by Applicable Law to remain closed.

“Business Day”  means  any  day  other  than  Saturday,  Sunday  or  other  day  on  which  commercial  banks  in  The  City  of

“Change of Control of the Company” means a change in ownership or control of the Company effected through any of
the following transactions: (a) a merger, consolidation or other reorganization approved by the Company’s stockholders, unless securities
representing  more  than  fifty  percent  (50%)  of  the  total  combined  voting  power  of  the  voting  securities  of  the  successor  corporation  are
immediately thereafter beneficially owned, directly or indirectly and in substantially the same proportion, by the Persons who beneficially
owned  the  Company’s  outstanding  voting  securities  immediately  prior  to  such  transaction;  (b)  a  stockholder-approved  sale,  transfer  or
other disposition of all or substantially all of the Company’s assets; or (c) the closing of any transaction or series of transactions to which
any Person or any group of Persons comprising a “group” within the meaning of Rule 13d-5(b)(1) of the Exchange Act becomes directly or
indirectly  the  beneficial  owner  (within  the  meaning  of  Rule  13d-3  or  the  Exchange Act)  of  securities  possessing  (or  convertible  into  or
exercisable  for  securities  possessing)  more  than  fifty  percent  (50%)  of  the  total  combined  voting  power  of  the  Company’s  securities  (as
measured in terms of the power to vote with respect to the election of Board members) outstanding immediately after the consummation of
such  transaction  or  series  of  transactions,  whether  such  transaction  involves  a  directly  issuance  from  the  Company  or  the  acquisition  of
outstanding securities held by one or more of the Company’s existing stockholders.

“Closing” means the closing of the purchase and sale of the Securities pursuant to  Section 2.1.

date and time as is mutually agreed to by the Company and the Investor.

“Closing Date” means the date and time of the Closing and shall be a date no later than November 11, 2016 or such other

“Common Stock” means the common stock of the Company, par value $0.00001 per share.

“Company” has the meaning set forth in the Preamble.

“Company Plans” has the meaning set forth in Section 3.1(k).

-2-

 
 
 
 
 
 
 
 
 
 
 
 
 
“Disclosure Letter” has the meaning set forth in the lead-in paragraph to Article III.

“Disclosure Materials” has the meaning set forth in Section 3.1(h).

“Effectiveness Period” has the meaning set forth in Section 6.1(b).

“Environmental Laws” means any and all federal, state, local, and foreign statutes, laws, regulations, ordinances, rules,
judgments, orders, decrees, permits, concessions, grants, franchises, licenses, agreements or governmental restrictions relating to pollution
and  the  protection  of  the  environment  or  the  release  of  any  materials  into  the  environment,  including  but  not  limited  to  those  related  to
Hazardous Materials.

“Exchange Act” means the Securities Exchange Act of 1934, as amended.

“GAAP” has the meaning set forth in Section 3.1(h).

“Hazardous Material”  means  any  and  all  pollutants,  toxic  or  hazardous  wastes  or  other  substances  that  might  pose  a
hazard  to  health  and  safety,  the  removal  of  which  may  be  required  or  the  generation,  manufacture,  refining,  production,  processing,
treatment, storage, handling, transportation, transfer, use, disposal, release, discharge, spillage, seepage or filtration of which is or shall be
restricted,  prohibited  or  penalized  by  any  applicable  law,  including,  without  limitation,  asbestos,  urea  formaldehyde  foam  insulation,
polychlorinated  biphenyls,  petroleum,  petroleum  products,  lead  based  paint,  radon  gas  or  similar  restricted,  prohibited  or  penalized
substances.

“Indemnified Party” has the meaning set forth in Section 6.4(c).

“Indemnifying Party” has the meaning set forth in Section 6.4(c).

“Insolvent” has the meaning set forth in Section 3.1(i).

“Investor” has the meaning set forth in the Preamble.

“Investor  Controlled  Entity” shall  mean  an  entity  of  which  the  Investor  collectively  owns  or  controls,  directly  or
indirectly, not less than a majority of the outstanding voting power entitled to vote in the election of directors of such entity (or, in the event
the entity is not a corporation, the governing members, board or other similar body of such entity).

first refusal, mortgage, deed of trust, title retention, conditional sale or other security arrangement, or adverse claim of title.

“Lien” means, with respect to any asset, any pledge, lien, collateral assignment, security interest, encumbrance, right of

limitation, reasonable attorneys’ fees.

“Losses”  means  any  and  all  losses,  claims,  damages,  liabilities,  settlement  costs  and  expenses,  including,  without

-3-

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Material Adverse Effect ” means (i) a material adverse effect on the legality, validity, or enforceability of any of the
Transaction Documents, (ii) a material adverse effect on the results of operations, assets, business or financial condition of the Company
and the Subsidiaries, taken as a whole on a consolidated basis, or (iii) a material adverse effect on the Company’s ability to perform on a
timely basis its obligations under any of the Transaction Documents.

“Material Permits” has the meaning set forth in Section 3.1(m).

“Non-Voting Convertible Securities ” means any securities of the Company that are convertible into, exchangeable for
or otherwise exercisable to acquire Voting Stock of the Company, including convertible securities, warrants, rights or options to purchase
Voting Stock of the Company.

“Person” means any individual, corporation, limited liability company, partnership, joint venture, trust, incorporated or
unincorporated  association,  joint  stock  company,  unincorporated  organization,  a  government  or  any  department,  subdivision  or  agency
thereof, or other entity of any kind.

“Preferred Stock” means the preferred stock of the Company, par value $0.00001 per share.

proceeding, such as a deposition), whether commenced or threatened in writing.

“Proceeding”  means  an  action,  claim,  suit,  investigation  or  proceeding  (including,  without  limitation,  or  a  partial

“Prospectus” means the prospectus included in a Registration Statement (including, without limitation, a prospectus that
includes  any  information  previously  omitted  from  a  prospectus  filed  as  part  of  an  effective  registration  statement  in  reliance  upon  Rule
430A promulgated under the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the
offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the
Prospectus including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in
such Prospectus.

“Purchase Price” has the meaning set forth in Section 2.1.

“Registrable  Securities”  means  the  Shares  and  the  Warrant  Shares  issued  or  issuable  pursuant  to  the  Transaction
Documents, together with any securities issued or issuable upon any stock split, dividend or other distribution, recapitalization or similar
event with respect to the foregoing.

“Registration  Statement”  means  each  registration  statement  filed  under Article  VI,  including  (in  each  case)  the
Prospectus, amendments and supplements to such registration statement or Prospectus, including pre- and post-effective amendments, all
exhibits thereto, and all material incorporated by reference or deemed to be incorporated by reference in such registration statement.

“Regulation D” has the meaning set forth in the Background.

-4-

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Rule  144,”  “Rule  144(c),”  “Rule  415,”  and  “Rule  424”  means  Rule  144,  Rule  144(c),  Rule  415  and  Rule  424,
respectively, promulgated by the SEC pursuant to the Securities Act, as such Rules may be amended from time to time, or any similar rule
or regulation hereafter adopted by the SEC having substantially the same effect as such Rule.

“SEC” has the meaning set forth in the Background.

“SEC Reports” has the meaning set forth in Section 3.1(h).

“Securities” means, collectively, the Shares purchased hereunder, the Warrants and the Warrant Shares.

“Securities Act” has the meaning set forth in the Background.

“Shares” has the meaning set forth in the Background.

“Subsidiary” means any direct or indirect subsidiary of the Company.

or comparable securities trading market, or (b) if trading ceases to occur on any such market, any Business Day.

“Trading Day” means (a) any day on which the Securities are listed or quoted and traded on The Nasdaq Stock Market

“Transaction Documents” means this Agreement, the schedules and exhibits attached hereto, and the Warrants.

“Transfer Agent” means Wells Fargo or any successor transfer agent for the Company.

anniversary of the Closing Date or (ii) the effective date of the termination of the Strategic Alliance Agreement.

“Voting  Period ”  means  the  period  beginning  on  the  Closing  Date  and  ending  on  the  earlier  of  (i)  the  three  year

vote in the election of members of the Board.

“Voting Stock” means shares of Common Stock and any other securities of the Company having the ordinary power to

“Warrants” has the meaning set forth in the Background.

stock split, dividend or other distribution, recapitalization or similar event).

“Warrant Shares” means the shares of Common Stock to be issued upon exercise of the Warrants (as adjusted by any

“13D Group” means any group of Persons that would be required under Section 13(d) of the Exchange Act, and the rules
and  regulations  promulgated  thereunder,  to  file  a  statement  on  Schedule  13D  or  Schedule  13G  with  the  SEC  as  a  “person”  within  the
meaning of Section 13(d)(3) of the Exchange Act if such group beneficially owned Voting Stock representing more than 5% of any class of
Voting Stock then outstanding.

-5-

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ARTICLE II
PURCHASE AND SALE

2.1         Purchase and Sale of the Shares and Warrants. Subject to the terms and conditions of this Agreement, the Investor hereby
agrees  to  purchase,  and  the  Company  hereby  agrees  to  sell  and  issue  to  the  Investor,  the  Shares  and  Warrants  as  set  forth  opposite  the
Investor’s name on Exhibit A for the aggregate purchase price (the “ Purchase Price”) set forth opposite the Investor’s name on Exhibit A.

2.2         Closing.

(a)          At the Closing, the Company shall deliver to the Investor (i) the Shares and Warrants, registered in the name of
the Investor as indicated on Exhibit A and (ii) a certificate, in the form set forth on Exhibit C, executed by the secretary of the Company
and  dated  as  of  the  Closing  Date,  as  to  the  Certificate  of  Incorporation,  by-laws,  foreign  qualification,  incumbency  of  the  Company’s
officers and good standing of the Company and the resolutions adopted by the Company’s Board of Directors (the “Board”) authorizing
the transactions contemplated by the Transaction Documents.

immediately available funds to an account specified by the Company in writing.

(b)          At the Closing, the Investor shall deliver to the Company the Purchase Price to the Company by wire transfer of

ARTICLE III
REPRESENTATIONS AND WARRANTIES

3.1         Representations and Warranties of the Company . Except as disclosed in the SEC Reports filed since March 27, 2014 (but
excluding all disclosures contained in the exhibits to such SEC Reports and the schedules to such exhibits, excluding the “Risk Factors”
section contained in such SEC Reports, and excluding forward-looking statements identifying risks and uncertainties that are not historical
facts contained in such SEC Reports) or the Disclosure Letter delivered by the Company to the Investor concurrently with the execution
hereof (the “Disclosure Letter”), the Company hereby represents and warrants to the Investor as follows:

( a )          Subsidiaries.  The  Company  has  no  Subsidiaries  other  than  those  listed  on  Section 3.1(a)  of  the  Disclosure
Letter. Except as disclosed in  Section 3.1(a) of the Disclosure Letter, the Company owns, directly or indirectly, all of the capital stock or
comparable  equity  interests  of  each  Subsidiary  free  and  clear  of  any  Lien  and  all  the  issued  and  outstanding  shares  of  capital  stock  or
comparable equity interest of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights.

( b )          Organization and Qualification. Each of the Company and its Subsidiaries is an entity duly organized, validly
existing and in good standing under the Applicable Laws of the jurisdiction of its incorporation or organization (as applicable), with the
requisite legal authority to own or lease and use its properties and assets and to carry on its business as currently conducted. Neither the
Company nor any Subsidiary is in violation of any of the provisions of its respective certificate or articles of incorporation or by-laws or
other  organizational  or  charter  documents.  Each  of  the  Company  and  its  Subsidiaries  is  duly  qualified  to  do  business  and  is  in  good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it
makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, has not had and
would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

-6-

 
 
 
 
 
 
 
 
 
 
 
 
 
( c )          Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to
consummate the transactions contemplated by each of the Transaction Documents and otherwise to carry out its obligations hereunder and
thereunder.  The  execution  and  delivery  of  each  of  the  Transaction  Documents  by  the  Company  and  the  consummation  by  it  of  the
transactions contemplated hereby and thereby have been duly authorized by all necessary corporate action on the part of the Company and
no  further  consent  or  action  is  required  by  the  Company,  its  officers,  the  Board  or  its  stockholders.  The  issuance  of  the  Shares,  the
Warrants and the Warrant Shares do not require the approval of the stockholders of the Company. Each of the Transaction Documents has
been  (or  upon  delivery  will  be)  duly  executed  by  the  Company  and  is,  or  when  delivered  in  accordance  with  the  terms  hereof,  will
constitute, the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as may
be limited by (i) applicable bankruptcy, insolvency, reorganization or other Applicable Laws of general application relating to or affecting
the enforcement of creditors rights generally; and (ii) the effect of rules of law governing the availability of specific performance and other
equitable remedies.

( d )          No Conflicts. The execution, delivery and performance by the Company of the Transaction Documents and the
consummation  by  the  Company  of  the  transactions  contemplated  hereby  and  thereby  do  not  and  will  not  (i)  conflict  with  or  violate  any
provision  of  the  Company’s  or  any  Subsidiary’s  certificate  or  articles  of  incorporation,  by-laws  or  other  organizational  or  charter
documents; (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, or
give  to  others  any  rights  of  termination,  amendment,  acceleration  or  cancellation  (with  or  without  notice,  lapse  of  time  or  both)  of,  any
agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) to which the Company or any
Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected; or (iii) result in a violation
of any Applicable Law, except, in the case of clause (ii) or (iii), to the extent that such conflict or violation has not had and would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

( e )          Filings, Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or
order of, give notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or
other  Person  in  connection  with  the  execution,  delivery  and  performance  by  the  Company  of  the  Transaction  Documents  or  the
consummation  of  the  transactions  contemplated  hereby  and  thereby,  other  than  (i)  the  filings  required  to  comply  with  the  Company’s
registration  obligations  hereunder,  (ii)  the  application(s)  to  The  Nasdaq  Stock  Market  for  the  listing  of  the  shares  of  Common  Stock
purchased pursuant to this Agreement and the Warrant Shares for trading thereon in the time and manner required thereby, and (iii) filings
required under applicable U.S. federal and state securities laws.

-7-

 
 
 
 
 
 
 
f

(

)          The Securities.  The  Securities  are  duly  authorized  and,  when  issued  and  paid  for  in  accordance  with  the
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens and will not be subject to
preemptive rights, rights of first refusal, or similar rights of stockholders. The Company has reserved from its duly authorized capital stock
the maximum number of shares of Common Stock issuable pursuant to this Agreement and upon exercise of the Warrants.

( g )          Capitalization. As of November 3, 2016, the aggregate number of shares and type of all authorized, issued and
outstanding classes of capital stock, options and other securities of the Company (whether or not presently convertible into or exercisable or
exchangeable for shares of capital stock of the Company) consists of (i) 50,000,000 authorized shares of Common Stock, with 19,130,892
shares of Common Stock outstanding; (ii) 10,000,000 shares of Preferred Stock, none of which are outstanding; (iii) 1,683,462 shares of
Common Stock, on a diluted basis, reserved for issuance upon the exercise of outstanding warrants; and (iv) 4,676,508 shares of Common
Stock,  reserved  for  issuance  upon  the  exercise  of  outstanding  employee  stock  options  and/or  restricted  stock  units.  Since  November  3,
2016, the Company has not issued or granted, as applicable, any capital stock, options or other securities of the Company (whether or not
presently  convertible  into  or  exercisable  or  exchangeable  for  shares  of  capital  stock  of  the  Company). All  outstanding  shares  of  capital
stock are duly authorized, validly issued, fully paid and nonassessable and have been issued in compliance with all applicable securities
laws and regulations. Except as disclosed in this Section 3.1(g) or in Section 3.1(g) of the Disclosure Letter, the Company does not have
outstanding any other options, warrants, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities,
rights  or  obligations  convertible  into  or  exercisable  or  exchangeable  for,  or  entered  into  any  agreement  giving  any  Person  any  right  to
subscribe for or acquire, any shares of Preferred Stock or Common Stock, or securities or rights convertible or exchangeable into shares of
Preferred  Stock  or  Common  Stock.  There  are  no  anti-dilution  or  price  adjustment  provisions  contained  in  any  security  issued  by  the
Company  (or  in  any  agreement  providing  rights  to  security  holders)  and  the  issuance  and  sale  of  the  Securities  will  not  obligate  the
Company to issue shares of Common Stock or other securities to any Person (other than the Investor) and will not result in a right of any
holder of securities to adjust the exercise, conversion, exchange or reset price under such securities. To the knowledge of the Company,
based solely on an examination of Schedules 13D and Schedules 13G on file with the SEC, except pursuant to this Agreement, no Person or
group of related Persons beneficially owns (as determined pursuant to Rule 13d-3 under the Exchange Act) or has the right to acquire, by
agreement  with  or  by  obligation  binding  upon  the  Company,  beneficial  ownership  of  in  excess  of  five  percent  (5%)  of  the  outstanding
Common Stock.

-8-

 
 
 
 
 
 
( h )          SEC  Reports;  Financial  Statements .  The  Company  has  filed  all  reports  required  to  be  filed  by  it  under  the
Securities Act  and  the  Exchange Act  since  March  27,  2014,  including  pursuant  to  Sections  13(a)  or  15(d)  of  the  Exchange Act,  or  has
received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. Such
reports required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) of
the Exchange Act, together with any materials filed or furnished by the Company under the Securities Act and the Exchange Act, whether
or not any such reports were required being collectively referred to herein as the “SEC Reports” and, together with this Agreement and the
Disclosure Letter, the “Disclosure Materials”. As of their respective dates, the SEC Reports filed by the Company complied in all material
respects  with  the  requirements  of  the  Securities  Act  and  the  Exchange  Act,  as  applicable,  and  the  rules  and  regulations  of  the  SEC
promulgated thereunder, and none of the SEC Reports, when filed by the Company, contained any untrue statement of a material fact or
omitted  to  state  a  material  fact  required  to  be  stated  therein  or  necessary  in  order  to  make  the  statements  therein,  in  the  light  of  the
circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Reports comply
in all material respects with applicable accounting requirements and the rules and regulations of the SEC with respect thereto as in effect at
the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles
applied on a consistent basis during the periods involved (“GAAP”), except as may be otherwise specified in such financial statements or
the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all
material respects the consolidated financial position of the Company and its consolidated Subsidiaries taken as a whole as of and for the
dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal,
immaterial,  year-end  audit  adjustments. All  material  agreements  to  which  the  Company  or  any  Subsidiary  is  a  party  or  to  which  the
property or assets of the Company or any Subsidiary are subject that are required to be filed with the SEC or identified on the SEC Reports
are included as part of or identified in the SEC Reports. The Company is eligible to use Form S-3 to register the resale of the Registrable
Securities. The Company has not received any comments from  the  SEC  or  the  staff  of  the  SEC  Division  of  Corporation  Finance  on  the
Company’s  SEC  Reports  (or  any  Company  filings  with  the  SEC  during  the  years  ended  December  31,  2014  and  2015)  that  remain
unresolved.

( i )          No Change. Except as otherwise disclosed in the SEC Reports, since March 27, 2014, (A) there has been no
event,  occurrence  or  development  that,  individually  or  in  the  aggregate,  has  had  or  would  reasonably  be  expected  to  have  a  Material
Adverse Effect, (B) the Company has not incurred any liabilities (contingent or otherwise) other than those arising from operations in the
ordinary course of business consistent with past practice, and (C) the Company has not declared or made any dividend or distribution of
cash or other property to its stockholders, or purchased, redeemed, or made any agreements to purchase or redeem any shares of its capital
stock other than pursuant to the Company’s stock repurchase plan described in the SEC Reports. The Company has not taken any steps to
seek protection pursuant to any bankruptcy law nor does the Company believe that its creditors intend to initiate involuntary bankruptcy
Proceedings or have any actual knowledge of any fact which would reasonably lead a creditor to do so. The Company is not Insolvent (as
hereinafter defined) as of the date hereof, and will not be Insolvent after giving effect to the transactions contemplated hereby to occur at
the applicable Closing. For purposes of this Section 3.1(i), “Insolvent” means (i) the present fair saleable value of the Company’s assets is
less  than  the  amount  required  to  pay  the  Company’s  total  indebtedness,  (ii)  the  Company  is  unable  to  pay  its  debts  and  liabilities,
subordinated, contingent or otherwise, as such debts and liabilities become absolute and matured or (iii) the Company has unreasonably
small capital with which to conduct the business in which it is engaged as such business is now conducted and is proposed to be conducted.

-9-

 
 
 
 
 
 
j

(

)          Litigation.  Except  as  disclosed  in Section 3.1(j)  of  the  Disclosure  Letter  or  the  SEC  Reports,  there  is  no
Proceeding pending or, to the knowledge of the Company, threatened against the Company or any Subsidiary or any of its properties that
has or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. Neither the Company, nor, to the
knowledge of the Company, any director or officer thereof, is or has been the subject of any Proceeding involving a claim of violation of or
liability  under  federal  or  state  securities  laws  or  a  claim  of  breach  of  fiduciary  duty.  There  has  not  been,  and  to  the  knowledge  of  the
Company,  there  is  not  pending  or  contemplated,  any  investigation  involving  the  Company  or,  to  the  knowledge  of  the  Company,  any
current or former director or officer of the Company. Except as disclosed in the Disclosure Letter, neither the Company nor any Subsidiary
is  a  party  or  subject  to  the  provisions  of  any  order,  writ,  injunction,  judgment  or  decree  of  any  court  or  government  agency  or
instrumentality that has had or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. There is
no Proceeding by the Company or any Subsidiary currently pending or which the Company or any Subsidiary intends to initiate that would
reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. Since March 27, 2014, (i) the Common Stock
has been designated for quotation on The Nasdaq Stock Market, (ii) trading in the Common Stock has not been suspended by the SEC or
The  Nasdaq  Stock  Market  and  (iii)  the  Company  has  received  no  communication,  written  or  oral,  from  the  SEC  or  The  Nasdaq  Stock
Market regarding the suspension or delisting of the Common Stock.

(k)          Key Employees. There are no currently effective employment contracts, offer letters containing economic terms,
consulting agreements, deferred compensation arrangements, bonus plans, incentive plans, profit sharing plans, retirement agreements or
other employee compensation plans or agreements (“Company Plans”) containing terms and conditions that would result in the material
payment to any employee or former employee of the Company or any of its Subsidiaries of any material money or other property or the
acceleration, vesting or provision of any other material rights or benefits to any employee or former employee of the Company or any of its
Subsidiaries by virtue of the issuance of the Securities pursuant to this Agreement (either alone or upon the occurrence of any other event).

l

(

)           Registration  Rights  and  Voting  Rights.  Except  as  required  pursuant  to Article  VI  of  this Agreement,  the
Company  is  presently  not  under  any  obligation,  and  has  not  granted  any  rights,  to  register  any  of  the  Company’s  presently  outstanding
securities or any of its securities that may hereafter be issued that have not expired or been satisfied. To the knowledge of the Company, no
stockholder of the Company has entered into any agreement with respect to the voting of equity securities of the Company.

( m )         Compliance with Laws; Permits. Neither the Company nor any of its Subsidiaries is, or since March 27, 2014
has been, in violation of any Applicable Law in respect of the conduct of its business or the ownership of its properties, which violation has
had  or  would  reasonably  be  expected  to  have,  individually  or  in  the  aggregate,  a  Material  Adverse  Effect.  The  Company  and  its
Subsidiaries  possess  all  certificates,  authorizations  and  permits  issued  by  the  appropriate  federal,  state,  local  or  foreign  regulatory
authorities necessary to conduct their respective businesses as described in the SEC Reports (“Material Permits”), except where the failure
to possess such permits has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect, and neither the Company nor any Subsidiary has received any notice of Proceedings relating to the revocation or modification of
any  Material  Permit,  the  revocation  or  modification  of  which  has  had  or  would  reasonably  be  expected  to  have,  individually  or  in  the
aggregate, a Material Adverse Effect.

-10-

 
 
 
 
 
 
 
 
(n)          Foreign Assets Control Regulations, Etc.

(i) Neither the sale of the Securities by the Company hereunder nor its use of the proceeds thereof will violate
the Trading with the Enemy Act, as amended, or any of the foreign assets control regulations of the United States Treasury Department (31
CFR, Subtitle B, Chapter V, as amended) or any enabling legislation or executive order relating thereto.

(ii) Neither the Company nor any Subsidiary (i) is a Person described or designated in the Specially Designated
Nationals and Blocked Persons List of the Office of Foreign Assets Control or in Section 1 of the Anti-Terrorism Order or (ii) engages in
any dealings or transactions with any such Person. The Company and its Subsidiaries are in compliance, in all material respects, with the
USA Patriot Act.

(iii) No part of the proceeds from the sale of the Securities hereunder will be used, directly or indirectly, for any
payments to any governmental official or employee, political party, official of a political party, candidate for political office, or anyone else
acting in an official capacity, in order to obtain, retain or direct business or obtain any improper advantage, in violation of the United States
Foreign Corrupt Practices Act of 1977, as amended, assuming in all cases that such Act applies to the Company.

Investment Company Act of 1940, as amended, the ICC Termination Act of 1995, as amended, or the Federal Power Act, as amended.

( o )          Status  under  Certain  Statutes.  Neither  the  Company  nor  any  Subsidiary  is  subject  to  regulation  under  the

(p)          Environmental Matters.

(i) Neither the Company nor any Subsidiary has knowledge of any claim or has received any notice of any claim,
and  no  proceeding  has  been  instituted  raising  any  claim  against  the  Company  or  any  of  its  Subsidiaries  or  any  of  their  respective  real
properties now or formerly owned, leased or operated by any of them or other assets, alleging any damage to the environment or violation
of any Environmental Laws, except, in each case, such as could not reasonably be expected to result in a Material Adverse Effect.

(ii) Neither the Company nor any Subsidiary has knowledge of any facts which would give rise to any claim,
public or private, of violation of Environmental Laws or damage to the environment emanating from, occurring on or in any way related to
real properties now or formerly owned, leased or operated by any of them or to other assets or their use, except, in each case, such as could
not reasonably be expected to result in a Material Adverse Effect.

(iii)  Neither  the  Company  nor  any  Subsidiary  has  stored  any  Hazardous  Materials  on  real  properties  now  or
formerly  owned,  leased  or  operated  by  any  of  them  and  has  not  disposed  of  any  Hazardous  Materials  in  a  manner  contrary  to  any
Environmental Laws in each case in any manner that could reasonably be expected to result in a Material Adverse Effect.

(iv) All buildings on all real properties now owned, leased or operated by the Company or any Subsidiary are in
compliance with applicable Environmental Laws, except where failure to comply could not reasonably be expected to result in a Material
Adverse Effect.

-11-

 
 
 
 
 
 
 
 
 
 
 
 
 
 
( q )          Title to Property; Leases. The Company and its Subsidiaries have good and sufficient title to their respective
properties that individually or in the aggregate are material, including all such properties reflected in the most recent audited balance sheet
or  purported  to  have  been  acquired  by  the  Company  or  any  Subsidiary  after  said  date  (except  as  sold  or  otherwise  disposed  of  in  the
ordinary course of business), in each case free and clear of Liens. All leases that individually or in the aggregate are material are valid and
subsisting and are in full force and effect in all material respects.

r

(

)          Offering Valid. Assuming  the  accuracy  of  the  representations  and  warranties  of  the  Investor  contained  in
Section 3.2  hereof,  the  offer,  sale  and  issuance  of  the  Common  Stock,  the  Warrants,  and  the  Warrant  Shares  will  be  exempt  from  the
registration  requirements  of  the  Securities  Act,  and  will  have  been  registered  or  qualified  (or  are  exempt  from  registration  and
qualification) under the registration, permit or qualification requirements of all applicable state securities laws.

( s )          Private Placement. Neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf,
has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or
sale  of  the  Securities.  Neither  the  Company  nor  any  of  its Affiliates  nor,  any  Person  acting  on  the  Company’s  behalf  has,  directly  or
indirectly, at any time within the past six (6) months, made any offer or sale of any security or solicitation of any offer to buy any security
under circumstances that would (i) eliminate the availability of the exemption from registration under Regulation D in connection with the
offer  and  sale  by  the  Company  of  the  Securities  as  contemplated  hereby  or  (ii)  cause  the  offering  of  the  Securities  pursuant  to  the
Transaction Documents to be integrated with prior offerings by the Company for purposes of any Applicable Law or stockholder approval
provisions, including, without limitation, under the rules and regulations of The Nasdaq Stock Market, in a manner which would require
any stockholder approval.

( t )          Transfer Taxes. On the Closing Date, all documentary, stamp, issue, stock transfer and other taxes (other than
income  taxes)  required  to  be  paid  in  connection  with  the  sale  and  transfer  of  the  shares  of  Common  Stock  to  be  sold  to  the  Investor
hereunder will be, or will have been, fully paid or provided for by the Company, and all Applicable Laws imposing such taxes will be or
will have been complied with fully.

(u)          Placement Agent’s Fees. The Company has not employed any broker, investment banker, finder or other Person
in a similar capacity and has not incurred any liability for any financial advisory fees, brokerage fees, commissions or finder’s fees, and no
broker,  investment  banker,  finder  or  other  Person  in  a  similar  capacity  has  acted,  directly  or  indirectly,  for  the  Company  or  any  of  its
Subsidiaries, in connection with this Agreement or the transactions contemplated hereby. The Company shall pay, and hold the Investor
harmless against, any liability, loss or expense (including, without limitation, reasonable attorney’s fees and out-of-pocket expenses) arising
in  connection  with  any  such  claim  for  fees  arising  out  of  the  issuance  of  the  Securities  pursuant  to  this Agreement  and  the  Transaction
Documents.

-12-

 
 
 
 
 
 
 
 
 
( v )         Application of Takeover Protections . Except as described in Section 3.1(v) of the Disclosure Letter, there is no
control  share  acquisition,  business  combination,  poison  pill  (including  any  distribution  under  a  rights  agreement)  or  other  similar  anti-
takeover  provision  under  the  Company’s  charter  documents  or  the Applicable  Laws  of  its  state  of  incorporation  or  otherwise,  that  is  or
could become applicable to the Investor as a result of the Investor and the Company fulfilling their obligations or exercising their rights
under  the  Transaction  Documents,  including,  without  limitation,  as  a  result  of  the  Company’s  issuance  of  the  Securities  (including  the
issuance of the Warrant Shares) and the Investor’s ownership of the Securities.

3.2         Representations, Warranties and Covenants of the Investor . The Investor hereby represents and warrants to the Company

as follows:

(a)          Organization; Authority. The Investor is an entity duly organized, validly existing and in good standing under the
Applicable Laws of the jurisdiction of its organization with the requisite corporate, partnership or other power and authority to enter into
and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations thereunder. The
purchase by the Investor of the Securities hereunder has been duly authorized by all necessary corporate, partnership or other action on the
part of the Investor. This Agreement has been duly executed and delivered by the Investor and constitutes the valid and binding obligation
of  the  Investor,  enforceable  against  it  in  accordance  with  its  terms,  except  as  may  be  limited  by  (i)  applicable  bankruptcy,  insolvency,
reorganization or other Applicable Laws of general application relating to or affecting the enforcement of creditors rights generally, and (ii)
the effect of rules of law governing the availability of specific performance and other equitable remedies. The Investor is not required to
obtain any consent, waiver, authorization or order of, give notice to, or make any filing or registration with, any court or other federal, state,
local or other governmental authority or other Person in connection with the execution, delivery and performance by the Investor of the
Transaction  Documents  or  the  consummation  of  the  transactions  contemplated  hereby  and  thereby,  other  than  filings  required  under
applicable U.S. federal and state securities laws.

( b )          No Public Sale or Distribution . The Investor is (i) acquiring the Common Stock and the Warrants and (ii) upon
exercise of the Warrants will acquire the Warrant Shares issuable upon exercise thereof, not with a view towards, or for resale in connection
with, the public sale or distribution thereof, except pursuant to sales registered under the Securities Act or under an exemption from such
registration and in compliance with applicable federal and state securities laws, and the Investor does not have a present arrangement to
effect any distribution of the Securities to or through any person or entity; provided, however, that by making the representations herein, the
Investor  does  not  agree  to  hold  any  of  the  Securities  for  any  minimum  or  other  specific  term  and  reserves  the  right  to  dispose  of  the
Securities at any time in accordance with or pursuant to a registration statement or an exemption under the Securities Act.

( c )          Investor Status. At  the  time  the  Investor  was  offered  the  Securities,  it  was,  and  at  the  date  hereof  it  is,  an
“accredited  investor”  as  defined  in  Rule  501(a)  under  the  Securities Act  or  a  “qualified  institutional  buyer”  as  defined  in  Rule  144A(a)
under the Securities Act.

-13-

 
 
 
 
 
 
 
 
 
( d )          Experience of the Investor. The Investor, either alone or together with its representatives, has such knowledge,
sophistication  and  experience  in  business  and  financial  matters  so  as  to  be  capable  of  evaluating  the  merits  and  risks  of  the  prospective
investment in the Securities, and has so evaluated the merits and risks of such investment. The Investor understands that it must bear the
economic risk of this investment in the Securities, and is able to bear such risk and is able to afford a complete loss of such investment.

( e )          Access  to  Information.  The  Investor  acknowledges  that  it  has  had  access  to  the  Disclosure  Materials  and
information  about  the  Company  and  the  Subsidiaries  and  their  respective  financial  condition,  results  of  operations,  business,  properties,
management and prospects sufficient to enable it to evaluate its investment. No information, inquiry, or investigation conducted by or on
behalf of the Investor or its representatives or counsel shall modify, amend or affect the Investor’s right to rely on the truth, accuracy and
completeness of the Disclosure Materials and the Company’s representations and warranties contained in the Transaction Documents.

( f )          Restricted Securities. The Investor understands that  the  Securities  are  characterized  as  “restricted  securities”
under  the  U.S.  federal  securities  laws  inasmuch  as  they  are  being  acquired  from  the  Company  in  a  transaction  not  involving  a  public
offering and that under such laws and applicable regulations such securities may be resold without registration under the Securities Act only
in  certain  limited  circumstances.  The  Investor  has  been  advised  or  is  aware  that  it  may  be  deemed  to  be  an  “affiliate”  of  the  Company
within the meaning of the Securities Act following the execution of this Agreement.

( g )          Placement Agent’s Fees . The Investor has not employed any broker, investment banker, finder or other Person
in a similar capacity or incurred any liability for any financial advisory fees, brokerage fees, commissions or finder’s fees, and no broker,
investment banker, finder or other Person in a similar capacity has acted, directly or indirectly, for the Company or any of its Subsidiaries,
in  connection  with  this Agreement  or  the  transactions  contemplated  hereby.  The  Investor  shall  pay,  and  hold  the  Company  harmless
against,  any  liability,  loss  or  expense  (including,  without  limitation,  reasonable  attorney’s  fees  and  out-of-pocket  expenses)  arising  in
connection with any such claim for any such fees described in the preceding sentence arising out of the purchase of the Securities pursuant
to this Agreement.

( h )          Litigation. There is no Proceeding pending or, to the Investor’s knowledge, threatened against the Investor or
any subsidiary or any of its properties which in any manner challenge or seek to prevent, enjoin, alter or materially delay the transactions
contemplated by this Agreement.

( i )           No Ownership of Company Securities. Except as set in disclosure provided to the Company, as of the date of
this Agreement, neither the Investor, nor any Investor Controlled Entity or Affiliate of the Investor (other than any officer or director of the
Investor) beneficially owns any shares of Common Stock, or any other equity securities of the Company, or any options, warrants or other
rights to acquire equity securities of the Company or any other securities convertible into equity securities of the Company. Except as set in
disclosure  provided  to  the  Company,  since  March  27,  2014,  neither  the  Investor,  nor  any  Investor  Controlled  Entity,  or Affiliate  of  the
Investor (other than any officer or director of the Investor), has purchased, sold, transferred, made any short sale of, granted any option for
the purchase of, or entered into any hedging or similar transaction with the same economic effect as a sale of, any equity securities or any
options, warrants or other rights to acquire equity securities of the Company.

-14-

 
 
 
 
 
 
 
 
 
 
ARTICLE IV
OTHER AGREEMENTS OF THE PARTIES

4.1         Transfer Restrictions.

(a)          The Investor covenants that the Securities will only be disposed of pursuant to an effective registration statement
under,  and  in  compliance  with  the  requirements  of,  the  Securities Act,  to  the  Company  or  pursuant  to  an  available  exemption  from  the
registration requirements of the Securities Act, and in compliance with any applicable state securities laws. In connection with any transfer
of  Securities  other  than  pursuant  to  an  effective  registration  statement  or  to  the  Company,  the  Company  may  require  the  transferor  to
provide  to  the  Company  an  opinion  of  counsel  selected  by  the  transferor,  the  form  and  substance  of  which  opinion  shall  be  reasonably
satisfactory  to  the  Company,  to  the  effect  that  such  transfer  does  not  require  registration  under  the  Securities Act.  Notwithstanding  the
foregoing, the Company hereby consents to and agrees to register on the books of the Company and with its Transfer Agent, without any
such legal opinion, except to the extent that the Transfer Agent requests such legal opinion, any transfer of Securities by the Investor to an
Affiliate  of  the  Investor, provided,  that  (i)  the  transferee  certifies  to  the  Company  that  it  is  an  “accredited  investor,”  as  defined  in  Rule
501(a) under the Securities Act and (ii) the transferee agrees in writing to be subject to the terms and conditions of this Agreement.

any certificate evidencing any of the Securities:

(b)          The Investor agrees to the imprinting, so long as is required by this Section 4.1(b), of the following legends on

THESE  SECURITIES  HAVE  NOT  BEEN  REGISTERED  WITH  THE  SECURITIES AND  EXCHANGE  COMMISSION  OR
THE  SECURITIES  COMMISSION  OF  ANY  STATE  IN  RELIANCE  UPON  AN  EXEMPTION  FROM  REGISTRATION
UNDER  THE  SECURITIES ACT  OF  1933, AS AMENDED  (THE  “ SECURITIES ACT”),  OR ANY APPLICABLE  STATE
SECURITIES LAWS AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION  STATEMENT  UNDER  THE  SECURITIES  ACT  OR  PURSUANT  TO  AN  AVAILABLE  EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT
AND IN COMPLIANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS.

THESE  SECURITIES  ARE  SUBJECT  TO  TRANSFER  RESTRICTIONS  AS  SET  FORTH  IN  A  CERTAIN  SECURITIES
PURCHASE AGREEMENT  BETWEEN  THE  ISSUER AND  THE  ORIGINAL  HOLDER  OF  THESE  SHARES, A  COPY  OF
WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE ISSUER.

-15-

 
 
 
 
 
 
 
 
 
 
Certificates  evidencing  Securities  shall  not  be  required  to  contain  the  legends  set  forth  above  (i)  following  any  sale  of  such
Securities pursuant to a Registration Statement covering the resale of the Securities is effective under the Securities Act; (ii) following any
sale of such Securities pursuant to Rule 144 if the holder provides the Company with a legal opinion reasonably acceptable to the Company
to the effect that the Securities have been sold under Rule 144; (iii) if the Securities are eligible for sale under Rule 144(b)(1); or (iv) if the
holder provides the Company with a legal opinion reasonably acceptable to the Company to the effect that the legend is not required under
applicable requirements of the Securities Act (including controlling judicial interpretations and pronouncements issued by the staff of the
SEC). The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on
transfer set forth in this Section 4.1(b) unless required by Applicable Law.

(c)          Notwithstanding the foregoing provisions of this Section 4.1, during the Voting Period, Investor agrees that it
shall not sell, transfer or dispose of, directly or indirectly, any Securities, other than pursuant to an effective registration statement, pursuant
to Rule 144, pursuant to another available exemption from the registration requirements of the Securities Act in an unregistered block trade
executed on behalf of Investor, to the Company, in response to a Change of Control (or agreement related to a Change of Control), or a
tender or exchange offer for the Common Stock, as part of a merger or other transaction in which all outstanding shares of Common Stock
of the Company are converted into or exchanged for other consideration and is approved by the stockholders of the Company, or with prior
Board approval, unless the transferee agrees in writing to be bound by and subject to the terms and conditions of this Agreement.

4.2           Furnishing of Information. During the time a Registration Statement is required to be effective, the Company covenants
to  timely  file  (or  obtain  extensions  in  respect  thereof  and  file  within  the  applicable  grace  period)  all  reports  required  to  be  filed  by  the
Company after the date hereof pursuant to the Exchange Act. Upon the request of the Investor, the Company shall deliver to the Investor a
written certification of a duly authorized officer as to whether it has complied with the preceding sentence. As long as the Investor owns
Securities, if the Company is not required to file reports pursuant to the Exchange Act, it will prepare and furnish to the Investor and make
publicly available in accordance with Rule 144(c) such information as is required for the Investor to sell the Securities under Rule 144. The
Company  further  covenants  that  it  will  take  such  further  action  as  the  Investor  may  reasonably  request,  all  to  the  extent  necessary  from
time  to  time  to  enable  such  Person  to  sell  such  Securities  without  registration  under  the  Securities  Act  within  the  limitation  of  the
exemptions provided by Rule 144.

4.3           Integration. The Company shall not, and shall use its commercially reasonably efforts to ensure that no Affiliate thereof
shall, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities
Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act
of  the  sale  of  the  Securities  to  the  Investor  or  that  would  be  integrated  with  the  offer  or  sale  of  the  Securities  such  that  approval  of  the
stockholders  of  the  Company  would  be  required  pursuant  to  the  rules  and  regulations  of  The  Nasdaq  Stock  Market  or  a  comparable
securities trading market.

-16-

 
 
 
 
 
 
 
 
4 . 4           Reservation of Securities. The Company shall maintain a reserve from its duly authorized shares of Common Stock for
issuance pursuant to the Transaction Documents in such amount as may be required to fulfill its obligations to issue Warrant Shares under
the Transaction Documents. In the event that at any time the then authorized shares of Common Stock are insufficient for the Company to
satisfy  its  obligations  to  issue  such  Warrant  Shares  under  the  Transaction  Documents,  the  Company  shall  promptly  take  such  actions  as
may be required to increase the number of authorized shares.

4.5           Listing of Common Stock. The Company hereby agrees to use best efforts to maintain the listing of the Common Stock
on The Nasdaq Stock Market or a comparable securities trading market, and promptly following the Closing (but not later than the 30 day
anniversary  of  the  Closing)  to  list  the  Shares  and  Warrant  Shares  on  The  Nasdaq  Stock  Market.  The  Company  further  agrees,  if  the
Company applies to have the Common Stock traded on any other securities trading market, it will include in such application the Shares
and the Warrant Shares, and will take such other action as is necessary or desirable in the reasonable opinion of the Investor to cause the
Shares and Warrant Shares to be listed on such other securities trading market as promptly as possible. The Company will take all action
reasonably necessary to continue the listing and trading of its Common Stock on The Nasdaq Stock Market or comparable securities trading
market and will comply in all material respects with the Company’s reporting, filing and other obligations under the by-laws or rules of
such market.

4.6           Anti-Takeover Provisions. If any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or other similar anti-takeover provision under the Company’s charter documents or the Applicable Laws of its
state of incorporation or otherwise, that is or would reasonably be expected to become applicable to the Investor as a result of the Investor
and the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including, without limitation, as a
result of the Company’s issuance of the Securities and/or Investor’s exercise of Warrants and the Investor’s ownership of the Securities,
shall become applicable to the transactions contemplated by the Transaction Documents, the Company and the Board shall use best efforts
to grant such approvals and take such actions as are necessary so that the transactions contemplated by the Transaction Documents may be
consummated as promptly as practicable on the terms contemplated hereby and otherwise act to minimize the effects of any such statute or
regulation on the transactions contemplated hereby.

4.7           Notice of Transactions. Notwithstanding anything to the contrary herein, including Section 4.9, the Company agrees that

until the effective date of the termination of the Strategic Alliance Agreement, [***]. 

-17-

* Confidential Treatment Requested

 
 
 
 
 
 
 
 
4.8         Voting Agreement.

(other than any officer or director of the Investor) (the “Investor Group”) shall:

(a)          During the Voting Period, each of the Investor, any Investor Controlled Entity or any Affiliate of the Investor

(i)          vote all Common Stock of the Company they hold in each vote of the Company’s stockholders in the
manner recommended by the Board; provided that this Section 4.8(a) shall not apply to proposals (i) seeking approvals of the Company’s
stockholders with respect to amendments to the Company’s Certificate of Incorporation or by-laws that directly conflict with the rights of
the Investor under this Agreement, (ii) that directly affect the Investor by naming the Investor specifically in such amendment or (iii) that
seek  approval  of,  or  are  otherwise  made  in  connection  with,  any  transaction,  offer  or  proposal  that  would,  if  consummated,  result  in  a
Change of Control of the Company; and

vote all Common Stock of the Company they hold in favor of individuals recommended by the Board for election to the Board.

(ii)         with respect to votes of the Company’s stockholders relating to the election of members of the Board,

(b)          During the Voting Period, the Investor shall take such actions as may be reasonably necessary to ensure that any
Common  Stock  held  by  any  member  of  the  Investor  Group  are  present  for  any  vote  of  the  Company’s  stockholders  for  purposes  of
establishing a quorum with respect to such vote.

4.9         Standstill.

(a)          The Investor agrees that during the Voting Period, no member of the Investor Group shall directly or indirectly:

(i)                    act,  alone  or  in  concert  with  others,  to  seek  to  control  the  management,  Board  or  policies  of  the

Company;

(ii)                  enter  into  any  joint  venture,  securities  lending  or  option  agreement,  put  or  call,  guarantee  of  loans,
guarantee of profits or division of losses or profits, contract, arrangement or understanding with any Person with respect to any securities of
the Company or any Subsidiary of the Company;

Shares;

(iii)                acquire  additional  shares  of  Voting  Stock  without  the  consent  of  the  Board,  except  for  the  Warrant

(iv)        solicit or participate in the solicitation of proxies with respect to any Voting Stock, or seek to advise or
influence any person with respect to the voting of any Voting Stock (other than as otherwise provided or contemplated by this Agreement);

-18-

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
subject any Voting Stock to any arrangement or agreement with any third party with respect to the voting of such Voting Stock;

(v)         deposit any Voting Stock in a voting trust or, except as otherwise provided or contemplated herein,

purpose of acquiring, holding, voting or disposing of Voting Stock or Non-Voting Convertible Securities;

(vi)                join  a  13D  Group  (other  than  a  group  comprising  solely  of  the  Investor  and  its Affiliates)  for  the

announcement regarding the possibility of a business combination or merger involving the Company or any of its Subsidiaries;

(vii)              take  any  action  which  would  reasonably  be  expected  to  require  the  Company  to  make  a  public

(viii)      publically disclose any intention, plan or arrangement inconsistent with the foregoing;

(ix)         knowingly advise, assist or encourage any other Persons in connection with any of the foregoing; or

or indirectly, amend or waive any provision of this Section 4.9(a) in a manner that requires public disclosure of such request.

(x)          request that the Company (or its respective directors, officers, affiliates, employees or agents), directly

Notwithstanding anything to the contrary in this Agreement, (i) the prohibitions in this Article IV shall not affect
the Investor’s ability to hold the Shares, the Warrants and the Warrant Shares, (ii) the provisions of Section 4.8 and this Section 4.9 shall
not prohibit any member of the Investor Group from making or disclosing any offer or proposal on a confidential basis to the Board (and, if
the Board rejects that offer or proposal or fails to enter onto a binding agreement with respect to such offer or proposal within 30 days,
making a public announcement regarding such offer or proposal) in connection with a potential business combination or merger transaction
with Investor that would result in a Change of Control of the Company, (iii) if a Change of Control of the Company has occurred, then the
provisions of Section 4.7, Section 4.8 and this Section 4.9 shall immediately terminate without further force or effect and the Company and
the  Investor  shall  be  released  from  compliance  therewith,  (iv)  if  (x)  the  Company  has  entered  into  any  agreement  to  effect  a  Change  of
Control  of  the  Company  or  (y)  a  third  party  has  made  a  public  offer  or  proposal  (including  a  tender  or  exchange  offer)  or  publicly
announced an intention to make any such offer or proposal that would, if consummated, result in a Change of Control of the Company,
then, in each case in this clause (iv), the Company and the Investor shall be released from the provisions of Section 4.7, Section 4.8 and this
Section  4.9  for  the  pendency  of  such  agreement,  offer  or  proposal,  and  (v)  the  provisions  of  Section  4.8  and  this  Section  4.9  shall  not
prohibit the Investor from disclosing the acquisition of the Shares, Warrants and Warrant Shares hereunder on Form 13D or Form 13G,
provided that the Investor shall give the Company prior notice of such filing.

-19-

 
 
 
 
 
 
 
 
 
 
 
4 . 1 0       Lock-Up. The Investor hereby agrees not to sell, transfer or otherwise dispose of, directly or indirectly, any Shares or
Warrant  Shares  or  enter  into  any  swap  or  other  arrangement  that  transfers  to  another  Person  any  of  the  economic  consequences  of
ownership  of  Shares  or  Warrant  Shares  until  the  six  month  anniversary  of  the  Closing,  except  (i)  to  the  Company,  (ii)  in  response  to  a
Change of Control (or agreement related to a Change of Control), or a tender or exchange offer for the Common Stock (other than a tender
or exchange offer by any member of the Investor Group), (iii) as part of a merger or other transaction in which all outstanding shares of
Common  Stock  of  the  Company  are  converted  into  or  exchanged  for  other  consideration  and  is  approved  by  the  stockholders  of  the
Company, (iv) a transfer to an Affiliate of the Investor, provided such Affiliate agrees in writing to be bound by the terms of Section 4.1,
Section 4.8, Section 4.9, and this Section 4.10, or (v) with prior Board approval. From and after the six month anniversary of the Closing
Date through the end of the Voting Period, the Investor hereby agrees not to sell, transfer or otherwise dispose of Shares or Warrant Shares
in  any  calendar  week  in  an  amount  in  excess  of  1%  of  the  total  outstanding  shares  of  the  Company,  other  than  (i)  in  any  transaction
provided for in clauses (i) – (v) of the immediately preceding sentence or (ii) pursuant to an underwritten offering or a block trade executed
on behalf of Investor.

4.11       Press Releases. No later than the Trading Day immediately following the execution of this Agreement, the Company will
issue  a  press  release  disclosing  the  transactions  contemplated  by  the Agreement,  and  the  Company  shall  file  a  Form  8-K  relating  to  the
Transaction Documents. The Company shall provide the Investor with a reasonable opportunity to review and provide comments on the
drafts of such press release and Form 8-K. The Company and the Investor shall consult with each other in issuing any subsequent press
releases with respect to the transactions contemplated hereby, and the Company and the Investor shall not issue any such subsequent press
release or otherwise make any such public statement without the prior consent of the other party, which consent shall not be unreasonably
withheld,  conditioned  or  delayed,  except  if  such  disclosure  is  required  by Applicable  Law,  in  which  case  the  disclosing  party  shall  if
possible promptly provide the other party with prior notice of such public statement or communication.

4.12       Antitrust Filings. If the exercise of the Warrants requires any antitrust filings under Applicable Law, then the Investor and

the Company agree to make any such required filings and to cooperate with each other in making any such filings.

4 . 1 3        Information Rights. Until such time that Investor has sold, transferred or otherwise disposed of, directly or indirectly,
more than 381,776 Shares, the Company will furnish, or cause to be furnished, to the Investor such additional information regarding the
Investor's investment in the Company as the Investor may reasonably request, including such information as is necessary or appropriate to
permit the Investor Group to comply on a timely basis with their financial reporting obligations in respect of the Investor's investment in the
Company. Any such information will be subject to the provisions of, and treated as “Confidential Information” under, that certain strategic
alliance agreement, dated as of November 6, 2016, between the Company and Investor.

5.1         Conditions Precedent to the Obligations of the Investor. The obligation of the Investor to acquire Securities at the Closing

is subject to the satisfaction or waiver by the Investor, at the Closing, of each of the following conditions:

ARTICLE V
CONDITIONS PRECEDENT

-20-

 
 
 
 
 
 
 
 
 
 
( a )          Representations and Warranties . The representations and warranties of the Company contained herein shall be
true  and  correct  in  all  material  respects  (other  than  those  representations  and  warranties  that  are  qualified  by  materiality  or  Material
Adverse Effect qualifiers, which shall be true and correct in all respects) as of the date when made and as of the Closing as though made on
and as of such date.

( b )          Performance.  The  Company  shall  have  performed,  satisfied  and  complied  in  all  material  respects  with  all
covenants, agreements and conditions required by the Transaction Documents to be performed, satisfied or complied with by it at or prior
to the Closing.

( c )          No  Stockholder Approval  Required .  No  approval  on  the  part  of  the  stockholders  of  the  Company  shall  be
required in connection with the execution and delivery by the Company of this Agreement and the other Transaction Documents and the
consummation of the transactions to be performed by the Company contemplated by the Transaction Documents.

(d)          Regulatory Approvals. All material approvals, authorizations and consents of any governmental entity or Person
required  to  consummate  the  transactions  contemplated  by  this  Agreement  and  the  other  Transaction  Documents  (including  any  such
approvals, authorizations and consents under applicable foreign antitrust laws) shall have been obtained and remain in full force and effect,
and all statutory waiting periods relating to such approvals, authorizations and consents shall have expired or been terminated.

( e )          Qualification  Under  State  Securities  Laws. All  registrations,  qualifications,  permits  and  approvals,  if  any,
required to be obtained prior to the Closing under applicable state securities laws shall have been obtained for the lawful execution, delivery
and performance of this Agreement and the other Transaction Documents, including, without limitation, the offer and sale of the Securities.

( f )           No Litigation. No litigation, order, writ, injunction, judgment, decree or other claim shall be pending or, to the
knowledge of the Investor, threatened that questions the validity of this Agreement or the other Transaction Documents or the right of the
Company or the Investor to enter into such agreements or to consummate the transactions contemplated hereby and thereby.

( g )           No Violation. No statute, rule, regulation, order, or interpretation shall have been enacted, entered or deemed
applicable by any domestic or foreign government or governmental or administrative agency or court which would make the transactions
contemplated by the Agreement or the other Transaction Documents illegal.

5 . 2         Conditions Precedent to the Obligations of the Company. The obligation of the Company to sell the Securities at the

Closing is subject to the satisfaction or waiver by the Company, at the Closing, of each of the following conditions:

true and correct in all material respects as of the date when made and as of the Closing Date as though made on and as of such date.

( a )           Representations and Warranties . The representations and warranties of the Investor contained herein shall be

-21-

 
 
 
 
 
 
 
 
 
 
 
 
 
( b )          Performance.  The  Investor  shall  have  performed,  satisfied  and  complied  in  all  material  respects  with  all
covenants,  agreements  and  conditions  required  by  this Agreement  and  the  other  Transaction  Documents  to  be  performed,  satisfied  or
complied with by the Investor at or prior to the Closing.

(c)          Regulatory Approvals. All material approvals, authorizations and consents of any governmental entity or Person
required  to  consummate  the  transactions  contemplated  by  this  Agreement  and  the  other  Transaction  Documents  (including  any  such
approvals, authorizations and consents under applicable foreign antitrust laws) shall have been obtained and remain in full force and effect,
and all statutory waiting periods relating to such approvals, authorizations and consents shall have expired or been terminated.

( d )          Qualification  Under  State  Securities  Laws. All  registrations,  qualifications,  permits  and  approvals,  if  any,
required to be obtained prior to the Closing under applicable state securities laws shall have been obtained for the lawful execution, delivery
and performance of this Agreement and the other Transaction Documents, including, without limitation, the offer and sale of the Securities.

( e )          No Litigation. No litigation, order, writ, injunction, judgment, decree or other claim shall be pending or, to the
knowledge of the Company, threatened that questions the validity of this Agreement or the other Transaction Documents or the right of the
Company or the Investor to enter into such agreements or to consummate the transactions contemplated hereby and thereby.

( f )          No Violation. No statute, rule, regulation, order, or interpretation shall have been enacted, entered or deemed
applicable by any domestic or foreign government or governmental or administrative agency or court which would make the transactions
contemplated by this Agreement or the other Transaction Documents illegal.

6.1         Registration Statement.

ARTICLE VI
REGISTRATION RIGHTS

(a)          Until such time as the date that all Registrable Securities covered by such Registration Statement have been sold
or  can  be  sold  publicly  under  Rule  144  without  volume  limitation,  upon  written  request  by  the  Investor,  the  Company  shall,  as  soon  as
reasonably  practicable  following  Investor’s  request,  prepare  and  file  with  the  SEC  a  Registration  Statement  covering  the  resale  of  such
portion of the Registrable Securities requested by the Investor for an offering to be made on a continuous basis pursuant to Rule 415. Each
Registration Statement shall be on Form S-3 or any successor form thereto (except if the Company is not then eligible to register for resale
the Registrable Securities on Form S-3 or any successor form thereto, in which case such registration shall be on another appropriate form
in accordance with the Securities Act and the Exchange Act). The Company shall not be obligated to file and have declared effective more
than  two  (2)  Registration  Statements  per  year  pursuant  to  this Article  VI  and  each  registration  hereunder  shall  include  Registrable
Securities  consisting  of  not  less  than  100,000  shares  of  Common  Stock  (as  adjusted  by  any  stock  split,  dividend  or  other  distribution,
recapitalization or similar event).

-22-

 
 
 
 
 
 
 
 
 
 
 
 
(b)          The Company shall use its best efforts to cause each Registration Statement to be declared effective by the SEC
as promptly as practical after the filing thereof (but in no event sooner than six (6) months after the Closing Date of this Agreement), and,
subject to Section 6.1(e), shall use its best efforts to keep each Registration Statement continuously effective under the Securities Act for all
Registrable Securities for a period up to the earlier of seventy five (75) days or until the date that all Registrable Securities covered by such
Registration Statement have been sold or can be sold publicly under Rule 144 on a single day (the “Effectiveness Period”).

receiving notification from the SEC that a Registration Statement has been declared effective.

(c)          The Company shall notify the Investor in writing promptly (and in any event within two (2) Trading Days) after

under the Securities Act to effect the registration contemplated hereunder.

(d)          The Company may require the Investor to provide such information regarding the Investor as may be required

(e)          If at any time after a Registration Statement has become effective, the Company is engaged in any plan, proposal
or  agreement  with  respect  to  any  financing,  acquisition,  recapitalization,  reorganization  or  other  material  transaction  or  development  the
public disclosure of which would be detrimental to the Company, then the Company may direct that such request be delayed or that use of
the  Prospectus  contained  in  such  Registration  Statement  be  suspended,  as  applicable,  for  a  period  of  up  to  forty-five  (45)  days.  The
Company  will  notify  the  Investor  of  the  delay  or  suspension.  In  the  case  of  notice  suspending  an  effective  Registration  Statement,  the
Investor  will  immediately  discontinue  any  sales  of  Registrable  Securities  pursuant  to  such  Registration  Statement  until  the  Investor  has
received copies of a supplemented or amended Prospectus or until the Investor is advised in writing by the Company that the then-current
Prospectus may be used and has received copies of any additional or supplemental filings that are incorporated or deemed incorporated by
reference in such Prospectus. The Company may exercise the rights provided by this Section 6.1(e) for an aggregate of ninety (90) days
within any 365-day period.

Securities covered by a Registration Statement.

(f)                    The  Company  will  use  its  best  efforts  to  cooperate  with  the  Investor  in  the  disposition  of  the  Registrable

6.2         Registration Procedures. In connection with the Company’s registration obligations hereunder, the Company shall:

(a)          (i) Prepare and file with the SEC such amendments, including post-effective amendments, to each Registration
Statement and the Prospectus used in connection therewith as may be necessary to keep each Registration Statement continuously effective,
as  to  the  applicable  Registrable  Securities  for  the  Effectiveness  Period  and  prepare  and  file  with  the  SEC  such  additional  Registration
Statements in order to register for resale under the Securities Act all of the Registrable Securities during the Effectiveness Period; (ii) cause
the related Prospectus to be amended or supplemented by any required Prospectus supplement, and as so supplemented or amended to be
filed pursuant to Rule 424; (iii) respond as promptly as reasonably practical, to any comments received from the SEC with respect to each
Registration Statement or any amendment thereto; and (iv) comply in all material respects with the provisions of the Securities Act and the
Exchange Act applicable to the Company with respect to the disposition of all Registrable Securities covered by a Registration Statement
during  the  applicable  period  in  accordance  with  the  intended  methods  of  disposition  by  the  Investor  thereof  set  forth  in  a  Registration
Statement as so amended or in such Prospectus as so supplemented.

-23-

 
 
 
 
 
 
 
 
 
 
 
(b)          Notify the Investor as promptly as reasonably practical, and confirm such notice in writing no later than two (2)
Trading  Days  thereafter,  of  any  of  the  following  events:  (i)  any  Registration  Statement  or  any  post-effective  amendment  is  declared
effective;  (ii)  the  Company  becomes  aware  that  the  SEC  has  issued  any  stop  order  suspending  the  effectiveness  of  any  Registration
Statement  or  initiates  any  Proceedings  for  that  purpose;  (iii)  the  Company  receives  notice  of  any  suspension  of  the  qualification  or
exemption from qualification of any Registrable Securities for sale in any jurisdiction, or the initiation or threat of any Proceeding for such
purpose; or (iv) the financial statements included in any Registration Statement become ineligible for inclusion therein or any Registration
Statement or Prospectus or other document contains any untrue statement of a material fact or omits to state any material fact required to be
stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.

(c)          Use its best efforts to avoid the issuance of or, if issued, obtain the withdrawal of (i) any order suspending the
effectiveness  of  any  Registration  Statement,  or  (ii)  any  suspension  of  the  qualification  (or  exemption  from  qualification)  of  any  of  the
Registrable Securities for sale in any jurisdiction, as soon as possible.

(d)          If requested by the Investor, promptly provide the Investor, without charge, at least one conformed copy of each
Registration Statement and each amendment thereto, including financial statements and schedules, and all exhibits to the extent requested
by the Investor (including those previously furnished or incorporated by reference) promptly after the filing of such documents with the
SEC.

(e)          Promptly deliver to the Investor, without charge, as many copies of the Prospectus or Prospectuses (including
each  form  of  prospectus)  and  each  amendment  or  supplement  thereto  as  the  Investor  may  reasonably  request.  The  Company  hereby
consents to the use of such Prospectus and each amendment or supplement thereto by the Investor in connection with the offering and sale
of the Registrable Securities covered by such Prospectus and any amendment or supplement thereto to the extent permitted by federal and
state securities laws and regulations.

(f)          Prior to any public offering of Registrable Securities, use its best efforts to register or qualify or cooperate with
the Investor in connection with the registration or qualification (or exemption from such registration or qualification) of such Registrable
Securities for offer and sale under the securities or Blue Sky laws of such jurisdictions within the United States as the Investor requests in
writing,  to  keep  each  such  registration  or  qualification  (or  exemption  therefrom)  effective  for  so  long  as  required,  but  not  to  exceed  the
duration of the Effectiveness Period, and to do any and all other acts or things reasonably necessary or advisable to enable the disposition in
such  jurisdictions  of  the  Registrable  Securities  covered  by  a  Registration  Statement; provided, however,  that  the  Company  shall  not  be
obligated to file any general consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction
in which it would not otherwise be required to qualify but for this Section 6.2(f) or to subject itself to taxation in respect of doing business
in any jurisdiction in which it is not otherwise so subject.

-24-

 
 
 
 
 
 
 
 
 
(g)          Upon sale of such Registrable Securities pursuant to an effective Registration Statement, cooperate with the
Investor to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be delivered to a transferee,
which  certificates  shall  be  free,  to  the  extent  permitted  by  this Agreement  and  under Applicable  Law,  of  all  restrictive  legends,  and  to
enable such Registrable Securities to be in such denominations and registered in such names as any the Investor may reasonably request.

(h)          Promptly upon the occurrence of any event described in Section 6.2(b)(iv), prepare a supplement or amendment,
including a post-effective amendment, to a Registration Statement or a supplement to the related Prospectus or any document incorporated
or  deemed  to  be  incorporated  therein  by  reference,  and  file  any  other  required  document  so  that,  as  thereafter  delivered,  neither  such
Registration Statement nor such Prospectus will contain an untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.

of the Securities.

(i)          Comply with all rules and regulations of the SEC applicable to the Company in connection with the registration

(j)          The Company shall comply with all applicable rules and regulations of the SEC under the Securities Act and the
Exchange Act,  including,  without  limitation,  Rule  172  under  the  Securities Act,  file  any  final  Prospectus,  including  any  supplement  or
amendment thereof, with the SEC pursuant to Rule 424  under  the  Securities Act,  promptly  inform  the  holders  in  writing  if,  at  any  time
during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof, the holders are
required to make available a Prospectus in connection with any disposition of Registrable Securities and take such other actions as may be
reasonably necessary to facilitate the registration of the Registrable Securities hereunder.

6 . 3         Registration Expenses. The Company shall pay all fees and expenses incident to the performance of or compliance with
Article VI of this Agreement, including, without limitation, (a) all registration and filing fees and expenses, including without limitation
those related to filings with the SEC, The Nasdaq Stock Market or comparable securities trading market and in connection with applicable
state  securities  or  Blue  Sky  laws,  (b)  printing  expenses  (including  without  limitation  expenses  of  printing  certificates  for  Registrable
Securities),  (c)  messenger,  telephone  and  delivery  expenses  incurred  by  the  Company,  (d)  fees  and  disbursements  of  counsel  for  the
Company, (e) fees and expenses of all other Persons retained by the Company in connection with the consummation of the transactions
contemplated  by  this Agreement,  (f)  reasonable  fees  and  expenses  of  one  special  counsel  for  the  Investor  (not  to  exceed  $25,000  per
registration or $100,000 in the aggregate for all registrations pursuant to this Agreement); and (g) all listing fees to be paid by the Company
to  The  Nasdaq  Stock  Market  or  comparable  securities  trading  market; provided, however, that the Company shall not be responsible for
underwriting discounts and commissions of the Investor.

-25-

 
 
 
 
 
 
 
 
 
6.4         Indemnification.

( a )          Indemnification  by  the  Company .  The  Company  shall,  notwithstanding  any  termination  of  this Agreement,
indemnify and hold harmless the Investor, the officers, directors, partners, members, agents and employees of each of them, each Person
who  controls  the  Investor  (within  the  meaning  of  Section  15  of  the  Securities Act  or  Section  20  of  the  Exchange Act)  and  the  officers,
directors,  partners,  members,  agents  and  employees  of  each  such  controlling  Person,  to  the  fullest  extent  permitted  by Applicable  Law,
from  and  against  all  Losses  arising  out  of  or  relating  to  any  untrue  or  alleged  untrue  statement  of  a  material  fact  contained  in  any
Registration Statement, any Prospectus or any form of Company prospectus or in any amendment or supplement thereto or in any Company
preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or
necessary  to  make  the  statements  therein  (in  the  case  of  any  Prospectus  or  form  of  prospectus  or  supplement  thereto,  in  the  light  of  the
circumstances under which they were made) not misleading, provided, however, that the Company shall not be liable in any such case to
the extent that such Losses arise out of, or are based upon, an untrue statement or omission or alleged untrue statement or omission made in
such  Registration  Statement  in  reliance  upon  and  in  conformity  with  information  that  relates  solely  to  the  Investor  or  the  Investor’s
proposed  method  of  distribution  of  Registrable  Securities  and  was  provided  by  the  Investor  in  writing  for  use  in  such  Registration
Statement, such Prospectus or such form of Prospectus or in any amendment or supplement thereto.

( b )          Indemnification  by  the  Investor.  The  Investor  shall,  notwithstanding  any  termination  of  this Agreement,
indemnify and hold harmless the Company, its officers, directors, partners, members, agents and employees of each of them, each Person
who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the officers,
directors,  partners,  members,  agents  and  employees  of  each  such  controlling  Person,  to  the  fullest  extent  permitted  by Applicable  Law,
from and against all Losses arising out of any untrue statement of a material fact contained in any Registration Statement, any Prospectus or
any form of Company prospectus or in any amendment or supplement thereto or in any Company preliminary prospectus, or arising out of
or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein
(in the case of any Prospectus or form of prospectus or supplement thereto, in the light of the circumstances under which they were made)
not misleading, in each case, on the effective date thereof, but only to the extent that such untrue statement or omission is based solely upon
information regarding the Investor furnished to the Company by the Investor in writing expressly for use therein, or to the extent that such
information solely relates to the Investor or the Investor’s proposed method of distribution of Registrable Securities and was provided by
the Investor for use in such Registration Statement, such Prospectus or such form of Prospectus or in any amendment or supplement thereto.
In no event shall the liability of the Investor under this Article VI be greater in amount than the dollar amount of the net proceeds received
by the Investor upon the sale of the Registrable Securities giving rise to such indemnification obligation.

-26-

 
 
 
 
 
 
 
( c )          Conduct of Indemnification Proceedings .  If  any  Proceeding  shall  be  brought  or  asserted  against  any  Person
entitled to indemnity hereunder (an “Indemnified Party”), such Indemnified Party shall promptly notify the Person from whom indemnity
is sought (the “Indemnifying Party”) in writing, and the Indemnifying Party shall assume the defense thereof, including the employment
of counsel reasonably satisfactory to the Indemnified Party and the payment of all reasonable fees and expenses incurred in connection with
defense  thereof; provided,  that  the  failure  of  any  Indemnified  Party  to  give  such  notice  shall  not  relieve  the  Indemnifying  Party  of  its
obligations or liabilities pursuant to this Agreement, except (and only) to the extent that such failure shall have materially and adversely
prejudiced the Indemnifying Party. An Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to
participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties
unless:  (i)  the  Indemnifying  Party  has  agreed  in  writing  to  pay  such  fees  and  expenses;  (ii)  the  Indemnifying  Party  shall  have  failed
promptly to assume the defense of such Proceeding; or (iii) the named parties to any such Proceeding (including any impleaded parties)
include  both  such  Indemnified  Party  and  the  Indemnifying  Party,  and  such  Indemnified  Party  shall  have  been  advised  by  counsel  that  a
conflict  of  interest  is  likely  to  exist  if  the  same  counsel  were  to  represent  such  Indemnified  Party  and  the  Indemnifying  Party  or  that
additional  or  different  defenses  may  be  available  to  the  Indemnified  Party  (in  which  case,  if  such  Indemnified  Party  notifies  the
Indemnifying Party in writing that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party
shall not have the right to assume the defense thereof and the reasonable fees and expenses of separate counsel shall be at the expense of
the Indemnifying Party), it being understood, however, that the Indemnifying Party shall not, in connection with any one such Proceeding
(including separate Proceedings that have been or will be consolidated before a single judge) be liable for the fees and expenses of more
than one separate firm of attorneys at any time for all Indemnified Parties. The Indemnifying Party shall not be liable for any settlement of
any such Proceeding effected without its written consent, unless such consent is unreasonably withheld or delayed. No Indemnifying Party
shall, without the prior written consent of the Indemnified Party, effect any settlement of any pending Proceeding in respect of which any
Indemnified Party is a party, unless such settlement includes an unconditional release of such Indemnified Party from all liability on claims
that are the subject matter of such Proceeding. All reasonable fees and expenses of the Indemnified Party (including reasonable fees and
expenses to the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with
this Section 6.4(c))  shall  be  paid  to  the  Indemnified  Party,  as  incurred,  within  twenty  (20)  Trading  Days  of  written  notice  thereof  to  the
Indemnifying Party (regardless of whether it is ultimately determined that an Indemnified Party is not entitled to indemnification hereunder;
provided, that the Indemnifying Party shall reimburse all such fees and expenses to the extent it is finally judicially determined that such
Indemnified Party is not entitled to indemnification hereunder).

-27-

 
 
 
 
 
( d )          Contribution. If a claim for indemnification under Section 6.4(a) or (b) is unavailable to an Indemnified Party
(by reason of public policy or otherwise), then each Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to
the amount paid or payable by such Indemnified Party as a result of such Losses, in such proportion as is appropriate to reflect the relative
fault of the Indemnifying Party and Indemnified Party in connection with the actions, statements or omissions that resulted in such Losses
as  well  as  any  other  relevant  equitable  considerations.  The  relative  fault  of  such  Indemnifying  Party  and  Indemnified  Party  shall  be
determined  by  reference  to,  among  other  things,  whether  any  action  in  question,  including  any  untrue  or  alleged  untrue  statement  of  a
material  fact  or  omission  or  alleged  omission  of  a  material  fact,  has  been  taken  or  made  by,  or  relates  to  information  supplied  by,  such
Indemnifying Party or Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or
prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include,
subject to the limitations set forth in Section 6.4(c), any reasonable attorneys’ or other reasonable fees or expenses incurred by such party in
connection  with  any  Proceeding  to  the  extent  such  party  would  have  been  indemnified  for  such  fees  or  expenses  if  the  indemnification
provided for in this Section 6.4(d) was available to such party in accordance with its terms. The parties hereto agree that it would not be just
and equitable if contribution pursuant to this Section 6.4(d) were determined by pro rata allocation or by any other method of allocation that
does not take into account the equitable considerations referred to in the immediately preceding paragraph. Notwithstanding the provisions
of this Section 6.4(d), the Investor shall not be required to contribute, in the aggregate, any amount in excess of the amount by which the
net proceeds actually received by the Investor from the sale of the Registrable Securities subject to the Proceeding exceeds the amount of
any  damages  that  the  Investor  has  otherwise  been  required  to  pay  by  reason  of  such  untrue  or  alleged  untrue  statement  or  omission  or
alleged  omission.  No  Person  guilty  of  fraudulent  misrepresentation  (within  the  meaning  of  Section  11(f)  of  the  Securities Act)  shall  be
entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation.

6 . 5         Dispositions. The Investor agrees that it will comply with the prospectus delivery requirements of the Securities Act as
applicable  to  it  in  connection  with  sales  of  Registrable  Securities  pursuant  to  a  Registration  Statement  and  shall  sell  its  Registrable
Securities in accordance with the Plan of Distribution set forth in the Prospectus. The Investor further agrees that, upon receipt of a notice
from the Company of the occurrence of any event of the kind described in Sections 6.2(b)(ii), (iii) or (iv), the Investor will use best efforts
to discontinue disposition of Registrable Securities under a Registration Statement until the Investor is advised in writing by the Company
that  the  use  of  the  Prospectus,  or  amended  Prospectus,  as  applicable,  may  be  used.  The  Investor  acknowledges  and  agrees  that  the
provisions of Section 4.9 of this Agreement shall apply with respect to any proposed disposition pursuant to a Registration Statement filed
pursuant to this Article VI. The Company may provide appropriate stop orders to enforce the provisions of this paragraph.

6.6         [Reserved.]

6 . 7         Assignment  of  Registration  Rights.  The  registration  rights  under  this Article VI  of  this Agreement  with  respect  to
applicable shares transferred by Investor pursuant to this agreement shall be automatically transferred to any transferee of all or any portion
of Investor’s Registrable Securities, to the extent of such shares transferred, if (a) Investor agrees in writing with the transferee or assignee
to assign such rights and a copy of such agreement is furnished to the Company within a reasonable time after such assignment; (b) the
Company is furnished with written notice of (i) the name and address of such transferee and (ii) the securities with respect to which such
registration  rights  are  being  transferred;  (c)  following  such  transfer  or  assignment,  the  further  disposition  of  such  securities  by  the
transferee is restricted under this Agreement, the Securities Act and applicable state securities laws; (d) at or before the time the Company
receives the written notice contemplated by clause (b) of this sentence the transferee agrees in writing to be bound by all of the provisions
of this Agreement; and (e) such transfer shall have been made in accordance with the applicable requirements of this Agreement.

-28-

 
 
 
 
 
 
 
 
ARTICLE VII
MISCELLANEOUS

7 . 1         Termination. This Agreement may be terminated by the Company or the Investor, by written notice to the other, if the
Closing has not been consummated by the third Business Day following the date of this Agreement;  provided, that no such termination will
affect the right of any party to sue for any breach by the other party (or parties).

7 . 2         Fees and Expenses. The Company shall pay all Transfer Agent fees, documentary, stamp, issue and transfer taxes and

other taxes and duties levied in connection with the sale, issuance and transfer of the Securities.

7 . 3         Entire Agreement.  The  Transaction  Documents,  the  Strategic Alliance Agreement  and  the  non-disclosure  agreement
dated  April  9,  2014  between  the  Company  and  the  Investor,  together  with  the  exhibits  and  schedules  thereto,  contain  the  entire
understanding  of  the  parties  with  respect  to  the  subject  matter  hereof  and  supersede  all  prior  agreements  and  understandings,  oral  or
written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

7 . 4         Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is
delivered via facsimile at the facsimile number specified in this Section 7.4 prior to 6:30 p.m. (New York City time) on a Trading Day, (b)
the  next  Trading  Day  after  the  date  of  transmission,  if  such  notice  or  communication  is  delivered  via  facsimile  at  the  facsimile  number
specified in this Section 7.4 on a day that is not a Trading Day or later than 6:30 p.m. (New York City time) on any Trading Day, (c) the
Trading Day following the date of deposit with a nationally recognized overnight courier service, or (d) upon actual receipt by the party to
whom such notice is required to be given. The addresses, facsimile numbers for such notices and communications are as follows:

Notices for the Company:

Energous Corporation, Inc.
3590 North First Street, Suite 210
San Jose, CA 95134
Attention:  Brian Sereda
Telephone No.:  (408) 963-0200

-29-

 
 
 
 
 
 
 
 
 
 
 
With a copy to:

Fenwick & West LLP
801 California Street
Mountain View, CA 94041
Attention:  Mark Leahy and Horace Nash
Telephone No.:  (650) 988-8500
Facsimile No.:   (650) 938-5200

Notices for the Investor:

Dialog Semiconductor plc
100 Longwater Avenue
Green Park
Reading, RG2 6GP
Attn: Legal Department
Telephone No.: +44 (0) 1793 757700

7.5         Amendments; Waivers. No provision of this Agreement may be waived or amended except in a written instrument signed,
in the case of an amendment, by the Company and the Investor or in the case of a waiver, by the party against whom the waiver is to be
effective.  No  waiver  of  any  default  with  respect  to  any  provision,  condition  or  requirement  of  this Agreement  shall  be  deemed  to  be  a
continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof,
nor shall any delay or omission of either party to exercise any right hereunder in any manner impair the exercise of any such right.

7 . 6         Construction. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be
deemed to limit or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen by
the parties to express their mutual intent, and no rules of strict construction will be applied against any party.

7.7         Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and  permitted  assigns.  The  Company  shall  not  assign  this Agreement  or  any  rights  or  obligations  hereunder  without  the  prior  written
consent of the Investor. Notwithstanding the foregoing, nothing in this Section 7.7 shall prevent any assignment of this Agreement by the
Company or the Investor that is deemed to occur in connection with a Change of Control of the Company. The Investor may assign some
or all of its rights hereunder in connection with transfer of any of its Securities without the consent of the Company, in which event such
assignee shall be deemed to be an Investor hereunder with respect to such assigned rights.

7 . 8         No  Third-Party  Beneficiaries.  This Agreement  is  intended  for  the  benefit  of  the  parties  hereto  and  their  respective
successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except that
each Indemnified Party is an intended third party beneficiary of Section 6.4 and (in each case) may enforce the provisions of such Section
6.4 directly against the parties with obligations thereunder.

-30-

 
 
 
 
 
 
 
 
 
 
 
 
7

.

9         Governing  Law;  Venue;  Service  of  Process;  Waiver  of  Jury  Trial .  ALL  QUESTIONS  CONCERNING  THE

CONSTRUCTION,  VALIDITY,  ENFORCEMENT AND  INTERPRETATION  OF  THIS AGREEMENT  SHALL  BE  GOVERNED  BY
AND  CONSTRUED  IN ACCORDANCE  WITH  THE  LAWS  OF  THE  STATE  OF  NEW  YORK,  WITHOUT  GIVING  EFFECT  TO
THAT BODY OF LAWS PERTAINING TO CONFLICT OF LAWS. EACH PARTY HEREBY IRREVOCABLY SUBMITS TO THE
NON-EXCLUSIVE  JURISDICTION  OF  THE  STATE  AND  FEDERAL  COURTS  SITTING  IN  THE  CITY  OF  NEW  YORK,
BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH
OR WITH ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED HEREIN (INCLUDING WITH RESPECT TO THE
ENFORCEMENT  OF ANY  OF  THE  TRANSACTION  DOCUMENTS), AND  HEREBY  IRREVOCABLY  WAIVES, AND AGREES
NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE
JURISDICTION  OF ANY  SUCH  COURT AND  THAT  SUCH  SUIT, ACTION  OR  PROCEEDING  IS  IMPROPER.  EACH  PARTY
HEREBY  IRREVOCABLY  WAIVES  PERSONAL  SERVICE  OF  PROCESS AND  CONSENTS  TO  PROCESS  BEING  SERVED  IN
ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF VIA REGISTERED OR CERTIFIED MAIL OR
OVERNIGHT DELIVERY (WITH EVIDENCE OF DELIVERY) TO SUCH PARTY AT THE ADDRESS IN EFFECT FOR NOTICES
TO  IT  UNDER  THIS  AGREEMENT  AND  AGREES  THAT  SUCH  SERVICE  SHALL  CONSTITUTE  GOOD  AND  SUFFICIENT
SERVICE  OF  PROCESS AND  NOTICE  THEREOF.  NOTHING  CONTAINED  HEREIN  SHALL  BE  DEEMED  TO  LIMIT  IN ANY
WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW. THE COMPANY AND INVESTOR HEREBY
WAIVE ALL RIGHTS TO A TRIAL BY JURY.

7 . 1 0       Survival. The representations and warranties contained herein shall survive the Closing. The agreements and covenants

contained herein shall survive the Closing in accordance with their respective terms.

7 . 1 1       Execution.  This Agreement  may  be  executed  in  two  or  more  counterparts,  all  of  which  when  taken  together  shall  be
considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the
other  party,  it  being  understood  that  both  parties  need  not  sign  the  same  counterpart.  In  the  event  that  any  signature  is  delivered  by
facsimile transmission or email attachment, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf  such  signature  is  executed)  with  the  same  force  and  effect  as  if  such  facsimile  or  email-attached  signature  page  were  an  original
thereof.

7 . 1 2       Severability. If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and
enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties
will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing, shall incorporate
such substitute provision in this Agreement.

-31-

 
 
 
 
 
 
 
 
7.13       Replacement of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall promptly issue or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and
substitution therefor, a new certificate or instrument, and the Investor will pay only those costs and expenses that are customarily charged
by or on behalf the Company or the Transfer Agent to any stockholder of the Company in connection therewith. The Company may require
the execution by the holder thereof of a customary lost certificate affidavit of that fact and a customary agreement to indemnify and hold
harmless the Company (and Transfer Agent, if applicable) for any losses in connection therewith.

7 . 1 4       Remedies. In addition to being entitled to exercise all rights provided herein or granted by Applicable Law, including
recovery of damages, the Investor and the Company will be entitled to seek specific performance under the Transaction Documents. The
parties  agree  that  monetary  damages  may  not  be  adequate  compensation  for  any  loss  incurred  by  reason  of  any  breach  of  obligations
described in the foregoing sentence and hereby agrees to waive in any action for specific performance of any such obligation (other than in
connection with any action for temporary restraining order) the defense that a remedy at law would be adequate.

7.15       Adjustments in Share Numbers and Prices. In the event of any stock split, subdivision, dividend or distribution payable in
shares of Common Stock (or other securities or rights convertible into, or entitling the holder thereof to receive directly or indirectly shares
of  Common  Stock),  combination  or  other  similar  recapitalization  or  event  occurring  after  the  date  hereof  and  prior  to  the  Closing,  each
reference in any Transaction Document to a number of shares or a price per share shall be amended to appropriately account for such event.

[SIGNATURE PAGES TO FOLLOW]

-32-

 
 
 
 
 
 
 
 
IN  WITNESS  WHEREOF,  the  parties  hereto  have  caused  this  Securities  Purchase  Agreement  to  be  duly  executed  by  their

respective authorized signatories as of the date first indicated above.

COMPANY:

ENERGOUS CORPORATION, INC.

By: /s/ Stephen R. Rizzone

Name: Stephen R. Rizzone

Title: President and Chief Executive Officer

Signature Page to Securities Purchase Agreement

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INVESTOR:

DIALOG SEMICONDUCTOR PLC

By: /s/ Mark Tyndall

Name: Mark Tyndall

Title: SVP Corporate Development and Strategy

Signature Page to Securities Purchase Agreement

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exhibits:

A

B

C

Securities Purchased

Form of Warrant

Form of Secretary’s Certificate - Company

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dialog Semiconductor plc.

Investor

  Common Stock     Warrants
763,552     

763,552    $

    Purchase Price  
10,000,011.48 

EXHIBIT A
SECURITIES PURCHASED

 
 
 
   
 
 
Exhibit B
FORM OF WARRANT

 
 
 
 
NEITHER  THESE  SECURITIES  NOR  THE  SECURITIES  FOR  WHICH  THESE  SECURITIES ARE  EXERCISABLE  HAVE
BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF
ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION  FROM,  OR  IN  A  TRANSACTION  NOT  SUBJECT  TO,  THE  REGISTRATION  REQUIREMENTS  OF  THE
SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THESE SECURITIES AND
THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A
BONA  FIDE  MARGIN ACCOUNT  OR  OTHER  LOAN  SECURED  BY  SUCH  SECURITIES  IN ACCORDANCE  WITH  THE
PURCHASE AGREEMENT (AS DEFINED BELOW).

ENERGOUS CORPORATION

WARRANT

Warrant No. 002

Dated:  November [__], 2016

Energous  Corporation,  a  Delaware  corporation  (the  “Company”),  hereby  certifies  that,  for  value  received,  Dialog
Semiconductor plc., a public limited company organized under the laws of England and Wales (“Dialog”), or its successors or assigns (the
“Holder”), is entitled to purchase from the Company up to a total of 763,552 shares of common stock, $.00001 par value per share (the
“Common Stock”), of the Company (each such share, a “Warrant Share” and all such shares, the “Warrant Shares”) at an exercise price
initially equal to $17.0257 per share (as adjusted from time to time as provided in Section 9, the “Exercise Price”), at any time on or after
date which is six months and one day after the date hereof (the “Earliest Exercise Date”) and through and including November [__], 2019
(the “Expiration Date”), subject to the following terms and conditions. This Warrant (this “Warrant”) is issued pursuant to that certain
Securities Purchase Agreement, dated as of the date hereof, by and among the Company and the Investor named therein (as amended from
time to time, the “Purchase Agreement ”) and that certain Strategic Alliance Agreement, dated as of the date hereof, by and among the
Company and Dialog Semiconductor (UK) Ltd. (the “Strategic Alliance Agreement”).

1 .           Definitions. In addition to the terms defined elsewhere in this Warrant, capitalized terms that are not otherwise defined

herein have the meanings given to such terms in the Purchase Agreement.

2.           Registration of Warrant. The Company shall register this Warrant, upon records to be maintained by the Company for that
purpose (the “Warrant Register”), in the name of the Holder of record hereof. The Company may deem and treat the registered Holder of
this  Warrant  as  the  absolute  owner  hereof  for  the  purpose  of  any  exercise  hereof  or  any  distribution  to  the  Holder,  and  for  all  other
purposes,  absent  actual  notice  to  the  contrary.  The  Warrant  Shares  shall  be  afforded  the  registration  rights  set  forth  in Article  VI  of  the
Purchase Agreement.

 
 
 
 
 
 
 
 
 
 
3.           Exercise and Duration of Warrant.

(a)                    This  Warrant  shall  be  exercisable  by  the  Holder  at  any  time  and  from  time  to  time  on  or  after  the  Earliest
Exercise Date to and including the Expiration Date. At 6:30 P.M., New York City time, on the Expiration Date, the portion of this Warrant
not exercised prior thereto shall be and become void and of no value.

(b)          The Holder may exercise this Warrant by delivering to the Company an exercise notice, in the form attached
hereto  (the  “Exercise  Notice”),  appropriately  completed  and  duly  signed,  and  the  date  such  items  are  delivered  to  the  Company  (as
determined  in  accordance  with  the  notice  provisions  hereof)  is  an  “Exercise Date.”  The  Holder  shall  be  required  to  deliver  the  original
Warrant in order to effect an exercise hereunder unless the Holder shall deliver an affidavit of loss or such other documentation reasonably
requested by the Company in lieu of such original Warrant in connection with any such exercise. Execution and delivery of the Exercise
Notice in respect of less than all the Warrant Shares issuable upon exercise of this Warrant shall have the same effect as cancellation of the
original  Warrant  and  issuance  of  a  new  warrant  to  purchase  Common  Stock,  in  substantially  the  form  of  this  Warrant  (any  such  new
warrant, a “New Warrant”), evidencing the right to purchase the remaining number of Warrant Shares.

(c)          This Warrant shall not be exercisable through the making of a cash payment of the Exercise Price, but instead
the  Holder  may  only  exercise  this  Warrant  by  converting  this  Warrant  into  shares  of  Common  Stock,  in  which  event  the  Company  will
issue to the Holder the number of shares of Common Stock equal to the amount resulting from the following equation:

X = (A - B) x C where:
A

X  =

the number of shares of Common Stock issuable upon exercise pursuant to this Section 3(d);

A  =

the Current Market Price Per Common Share (as defined in  Section 10) on the date on which the Holder delivers
an Exercise Notice to the Company pursuant to Section 3(b);

B  =

the Exercise Price; and

C  =

the number of shares of Common Stock as to which this Warrant is being exercised pursuant to Section 3(b).

If the foregoing calculation results in zero or a negative number, then no shares of Common Stock shall be issued upon exercise

pursuant to this Section 3(d).

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.           Delivery of Warrant Shares.

(a)          Upon exercise of this Warrant, the Company shall promptly issue or cause to be issued and cause to be delivered
to or upon the written order of the Holder and in such name or names as the Holder may designate, a certificate for the Warrant Shares
issuable upon such exercise (i) free of restrictive legends if (x) sold under a registration statement covering the resale of the Warrant Shares
and naming the Holder as a selling stockholder or (y) if such shares are freely transferable without volume restrictions pursuant to Rule 144
under  the  Securities Act,  or  (ii)  if  such  shares  are  not  freely  transferable  without  volume  restrictions  pursuant  to  Rule  144  under  the
Securities Act, such certificate will bear the legends set forth in Section 4.1(b) of the Purchase Agreement. The Holder, or any Person so
designated by the Holder to receive Warrant Shares, shall be deemed to have become the holder of record of such Warrant Shares as of the
Exercise Date. The Company shall, upon request of the Holder, use best efforts to deliver, or to cause its transfer agent to deliver, Warrant
Shares  hereunder  electronically  through  The  Depository  Trust  Company  or  another  established  clearing  corporation  performing  similar
functions.

(b)          This Warrant is exercisable, either in its entirety or, from time to time, for a portion of the number of Warrant
Shares.  Upon  surrender  of  this  Warrant  following  one  or  more  partial  exercises,  the  Company  shall  issue  or  cause  to  be  issued,  at  its
expense, a New Warrant evidencing the right to purchase the remaining number of Warrant Shares.

(c)          The Company’s obligations to issue and deliver Warrant Shares in accordance with the terms hereof are absolute
and  unconditional,  irrespective  of  any  action  or  inaction  by  the  Holder  to  enforce  the  same,  any  waiver  or  consent  with  respect  to  any
provision  hereof,  the  recovery  of  any  judgment  against  any  Person  or  any  action  to  enforce  the  same,  or  any  setoff,  counterclaim,
recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other Person of any obligation to the Company
or  any  violation  or  alleged  violation  of  law  by  the  Holder  or  any  other  Person,  and  irrespective  of  any  other  circumstance  which  might
otherwise limit such obligation of the Company to the Holder in connection with the issuance of Warrant Shares. Nothing herein shall limit
the  Holder’s  right  to  pursue  any  other  remedies  available  to  it  hereunder,  at  law  or  in  equity  including,  without  limitation,  a  decree  of
specific  performance  and/or  injunctive  relief  with  respect  to  the  Company’s  failure  to  timely  deliver  certificates  representing  shares  of
Common Stock upon exercise of this Warrant as required pursuant to the terms hereof.

5.           Exchange, Transfer or Assignment of Warrant.

(a)          Each taker and holder of this Warrant, by taking or holding the same, consents and agrees that the registered
holder hereof may be treated by the Company and all other Persons dealing with this Warrant as the absolute owner hereof for any purpose
and as the Person entitled to exercise the rights represented hereby.

(b)          Subject to compliance with applicable securities laws and the Purchase Agreement, the Holder shall be entitled,
without obtaining the consent of the Company, to assign and transfer this Warrant, at any time in whole or from time to time in part, to an
Affiliate  of  the  Holder,  provided  such Affiliate  agrees  in  writing  to  be  bound  by  the  terms  of  Section  4.1,  Section  4.8,  Section  4.9,  and
Section 4.10 of the Purchase Agreement. The Holder may not otherwise sell, assign or transfer this Warrant, in whole or part. Subject to the
preceding  sentence,  upon  surrender  of  this  Warrant  to  the  Company,  together  with  the  form  of  warrant  assignment  attached  hereto  (the
“Warrant Assignment ”)  duly  executed,  the  Company  shall,  as  promptly  as  practicable  and  without  charge,  execute  and  deliver  a  new
Warrant  in  the  name  of  the  assignee  or  assignees  named  in  such  Warrant Assignment  and,  if  the  Holder’s  entire  interest  is  not  being
assigned, in the name of the Holder and this Warrant shall promptly be canceled.

 
 
 
 
 
 
 
 
 
 
6 .           Charges, Taxes and Expenses. The Company shall pay any and all documentary, stamp, issue, transfer and other similar
taxes that may be payable upon the initial issuance of the Warrants hereunder. Issuance and delivery of certificates for shares of Common
Stock  upon  exercise  of  this  Warrant  shall  be  made  without  charge  to  the  Holder  for  any  documentary,  stamp,  issue,  transfer  and  other
similar tax, withholding tax, transfer agent fee or other  incidental  tax  or  expense  in  respect  of  the  issuance  of  such  certificates  upon  the
exercise of the Warrants hereunder, all of which taxes and expenses shall be paid by the Company; provided, however, that the Company
shall not be required to pay any tax which may be payable in respect of any transfer involved in the issuance, delivery or registration of any
certificates for Warrant Shares or Warrant in a name other than that of the Holder.

7 .           Replacement of Warrant. If this Warrant is mutilated, lost, stolen or destroyed, the Company, at no cost to Holder, shall
issue or cause to be issued in exchange and substitution for and upon cancellation hereof, or in lieu of and substitution for this Warrant, a
New Warrant, but only upon receipt of an affidavit of such loss, theft or destruction and customary indemnity, if requested.

8 .           Reservation of Warrant Shares. The Company covenants that it will at all times reserve and keep available out of the
aggregate of its authorized but unissued and otherwise unreserved Common Stock, solely for the purpose of enabling it to issue Warrant
Shares upon exercise of this Warrant as herein provided, the number of Warrant Shares which are then issuable and deliverable upon the
exercise of this entire Warrant, free from preemptive rights or any other contingent purchase rights of persons other than the Holder (after
giving  effect  to  the  adjustments  and  restrictions  of Section 9,  if  any).  The  Company  covenants  that  all  Warrant  Shares  so  issuable  and
deliverable shall, upon issuance and the payment of the applicable Exercise Price in accordance with the terms hereof, be duly and validly
authorized,  issued,  fully  paid  and  nonassessable  and  free  and  clear  of  all  liens,  security  interests,  charges  and  other  encumbrances  or
restrictions on sale, except to the extent created by the Holder. The Company will use reasonable commercial efforts to take all such action
to assure that such shares of Common Stock may be issued as provided herein without violation of any applicable law or regulation, or of
any requirements of any securities exchange or automated quotation system upon which the Common Stock may be listed, in each case,
applicable to the Company.

9.           Certain Adjustments. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant are subject

to adjustment from time to time as set forth in this Section 9.

( a )          Stock  Dividends,  Splits  and  Combinations.  If  the  Company,  at  any  time  while  this  Warrant  is  outstanding,
(i) pays a stock dividend on its Common Stock or otherwise makes a distribution on its Common Stock that is payable in shares of Common
Stock,  (ii)    subdivides  outstanding  shares  of  Common  Stock  into  a  larger  number  of  shares,  or  (iii)  combines  outstanding  shares  of
Common Stock into a smaller number of shares, then in each such case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock outstanding immediately before such event and of which the denominator shall
be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to clause (i) of this
paragraph shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend
or distribution, and any adjustment pursuant to clause (ii) or (iii) of this paragraph shall become effective immediately after the effective
date of such dividend, distribution, subdivision or combination.

 
 
 
 
 
 
 
 
( b )          Fundamental Transactions. If any capital reorganization, reclassification of the capital stock of the Company,
consolidation  or  merger  of  the  Company  with  another  corporation,  or  sale,  transfer  or  other  disposition  of  all  or  substantially  all  of  the
Company’s  assets  to  another  corporation  shall  be  effected  (all  such  transactions  being  hereinafter  referred  to  as  a  “ Fundamental
Transaction”), then the Company shall ensure that lawful and adequate provision shall be made whereby the Holder shall thereafter have
the  right  to  purchase  and  receive  upon  the  basis  and  upon  the  terms  and  conditions  herein  specified  and  in  lieu  of  the  Warrant  Shares
immediately theretofore issuable upon exercise of this Warrant, such shares of stock, securities or assets as would have been issuable or
payable  with  respect  to  or  in  exchange  for  a  number  of  Warrant  Shares  equal  to  the  number  of  Warrant  Shares  immediately  theretofore
issuable upon exercise of this Warrant, had such reorganization, reclassification, consolidation, merger, sale, transfer or other disposition
not taken place, and in any such case appropriate provision shall be made with respect to the rights and interests of the Holder to the end
that the provisions hereof (including, without limitation, provision for adjustment of the Exercise Price) shall thereafter be applicable, as
nearly equivalent as may be practicable in relation to any share of stock, securities or assets thereafter deliverable upon the exercise thereof.
The Company shall not effect any such consolidation, merger, sale, transfer or other disposition unless prior to or simultaneously with the
consummation  thereof  the  successor  corporation  (if  other  than  the  Company)  resulting  from  such  consolidation  or  merger,  or  the
corporation purchasing or otherwise acquiring such assets or other appropriate corporation or entity shall assume the obligation to deliver to
the  Holder,  at  the  last  address  of  the  Holder  appearing  on  the  books  of  the  Company,  such  shares  of  stock,  securities  or  assets  as,  in
accordance  with  the  foregoing  provisions,  the  Holder  may  be  entitled  to  purchase,  and  the  other  obligations  under  this  Warrant.  The
provisions of this Section 9(b) shall similarly apply to successive reorganizations, reclassifications, consolidations, mergers, sales, transfers
or other dispositions, each of which transactions shall also constitute a Fundamental Transaction.

(c)          Number of Warrant Shares. Simultaneously with any adjustment to the Exercise Price pursuant to this Section 9,
the number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased (as the case may be),
proportionately, so that after such adjustment the aggregate Exercise Price payable hereunder for the decreased or increased (as the case
may be) number of Warrant Shares shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment.

( d )          Calculations. All calculations under this Section 9 shall be made to the nearest cent or the nearest 1/100th of a
share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for
the account of the Company, and the disposition of any such shares shall be considered an issue or sale of Common Stock. No adjustment
in the Exercise Price or the number of Warrant Shares issuable upon exercise of the Warrant, as the case may be, shall be required if the
amount  of  such  adjustment  would  be  less  than  1/10th  of  a  cent  or  1/100th  of  a  share,  as  the  case  may  be; provided, however,  that  any
adjustments  which  by  reason  of  this Section 9(d)  are  not  required  to  be  made  shall  be  carried  forward  and  taken  into  account  in  any
subsequent adjustment.

 
 
 
 
 
 
( e )          Notice of Adjustments . Upon the occurrence of each adjustment pursuant to this Section 9, the Company at its
expense will promptly compute such adjustment in accordance with the terms of this Warrant and prepare a certificate setting forth such
adjustment, including a statement of the adjusted Exercise Price and adjusted number or type of Warrant Shares or other securities issuable
upon exercise of this Warrant (as applicable), describing the transactions giving rise to such adjustments and showing in detail the facts
upon which such adjustment is based. Upon any such occurrence and/or otherwise upon written request by or on behalf of the Holder, the
Company will promptly deliver a copy of each such certificate to the Holder and to the Transfer Agent.

(f)          Notice of Corporate Events. If the Company (i) declares a dividend or any other distribution of cash, securities or
other property in respect of its Common Stock, including without limitation any granting of rights or warrants to subscribe for or purchase
any  capital  stock  of  the  Company,  (ii)  enters  into  any  agreement  contemplating,  or  solicits  stockholder  approval  for,  any  Fundamental
Transaction  or  Change  of  Control  or  (iii)  authorizes  the  voluntary  dissolution,  liquidation  or  winding  up  of  the  affairs  of  the  Company,
then the Company shall deliver to the Holder a notice describing the material terms and conditions of such transaction, including the effect
on the Exercise Price and the number, kind or class of securities or other property issuable upon exercise of this Warrant, at least fifteen
calendar days prior to the applicable record or effective date on which a Person would need to hold Common Stock in order to participate in
or vote with respect to such transaction, and the Company will take all steps reasonably necessary to facilitate the exercise of the Warrant
pursuant  to Section 3(b)  (which  exercise  may  be  conditioned  upon  the  occurrence  of  such  event); provided, however,  that  the  failure  to
deliver such notice or any defect therein shall not affect the validity of the corporate action required to be described in such notice.

1 0 .          Fractional Shares. The Company shall not be required to issue or cause to be issued fractional Warrant Shares on the
exercise of this Warrant. If any fraction of a Warrant Share would, except for the provisions of this  Section 10, be issuable upon exercise of
this Warrant, then the number of Warrant Shares to be issued will be rounded down to the nearest whole share.

11.          Notices. Any and all notices or other communications or deliveries hereunder (including without limitation any Exercise
Notice)  shall  be  in  writing  and  shall  be  deemed  given  and  effective  on  the  earliest  of  (i)  the  date  of  transmission,  if  such  notice  or
communication is delivered via facsimile at the facsimile number specified in the Purchase Agreement prior to 6:30 p.m. (New York City
time) on a Trading Day, (ii) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile
at the facsimile number specified in the Purchase Agreement on a day that is not a Trading Day or later than 6:30 p.m. (New York City
time)  on  any  Trading  Day,  (iii)  the  Trading  Day  following  the  date  of  delivery  to  the  courier  service,  if  sent  by  nationally  recognized
overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. The address for such notices
or communications shall be as set forth in the Purchase Agreement.

 
 
 
 
 
 
 
1 2 .          Warrant Agent .  The  Company  shall  serve  as  warrant  agent  under  this  Warrant.  Upon  thirty  (30)  days’  notice  to  the
Holder,  the  Company  may  appoint  a  new  warrant  agent. Any  corporation  into  which  the  Company  or  any  new  warrant  agent  may  be
merged  or  any  corporation  resulting  from  any  consolidation  to  which  the  Company  or  any  new  warrant  agent  shall  be  a  party  or  any
corporation to which the Company or any new warrant agent transfers substantially all of its corporate trust or stockholder services business
shall  be  a  successor  warrant  agent  under  this  Warrant  without  any  further  act. Any  such  successor  warrant  agent  shall  promptly  cause
notice of its succession as warrant agent to be mailed (by first class mail, postage prepaid) to the Holder at the Holder’s last address as
shown on the Warrant Register.

13.          Miscellaneous.

(a)                    The  Company  shall  not,  by  amendment  of  its  Certificate  of  Incorporation  or  Bylaws,  or  through  any
reorganization,  transfer  of  assets,  consolidation,  merger,  scheme  of  arrangement,  dissolution,  issue  or  sale  of  securities  or  any  other
voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good
faith carry out all the provisions of this Warrant. Without limiting the generality of the foregoing, the Company (i) will not increase the par
value of any Warrant Shares above the amount payable therefor on such exercise and (ii) will not, and will not permit its transfer agent to,
close its stockholder books or records in any manner which interferes with the timely exercise of this Warrant.

( b )          GOVERNING LAW; VENUE; SERVICE OF PROCESS; WAIVER OF JURY TRIAL . ALL  QUESTIONS

CONCERNING  THE  CONSTRUCTION,  VALIDITY,  ENFORCEMENT AND  INTERPRETATION  OF  THIS AGREEMENT  SHALL
BE  GOVERNED  BY AND  CONSTRUED  IN ACCORDANCE  WITH  THE  LAWS  OF  THE  STATE  OF  NEW  YORK,  WITHOUT
GIVING EFFECT TO THAT BODY OF LAWS PERTAINING TO CONFLICT OF LAWS. EACH PARTY HEREBY IRREVOCABLY
SUBMITS TO THE NON-EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE CITY OF NEW
YORK,  BOROUGH  OF  MANHATTAN,  FOR  THE  ADJUDICATION  OF  ANY  DISPUTE  HEREUNDER  OR  IN  CONNECTION
HEREWITH  OR  WITH  ANY  TRANSACTION  CONTEMPLATED  HEREBY  OR  DISCUSSED  HEREIN  (INCLUDING  WITH
RESPECT  TO  THE  ENFORCEMENT  OF  ANY  OF  THE  TRANSACTION  DOCUMENTS),  AND  HEREBY  IRREVOCABLY
WAIVES,  AND  AGREES  NOT  TO  ASSERT  IN  ANY  SUIT,  ACTION  OR  PROCEEDING,  ANY  CLAIM  THAT  IT  IS  NOT
PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT AND THAT SUCH SUIT, ACTION OR PROCEEDING
IS  IMPROPER.  EACH  PARTY  HEREBY  IRREVOCABLY  WAIVES  PERSONAL  SERVICE  OF  PROCESS AND  CONSENTS  TO
PROCESS  BEING  SERVED  IN  ANY  SUCH  SUIT,  ACTION  OR  PROCEEDING  BY  MAILING  A  COPY  THEREOF  VIA
REGISTERED  OR  CERTIFIED  MAIL  OR  OVERNIGHT  DELIVERY  (WITH  EVIDENCE  OF  DELIVERY)  TO  SUCH  PARTY AT
THE ADDRESS  IN  EFFECT  FOR  NOTICES  TO  IT  UNDER  THIS AGREEMENT AND AGREES  THAT  SUCH  SERVICE  SHALL
CONSTITUTE  GOOD AND  SUFFICIENT  SERVICE  OF  PROCESS AND  NOTICE  THEREOF.  NOTHING  CONTAINED  HEREIN
SHALL  BE  DEEMED  TO  LIMIT  IN ANY  WAY ANY  RIGHT  TO  SERVE  PROCESS  IN ANY  MANNER  PERMITTED  BY  LAW.
EACH OF THE COMPANY AND THE HOLDER HEREBY WAIVES ALL RIGHTS TO A TRIAL BY JURY.

 
 
 
 
 
 
 
limit or affect any of the provisions hereof.

(c)          The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to

(d)          In case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the
validity and enforceability of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby and
the parties will attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonable substitute
therefor, and upon so agreeing, shall incorporate such substitute provision in this Warrant.

(e)          No course of dealing or any delay or failure to exercise any right hereunder on the part of the Holder shall
operate  as  a  waiver  of  such  right  or  otherwise  prejudice  the  Holder’s  rights,  powers  or  remedies,  notwithstanding  all  rights  hereunder
terminate on the Expiration Date.

(f)          No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant or purchase
Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the
purchase  price  of  any  Common  Stock  or  as  a  stockholder  of  the  Company,  whether  such  liability  is  asserted  by  the  Company  or  by
creditors of the Company.

(g)          The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages,
will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive the defense in
any action for specific performance that a remedy at law would be adequate.

the written consent of the Company and the Holder.

(h)          Any term of this Warrant may be amended and the observance of any term of this Warrant may be waived with

[SIGNATURE PAGE FOLLOWS]

 
 
 
 
 
 
 
 
 
 
IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by its authorized officer as of the date first

indicated above.

ENERGOUS CORPORATION

By:
Name:
Title:

 
 
 
 
 
 
 
 
 
 
 
 
 
 
(To be executed by the Holder to exercise the right to purchase shares of Common Stock under the foregoing Warrant)

FORM OF EXERCISE NOTICE

To: Energous Corporation

The  undersigned  is  the  Holder  of  Warrant  No.  _______  (the  “ Warrant”)  issued  by  Energous  Corporation,  a  Delaware  corporation  (the
“Company”). Capitalized terms used herein and not otherwise defined herein have the respective meanings set forth in the Warrant.

1.

2.

3.

The Warrant is currently exercisable to purchase a total of ______________ Warrant Shares.

The undersigned Holder hereby exercises its right to purchase _________________ Warrant Shares pursuant to the Warrant.

Following this exercise, the Warrant shall be exercisable to purchase a total of ______________ Warrant Shares.

Dated:  ____________________, ______

Name of Holder:

(Print)

By:
Name:
Title:

(Signature must conform in all respects to name of holder as
specified on the face of the Warrant)

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FORM OF WARRANT ASSIGNMENT

Dated ________________, _____

FOR VALUE RECEIVED, _______________________ hereby sells, assigns and

transfers unto _____________________________ (the “Assignee”),

(please type or print in block letters)

its right to purchase up to ______________ shares of Common Stock represented by this Warrant and does hereby irrevocably constitute
and appoint _______________________ Attorney, to transfer the same on the books of the Company, with full power of substitution in the
premises.

(insert address)

Signature:

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EXHIBIT C
FORM OF SECRETARY’S CERTIFICATE - COMPANY

 
 
 
 
Energous Corporation
Secretary’s Certificate

I, Brian Sereda, certify that I am the Secretary of Energous Corporation, a Delaware corporation (the “Company”), and that, as
such,  I  am  authorized  to  execute  this  certificate  on  behalf  of  the  Company  and  in  connection  with  that  certain  Securities  Purchase
Agreement, dated as of November 6, 2016 (the “Purchase Agreement”), by and among the Company and the Investor named therein (the
“Investor”), and do hereby further certify that:

1.   Attached hereto as Exhibit A is a true and complete copy of the Second Amended and Restated Certificate of Incorporation of the
Company filed with the Secretary of State of the State of Delaware (the “Certificate of Incorporation”), as amended by that Certificate of
Amendment dated March 26, 2016; no other amendments to the Certificate of Incorporation have been adopted, the Company has not filed
any amendments to the Certificate of Incorporation with the Secretary of State of the State of Delaware, and no action has been taken by
the  Company,  its  shareholders,  directors  or  officers  in  contemplation  of  the  filing  of  any  such  amendment  or  other  document;  the
Certificate of Incorporation remains in full force and effect on the date hereof;

2.   Attached hereto as Exhibit B is a certificate of good standing certified by the Secretary of State of the State of Delaware;

3.   Attached hereto as Exhibit C is a certificate of foreign qualification certified by the Secretary of State of the State of California;

4.   Attached hereto as Exhibit D is a true and complete copy of the By-laws of the Company; such By-laws have not been amended

and are in full force and effect as of the date hereof;

5.   Attached hereto as Exhibit E are true and complete copies of the resolutions adopted by the Board of Directors of the Company,
either  at  a  meeting  or  meetings  properly  held  or  by  the  unanimous  written  consent  of  the  Board  of  Directors,  relating  to  the  issuance,
offering and sale of the shares of the Company’s common stock (the “Common Stock”) and the warrants to purchase shares of Common
Stock (the “Warrants”) pursuant to the Purchase Agreement; all of such resolutions were duly adopted, have not been amended, modified
or  rescinded  and  remain  in  full  force  and  effect;  and  such  resolutions  are  the  only  resolutions  adopted  by  the  Board  of  Directors  with
respect to the issuance, offering and sale of the Common Stock and Warrants pursuant to the Purchase Agreement;

6.   Attached hereto as Exhibit F is a true and complete copy of an incumbency certificate of the Company’s officers.

[Signature page follows]

 
 
 
 
 
 
 
 
 
 
 
 
In witness whereof, I have hereunto signed my name this _____ day of November, 2016.

By:
Brian Sereda, Secretary

 
 
 
 
 
 
 
 
 
Exhibit A
Certificate of Incorporation

 
 
 
 
Exhibit B
Delaware Good Standing

 
 
 
 
Exhibit C
Foreign Qualification

 
 
 
 
Exhibit D
By-laws

 
 
 
 
Exhibit E
Board of Director Resolutions

 
 
 
 
Exhibit F
Incumbency Certificate

The undersigned individuals of Energous Corporation, a Delaware corporation (the “Corporation”), are designated as appropriate parties
with  the  power  and  authority  to  enter  into  contracts,  agreements  and  to  provide  written  directions  pertaining  to  services  associated  with
stock transfer and registrar needs:

Name

Title

Signature

Stephen R. Rizzone

  President and Chief Executive Officer

Brian Sereda

  Chief Financial Officer and Secretary

IN WITNESS WHEREOF I have hereunto set my hand and the Corporate Seal of the Corporation this __ day of November, 2016.

Name: Brian Sereda
Title:  Secretary

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
Subsidiaries of Energous Corporation

None.

EXHIBIT 21.1

 
 
 
 
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements of Energous Corporation on Form S-3 (No. 333-203622) and
Forms S-8 (No. 333-196360, 333-203152, 333-204690, 333-210239 and 333-214785) of our report dated March 16, 2017, with respect to
our audits of the financial statements of Energous Corporation as of December 31, 2016 and 2015 and for the years ended December 31,
2016, 2015 and 2014, which report is included in this Annual Report on Form 10-K of Energous Corporation for the year ended December
31, 2016.

EXHIBIT 23.1

/s/ Marcum LLP
Marcum LLP
Melville, New York
March 16, 2017

 
 
 
  
 
 
 
 
 
 
EXHIBIT 31.1

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Stephen R. Rizzone, certify that:

1.

2.

3.

4.

I have reviewed this Annual Report on Form 10-K of Energous Corporation;

Based  on  my  knowledge,  this  report  does  not  contain  any  untrue  statement  of  a  material  fact  or  omit  to  state  a  material  fact
necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with
respect to the period covered by this report;

Based  on  my  knowledge,  the  financial  statements,  and  other  financial  information  included  in  this  report,  fairly  present  in  all
material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in
this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under  our  supervision,  to  provide  reasonable  assurance  regarding  the  reliability  of  financial  reporting  and  the  preparation  of
financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on
such evaluation; and

d) Disclosed  in  this  report  any  change  in  the  registrant's  internal  control  over  financial  reporting  that  occurred  during  the
registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.

The  registrant's  other  certifying  officer(s)  and  I  have  disclosed,  based  on  our  most  recent  evaluation  of  internal  control  over
financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing
the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information;
and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's

internal control over financial reporting.

Date: March 16, 2017

/s/ Stephen R. Rizzone
Name:  Stephen R. Rizzone
Title:    President, Chief Executive Officer and Director

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EXHIBIT 31.2

CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Brian Sereda, certify that:

1.

2.

3.

4.

I have reviewed this Annual Report on Form 10-K of Energous Corporation;

Based  on  my  knowledge,  this  report  does  not  contain  any  untrue  statement  of  a  material  fact  or  omit  to  state  a  material  fact
necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with
respect to the period covered by this report;

Based  on  my  knowledge,  the  financial  statements,  and  other  financial  information  included  in  this  report,  fairly  present  in  all
material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in
this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under  our  supervision,  to  provide  reasonable  assurance  regarding  the  reliability  of  financial  reporting  and  the  preparation  of
financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on
such evaluation; and

d) Disclosed  in  this  report  any  change  in  the  registrant's  internal  control  over  financial  reporting  that  occurred  during  the
registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.

The  registrant's  other  certifying  officer(s)  and  I  have  disclosed,  based  on  our  most  recent  evaluation  of  internal  control  over
financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing
the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information;
and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's

internal control over financial reporting.

Date: March 16, 2017

/s/ Brian Sereda
Name:  Brian Sereda
Title: Vice President and Chief Financial Officer

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

EXHIBIT 32.1

In connection with the Annual Report of Energous Corporation (the “Company”) on Form 10-K for the year ended December 31, 2016 as
filed  with  the  Securities  and  Exchange  Commission  on  the  date  hereof  (the  “Report”),  we,  Stephen  R.  Rizzone,  President  and  Chief
Executive Officer of the Company, and Brian Sereda, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as
adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

(2)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The  information  contained  in  the  Report  fairly  presents,  in  all  material  respects,  the  financial  condition  and  results  of
operations of the Company.

A  signed  original  of  this  written  statement  required  by  Section  906  has  been  provided  to  Energous  Corporation  and  will  be  retained  by
Energous Corporation and furnished to the Securities and Exchange Commission or its staff upon request.

/s/ Stephen R. Rizzone
Name: Stephen R. Rizzone
Title:
Date: March 16, 2017

President, Chief Executive Officer and Director

/s/ Brian Sereda
Name: Brian Sereda
Title: Vice President and Chief Financial Officer
Date: March 16, 2017